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Background
Pressure ulcers are associated with ill health and poor mobility and are a
considerable healthcare problem worldwide. Risk assessment is considered the
cornerstone to pressure ulcer prevention.
Aim
To develop a Risk Assessment Framework for use with adult populations in clinical
practice, underpinned by a risk factor Minimum Data Set.
Methods
The methodological approach comprised 4 phases:
1) Systematic review of pressure ulcer risk factors.
2) Consensus study involving 17 international experts with service user
involvement.
3) Conceptual framework and theoretical causal pathway development.
4) Design and pre-testing of the draft Risk Assessment Framework using cognitive
pre-testing methods, incorporating 3 sessions and 34 nurses.
Results
1) The review of 54 studies identified 3 primary risk factor domains, mobility/activity,
skin/pressure ulcer status and perfusion (including diabetes), but suggests no
single factor can explain pressure ulcer development.
2) The consensus study facilitated the agreement of risk factors and assessment
items of the Minimum Data Set (including immobility, pressure ulcer and skin status,
perfusion, diabetes, skin moisture, sensory perception and nutrition), allowing the
development of a draft Risk Assessment Framework.
3) The new conceptual framework incorporates key physiological and
biomechanical components and their impact on internal strains, stresses and
damage thresholds. Direct and key indirect causal factors suggested in the
theoretical causal pathway are mapped to the physiological and biomechanical
components of the framework.
(4) The design and pre-testing of the Risk Assessment Framework confirmed
content validity and led to improved usability over the course of the pre-test. The
preliminary Risk Assessment Framework incorporates the Minimum Data Set, a 2
stage assessment process (screening and full assessment), support for decision
making and primary prevention and secondary prevention/treatment pathways.
xi
Conclusion
The resulting Risk Assessment Framework makes an important contribution to the
pressure ulcer field and now requires further clinical validation and evaluation.
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1Chapter 1 Background
1.1 Introduction
This chapter provides an overview of the PhD Thesis and the origins of its
development within the context of a National Institute of Health Research (NIHR)
funded Pressure UlceR Programme Of ReSearch (PURPOSE). It goes on to
provide a general overview of pressure ulcers, explaining what they are, their
classification (in terms of severity), the extent of the pressure ulcer problem, their
effect on patients’ quality of life as well as their financial impact. Pressure ulcer
conceptual frameworks and aetiology are then considered and risk factors are
introduced. Finally commonly encountered preventative interventions for adult
populations (skin assessment, repositioning, support surfaces, nutrition) are
discussed.
1.2 Thesis Overview
This PhD Thesis provides a detailed account of research undertaken to develop a
decision tool, the Pressure Ulcer Risk Assessment Framework (with underpinning
Minimum Data Set), to be used for the prevention and management of generic
mobility related pressure ulcers, for adult populations, in clinical practice. It explores
the need for the new Risk Assessment Framework and its required properties to
support clinical decision making in the assessment of pressure ulcer risk and and
subsequent care planning/delivery. The Thesis critically examines the adopted
research pathway which incorporates 4 distinct phases:
1) Systematic review of pressure ulcer risk factors.
2) Consensus study involving 17 international experts with service user
involvement.
3) Conceptual framework and theoretical causal pathway development.
4) Design and pre-testing of the draft Risk Assessment Framework using
cognitive pre-testing methods
Work undertaken for this PhD Thesis links to a wider programme of research
described below.
21.3 Origins of the PhD
The origins of this PhD are nestled in the NIHR PURPOSE Programme of
Research which comprised two research themes:
 Theme 1: To reduce the impact of pressure ulcers on patients through early
identification of patients at risk of developing pressure ulceration.
 Theme 2: To reduce the impact of pressure ulcers on patients through the
development of methods to capture patient-reported HRQL and health
utilities for routine clinical use and future research.
Theme 1 was particularly pertinent to this PhD as it focussed on improving our
understanding of individuals’ and organisational risk factors and on improving the
quality of risk assessments. Theme 1 comprised three work packages:
 The pain package aimed to determine the extent of pressure area and
pressure ulcer pain and explore the role of pain as a predictor of Category
≥2 pressure ulcers in acute hospital and community populations and 
incorporated a pain prevalence study and a pain cohort study.
 The severe pressure ulcer package aimed to describe and explain the ways
in which the organisation of treatment/care influences the development of
severe pressure ulcers and identify ways to improve cause analyses.
 The Risk Assessment Framework package aimed to agree a pressure ulcer
risk factor Minimum Data Set to underpin the development and validation of
an evidence-based Risk Assessment Framework to guide decision making
about the risk of developing and progression of pressure ulceration.
The Risk Assessment Work package of the NIHR PURPOSE Programme was led
by the researcher (SC) and the first 4 phases of this work underpin this PhD Thesis.
1.4 Pressure Ulcer Definition
Pressure ulcers are defined as ‘localised injury to the skin and/or underlying tissue
usually over a bony prominence, as a result of pressure, or pressure in combination
with shear’ (NPUAP/EPUAP 2009). Classification systems have been developed
which incorporate numerical categories, sometimes referred to as grades or stages
(terms which are used interchangeably or as reported in primary studies throughout
this thesis) to describe the severity of the ulcer and the tissue layers involved (Shea
1975; Torrance 1983; AHCPR 1992; EPUAP 1999; NPUAP/EPUAP 2009). The
most widely used pressure ulcer classification system was developed by the
NPUAP and EPUAP (2009) and incorporates 4 numerical categories and 2
3additional categories described in Table 1.1. Category/grade 1 pressure ulcers are
areas of skin redness which do not blanch under light pressure and, whilst included
in pressure ulcer classification, are more usually regarded as a precursor to
pressure ulcer development (Nixon and McGough 2001). Previous classification
systems have considered blanching redness as stage I (Torrance 1983) but this is
considered to be a transient state (Nixon, Cranny and Bond 2007). Category/grade
2 pressure ulcers, involve skin damage and are reportable as clinical incidents
across the NHS. Category/grade 3 or 4 pressure ulcers involve loss of fat, muscle
and bone and represent serious clinical events and are increasingly subject to
complaints and medical malpractice investigations. Indeed, changes in legislation
and guidance relating to mental capacity and safeguarding (Department of Health
(DH) 2000; The Mental Capacity Act 2005; Department for Education and Skills
2006; DH 2010) has prompted pressure ulcers to be investigated as part of the
safeguarding vulnerable adult’s agenda.
Additional categories of unstageable (full thickness tissue loss in which actual depth
of the ulcer is completely obscured by slough and/or eschar) and suspected deep
tissue injury are also incorporated in the classification system for implementation in
the US (NPUAP/EPUAP 2009). The suspected deep tissue injury category relates
to an alternative pathway for pressure ulcer development first identified in an early
pathological study whereby necrosis of muscle and fat occurs before destruction of
the superficial layers and the appearance of a deep ulcer (as opposed to the ulcer
presenting as superficial loss of the epidermis that progresses to deeper tissues if
the pressure remains unrelieved) (Barton and Barton 1981).
4Table 1.1 NPUAP/EPUAP Pressure Ulcer Classification System (2009)
Category/Grade Description
Cat/grade I
Non-blanchable
erythema
Intact skin with non-blanchable redness of a localised area usually over
a bony prominence. Darkly pigmented skin may not have visible
blanching; its color may differ from the surrounding area.
The area may be painful, firm, soft, warmer or cooler as compared to
adjacent tissue. Category/stage I may be difficult to detect in individuals
with dark skin tones. May indicate ‘at risk’ persons (a heralding sign of
risk)
Cat/grade II
Partial thickness
skin loss
Partial thickness loss of dermis presenting as a shallow open ulcer with
a red pink wound bed, without slough. May also present as an intact or
open/ruptured serum-filled filled blister.
Presents as a shiny or dry shallow ulcer without slough or bruising*.
This category/stage should not be used to describe skin tears, tape
burns, perineal dermatitis, maceration or excoriation.
* Bruising indicates suspected deep tissue injury
Cat/grade III
Full thickness
skin loss
Full thickness tissue loss. Subcutaneous fat may be visible but bone,
tendon or muscle are not exposed. Slough may be present but does not
obscure the depth of tissue loss. May include undermining and
tunneling.
The depth of a category/stage III pressure ulcer varies by anatomical
location. The bridge of the nose, ear occiput and malleolus do not have
subcutaneous tissue and category/stage III ulcers can be shallow. In
contrast, areas of significant adiposity can develop extremely deep
category/stage III pressure ulcers. Bone/tendon is not visible ore directly
palpable.
Cat/grade IV
Full thickness
tissue loss
Full thickness tissue loss with exposed bone, tendon or muscle. Slough
or eschar may be present on some parts of the wound bed. Often
include undermining and tunneling.
The depth of a category/stage IV pressure ulcer varies by anatomical
location. The bridge of the nose, ear occiput and malleolus do not have
subcutaneous tissue and these ulcers can be shallow. Category/stage
IV ulcers can extend into muscle and/or supporting structures (e.g.
fascia, tendon, or joint capsule) making osteomyelitis possible. Exposed
bone/tendon is visible or directly palpable.
Cat/grade U
(Unstageable/
Unclassified)
Full thickness
skin or tissue
loss – depth
unknown
Full thickness tissue loss in which the base of the ulcer is covered by
slough (yellow, tan, grey, green, or brown) and/or eschar (tan, brown, or
black) in the wound bed.
Until enough slough and/or eschar is removed to expose the base of the
wound, the true depth, and therefore category/stage, cannot be
determined. Stable (dry adherent, intact without erythema or fluctuance)
eschar on heels serves as ‘the body’s natural (biological) cover’ and
should not be removed
Suspected
Deep Tissue
Injury (DTI) –
Depth
Unknown
Purple or maroon localized area of discolored intact skin or blood-filled
blister due to damage of underlying soft tissue from pressure and/or
shear. The area may be preceded by tissue that is painful, firm, mushy,
boggy, warmer or cooler as compared to adjacent tissue.
Deep tissue injury may be difficult to detect in individuals with dark skin
tones. Evolution may include a thin blister over a dark wound bed. The
wound may further evolve and become covered by thin eschar.
Evolution may be rapid exposing additional layers of tissue even with
optimal treatment.
51.5 The Extent of the Problem
In the literature the extent of the pressure ulcer problem is explained most
commonly via prevalence and incidence rates. Prevalence is defined as ‘a cross-
sectional count of the number of cases at a specific point in time’ (Kaltenthaler et al.
2001) and includes old and new pressure ulcers. It provides an indication of the
extent of chronic disease particularly relating to severe pressure ulcers and the
burden these pose to services (Bridel 1993). Incidence relates to new cases of
disease occurring in a population that were initially disease free (Fletcher, Fletcher
and Fletcher 2005). Cumulative incidence refers to the proportion of the population
studied that develops a new pressure ulcer over a specified time period
(Baharestani et al. 2009). Incidence is a useful measure of an acute and quickly
recoverable event such as a superficial pressure ulcer (Bridel 1993). Care should
be taken when interpreting prevalence and incidence studies due to confusion over
definitions of the terms incidence and prevalence, difficulties associated with
conducting the studies (i.e. collecting and recording data, defining the study
populations, identifying and classifying pressure ulcers), and lack of awareness of
the pitfalls of comparing prevalence and incidence studies (Baharestani et al.
2009).
Pressure ulcers are a significant healthcare problem worldwide. A review of
pressure ulcer prevalence and incidence data for the UK, US and Canada,
incorporating sixty primary studies, reported great variation in both prevalence and
incidence (Table 1.2) data (Kaltenthaler et al. 2001). This was attributed to the
substitution of incidence for prevalence in analysis, use of different classification
systems, under-reporting of pressure ulcers on transfer from different care
facilitates and when pressure ulcers were used as a quality marker, inappropriate
comparison of prevalence data by not taking case-mix into account and use of
different study designs and methods of data collection (Kaltenthaler et al. 2001). It
should be acknowledged that the variability of methods used meant that the results
were not always comparable (Kaltenthaler et al. 2001).
6Table 1.2 Pressure ulcer Prevalence and Incidence Ranges reported in
Kaltenhaler et al 2001
UK USA and Canada
Hospital Prevalence 5.1 to 32.1% 4.7% to 29.7%
Community Prevalence 4.4 to 6.8% 19.2% to 29%
Nursing Home Prevalence 4.6 to 7.5% 15.3% to 20.7%
Hospital Incidence 2.2% per annum to 29%
over a maximum period of
6 weeks
8.5% over a one to four
week period to 13.4% for
a maximum of two weeks
Community Incidence 20% over a maximum
period of 6 weeks
0% over a six month
period to 16.5% (time
period not stated)
Nursing Home Incidence None reported 6.2% over 6 months to
13.2% over one year
Another review of pressure ulcer incidence and prevalence was undertaken and
included studies that were conducted over an 11 year period, from January 2000-
November 2011 (Pieper 2012). The review included 43 studies (18 conducted in US
hospitals and 24 in international hospitals) and reported varying pressure ulcer
rates in different clinical settings. For general acute settings prevalence ranged
from 11.9 to 15.8% and incidence ranged from 2.8-9.0%, confirming that pressure
ulcers remain an important healthcare problem.
More locally a prevalence study conducted in 9 UK acute hospitals including 3,397
patients found 502 (14.8%) patients to have 1066 pressure ulcers (mean 2.1 per
patient, SD 1.63, range 1-13) (Briggs et al. 2013). The majority of the ulcers were
Grade 1 (70.5%; 752/1066), with grade 2 (22.2%; 237/1066) and severe pressure
ulcers (7.2%; 77/1066) being reported less frequently (Briggs et al. 2013). Pressure
ulcers most frequently occur on the sacrum followed by the heels, with other sites
including the buttocks, trochanter, hips, elbows and ankles (Dealey 1991;
Schoonhoven, Bousema and Buskens 2007; Vowden and Vowden 2009).
1.6 Quality of Life
Several qualitative studies have highlighted the negative impact pressure ulcers
have on patients’ quality of life. Key emerging themes include pain, exudate levels,
loss of independence, emotional factors, worry about healing, relationships, body
image and social isolation (Fox 2002) and pain, restricted life and coping with
7pressure ulcers (Hopkins et al. 2006). Furthermore, a systematic review of quality of
life incorporating 31 primary studies of both qualitative and quantitative research
designs found that pressure ulcers and related interventions had a detrimental
effect on the patients’ quality of life (Gorecki et al. 2009). The review which involved
a meta-synthesis of studies involving direct patient reports highlighted that concerns
related to severe pain, treatments increasing discomfort and pain, health care
professionals ignoring patient views and concerns, lack of action to warning signs
(e.g. pain) and physical, social and psychological aspects of care not being met.
Pressure ulcers are also associated with longer hospitalisation (Dealey, Posnett
and Walker 2012).
1.7 Financial Burden
It is estimated that pressure ulcer management accounts for 4% of the total UK
NHS expenditure (Bennett, Dealey and Posnett 2004) and recent work indicates the
mean cost of treating a pressure ulcer in the UK varies from £1,214 (category I) to
£14,108 (category IV) (Dealey, Posnett and Walker 2012). In the Netherlands
Severens et al estimated the cost to amount to 1% of the total healthcare budget
(Severens et al. 2002), with more recent estimates suggesting this is between 1.21
-1.41% for hospitals alone (Schuurman et al. 2009). Annual pressure ulcer
preventative costs in Dutch hospitals are estimated to be €27.5 - 63.6 million, while
treatment costs are estimated to be considerably more, amounting to €174.5-178.8
million (Schuurman et al. 2009). In the US the Agency for Healthcare Research and
Quality (AHRQ) reported that pressure ulcer costs were $9.1-11.6 billion annually,
and approximately 60,000 patient deaths per year were directly related to pressure
ulcers (Berlowitz et al. 2011).
1.8 Pressure Ulcer Conceptual Frameworks
A pressure ulcer conceptual framework provides a theoretical model of the critical
determinants of pressure ulcer development. This is important for both research
and clinical practice. From a research perspective, pressure ulcer studies should be
underpinned by a conceptual framework that is informed by evidence from all
relevant fields of enquiry. This will guide study aims and objectives and allow theory
to be tested, to further develop the evidence base and conceptual framework. From
a clinical perspective conceptual frameworks are used to underpin pressure ulcer
prevention strategies. It is therefore critically important that they are updated as
new evidence emerges to facilitate translation of evidence into practice. Several
8pressure ulcer conceptual frameworks have been proposed over the last three
decades (Braden and Bergstrom 1987; Defloor 1999; NPUAP/EPUAP 2009; Benoit
and Mion 2012).
Braden and Bergstrom, in their conceptual model implicated intensity and duration
of pressure and tissue tolerance. The latter related to the ability of the skin and its
underlying structures to tolerate pressure without damage (Braden and Bergstrom
1987). It was proposed that tissue tolerance would be influenced by extrinsic and
intrinsic factors incorporating pressure ulcer risk factors. Defloor (1999) developed
his conceptual scheme highlighting the importance of pressure (in the form of
compressive and shearing forces), while recognising that tissue tolerance is an
important consideration (Defloor 1999). However, he viewed the latter as an
‘intermediate variable and not a causal factor’. Benoit and Mion (2012) developed
their conceptual model for critically ill patients and also incorporate pressure and
tissue tolerance with the latter highlighting extrinsic factors (Braden moisture and
friction and shear) and intrinsic factors (metabolic supply and demand, pressure
distribution capacity and threats to skin integrity).
Another conceptual framework was proposed by NPUAP/EPUAP (2009) and
underpins international guidance on the prevention and treatment of pressure
ulcers. It is based on factors that influence mechanical boundary conditions and the
susceptibility of the individual (Figure 1.1). The framework provides a theoretical
model of the important biomechanical and physiological conditions (of both the local
area and systemically) which influence the development of pressure ulcers. A
summary of the aetiological factors that lead to pressure ulcer development and a
glossary of terms is presented in Table 1.3.
9Figure 1.1 NPUAP/EPUAP (2009) Factors that Influence Susceptibility
Used with permission from the National Pressure Ulcer Advisory Panel, 8th May 2014
Risk
Factors
Mechanical Boundary conditions
Magnitude of mechanical load
Time duration of the mechanical load
Type of loading (shear, pressure, friction)
Mechanical properties of the tissue
Geometry (morphology) of the tissue and
bones
Internal strains
Stresses
Transport
Pressure
Ulcer?
Damage
ThresholdSusceptibility of the individual
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Table 1.3 Glossary of Biomechanical Terms based on NPUAP/EPUAP
(2009) Clinical Practice Guidelines and Oomens, Loerakker and Bader
(2010 (Oomens, Loerakker and Bader 2010).
External Mechanical Load: comprises of all modes of external loading applied to a
person’s skin as a result of contact between the skin and a support surface
(including air-filled or water filled devices which provide support) or contact between
the skin of two body surfaces. The loading can be resolved into:
Normal force: perpendicular to the skin surface; or
Shear force: parallel to the skin surface
Pressure: normal force per unit surface area
In a clinical situation, shear forces require actual contact between the skin and the
support surface, associated with normal forces, so that the skin will be exposed to a
combination of both normal and shear forces.
Normal forces are distributed over the contact area which necessitates use of the
term pressure, namely normal force divided by the contact area. Shear forces are
also distributed over the contact area and create external shear stresses.
Friction: technically this describes all phenomena that relate to interface properties
and sliding of surfaces with respect to each other (e.g. a person's skin over clothing
or bed sheets). In pressure ulcer literature the term ‘friction’ has often been defined
as the contact force parallel to the skin surface in case of ‘sliding’ (i.e. sliding of
surfaces along each other).
Mechanical Boundary Condition: the mechanical load that is applied to the skin
at the interface with the supporting surface represents a boundary condition.
Non-uniform Force: localised to a specific area of the skin surface for which the
magnitude of force may be variable.
Deformation: change of dimension (shape) as a result of applied loading.
Strain: a measure of the relative deformation.
Stress: force transferred per unit area. Pressure represents a special type of stress
where the forces are all normal to the area over which they act.
Morphology: size and shape of the different tissue layers.
Mechanical Properties of the Tissue: refers to the stiffness and strength of the
tissue material.
Transport Properties: refers to the rate of transport of biomolecules into/out of
tissues which may be either passive or active in nature. Active transport, which is
sometimes called convection, involves metabolite transport by flow in blood and/or
lymph vessels.
Reprinted from Journal of Advanced Nursing, Coleman, S., Nixon, J., Keen, J., Wilson, L., McGinnis, E., Dealey,
C., Stubbs, N., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D., Jude, E., Vowden, P.,
Schoonhoven, L., Bader, D.L., Gefen, A., C.W.J., O. & Nelson, E.A. A New Pressure Ulcer Conceptual Framework
2014 online, DOI:10.1111/jan.12405
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1.9 Pressure Ulcer Aetiology
The primary cause of pressure ulcers is mechanical load in the form of pressure or
pressure and shear, applied to soft tissues, generally over a bony prominence
(NPUAP/EPUAP 2009). Load that is distributed in a non-uniform or localised
manner, as opposed to a uniform distribution, is potentially far more damaging to
the tissues and shear forces are thought to increase tissue damage caused by
pressure (Dinsdale 1974; Defloor 1999; Linder-Ganz and Gefen 2007). Shear
forces are increased by friction which keeps the skin in position against the support
surface while the patients body moves (i.e. as occurs when a patient in the semi-
recumbant position slips down the bed) (Reger et al. 2010). While it is universally
recognised that both intensity and duration of pressure are of prime relevance in the
development of pressure ulcers, it is difficult to determine the relative contribution of
these two parameters.
Laboratory and animal studies propose several aetiological mechanisms by which
stress and internal strain interact with damage thresholds to result in pressure ulcer
development including localised ischemia, reperfusion injury, impaired lymphatic
drainage and sustained cell deformation (Bouten et al. 2003):
 Localised ischemia: conventionally, ischemia was thought to be the
dominant aetiological factor associated with pressure ulcer development.
Obstruction or occlusion of the blood vessels in soft tissues caused by
external loading results in ischemia, reduced supply of nutrients to cells and
elimination of metabolites (and associated change of pH) from localised
areas eventually leading to tissue damage (Kosiak 1961; Bader, Barnhill
and Ryan 1986; Dinsdale 1974; Gawlitta et al. 2007).
 Reperfusion injury: during the unloading reperfusion phase, damage caused
by ischemia may be exacerbated as a direct result of the release of harmful
oxygen free radicals (Peirce, Skalak and Rodeheaver 2000; Unal et al.
2001; Tsuji et al. 2005)
 Impaired lymphatic drainage: Occlusion of lymph vessels in soft tissues
caused by external loading is associated with an accumulation of waste
products and an increase in interstial fluid contributing to pressure ulcer
development (Miller and Seale 1981; Reddy, Cochran and Krouskop 1981).
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 Deformation: recent studies involving, animal, engineered muscle tissue and
finite element modelling have focused on the role of deformation in pressure
ulcer development. These studies revealed that strains of sufficient
magnitude have the potential to cause cell death over very short periods of
time (Gefen et al. 2008). Gawlitta et al considered the differences in
influence of deformation and ischemia, using tissue engineered muscle, and
found that deformation per se had an immediate effect whereas hypoxia
reduced cell viability over prolonged loading periods (Gawlitta et al. 2007) .
Furthermore, animal experiments involving 2 hours of muscle compression
showed that while a complete area of muscle was ischemic, damage
occurred in specific regions where high shear strain values were observed
(Stekelenburg et al. 2007). Subsequent work using finite element
simulations revealed that the areas of tissue damage coincided with those in
which the predicted strains exceeded a critical threshold (Ceelen et al.
2008).
 Once the critical threshold has been exceeded the length of the exposure
determined the extent of tissue damage, (Loerakker et al. 2010). Loerakker
further examined the additional effects of reperfusion(Loerakker 2011). The
results indicated that over short periods of loading exposure the level of
deformation was the most important factor in the damage process for
muscle tissue, while ischemia and reperfusion gradually become dominant
over prolonged exposure periods.These bioengineering studies have
provided important new insights into the damage thresholds for muscle
tissue, but skin and fat are also implicated in pressure ulcer development.
Bouten et al suggest that the type of ulcer that develops (i.e. those presenting as
superficial loss of the epidermis that progresses to deeper tissues if the pressure
remains unrelieved or deep tissue injury with necrosis of muscle and fat before
destruction of the superficial layers and the appearance of a deep ulcer) depends
on the nature of the surface loading: superficial pressure ulcers are mainly caused
by shear stresses within the skin layers while deep ulcers are mainly caused by
sustained compression of the tissues (Bouten et al. 2003).
At the present time, there is insufficient evidence to provide definitive numerical
values for the duration of pressure or damage thresholds for pressure ulcer
development in a human population. The original Reswick and Rogers (Reswick
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and Rogers 1976) curve has been revised (Figure 1.2), as illustrated in the
NPUAP/EPUAP clinical practice guideline (2009), to more accurately reflect the risk
of tissue damage at the extremes of the loading periods (i.e. at very short and very
long loading times): this indicates that the magnitude of pressure to induce tissue
damage in the short-term is less than originally predicted by Reswick and Rogers
and a new pressure/time curve was proposed (Linder-Ganz et al. 2006;
Stekelenburg et al. 2007).
Figure 1.2 New proposal for pressure/time curve (NPUAP/EPUAP 2009)
Used with permission from the National Pressure Ulcer Advisory Panel, 8th May 2014
Furthermore, there is inherent variability in both individual susceptibility and local
tolerance to loading parameters associated with factors including morphology and
the mechanical properties of the intervening tissues. These, in turn, are affected by
the patients’ characteristics, health status and exposure to specific risk factors. This
suggests that epidemiological evidence should also be considered in the
development of a pressure ulcer conceptual framework, to facilitate translation of
biomechanical/physiological concepts to characteristics which nurses can observe
in their patients.
1.10Introduction Pressure Ulcer Risk Factors
Populations who have been found to be at high risk of pressure ulcer development
include patients who are elderly, have experienced trauma, have spinal cord injury,
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are acutely ill and those in intensive care, long-term homes or community care
environements (NPUAP/EPUAP 2009). These populations are more likely to be
characterised by pressure ulcer risk factors. Risk factors are characteristics
associated with an increased risk of becoming diseased (Fletcher, Fletcher and
Fletcher 2005).
Within the pressure ulcer field epidemiological studies of different research designs
and varying quality have considered the risk factors for pressure ulcer development.
These consider whether risk factors are independently associated with pressure
ulcer development, that is, “a risk factor that retains its statistical association with
the outcome when other established risk factors for the outcome are included in the
statistical model” (Brotman et al. 2005). However, it should be noted that being
‘independent’ is a statistical concept, depends on the risk factor variables included
in the model and does not imply causality (Brotman et al. 2005). Careful
consideration should therefore be given to the whether the statistical associations
have clinical relevance.
Early epidemiological studies identified reduced activity and mobility as the key risk
factor for pressure ulcer development (Allman et al. 1995; Berlowitz and Wilking
1989). Other risk factor themes which have been considered include skin condition,
perfusion, moisture and nutrition, but the relative contribution these make to
pressure ulcer development cannot be reliably determined from individual studies.
An improved understanding of the relative contribution risk factors make to the
development of pressure ulcers could improve our ability to identify patients at high
risk of pressure ulcer development and target resources appropriately. Pressure
ulcer risk factors will be discussed in more detail in chapters 2 and 3.
1.11Pressure Ulcer Prevention
Pressure ulcers have been identified in successive Department of Health policies
as a key quality indicator (DH 2001a; DH 2001b). The NHS 2010-2015 From Good
to Great document, sets out the ambitious aim of eliminating all avoidable pressure
ulcers in NHS provided care (DH 2009a) and a Commissioning for Quality and
Innovation (CQUIN) payment framework has been developed to facilitate this (DH
2008). Pressure ulcers have subsequently been identified as high impact actions for
Nursing and Midwifery (DH 2009b) and are incorporated into the new NHS
monitoring tool, the Safety Thermometer (HSCIC 2013).
Pressure ulcer prevention strategies highlight the importance of five key elements
incorporating risk assessment, skin assessment/care, nutrition, support surface/
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pressure relieving devices, repositioning and nutrition (NICE 2005; NPUAP/EPUAP
2009; NICE 2014). Risk assessment is widely accepted as the cornerstone to
prevention, as identifying those at increased risk of pressure ulcer development can
facilitate the development and instigation of appropriate preventative interventions
in clinical practice. Risk assessment will be discussed in more detail in Chapter 2.
1.11.1 Skin Assessment/Care
Clinical guidelines emphasise the importance of incorporating skin assessment into
pressure ulcer risk assessment policies and educating professional how to
undertake skin assessment (NPUAP/EPUAP 2009; NICE 2014). Skin assessment
allows the identification of early pressure damage (Dealey 2005) and also gives an
indication of the effectiveness of preventative interventions. Skin assessment in
clinical practice is reliant on the nurse directly observing the pressure area/ulcer.
While the NPUAP/EPUAP (2009) pressure ulcer classification system offers a
structured tool for the assessment of pressure ulcers, no such tool is available for
assessment of skin vulnerability (i.e. the pre-cursor to pressure ulcer development).
At present this relies on the nurse’s skill and experience at undertaking this.
Blanching erythema of the skin indicates that the body has not recovered from
previous loading and the need for an informed clinical decision regarding the risk of
pressure ulcer development (Nixon and McGough 2001), which may prompt more
frequent repositioning or different support surface allocation. Recent guidance
advocates the use of finger palpation or discopy to identify whether discolouration is
non-blanching erythema and consideration of any pain or discomfort reported by
the patient (NICE 2014).
Other aspects of skin vulnerability that have been noted in the literature include
dryness which reduces tensile strength and flexibility (Clark et al. 2010) and
moisture (e.g. from incontinence and perspiration) which can cause skin
maceration, increasing the likelihood of friction and shear (Defloor 1999; Reger et
al. 2010). The management of controlling the cause of extreme temperature and
skin moisture has been emphasised (Clark et al. 2010). Where skin moisture is a
problem consideration should be given to the aetiology of any lesion noted and
whether pressure is present, as historically trunk wounds have been labelled as
pressure ulcers but there is confusion between Incontinence Associated Dermatitis
(IAD) (which can occur without the presence of pressure) and superficial pressure
ulcers (Beeckman et al. 2011; Doughty 2012). Guidance advocates effective skin
care to ensure skin is well hydrated (i.e. by use of emollients for dry skin) or
protected from excessive moisture exposure (i.e. with barrier products) and that
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pressure areas are not massaged or vigorously rubbed (NPUAP/EPUAP 2009;
NICE 2014).
1.11.2 Support Surfaces
As pressure (and shear) is the primary cause of pressure ulcer development
(NPUAP/EPUAP 2009) much effort is made to reduce this for immobile patients in
clinical practice. This is achieved by the provision of specialist support surfaces
(mattresses and cushions) and repositioning the patient. Support surfaces are used
to reduce pressure to vulnerable skin sites. These either mould to the patients’
body, dispersing their weight over a large area providing ‘constant low pressure’
(McInnes et al. 2011) or they mechanically vary the pressure beneath the patient,
so reducing the duration of the applied pressure (alternating pressure mattresses).
Constant low pressure mattresses include those made of foam, foam and air, foam
and gel, profiled foam, hammocks, air suspension, water suspension and air-
particulate suspension/air fluidised (McInnes et al. 2011). The most commonly
encountered constant low pressure mattresses in clinical practice are made from
foam and are classified as ‘low tech’ devices (i.e. of a lower technical specification).
Alternating pressure devices involve the inflation and deflation of air filled cells and
are available as cushions, mattress overlays, single or multi-layer mattress
replacements and are classified as ‘high tech’ devices (i.e. of a high specification)
(McInnes et al. 2011). Some support surfaces also assist with the management of
heat and moisture (Clark et al. 2010).
The use of pressure relieving equipment has implications for patients quality of life.
A qualitative study of patients who live with pressure ulcers reported the impact of
alternating pressure mattresses on patient’s pain was considerable (Hopkins et al.
2006). Another study comparing alternating pressure overlay mattresses with
alternating pressure replacement mattresses found that some patients found the
mattresses uncomfortable, noisy and reported difficulties in moving in bed (Nixon et
al. 2006a). It is therefore important to consider the patients personal circumstance
and preferences and involve them in the decision making process when making
equipment choices.
A Cochrane review of the effectiveness of support services on the prevention of
pressure ulcers was undertaken which included 53 studies evaluating the
effectiveness of various mattress types (McInnes et al. 2011). The review identified
limitations in the literature including poor study quality and the lack of definition of
standard hospital mattresses in many of the primary studies making interpretation
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difficult. However, for the five studies that compared foam alternatives with the
standard hospital foam mattresses the results were pooled (RR 0.40 95% CI 0.21 to
0.74) and a separate UK study analysis (RR 0.41; 95% CI 0.19 to 0.87) was
undertaken (where variation in the term ‘standard hospital mattress’ was less likely)
where the significant benefit of alternative foam over standard foam was
maintained. Due to continued heterogeneity a further analysis was undertaken
(excluding one study which included grade 1 pressure ulcers) which still favoured
the alternative foam support (RR 0.29 95% CI 0.16 to 0.52) but there was
inadequate evidence of which specific alternative foam mattress was superior
(McInnes et al. 2011).
The review also considered comparisons between alternating pressure mattress’s
and standard hospital mattresses and constant low pressure and alternating
pressure mattresses (McInnes et al. 2011). The alternating pressure and standard
hospital mattress comparison, involved two studies which indicated a statistically
significant reduction in pressure ulcer development in the alternating pressure
mattress group (RR 0.31; 95% CI 0.17 to 0.58). However this should be interpreted
cautiously as the studies were at high risk of bias. The constant low pressure and
alternating pressure mattress comparison was considered in 10 studies but the
advantages of one over the other remains unclear (McInnes et al. 2011). This has
important clinical implications as both constant low pressure and alternating
pressure devices are routinely used in clinical practice yet evidence about the
benefits of one over the other is lacking. The financial implications and potential
savings related to equipment choices are substantial, with the unit cost for constant
low pressure high specific foam mattress being £18-£600, while the unit cost for an
alternating pressure replacement mattress is £1000-£5000.
The Cochrane review (McInnes et al. 2011) was recently adapted and updated by
NICE (2014) to consider the most clinical and cost-effective pressure re-distributing
device for pressure ulcer prevention, to inform their clinical guideline. NICE
acknowledged the limited evidence of effectiveness for redistributing devices and
recommended this as a key research priority (NICE 2014). This work is being taken
forward by the PRESSURE 2 (ISRCTN01151335) study which is currently in
progress and is comparing high specification foam with alternating pressure
mattresses.
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In light of equipment related findings the recent NICE guidance makes the following
recommendations for pressure ulcer prevention ((NICE 2014), Section 5.3)):
• ‘the use a high-specification foam mattress for adults who are admitted to
secondary care
• the use a high-specification foam mattress for adults who are assessed as
being at high risk of developing a pressure ulcer in primary and community care
settings
• Consider a high-specification foam theatre mattress or an equivalent pressure
redistributing surface for all adults who are undergoing surgery.
• Consider the seating needs of people at risk of developing a pressure ulcer who
are sitting for prolonged periods.
• Consider a high-specification foam or equivalent pressure redistributing cushion
for adults who use a wheelchair or who sit for prolonged periods’.
There is further guidance for adults with an existing pressure ulcer including that the
‘use of a dynamic support surfaces should be considered for adults with a pressure
ulcer, where the use of high-specification foam mattresses is not sufficient to
redistribute pressure’ (NICE 2014).
In addition to mattresses and cushions there are also some pressure relieving
devices which have been developed to reduce pressure to heels. Guidance
indicates that heel devices should ‘elevate the heel completely in such a way as to
distribute the weight of the leg along the calf without putting pressure on the
Achilles tendon. The knee should be in slight flexion’ (hyperextension of the knee
may cause obstruction to the popliteal vein predisposing a deep vein thrombosis).
(NPUAP/EPUAP 2009).
NICE (2014) recently undertook a systematic review in relation to heel devices for
pressure ulcer prevention. The review involved 16 studies which compared the
effectiveness of different devices on heel pressure ulcer development. Due to the
limited evidence of effectiveness of any one device, NICE recommends that for
adults at high risk of developing a heel pressure ulcer strategies to offload heel
pressure should be discussed with the patient and where appropriate their family or
carers, as part of an individualised care plan (NICE 2014).
1.11.3 Repositioning
Repositioning the patient is undertaken to relieve pressure from areas vulnerable to
pressure damage e.g. turning a patient onto their side to relieve pressure on the
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buttocks sacrum and heels. Repositioning practice stems from early small studies
of inadequate design that noted a link between increased patient movement (Exton-
Smith and Sherwin 1961) and regular turning (as often as 12 times in a 24 hour
period) (Norton, McClaren and Exton-Smith 1962) and lower pressure ulcer
incidence. Another quasi-experimental study was undertaken to determine the
effects of 1 hourly, 1.5 hourly and 2 hourly turning on the skin over the sacrum and
trochanter of 16 healthy, older adults (Knox, Anderson and Anderson 1994). The
results indicated that while skin temperature increased significantly with increasing
time of immobility, particularly over the trochanters, measures of interface
pressures did not show any significant changes. The effects on skin colour were
also noted and are detailed below in Table 1.4.
Table 1.4 Repositioning effects on skin colour reported by Knox et al
(1994)
No redness Moderate redness Severe Redness
1 hourly 6 (38%) 7 (44%) 3 (19%)
1.5 hourly 7 (44%) 4 (25%) 5 (31%)
2 hourly 8 (50%) 3 (19%) 5 (31%)
The limitations of this study relate to the inappropriate study design (i.e. is not an
RCT) and small sample (n=16) not being representative of the pressure ulcer
population (i.e. people with pressure ulcers are not healthy and usually have co-
morbidities). Nethertheless, the study recommended that 1 and 1 1/2 hourly time
period be considered a viable alternative to the 2 hourly turning interval (Knox,
Anderson and Anderson 1994).
Several more recent studies using cluster randomisation design have considered
the effects of repositioning on pressure ulcer incidence in elderly populations
(Defloor, Bacquer and Grypdonck 2005; Vanderwee et al. 2007; Moore 2009). The
first considered the effect of various combinations of turning regimes and pressure
reducing devices (2 hourly turning on a standard hospital mattress, 3 hourly turning
on a standard hospital mattress, 4 hourly turning on a viscoelastic foam mattress
and turning every 6 hours on a viscoelastic foam mattress) compared with standard
care (based on nurses clinical judgement including the use of water, alternating
pressure mattresses, sheep skins and gel cushions) on the incidence of non-
blanchable erythema (grade1) and pressure ulcers (grade 2>) involving 838 nursing
home patients (Defloor, Bacquer and Grypdonck 2005). The results for the group
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allocated to 4 hourly turning on a viscoelastic foam mattress had a significantly
lower (p = 0.003, OR 0.12, 95% CI 0.03-0.48) incidence of pressure ulcers (3%, n =
2/66) compared with the other groups where the incidence ranged between 14.3 (n
= 9/63) and 24.1% (n = 14/58).
Another nursing home study involving 235 patients that were all nursed on
viscoelastic foam overlays, compared the pressure ulcer incidence (grade 2-4) of
an experimental group (repositioned alternately 2 hours in a lateral position and 4
hours in a supine/semi-fowler position) with a control group (nursed in the same
positions as the experimental group but being re-positioned every 4 hours for all
positions) (Vanderwee et al. 2007). While the results indicated a lower pressure
ulcer incidence in the experimental group (16.4%; n = 20/122, compared with
21.2%; n = 24/113 in the control group) this was not statistically significant. Given
that the interventions for each group were similar the results are not surprising.
Another study of 213 patients undertaken in a long-term care hospital compared the
pressure ulcer incidence (grade 1-4) of an experimental group being turned 3 hourly
at night (using the 30 degree tilt method) and the control group receiving standard
care (on average being turned 6 hourly, 90 degree lateral rotation) (Moore 2009).
The results indicated statistically significant differences (p=.035, 95% CI .031-.038)
in incidence rates with the experimental group having 3% (n = 3/99) incidence
compared with 11% (n = 13/114) incidence of the control group.
A very recent multi-site randomised trial was undertaken in US and Canadian
Nursing Homes and included 967 patients. In this study patients were randomly
allocated using risk stratification (moderate and high according to Braden Scale) to
a repositioning schedule (2, 3 or 4 hourly) while being nursed on high density foam
mattresses (Bergstrom et al. 2013). Overall the incidence of pressure ulcers (stage
1-U) in the study was low (2%), with only 19 participants developing a total of 21
pressure ulcers (stage 2: n = 19; stage1: n = 2). This low incidence presented a
problem for detecting differences between the interventions and the results
indicated there was no significant difference in pressure ulcer incidence (p = .68)
between the three different repositioning schedule groups (Bergstrom et al. 2013). It
is likely that the highly protocolised care, compliance monitoring and use of
preventative equipment prompted reduced pressure ulcer incidence. This is an
important consideration for future research in the area. Interpreting the results of
repositioning studies and their implications for practice is generally hampered the
by the varying comparisons made and different support surfaces used.
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The recent NICE guidance incorporates a systematic review of repositioning
effectiveness. The search for this review included studies identified up to August
2013 and so did not include Bergstrom et al’s (2013) most recent study reported
above. However, it did identify 3 additional parallel RCTs (Smith and Malone 1990;
Young 2004; van Nieuwenhoven et al. 2006) which considered the effectiveness of
various repositioning schedules on pressure ulcer incidence. Two of the studies
were very small (Smith and Malone 1990; Young 2004) and none found any
significant differences between the interventions considered.
Despite the limited evidence of effectiveness, repositioning provides a common
sense and widely accepted approach to prevention (NICE 2005; NPUAP/EPUAP
2009; NICE 2014). Recent guidance advocates that adults who are assessed as
being ‘at risk’ or at ‘high risk’ of pressure ulcer development should change their
own position or have assistance to change their position (using appropriate
equipment) at least every 6 hours or 4 hours respectively (NICE 2014) .
1.11.4 Nutrition
While there is face validity among clinicians for poor nutrition being a risk factor for
pressure ulcer development (and for delayed healing) the exact causal relationship
between poor nutrition and pressure ulcer development remains unclear
(NPUAP/EPUAP 2009). Studies have explored the effectiveness of various types of
nutritional support on pressure ulcer prevention. A Cochrane systematic review was
undertaken which included 8 trials (mostly small and of poor methodological quality)
with regard to the effectiveness of enteral (absorbed by digestive system i.e.
supplements via mouth or nasal passages) and parenteral (outside the digestive
system i.e. IV infusion or intramuscular injection) nutrition on the prevention and
treatment of pressure ulcers (Langer et al. 2003). Because of heterogeneity of
patients groups, interventions and outcomes meta-analysis was deemed
inappropriate. From a pressure ulcer prevention perspective the comparison of
mixed nutritional supplements with a standard hospital diet was made in four
studies. While all reported a reduced pressure ulcer incidence, 3 of the 4 studies
lacked power while the fourth demonstrated a reduction in pressure ulcer incidence
with an RR 0.83, 95% CI 0.70-0.99 (Langer et al. 2003).
Four studies considered in the Cochrane Review (Langer et al. 2003) were included
in a recent systematic review to identify the most clinically and cost effective
nutritional interventions for the prevention of pressure ulcers (NICE 2014). After
separating the differences in the studies in terms of populations, interventions and
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outcomes this review undertook meta-analyse. The review identified 4 additional
studies so a total of 8 studies were included in different aspects of the review. Five
RCTs of older hospital patients in multiple settings considered the effect of a
standard hospital diet compared with a standard hospital diet and nutritional
supplements of various composition and these were subject to meta-analyse (Delmi
et al. 1990; Hartgrink et al. 1998; Bourdel-Marchasson et al. 2000; Houwing et al.
2003; Dennis, Lewis and Warlow 2005). The results indicated the studies were at
very serious risk of bias and found the incidence of pressure ulcers for those
receiving a standard hospital diet was 10.7% (n=269/2516) compared with 7.6%
(n=185/2435) for those receiving standard hospital diet and nutritional supplements
(NICE 2014). The review authors acknowledged that this evidence mainly related to
those with inadequate nutritional status and recommended that nutritional
supplements and subcutaneous or intravenous fluids, need not be offered to adults
who have adequate nutritional intake and hydration specifically for pressure ulcer
prevention (NICE 2014).
However, as poor nutrition is considered a reversible pressure ulcer risk factor,
prevention and treatment guidelines promote the early identification and
management of poor nutrition and support the use of nutritional screening (using a
valid and reliable tool) to prompt appropriate dietetic referral and nutritional plans of
care and interventions (NICE 2005; NPUAP/EPUAP 2009; NICE 2014).
1.11.5 Pressure Ulcer Prevention Initiative
In the literature there is evidence of quality/prevention/bundle initiatives whereby
various combinations of the above preventative measures (i.e. risk assessment,
skin assessment/care, repositioning, support surface allocation, nutritional
assessment/care) are implemented in health care organisations and incidence or
prevalence monitoring is undertaken before and after implementation to detect
changes in pressure ulcer rates (Courtney, Ruppman and Cooper 2006; Gibbons et
al. 2006; Hiser et al. 2006; Tippet 2009; Baldelli and Paciella 2008; Elliott, McKinley
and Fox 2008; McInerney 2008; Lyman 2009; Orsted, Rosenthal and Woodbury
2009; Gray-Siracusa and Schrier 2011). These initiatives also incorporate
leadership/management and staff resource components, staff education and
feedback mechanisms. They all claim to have made improvements in their pressure
ulcer rates e.g. in acute care hospitals Hiser et al reported a reduced overall
prevalence from 9.2% before the initiative to 6.6% following implementation (Hiser
et al. 2006); Baldelli and Paciella reported pre initiative prevalence of 22% and
incidence of 12% before implementation and 15% prevalence and 7% incidence
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after implementation (Baldelli and Paciella 2008); and McInerney reported a pre-
initiative hospital acquired prevalence of 12.8% and a 5.1% prevalence post-
implementation (McInerney 2008). Gibbons et al (2006) reported pressure ulcer
incidence was reduced from an estimated annualized incidence of 365 in 2004, to
256 in 2005 following implementation of the SKIN bundle initiative.
The SKIN bundle is perhaps the most widely acknowledged prevention initiative in
the UK and while it has been implemented in Wales (Whitlock 2011) and Scotland it
was originally developed in Florida US in a large adult in-patient facility (Gibbons et
al. 2006). The development process for the SKIN bundle involved establishing a
local leadership team, undertaking a literature review of best practice, reviewing
current processes and undertaking and ‘expert meeting’ involving representative
from the Institute of Healthcare Improvement and Ascention health as well as
Wound Ostomy and Continence Nurses from across the US. This led to the
development of the SKIN bundle to be used for patients who were considered to be
at risk of pressure ulcer development as determined by the Risk Assessment
Instrument. SKIN refers to (Gibbons et al. 2006):
 Surfaces – mattress/ cushion on which the patients’ lay or sit
 Keep the patient turning or moving
 Incontinence – manage incontinence
 Nutrition and hydration
The SKIN initiative was supported by staff training, a tool kit for implementation, a
simple reminder chart of SKIN guidance and the pressure ulcer monitoring tool to
ensure compliance in the documentation of the SKIN Bundle.
The prevention initiative area of literature is limited by the use of before and after
study designs, use of prevalence data and high likelihood of publication bias (i.e.
institutions who do not demonstrate improved rates are unlikely to publish). The
effectiveness of such strategies can only be established through an adequately
powered RCT. This would be no simple undertaking as such a trial would have both
methodological and ethical challenges, owing to the wide use of preventative
interventions finding control groups could be problematic.
1.12Summary and Subsequent Thesis Chapters
Pressure ulcers remain a significant problem worldwide. They have a detrimental
effect on patients’ quality of life and present a financial burden to healthcare
organisations. Pressure ulcer prevention guidance advocates the use of risk
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assessment, skin assessment/care, repositioning, support surface provision and
nutritional assessment and interventions. Risk Assessment is viewed as the
foundation for prompting preventative interventions and the subsequent chapters of
this Thesis considers the key phases of work undertaken to develop a new
pressure ulcer Risk Assessment Framework for use in clinical practice,
incorporating:
 Chapter 2, Risk Assessment: to provide an overview of pressure ulcer risk
assessment and existing Risk Assessment Instruments within the context of
wider health measurement. It will consider important psychometric
properties in the development and validation of an instrument, highlight the
need for a new approach to pressure ulcer risk assessment in practice and
propose a methodological approach to achieve this.
 Chapter 3, Systematic Review of Pressure Ulcer Risk Factors: to provide a
clearer understanding of the risk factors most predictive of pressure ulcer
development, using the best quality evidence.
 Chapter 4 Using Consensus Methods to Develop a Risk Assessment
Framework: in the absence of absolute evidence relating to pressure ulcer
risk factors consensus methods were used to identify the risk factors most
important for summarising pressure ulcer risk.
 Chapter 5, The Development of a new Pressure Ulcer Conceptual
Framework: explores the critical determinants of pressure ulcer
development. Using the results of the consensus study and risk factor
terminology physiological and biomechanical elements were translated to
characteristics which nurses can observe in their patients.
 Chapter 6, Design and Pre-Testing of the Risk Assessment Framework:
considers the design of the Risk Assessment Framework incorporating the
weighting and colour coding of risk factor items and support for clinical
decision making.
Each chapter explores methodological considerations associated with the work,
critically reviews its strengths and weaknesses and presents and discusses the
results. The final General Discussion Chapter (7) summarises the key findings
of this PhD and discusses the overall methodological approach, its limitations
and highlights areas of methodological development and innovation. It goes on
to discuss the implications of this PhD for clinical practice and research and to
discuss plans for the ongoing validation of the Risk Assessment Framework.
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Chapter 2 Risk Assessment
2.1 Introduction
This chapter provides a general overview of pressure ulcer risk assessment and
Risk Assessment Instruments in the context of health measurement. It details the
characteristics of the most commonly used Risk Assessment Instruments that were
considered in a recent NICE systematic review (NICE 2014), as well as the basis of
their development. It will discuss important psychometric properties incorporating
validity, reliability and usability in instrument development and how they have been
evaluated. It will also highlight key methodological limitations associated with this
area of literature. It will go on to highlight the need for the development of a new
Risk Assessment Framework for adult populations in clinical practice, describe the
aims of this PhD and provide an overview of the adopted methodological approach.
2.2 Pressure Ulcer Risk Assessment
It is not appropriate to prevent pressure ulcers by subjecting all patients to resource
intensive interventions (such as repositioning by nurses, expensive mattresses)
which may impact on their quality of life (by disturbing sleep, for example) and
divert nursing time from other essential areas, hence we must target care
appropriately. Targetting patients for whom pressure ulcer prevention interventions
are appropriate is achieved by considering the patients characteristics, a process
known as risk assesssment.
Regardless of context, risk assessment is widely accepted as being essential to
pressure ulcer prevention (AHCPR 1992; NICE 2003; NPUAP/EPUAP 2009; NICE
2014) as it allows ‘at risk’ patients to be identified, so that preventative interventions
can be put in place to reduce the risk of ulcer development. To support clinical
practice, Risk Assessment Instruments often referred to as ‘scales’ and sometimes
referred to as ‘tools’ or ‘measures’ have been developed. These are commonly
used to systematically identify patients at risk in preference to clinical ‘judgement’ of
risk alone (AHCPR 1992; NICE 2003; NPUAP/EPUAP 2009; NICE 2014). They are
thought to convey some advantages in that they set minimum standards of
assessment and give some structure to the assessment process and decision
making regarding the need to use (or not) preventative interventions
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(NPUAP/EPUAP 2009; Moore and Cowman 2014). Pressure ulcer Risk
Assessment Instruments enable the measurement of characteristics or risk factors
which are considered important in pressure ulcer development. The pressure ulcer
Risk Assessment Instruments that have undergone the most scrutiny in the
literature, reflecting their widespread use in clinical practice include the Norton,
Waterlow and Braden scales (Appendix1-3) (Gould et al. 2002; Pancorbo-Hidalgo
et al. 2006; Papanikolaou, Lyne and Anthony 2007; NICE 2014).
2.3 Risk Assessment Instruments within the wider Health
Measurement Context
At this point it is important to consider Risk Assessment Instruments within the
wider context of health measurement. Health Measurement is a very broad concept
which comprises both patient and population level assessment, monitoring and
evaluation of health (Ware Jr et al. 1981; SAC 2002; McDowell 2006). It is
undertaken for a variety of different reasons including measuring the effectiveness
of medical interventions, assessing quality of care, estimating needs of a
population, improving clinical decisions and understanding the causes and
consequences of differences in health (Ware Jr et al. 1981). The theoretical basis of
Health Measurement has grown over the last 30 years leading to the development
and validation of a wide range of instruments designed to measure health status
and quality of life (SAC 2002). While for some disciplines the word ‘instrument’ is
precisely defined (as for PRO instrument see Table 2.1), in the wider literature it is
considered an overarching term to describe a range of measures which assess or
diagnose aspects of health and disease via patient self-report or clinician
assessment (Liang et al. 1985; McDowell 2006; Streiner and Norman 2008; Cano
and Hobart 2011). The diverse range of instruments is demonstrated in the Health
and Psychosocial Instruments (HaPI) database which incorporates measurement
instruments such as questionnaires, interview schedules, vignettes/scenarios,
coding schemes, rating and other scales, checklists, indexes, tests and projective
techniques (HaPI Accessed Oct 2014).
Other related terminology that is commonly encountered in the literature includes
‘scales’ and ‘tools’ (Liang et al. 1985; McDowell 2006; Streiner and Norman 2008).
While precise definitions for scales are apparent (Table 2.1) this is not the case for
the tools. In the context of the pressure ulcer risk assessment literature the terms
‘scales’, ‘tools’ and ‘measures’ fulfil the definition of an instrument since they
incorporate measurement scales with scoring, interpretation and application
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guidance (Deeks 1996; Moore and Cowman 2014; NICE 2014). Throughout this
thesis the term ‘Risk Assessment Instrument’ will be used other than when the ‘term
‘scale’ appears in the title of specific instruments.
Further definitions have been developed for different types of scales, influenced by
how numerals are assigned (Stevens 1946). Stevens (1946) identified 4 types of
measurement scales comprising the Nominal, Ordinal, Interval and Ratio Scales
(descriptions for each were updated (McDowell 2006) and are highlighted in Table
2.1. Pressure ulcer Risk Assessment Instruments tend to incorporate ordinal
scoring systems in which scores for each risk factor are added together to give the
patients overall score (McGough 1999; Nixon and McGough 2001). This overall
score is then compared to a standard reference value to allocate the patient to a
level of risk (e.g. high risk, moderate risk, at risk). The score is a key consideration
in clinical decision making when planning preventative interventions in clinical
practice (Gould et al. 2002; Papanikolaou, Lyne and Anthony 2007; Kottner and
Balzer 2010).
The clinical decision making aspects of Risk Assessment Instrument’s link to
another related body of literature, ‘decision aids’ and ‘decision tools’. Decision aids
appear to be more focussed on patient decision making (Bekker, Hewison and
Thornton 2003; Neuman, Charlson and Temple 2007; Stiggelbout and Timmermans
2010; McDonald, Charles and Gafni 2011), i.e. aids for patients facing health
treatment or screening decisions and ‘are designed to prepare patients to make
informed decisions that are congruent to their own values’ (Nelson et al. 2007).
Whereas decision tools (Table 2.1) have broader application incorporating both
health professional and patient decision making (Liu, Wyatt and Altman 2006).
Decision tools have 4 key characteristics (Liu, Wyatt and Altman 2006):
 To aid a clinical decision by a health professional and/or patient.
 Decisions concern an individual patient.
 Uses patient data and knowledge to generate an interpretation that aids
clinical decision making
 Is used before the health professional or patient takes the relevant decision.
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Table 2.1 Key Health Measurement Terminology
Measurement: the assignment of numerals to objects or events according to rules’
(Stevens 1946).
Instrument: the constellation of items contained in questionnaires and interview
schedules along with their instructions to respondents, procedures for
administration, scoring, interpretation of results, and other instructions found in a
user manual (SAC 2002).
Scale: ‘the system of numbers or verbal anchors by which a value or score is
derived for an item’ (FDA DHHS 2009).
Nominal scales: ‘Numbers are assigned arbitrarily with no implication of an inherent
order to their categories, as in telephone numbers. Such scales may only
be used as classifications; no statistical analyses may be carried out that use the
numerical characteristics of the scale’ (McDowell 2006, p715).
Ordinal scales:’Classification into a scale that implies a distinct order among the
categories (e.g., building numbers on a street), but where there is no assumption
concerning the relative distance between adjacent values. Statistical methods such
as rank order correlations may be used, but addition and subtraction, or calculation
of averages, may not be appropriate’ (McDowell 2006, p715).
Interval scales: ‘Interval scales are so named because the distance between
adjacent numbers in one region of the scale is assumed to be equal to the distance
between adjacent numbers at another region of the scale (as in Fahrenheit or
Celsius scales). Addition and subtraction are permissible, but not multiplication or
division of such scales; statistical analyses such as the Pearson correlation, factor
analysis, or discriminant analysis may be used with interval scales’ (McDowell
2006, p715)
Ratio scales. ‘A ratio scale is an interval scale with a true zero point, so ratios
between values are meaningfully defined. Examples include weight, height, and
income, because in each case it is meaningful to speak of one value being so many
times greater or less than another value. All arithmetical operations, including
multiplication and division, may be applied, and all types of statistical analysis
may be used’ (McDowell 2006 p715).
Decision tool: ‘an active knowledge resource that uses patient data to generate
case-specific advice which supports decision making about individual patients by
health professional, the patients themselves or others concerned about them’ (Liu,
Wyatt and Altman 2006).
The decision tool field has been driven by the need to support health professionals
decision making in areas of clinical uncertainty, to improve their efficiency and cost
effectiveness (Stiell and Wells 1999). Many decision tools incorporate
measurement and fulfil the definition of an instrument. They take many different
forms including algorithm/flowcharts, care pathways, profile checklists,
diagnostic/prognostic models and may be computer (computerised decision support
systems: DSS) or paper based (Liu, Wyatt and Altman 2006). Examples of decision
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tools in the literature include anticoagulant management, glucose regulation, a
predictive instrument to estimate the risk of mortality following cardiovascular
surgery and other clinical prediction models (Randell et al. 2007; Boult et al. 2011;
Steyerberg 2010). Existing pressure ulcer Risk Assessment Instruments have some
features of decision tools and meet all of the criteria highlighted above (Liu, Wyatt
and Altman 2006), i.e. patient data is used to provide an overall score which is used
to guide decision making about preventative interventions. However the decision
making aspect of the instrument comes at the end of the assessment by use of the
overall score and is not integrated throughout the assessment process. This is
important as using the overall score to aid decision making could result in
inappropriate allocation of preventative or management interventions i.e. patients
with the same scores may need completely different preventative or management
interventions to address their needs.
2.4 The Development and Validation of Existing Pressure
Ulcer Risk Assessment Instruments
It has previously been proposed that there are three applications of health
instruments, comprising discrimination, prediction and evaluation (Kirshner and
Guyatt 1985). The purpose of intended use influences the measurement properties
of the instrument and its design (Kirshner and Guyatt 1985; Greenhalgh et al.
1998). In the context of pressure ulcer Risk Assessment Instruments all three
characteristics are relevant as an ideal instrument would allow prediction of those
most likely to develop a pressure ulcer (prediction), would allow ‘not at risk’, and ‘at
risk’ individuals to be distinguishable (discrimination). It would also be responsive
allowing changes in the patient’s condition (evaluation) to be identified over time. In
addition Risk Assessment Instruments need to be acceptable and relevant to
clinical nurses who will use them (Greenhalgh et al. 1998).
Key considerations in the development and evaluation of instruments relate to
establishing their psychometric properties, that is their validity and reliability
(Nunnally 1970). The overall concept of validity relates to ‘the degree to which the
instrument measures what it purports to measure’ (SAC 2002). Various types of
validity are of importance (see Table 2.2.) including content-related, construct-
related and criterion-related validity (SAC 2002). Another important property relates
to reliability or ‘the extent to which the measure is consistent and minimises random
error’ (Bowling 2009, p468). Attention should also be given to the usability and
acceptability of the instrument to clinical nurses. This is important as poor usability
and acceptability could impact upon the reliability and validity of the instrument.
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Table 2.2 provides an overview of potentially important characteristics and the
following sections consider existing Risk Assessment Instruments and whether
these characteristics have been considered in their development and evaluation.
2.4.1 Risk Assessment Instrument Development
The basis of existing pressure ulcer Risk Assessment Instrument development has
been largely overlooked in the literature but is of fundamental importance to the
validity and reliability of an instrument. An early systematic review identified more
than 40 pressure ulcer Risk Assessment Instruments but only seven were ‘original’
instruments (McGough 1999). Indeed, from the 13 Risk Assessment Instruments
included in the more recent systematic review (NICE 2014) of predictive validity and
detailed in Table 2.3 we can see that the majority have been developed on the
basis of a combination of existing instruments, clinical opinion and literature reviews
with only two original instruments (Bergstrom et al. 1987; Suriadi et al. 2008)
reporting a conceptual framework. Where development was informed by a literature
review it should be noted that these were in the main undertaken in the 1980s,
when the epidemiological evidence was limited in quality and quantity with
few studies exploring the contribution of individual risk factors to pressure ulcer
development (Table 2.3.3).
It has been argued that pressure ulcer Risk Assessment Instruments need to be
developed on the basis of multivariable analyses to identify factors that are
independently associated with pressure ulcer development (Bridel 1994; Cullum et
al. 1995; Nixon and McGough 2001). This would advance our understanding of the
relative contribution different risk factors make to pressure ulcer development. This
type of instrument development has in the main been undertaken only in single
centre populations, with methodological limitations including inadequate sample
sizes and/or use of the same data set for development and validation (Perneger et
al. 2002; Suriadi et al. 2008; Page, Barker and Kamar 2011) (Table 2.3).
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Table 2.2 Psychometric Properties of an Instrument
Property Definition
Data Quality
data
completeness and
acceptability
The extent to which scale items are completed and used to
allocate a risk category; quality of data is assessed by data
completeness for each element of the scale and score
distributions (McHorney et al. 1994).
Acceptability of instrument use with clinical nurses.
Usability Compliance with the recommended completion guidelines i.e. is
completed as intended. Easy to interpret and use.
Content Validity The extent to which items of an instrument adequately represent
the domain they are supposed to measure (Kaplan, Bush and
Berry 1976)
Construct Validity
Convergent
Validity
Discriminant
validity
Known group
differences
Evidence that relationships among items, domains and concepts
conform to a priori hypotheses concerning logical relationships
that should exist with measures of related concepts or scores
produced in similar or diverse patient groups.(FDA DHHS 2009)
Evidence that constructs are correlated with other measures of the
same or similar constructs; assessed by correlations between the
measure and other similar measures (Kaplan, Bush and Berry
1976)
Evidence that the scale is not correlated with measures of different
constructs; assessed on the basis of correlations with measures of
different constructs (Gorecki 2011)
The ability of the measure/scale to differentiate known groups;
assessed by comparing risk categories for subgroups who are
expected to differ on the construct being measured (significant
differences between known group or difference of expected
magnitude) (Gorecki 2011).
Reliability
Inter-rater
reliability
Test Re-Test
Reliability
The extent to which the measure is consistent and free from
random error (Bowling 2009).
Inter-rater reliability assesses the extent to which the results
obtained by two or more raters agree for the same population.
(Bowling 2009).
Test re-test reliability assesses the stability of the scale/tool over a
period of time in which the patient’s condition is not expected to
change(Bowling 2009).
Criterion Validity
Concurrent
Validity
Predictive Validity
The correlation of a scale with some other measure of the trait or
disorder under study, ideally, a ‘gold standard’ which has been
used and accepted in the field (Streiner and Norman 2008).
Independent corroboration that the instrument is measuring what it
intend to measure e.g. the corroboration of a physical functioning
scale with observable criteria (Bowling 2009).
The accuracy in separating patients who are at risk from patients
who are not at risk (Nixon and McGough 2001) .
Responsiveness An instruments ability to detect change (SAC 2002).
Adapted from Gorecki (Gorecki 2011) and PURPOSE Monograph (Nixon et al. Submitted).
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It is also noteworthy that only a few papers (Abruzzese 1985; Waterlow 1985;
Pritchard 1986; Cubbin and Jackson 1991) describing the development of Risk
Assessment Instruments included in the NICE (2014) review, reported limited
information of usability testing with clinical nurses (Table 2.3) and this could impact
the reliability of the instrument. The reporting of patient involvement in the
development of the Risk Assessment Instruments is also lacking and this is
important, particularly when considering the acceptability of assessment methods
(Table 2.3).
2.4.1.1 Content Validity
Content validity i.e. ensuring all relevant risk factors are included in Risk
Assessment Instruments is fundamental to measuring pressure ulcer risk. However,
due to the limitations of instrument development methods detailed above, there is
inconsistent inclusion of risk factors in existing Risk Assessment Instruments as
detailed in Table 2.4. Those most frequently incorporated are mobility, nutrition and
continence/moisture (Table 2.4). The variability of included risk factors in existing
Risk Assessment Instruments raises concern about their content validity and
therefore their ability to adequately identify risk (Nixon and McGough 2001; Gould
et al. 2002; Kottner and Balzer 2010).
It should also be noted that only a few instruments incorporate weighted risk factors
(and it is often not clear on what this is based), with most employing an equally
weighted scoring systems (Table 2.3). This assumes that each risk factor has an
equal role in pressure ulcer development, but their precise contribution is as yet
unknown and is likely to vary (Nixon and McGough 2001; Gould et al. 2002; Kottner
and Balzer 2010; Papanikolaou, Lyne and Anthony 2007). This will affect the
accuracy of the instrument in predicting those at risk.
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Table 2.3 Summary of the Risk Assessment Instruments Included in the NICE Systematic Review (NICE 2014) and their
Development
Instrument development
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Andersen
(Andersen et
al. 1982)
Denmark Ordinal score system incorporating 8 risk factors :
age, restricted mobility, incontinence, pronounced
emaciation, redness over bony prominence,
unconsciousness, dehydration, and paralysis
A score of 2 or more indicated risk.
Unconsciousness, paralysis and dehydration were
given a score of 2 while the remainder had a score
of 1. Not clear on what this weighting was based.
N Y
patients
admitted to
hospital with
acute
conditions
Y
As
previous
N N Clinical/ expert
opinion
Braden
(Bergstrom et
al. 1987)
US Ordinal score system incorporating 6 risk factors:
nutrition, mobility, activity, sensory perception,
moisture, friction and shear. Scores for each are of
equal weighting with the exception of friction and
shear.
Overall scores can range from 6-23 with lower
score indicating an increased risk of pressure
ulcer development. Originally a score of 16 or less
indicated the patient was ‘at risk’.
Y Y
rehabilitation
and nursing
home
population
P
clinical
use,
sensitivity
and
specificity
testing
needed
for each
setting
N N Conceptual
framework based
on overview of
literature
Modified
Braden
(Kwong et al.
China Ordinal scoring system incorporating the 5/6
original risk factors detailed in Braden (excluding
nutrition) plus 2 more: skin type and body build for
P * Y
Acute care
hospital in
Y
As
previous
N P Adapted from
Braden: Informed
by finding of
previous study
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Instrument development
Instrument Country Brief Description of Instrument
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2005) height. Scores for each are of equal weighting with
the exception of friction and shear.
Scores can range from 8-31 with lower scores
indicating greater risk. A score of 16 or less
indicated the patient is ‘at risk’.
China (Pang and Wong
1998)
Cubbin-
Jackon
(Cubbin and
Jackson
1991)
UK Ordinal score system incorporating 10 risk factors:
age, weight, general skin condition, mental
condition, mobility, incontinence and hygiene,
haemodynamic status, respiration, nutrition.
Scores for each are of equal weighting.
Score ranges from 10-40, those with a score of 24
or more were considered ‘at risk’.
N Y
Intensive
care patients.
Y
As
previous
N Y very small
pilot
Adapted from
Norton and ITU
clinical opinion
Douglas
(Pritchard
1986)
UK Ordinal score system adapted from Norton score
including activity, incontinence, mental state,
nutritional state and low haemoglobin, pain and
skin condition. Scores were of equal weighting.
Special risk factors including steroids, diabetes,
cytotoxic therapy and dyspnoea could lead to
further deductions in the score (2 for each- not
clear on what this was based).It was envisaged
that further speciality specific risk factors could be
added.
Lower scores indicated increased risk. Scores of
18 or less indicated ‘at risk)
N Y
medical ward
patients
Y
As
previous
and
possibility
for
adapting
to other
areas
N Y Adapted from
Norton
informed by
clinical opinion
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Instrument development
Instrument Country Brief Description of Instrument
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Fragmment
(Perneger et
al. 2002)
Switzerland Ordinal scoring system incorporating the following
risk factors: friction and shear, mobility, mental
status, age. Weighting based on regression
coefficients: age 0-4, mobility 0-2, mental status 0-
2, friction/shear 0-2
Low risk represented by a low score. 0-3 low risk,
4-6 require standard prevention, 7-10 more
intensive preventative interventions.
N Y
Acute care
hospital
Y
As
previous
N N Based on
multivariable
modelling of
Braden and
Norton risk
factors.
Gosnell
(Gosnell
1973; Gosnell
1989)
US Ordinal scoring system incorporating 5 risk factors:
mental status, continence, mobility, activity, and
nutrition. Scores for each range from 1-4 for each
with the exception of mental status (1-5) and
nutrition (1-3) In addition information regarding
colour, skin appearance, vital signs, fluid balance,
diet, interventions and medication is evident
though not included in the scoring system.
Scores can range from 5- 20 with lower score
indicating higher risk.
N Y
Over 65
extended
care facility.
P
Could be
used in
numerous
settings
N N Adapted from
Norton
Knoll
(Abruzzese
1985)
US Ordinal scoring system incorporating the following
risk factors: general health, mental status, activity,
mobility, incontinence, oral nutrition, oral fluid
intake and predisposing diseases.
The highest 2 scores for mobility, activity and
incontinence were given double weighting as
thought to be critical variables. Higher score
N Y-
Large
metropolitan
Hospital
U N Y Factors identified
from 1 year audit
and literature
review
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Instrument development
Instrument Country Brief Description of Instrument
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indicated higher risk. Score of 12 should be
considered ‘at risk’. Score can range from 0-33.
Norton
(Norton,
McClaren and
Exton-Smith
1962)
UK Ordinal scoring system incorporating the following
risk factors: general physical condition, mental
status, mobility, activity, and incontinence all with
equal weighting.
Scores can range from 5-20 with lower score
indicating increased risk. Scores of 14 or less
indicated liability to ulcers; scores of <12 indicated
very high risk.
N Y
Elderly
hospital
patients
n/a N N Originally
developed as a
pressure ulcer
research tool and
found to be
correlated with
PU incidence.
Subsequently
used as a clinical
risk assessment
instrument
Northern
Hospital
Pressure
Ulcer Plan
(Page, Barker
and Kamar
2011)
Australia Ordinal scale incorporating the following risk
factors: age (>65), admission to ICU during current
admission, reduced sensation, cognitive
impairment and requires assistance to move in
bed.
The weighting of scores was derived using risk
factor coefficients.
Each risk factor has a score of 1 point except
require assistance to move in bed which was given
a score of 2. The cut point of 3 or more indicated
high risk
N Y
Acute
hospitals
Y
As
previous
N N Literature
review, chart
audit , from 2
pressure ulcer
prevalence
surveys and
multivariable
analysis
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Instrument development
Instrument Country Brief Description of Instrument
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Risk
Assessment
Pressure sore
Scale (RAPS)
(Lindgren et
al. 2002)
Sweden Ordinal scale incorporating the following risk
factors: general physical condition, activity,
mobility, food intake, fluid intake, moisture,
sensory perception, friction and shear, body
temperature and serum albumin.
Body constitution and skin type were also in the
original scale though were subsequently excluded
as were found to be weakly correlated with the
scale as a whole and other items.
Scores for each are of equal weighting with the
exception of friction and shear.Score can range
from 12-39 with lower scores indicating greater risk
P Y
Acute
hospital with
mixed
populations
Y
Medical
patients
N N Based on the
Norton,
modified
Norton and
Braden.
Song and
Choi
(Song and
Choi 1991)
Information
regarding
scale obtained
from Song
and Choi
abstract and
Kim et al as
original main
Korea . Ordinal scale incorporating Braden scale risk
factors and body temp temperature and
medication. Scores for each are of equal weighting
with the exception of friction and shear. Score
range from 8-31 with lower scores indicating
higher risk.
Y
Y
Developed
for patients
with
neurological
problems
U U U Modified from
the Braden
scale.
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Instrument development
Instrument Country Brief Description of Instrument
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paper in
Korean (Kim
et al. 2005)
Suriadi and
Sanada
(Suriadi et al.
2008)
Indonesia
Ordinal scale incorporating interface pressure,
body temperature and cigarette smoking. Scores
were weighted using regression coefficient values.
Scores range from 0-9 with higher scores
indicating higher risk. The recommended cut-off is
>4.
Y Y
Intensive
care patients
Y N N Based on the
statistical
analysis of a
previous
prospective
ICU cohort
study
Waterlow
(Waterlow
1985)
UK Ordinal scoring system incorporating 10 risk
factors: nutrition/appetite, mobility, build/weight,
continence/ sex/age, skin type, tissue malnutrition,
neurological deficit, major surgery/trauma,
medication. The scoring system allowed multiple
scores for each category.
Scores can range from 2-20+. In the original
presentation of the Waterlow card a score of 10
indicated the patient was ‘at risk’; a score of 15
indicated the patient was at ‘high risk’ and; a score
of 20 indicated the patient was at very high risk.
N Y
Acute
hospital
U N Y Literature review,
clinical opinion
and survey
Table components (horizontal headers) adapted from (Bryant et al. In pres). Y-yes; N-no; P-partial P*-based on Braden, U-unclear
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Table 2.4 Risk factors included in Risk assessment Instruments included in the NICE systematic Review
Risk Factor
Domains
Anderson Braden Modified
Braden
Cubbin
Jackon
Fraggment Douglas Gosnell Knoll Norton NHP-
PUP
RAPS Song
and
Choi
Suriadi Waterlow Total
Mobility √ √ √ √ √  √ √ √ √ * √ √  √ 12 
Activity  √ √   √ √ √ √  √ √   8 
Mental state    √ √ √ √ √ √      6 
Moisture
(including
Continence)
√ √ √ √  √ √ √ √  √ √  √ 11 
General Physical
condition/general
health
       √ √  √    3 
Friction and
shear
 √ √  √      √ √   5 
Perfusion
(including
Haemodynamic
status, diabetes
or smoking)
   √  √ x2       √ √ x2 4 
Nutrition
(including food or
fluid intake)
√ dehyd √  √   √  √ √ x2   √x2 √  √x2 9 
Weight,
(including
emaciation or
body build for
height)
√  √ √           3 
Sex              √ 1 
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Risk Factor
Domains
Anderson Braden Modified
Braden
Cubbin
Jackon
Fraggment Douglas Gosnell Knoll Norton NHP-
PUP
RAPS Song
and
Choi
Suriadi Waterlow Total
Age √   √ √     √    √ 5 
Sensory
Perception
(including pain,
poor sensation or
cognitive
impairment)
 √ √   √    √ x2 √ √  √  7 
Skin condition √   √ √  √        √ 5 
Orthopaedic
surgery/
fracture below
waist
             √ 1 
Medication      √x2      √  √ 3 
Unconsciousness √              1 
Paralysis √              1 
Respiration    √  √         2 
Admission to ICU
during current
admission
         √     1 
Predisposing
diseases
       √       1 
Body Temp           √ √ √  3 
Interface
pressure
            √  1 
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Risk Factor
Domains
Anderson Braden Modified
Braden
Cubbin
Jackon
Fraggment Douglas Gosnell Knoll Norton NHP-
PUP
RAPS Song
and
Choi
Suriadi Waterlow Total
Serum albumin           √    1 
Hygiene    √           1 
*assistance to move in bed
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2.4.2 Instrument Validation
It is recognised that an appropriate validation process is dependent on the nature of
the instrument under development, always requires empirical investigations and ‘is
a matter of degree rather than an all or none property’ ((Nunnally 1967) pp75). The
literature relating to the validation of pressure ulcer Risk Assessment Instruments
has primarily focussed on predictive validity and reliability but other types of validity
and the responsiveness of the instrument to detect clinically relevant changes are
also relevant. A literature search of pressure ulcer risk assessment validation terms
was undertaken to reveal relevant literature (Appendix 4).
2.4.3 Reliability
Reliability relates to the degree to which measurement error is non-existent in the
obtained scores (Bowling 2009). Reliability is a vital requirement for any instrument
and underpins validity i.e. a large amount of measurement error would prevent
reflection of the criterion of interest (Kottner and Dassen 2008a). The literature
search (Appendix 4) identified pressure ulcer studies reporting the assessment of
the inter-rater reliability, that is the extent to which the results obtained by two or
more raters agree for the same population (Bowling 2009).
A systematic review considered the predictive validity and reliability of existing
pressure ulcer Risk Assessment Instruments and included 33 cohort studies or
controlled clinical trials (Pancorbo-Hidalgo et al. 2006). This review reported the
inter-rater reliability of the included Risk Assessment Instruments if reported in the
primary studies of the review and comprised13 studies considering the Braden
Scale, 2 studies considering the Norton Scale and 2 studies considering the
Waterlow Scale. It is presumed that the reliability rates reported in the review are
for Scale total scores (as is usually the case) rather than the individual items,
though this is not reported in the review (Pancorbo-Hidalgo et al. 2006). The review
reported high inter-rater reliability for the Braden (Pearson correlation coefficient: r
= 0.83-0.99), Norton (r= 0.99 and 100% agreement), and Waterlow Scales (r = 0.99
and 92.5% agreement). However it should be noted that only 2 studies considered
the reliability of the Waterlow Scale and the Norton Scale. Overall the Braden Scale
has been subjected to the most testing and suggests high levels of inter-rater
reliability for the total score.
Several more recent studies considered the inter-rater reliability of the Braden
Scale and the Waterlow Scale. The Braden Scale was considered in nursing home,
home care and intensive care settings (Kottner and Dassen 2008b; Kottner, Halfens
and Dassen 2009; Kottner and Dassen 2010) and the Waterlow Scale was also
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considered in the Intensive care study (Kottner and Dassen 2010) and in acute care
settings (Webster et al. 2010). Overall the results concur with those found
previously (Pancorbo Hidalgo), though inter-rater reliability was reduced for the
Waterlow total score in an intensive care environment where the total score
intraclass correlation coefficients (ICC) were 0.36 (95% CI 0.09-0.63) and 0.51
(95% CI 0.27-0.72) (Kottner and Dassen 2010).
Three studies also considered the inter-rater reliability for individual instrument
items which overall were lower than for total scores (Kottner and Dassen 2008b;
Kottner, Halfens and Dassen 2009; Kottner and Dassen 2010). This could be
important in considering the usability of the instrument and in identifying items
which may be more difficult to complete (Kottner and Dassen 2008b). The use of
test re-test reliability could also be usefully considered in order to assess the
stability of the Instrument over a period of time in which the patient’s condition is not
expected to change, but no evidence of this was found in the literature search
(Appendix 4).
2.4.4 Construct Validity
Evidence supporting construct validity comes from testing theoretical hypotheses,
often gained by consideration of known groups, convergent and discriminant validity
(Kaplan, Bush and Berry 1976; Kottner and Balzer 2010) as highlighted in Table
2.2. The search (Appendix 4) revealed evidence of these properties in the literature.
2.4.4.1 Convergent Validity
Several studies have considered the convergent validity of Risk Assessment
Instruments to assess its correlation with other similar measures. An observational
study of the Waterlow Score, Braden Scale and a Visual Analogue Scale (VAS) to
measure pressure ulcer risk was undertaken in two intensive care units in Germany
(Kottner and Dassen 2010). Correlation coefficients of the instrument sum scores
indicated the lowest correlations were between the visual analogue scale and the
Waterlow score (r = 0.51 and 0.52). The highest overall correlations were between
the Waterlow and Braden score (r =0.71 and 0.72). Overall the results indicate that
the 3 instruments (visual analogue scale, Waterlow Score and Braden Scale)
measured something similar (Kottner and Dassen 2010).
Others have considered the convergent validity of subscales of the Braden scale
(Powers et al. 2004; Omolayo et al. 2013). A small observational study evaluated
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the mobility subscale, involving 16 veteran home patients (4 for each of the 4
scores of the Braden mobility subscale) (Powers et al. 2004). The continuous
movement of participants was recorded using a Motion logger Actigraph (for 72
hours). The results indicated there was a significant increase in recorded activity as
the mobility sub-scale increased (Powers et al. 2004). The moisture subscale of the
Braden scale was also examined in a secondary analysis of a multi-site RCT
involving 343 patients (Omolayo et al. 2013). The results indicate a significant
inverse relationship, where increasing subscale scores were associated with
decreasing wet observations (Spearman rank correlation coefficient:rs =-0.233;
p<.0001) and soiled observations (rs= -0.133, p<0.13). A limitation of the study was
the inclusion of only patients with a total Braden Score of 10-14.
The convergent validity of some Instruments has also been considered alongside
care dependency measures. A cross sectional study incorporating 164 patients
correlated the scores of the Braden Scale, Norton Score and the Bartel Index
(Marrie, Ross and Rockwood 2003). The results indicated that the total scores for
all three correlated highly with each other (>0.80). Another study showed similar
findings in a large scale cross-sectional study (German national voluntary survey)
incorporating more than 10,000 participants from nursing home and hospital
settings (Mertens et al. 2008). This study found a high correlation between the Care
Dependency Scale total scores and Braden Scale total scores (nursing home
patients r = 0.79 (p<0.01), hospital patients r = 0.89 (p<0.001)). Other studies have
also found high correlations between Risk Assessment Scales and Care
Dependency measures (Balzer et al. 2007; Tannen et al. 2010).
2.4.4.2 Known Groups
Known-group comparisons are used to evaluate the clinical utility of instruments to
assess the extent to which the overall assessment or items are able to discriminate
between subgroups of patients known to differ in terms of clinical presentations
(Table 2.2) (Kerlinger 1973). This has been confirmed in intensive care populations
where higher prevalence and incidence rate are reflected by higher levels of
pressure ulcer risk (Kottner et al. 2009). Known groups were also considered in a
cross-sectional study that translated the risk assessment pressure sore (RAPs)
scale to Norwegian (Fossum et al. 2012). The known groups assessed were
nutrition/weight and pressure ulcer presence. It was anticipated that patients with
high RAPS scores would have a higher BMI (>23kg/m2) and larger calf
measurements (>31cm) and those with lower RAPs scores would have a lower BMI
(<23) and smaller calf measurement (<31cm). Those with pressure ulcers were
45
expected to have lower RAPS scores (indicating increased risk). The results
supported these hypotheses indicating significant differences (p=<0.001) between
the mean scores for these groups (Fossum et al. 2012).
2.4.4.3 Discriminant Validity
Discriminant validity relates to evidence that the scale is not correlated with
measures of different constructs (Table 2.2). Only one study was found in the
literature and this assessed discriminant validity by correlating 2 Risk Assessment
Instruments (Braden and Norton) and the Bartel Index against age. It reported
correlations of between 0.3 and 0.4 providing some evidence of discriminant validity
(Marrie, Ross and Rockwood 2003).
2.4.5 Responsiveness
Responsiveness is the ability of the Instrument to detect clinically significant
changes in the patient’s condition which affect pressure ulcer risk status. Logically
this should be an important feature in Risk Assessment Instruments as it could
assist in the required escalation of preventative interventions where a patient’s
condition has deteriorated. Despite this no evidence was found in the literature
search (Appendix 4).
2.4.6 Criterion Validity
The literature search (Appendix 4) identified a few studies considering concurrent
validity as detailed below.
2.4.6.1 Concurrent Validity
Two studies used illustrated patient scenarios to examine the concurrent criterion
validity of Risk Assessment Instruments (Gould et al. 2002; Gould et al. 2004). The
first study considered 3 Risk Assessment Scales (Norton, Waterlow and Braden)
and the nurses clinical judgement (Gould et al. 2002). The ‘gold standard’ used in
this study was the consensus views of an expert tissue viability panel who rated the
patients pressure ulcer risk from 1-10 on a visual analogue scale (VAS). The VAS
score results were categorised as low risk: 1-3, medium risk: 3.5-5; high risk: 5.5-
7.5: and very high risk: 8-10, though it is not clear how this was decided. The study
compared risk estimations made by clinical nurses using the 3 Instruments (Norton,
Waterlow and Braden) and their clinical judgement using the VAS, with the
consensus views of an expert tissue viability panel. (Gould et al. 2002). The study
included 236 clinical nurses (from acute and community sectors) and 941
assessments using four patient scenarios. The results indicated that the estimation
of risk using the above Instruments only exactly matched the risk categories of the
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expert panels’ views in 20% of cases for the Waterlow Score, 8.5% of cases for the
Braden Scale and 4.6% of cases for the Norton Score. The nurses clinical
judgement measured on the VAS demonstrated exact risk category matches with
that of the expert panels views on 69.1% of occasions (Gould et al. 2002). These
results favour the use of clinical judgement, though study limitations associated with
the use of patient scenarios, nurses ‘clinical judgement’ being contaminated by use
of the Risk Assessment Instruments, and the lack of reporting of correlation
coefficients should be acknowledged.
Furthermore, a follow-up study this time considering the Waterlow score and the
VAS and including 115 clinical nurses, incorporating 230 assessments (Gould et al.
2004) did not support the findings of the previous study (Gould et al. 2002). This
study used 2 patient scenarios and while the results related to the VAS (scenarios 1
differences mean -0.15, median 0; scenario 2 mean 0.97, median 1.0) were more
similar to that of the expert panel assessments than the Waterlow Score (scenarios
1 differences mean 0.84, median 1.0; scenario 2 mean 1.56, median 2.0) neither
agreed greatly with the expert panel. Indeed for one of the patient scenarios it was
concluded that neither the VAS or the Waterlow score was considered effective in
assessing that particular patients’ pressure ulcer risk (Gould et al. 2004).
2.4.7 Predictive Validity
Most commonly studies evaluating the value of pressure ulcer Risk Assessment
Instruments consider their predictive validity (Deeks 1996; NICE 2014). This is the
accuracy in separating patients who are at risk from patients who are not at risk
(Nixon and McGough 2001).
2.4.7.1 Sensitivity and Specificity
Evaluating predictive validity incorporates two important measures:
 Sensitivity – the extent to which a true characteristic is classified correctly
(Defloor and Grypdonck 2004).
 Specificity – the extent to which the absence of a characteristic is correctly
classified (Defloor and Grypdonck 2004).
The relationship between sensitivity and specificity is often illustrated in a receiver
operator characteristic curve (ROC). This plots the true positive results (sensitivity)
against the false-positive results (specificity) over a range of cut-off values (Table
2.5). Overall test accuracy is described as the area under the ROC curve, the larger
the area the better the test (Fletcher, Fletcher and Fletcher 2014).
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Table 2.5 The relationship between a Risk Assessment Instrument
result and pressure ulcer development
Pressure Ulcer development
Present Absent
Risk
assessment
scale
prediction
Positive
(at risk)
True positive
(correct)
False positive
(incorrect)
Negative
(not at risk)
False negative (incorrect) True negative (correct)
Based on Fletcher et al 2014 The relationship between a diagnostic test result and the
occurrence of disease
Measures of sensitivity and specificity are also routinely used in the evaluation of
diagnostic screening tests but there are important differences in the objectivity of
the measures involved as well as the overall aims of these instruments. Diagnostic
screening tests often incorporate information from objective laboratory measures
e.g. amniocentesis testing to detect babies with chromosomal abnormalities in pre-
natal care (Alfirevic, Mujezinovic and Sundberg 2009) and the Pap test to identify
those with cervical cancer (Nanda et al. 2000). However, the measurement of
pressure ulcer risk factors is more subjective because objective measures are not
available in routine practice. Nurses’ therefore use their clinical judgement
regarding the presence and magnitude of risk factors e.g. a nurse assesses a
patient’s mobility by a combination of observation, history taking and sometimes
liaison with other members of the Multi-Disciplinary Team rather than by an
objective measure. Skin vulnerability is another example where no objective
measure is routinely used, rather nurses’ use clinical assessment skills which
incorporates their subjective clinical judgement. These subjective measures are
more prone to error which could affect the predictive validity of an instrument.
In addition while diagnostic screening tests aim to identify the actual presence of
disease, Risk Assessment Instruments aim to identify the ‘risk’ of pressure ulcer
development i.e. before it happens so that preventative measures can be put in
place to avoid the development of a pressure ulcer (Defloor and Grypdonck 2004).
This is a critical difference and presents a challenge to the sensitivity and specificity
evaluation of pressure ulcer Risk Assessment Instruments. Firstly there is no
reference standard for pressure ulcer ‘risk’ and despite the differences between
pressure ulcer ‘risk’ and pressure ulcer ‘presence’, evaluation is commonly
achieved by comparing the Risk Assessment Instrument risk categorisation (i.e. at
risk or not at risk) with subsequent pressure ulcer outcome, i.e. pressure ulcer
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development or not (Kottner and Balzer 2010). Secondly, the instigation of
preventative interventions is a key element of standard clinical practice and this will
impact the instrument performance in the study population i.e. it is possible that
poor instrument performance is a result of effective preventative care (Deeks 1996;
Defloor and Grypdonck 2004). Preventative care is a confounding variable that
presents an irresolvable problem in predictive validity studies of Risk Assessment
Instruments as it would be unethical to withhold care (Defloor and Grypdonck 2004;
Gould et al. 2002). Risk Assessment Instruments are routinely used in clinical
practice to guide decision making about the instigations of preventative
interventions to reduce pressure ulcer development. Ideally then, their use would
prompt action to prevent pressure ulcer development in those at risk, which would
decrease sensitivity and specificity results, suggesting that predictive validity is not
an appropriate property to evaluate Risk Assessment Instruments (Deeks 1996;
Defloor and Grypdonck 2004). Furthermore, evaluation of predictive validity does
not provide useful information to indicate whether use of the Risk Assessment
Instrument leads to a reduction in pressure ulcer incidence (Deeks 1996)..
2.4.7.2 Predictive validity of existing instruments
Despite the limitations highlighted above there is a plethora of studies and several
systematic reviews examining predictive validity of pressure ulcer Risk Assessment
Instruments (Cullum et al. 1995; Pancorbo-Hidalgo et al. 2006; NICE 2014). The
Pancarbo-Hidalgo (2006) review was used as a reference for a more recent
systematic review conducted by NICE (2014). The NICE review identified 44
prospective cohort studies in which patients did not have pressure ulcers at
baseline. Overwhelmingly reports of the predictive validity of adult Risk Assessment
Instruments were about the Braden Scale (27) followed by the Norton Scale (11)
and the Waterlow Scale (10). Clinical judgment was also considered in 2 studies.
The results of the review should be interpreted cautiously as it was acknowledged
that the sensitivity, specificity and AUC measures were likely to be inaccurate due
to confounding of varying preventative treatments used in the included studies
(NICE 2014). The review also identified that included studies were generally at high
to very high risk of bias and had low pressure ulcer event rates (NICE 2014).
Interpretation is further complicated by:
 the use of different cut-off thresholds for Risk Assessment Scales.
 the use of different time periods for assessment (longer time periods may
result in increased pressure ulcer incidence and increased sensitivity).
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 heterogeneity of study populations (relating to age, comorbidities and other
risk factors) which would affect pressure ulcer incidence rates and
sensitivity/specificity.
 differences in pressure ulcer outcome definitions i.e. category 1 and
category 2 (which would affect incident rates and therefore predictive validity
measures).
Whilst recognising the limitations of the review, Table 2.66 provides an overview of
the AUC results for the three commonly used and researched Instruments (NICE
2014). It reports the summary statistic with its 95% confidence interval of the
median study and the range across studies (NICE 2014).
Table 2.6 Overview of NICE (2013) Review Evidence of AUC for 3
Commonly used and Researched Instruments
Scale No Studies AUC
(95% CI)
R:range of point estimates
Braden 9 74%
(70 to 78);
R: 55-88%
Waterlow 4 59%
(54 to 65);
R:54-90
Norton 2 56%
(51 to 61)
&
74% (70 to 78)
The criteria for the AUC were – 50.0-59.0: fail to discriminate; 60.0-69.0: poor
discrimination; 70.0-79.0: fair discrimination; 80.0-89.0: good discrimination; 90.0-100.0=
perfect discrimination.
Table 2.77 provides an overview of the sensitivity and specificity results for
particular cut- off thresholds (determined by instrument author recommendation) for
the three commonly used and researched instruments (NICE 2014).
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Table 2.7 Overview of NICE (2014) Review Evidence of Sensitivity and
Specificity for 3 Commonly used and Researched Instruments
Instrument Follow-up
period
Cut-off
threshold
No
Studies
Median
sensitivity
(95% CI)
R: range
Corresponding
specificity
(95% CI)
R: range
Braden <1 week
>1 week
<18
<18
4 75% (No CI)
R: 60-88%
80%
(68 to 89)
R: 46-100%
68%
(No CI)
R: 68-81%
73%
(66 to 79)
R: 14-100%
Waterlow > 1 week >10 3 87.5%
(47 to 100)
r: 82-90%
28%
(22 to 35)
R: 22-85%
Norton > 1 week <14 4 16%
(8 to 27) &
75%
(35 to 97)
R:0-89%
94%
(91 to 97)&
67%
(59 to 74)
R61-94%
The AUC results show that only the Braden scale median response and one study
of the Norton Scale has fair discrimination. In terms of sensitivity and specificity the
Braden Scale has the highest AUC and best balance between sensitivity and
specificity. The Waterlow Scale has the highest sensitivity at the cost of the lowest
specificity, while this situation is reversed for the Norton Scale. Clinical judgement
was also considered in a few studies of the review and found to have sensitivity of
50 % and 52% and specificity of 80% and 59% suggesting superiority of Risk
Assessment.
2.4.8 Effectiveness
The effectiveness of pressure ulcer Risk Assessment Instruments has been subject
to much discussion but few randomised controlled trials (RCTs) allowing
comparisons of pressure ulcer incidence rates for patients who undergo risk
assessment using an instrument, with those who undergo unstructured risk
assessment based on clinical judgement (Cullum et al. 1995; Deeks 1996; Kottner
and Balzer 2010; Pancorbo-Hidalgo et al. 2006; Beeckman et al. 2012). This was
considered in a Cochrane review which was subsequently updated (Moore and
Cowman 2010; Moore and Cowman 2014). The review identified only 2 eligible
RCTs (Saleh, Anthony and Parboteeah 2009; Webster et al. 2011) which showed
no statistically significant difference in pressure ulcer incidence rates between those
who underwent risk assessment using a Risk Assessment Instrument and those
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using the nurse’s clinical judgement. While there were methodological weaknesses
and high risk of bias with one study (Saleh, Anthony and Parboteeah 2009) due to
small sample, potential selection bias, attrition bias and performance and detection
bias, the second study (Webster et al. 2011) was considered to be at low risk of
bias (Moore and Cowman 2014). The review noted the lack of published literature
to assess the effectiveness of Risk Assessment Instruments on pressure ulcer
outcomes. It was concluded that at present there is no reliable evidence to indicate
that the use of structured Risk Assessment Instruments reduces the incidence of
pressure ulcer development (Moore and Cowman 2014). Conversely, neither is
there reliable evidence to support the use of clinical judgement over the use of Risk
Assessment Instruments. In addition, the statistical power of the studies included in
the Cochrane review has been questioned and it is proposed that there is a high
risk (>70%) that clinically relevant differences between groups were not detected
(Balzer et al. 2013). This needs to be considered when drawing conclusion from the
review and further robust research is needed to fully establish clinical effectiveness.
It is also important to note that the clinical effectiveness of a Risk Assessment
Instrument is underpinned by its practical application and other properties relating
to the development and validation of the instrument which are the focus of this PhD.
2.4.9 Summary of Existing Risk Assessment Scale development
and validation
The limited literature available for existing instrument development demonstrates a
lack of methodological rigour particularly with regard to ensuring content validity, as
many instruments were developed on the basis of earlier instruments, clinical
opinion and out of date literature reviews (Table 2.3) leading to the inconsistent
inclusion of risk factors (Table 2.4). There is also limited evidence of usability
testing during the development of existing instruments which is important when
considering the reliability and potential for widespread implementation and use of
the instrument. The involvement of patients to consider the acceptability of
assessment components of existing Risk Assessment Instruments is lacking which
could also impede implementation in clinical practice
The validation of existing Risk Assessment Instruments was most frequently
undertaken following instrument development and implementation and involved
consideration of reliability, aspects of validity and limited studies of effectiveness.
While there is some evidence relating to construct validity involving measurement of
convergent, known groups, and discriminant validity and criterion validity involving
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concurrent validity, overwhelmingly the evidence relates to predictive validity of
existing instruments (sections 2.4.2 - 2.4.7.2). However, the appropriateness of
using predictive validity to evaluate Risk Assessment Instruments is questioned and
a number of methodological issues highlighted.
2.5 The Need for a New Approach to Pressure Ulcer Risk
Assessment
Some of the limitations and methodological difficulties associated with the
development and validation of existing and widely used Risk Assessment
Instruments have been highlighted above and increasing evidence makes it timely
to re-consider conceptual and empirical base for instrument development. This has,
in the main, been lacking in the development of previous risk assessment
instruments (Table 2.3). In terms of the increasing epidemiological evidence, a
review of papers identified in previous publications (Nixon and McGough 2001;
Nixon et al. 2006b) identified the low quality of prospective cohort pressure ulcer
studies and their data sets including the lack of comparable data fields. This
suggested meta-analysis would not be feasible and highlighted the need to agree a
pressure ulcer risk factor Minimum Data Set to encourage the use of consistent
factors across studies. This would facilitate meta-analysis, case-mix adjustment and
provide the fundamental components for pressure ulcer risk assessment in clinical
practice.
In addition there are some practical problems associated with Risk Assessment
Instrument use in practice. While many were designed for use on patients without
pressure ulcers to identify those ‘at risk’, they are in practice often used for all
patients, that is those with and without existing pressure ulcers and they do not
differentiate between these two groups. This may be a key limitation, since it means
that nurses might disregard the presence of an existing ulcer in their clinical
assessment and decision making and hence fail to initiate appropriate secondary
prevention and treatment interventions, which could lead to the progression of a
more severe pressure ulcer. This resonates with findings from the Pressure UlceR
Programme of reSEarch (PURPOSE) severe pressure ulcer study, which was a
small retrospective case study that identified that nurses failed to respond to signs
that a patient had a pressure ulcer or was at risk of developing one (Pinkney et al.
2014). In addition, the PUPROSE pain cohort study indicated that the presence of a
Category 1 pressure ulcer is a key predictor of subsequent Category ≥2 pressure 
ulcers increasing the odds by 2-3 fold (Nixon et al. Submitted). However,
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assessment of skin condition is not universally incorporated into Risk Assessment
Instruments (only included in 5 of the 14 instruments considered in the NICE
systematic review –see Table 2.4) and is not included in some of the most widely
used instruments (Norton and Braden), which increases the risk of this important
factor being excluded from the nurses decision making process.
Another issue is that a full detailed risk assessment is undertaken on all patients
even those who are clearly not at risk. This unnecessarily diverts nursing time away
from other priorities. There is a need, therefore to streamline the assessment
process to incorporate a screening stage that would allow those who are obviously
‘not at risk’ to be quickly identified, preventing the need for a more detailed full
assessment. In addition, existing Risk Assessment Instrument incorporate scales
and numerical scoring systems to identify levels of risk which are often used to
provide the basis for care planning and the instigation of preventative interventions
(Gould et al. 2002; Papanikolaou, Lyne and Anthony 2007; Kottner and Balzer
2010). However, it is noteworthy that patients with the same score could have
different risk profiles and require different care interventions e.g. some patients may
require management of skin moisture and some may require management of poor
sensory perception. The use of an overall numerical score does not encourage
nurses to consider the patients individual risk profile in care planning and this could
lead to a lack of management of some risk factors.
While there remains some practical problems and empirical uncertainty regarding
the benefits of using existing Risk Assessment Instruments there are coherent
reasons for their continued use in clinical practice. Firstly, their use is advocated in
current pressure ulcer prevention guidance (NPUAP/EPUAP 2009; NICE 2014) and
is considered a key component of prevention initiatives such as the SKIN bundle
(Gibbons et al. 2006; Whitlock 2011). Secondly they offer a standardised and
transparent approach to the assessment process. This makes the use of Risk
Assessment Instruments appealing to clinical experts and healthcare organisations
who are concerned with delivering the UK NHS quality agenda including the Safety
Thermometer (DH 2012), as well as providing evidence of assessment to facilitate
legal defence in case of litigation (Kottner and Balzer 2010).
Taking into account the limitations of current Risk Assessment Instruments, a fresh
approach is needed to incorporate a minimum risk factor data set (to enable future
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multi-variable modelling and meta-analysis) and to enable a more thoughtful
approach to the assessment process which should facilitate the following:
 Discrimination of patients ‘at risk’ and ‘not at risk’ of pressure ulcer
development.
 Discrimination of patients with and without existing pressure ulcers
 Enhanced support for decision making with regard to:
i. the depth of the assessment required (i.e. screening and/or full
more detailed assessment)
ii. the relative importance of specific risk factors when considering the
patients risk status.
iii. Consideration of the patients individual risk profile (i.e. risk factors
present) to provide a ‘framework’ for care (i.e. underpin appropriate
care planning and the instigation of preventative/management
interventions).
The term ‘framework’ refers to a basic structure underlying a system, concept, or
text (Oxford and Dictionary Accessed October 2014) and in this context provides
the foundation for subsequent care planning. For this reason the new instrument
and decision tool will be referred to as the Pressure Ulcer Risk Assessment
Framework.
2.6 Aim of PhD
The overall aim of this PhD was to develop a Risk Assessment Framework for use
with adult populations in clinical practice, underpinned by a Pressure Ulcer
Minimum Data Set. The Risk Assessment Framework is intended to be used for the
prevention and management of generic mobility related pressure ulcers.
2.7 Methodological Overview
2.7.1 Important Psychometric Properties in the Development and
Validation of a New Risk Assessment Framework
In order to identify an appropriate methodological approach the requirements of the
new Risk Assessment Framework (section 2.5) were considered, allowing the key
psychometric properties of importance to be identified. While the new Framework
intends to move away from the traditional Risk Assessment Instrument approach of
incorporating numerical scales which allow risk to be condensed into a single score,
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the discriminatory and being able to identify pressure ulcer risk remain a key
requirement for the new Framework. In addition, the new Framework will still need
to incorporate some means of assigning a value for the presence of each risk
factor, which can be taken into consideration in the overall assessment of the
patients risk status and this is in keeping with scale characteristics (Table 2.1).
Therefore some of the properties considered in the development and validation of
traditional Risk Assessment Instruments are relevant and are discussed below.
The evaluative properties and the ability of the pressure ulcer Risk Assessment
Framework to detect clinically meaningful changes in patients’ condition over time is
also a key consideration despite being overlooked in the literature. This is an
important omission as in practice patients requiring an escalation of care
interventions may be missed, increasing the risk of pressure ulcer development.
Conversely, it could also result in those whose condition has improved, continuing
to receive unnecessary interventions resulting in the inappropriate use of scarce
resources.
At the development stage the underpinning and fundamental property that must be
addressed to achieve Framework requirements is that of content validity (Table
2.2). Content validity is important to ensure that the instrument adequately
represents the domain it is supposed to measure. It is important to establish content
validity before other psychometric properties are evaluated as testing other
measurement properties will not replace or rectify problems with content validity
(FDA DHHS 2009). The acceptability and usability (format, design, clarity,
comprehension, language) of the Risk Assessment Framework needs to be
considered to facilitate the long-term implementation of the decision tool. This is
particularly important due to the increased instructions and support for decision
making which are integrated into the Framework and the need to ensure these can
be interpreted as intended. This will also ensure its content is relevant to clinical
nurses and would provide useful information to inform decision making (Greenhalgh
et al. 1998). There is often a tension between maximising psychometric properties
and the feasibility for use in routine practice (Greenhalgh et al. 1998) and this
needs to be considered throughout development.
Moving forward the reliability (Table 2.2) of the Risk Assessment Framework will be
assessed allowing the consistency and stability of the decision tool to be
established (Streiner and Norman 2008). In addition, establishing the construct
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validity of the Risk Assessment Framework will incorporate consideration of
convergent, known groups and discriminant validity (Table 2.2). This is important as
it will demonstrate evidence of logical relationships among items, domains and
concepts that should exist with measures of related concepts or scores (FDA DHHS
2009). This is particularly relevant for the assessment of risk factor items that will be
incorporated into the Framework e.g. one would expect there to be an association
between the mobility items of the Risk Assessment Framework and mobility items
of the Braden Scale which would provide some evidence of convergent validity.
Evidence of known group differences could be considered by comparing the risk
categories allocated for groups of patients where there would be expected
differences e.g. elective and acute patients. It is recognised that construct validity is
an ongoing process and further aspects of construct validity can be assessed as
more is learnt about the instrument (Streiner and Norman 2008).
Once these fundamental aspects of validity are satisfied, the responsiveness of the
Risk Assessment Framework to detect clinically significant changes can be
assessed which is important as these changes would influence the instigation or
withdrawal of preventative interventions. The limitations associated with evaluating the
predictive validity of existing instruments are noted sections 2.4.7.1 and 2.4.9 and are
relevant to the Risk Assessment Framework i.e. the instigation of preventative
interventions prevents pressure ulcer development and affects the sensitivity and
specificity of the instrument. The new decision tool does not aim to predict those who
will develop a pressure ulcer, rather it aims to identify pressure ulcer risk and/or
pressure ulcer presence to support clinical decision making and prompt the instigations
of appropriate interventions, to address the patients specific risk profile. It is therefore
not appropriate to evaluate the predictive properties of the decision tool. The longer-
term evaluation should more usefully evaluate whether the use of the decision tool
impacts the process of care, particularly whether its use prompts the instigation
appropriate interventions in clinical practice. Furthermore, the impact of using the Risk
Assessment Framework on patient outcomes should be assessed to establish its
clinical effectiveness.
2.7.2 Methodological Considerations
As there is no universally recognised methodologicauol approach specific to the
development and validation of a pressure ulcer Risk Assessment Framework,
instrument development methods used in other fields were considered. The
theoretical basis of patient health status and patient reported outcome measures
has accepted methods for instrument development and validation (SAC 2002).
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Guidance for the review and evaluation of Patient Reported Outcome measures
(FDA DHHS 2009) and review criteria for health status and quality of life
instruments were developed (and subsequently updated) by the Scientific Advisory
Committee (SAC) of the Medical Outcomes Trust (SAC 2002). This guidance has
influenced the development and validation of quality of life instruments (Gorecki et
al. 2013) and the appraisal of health outcome measures (Bryant et al. In pres),
providing examples of its application in different fields and was considered relevant
to the development and validation of the Risk Assessment Framework. In addition
evidence relating to the development and validation of decision tools such as
clinical prediction models were considered (Steyerberg 2010).
The involvement of the population of intended use is generally considered important
in the development of health status, outcome measures, quality of life patient
reported outcome measures and decision tools (Greenhalgh et al. 1998; SAC 2002;
FDA DHHS 2009; Bryant et al. In pres; Liu, Wyatt and Altman 2006). For the
development of the Risk Assessment Framework the involvement of both nurses
and patients was considered important. Nurses are the key users of Risk
Assessment Instruments therefore their views should be sought with regard to the
content, acceptability and usability of the new Framework during its development,
though this is only reported for a few existing instruments (Table 2.3). While nurses
may be the key users of Risk Assessment Framework they should be used in
collaboration with the patient to facilitate shared decision making and it is proposed
that the patients’ views should be taken into account during Framework
development. This may be particularly relevant to the acceptability of the
assessment methods which could influence the usability and acceptability of the
Framework.
When considering the content validity and predictive properties of the Risk
Assessment Framework, methods for the development and validation of decision
tools such as clinical prediction models are available. These include multivariable
modelling (either from single studies or meta-analysis from a number of studies) to
identify the content items for a risk instrument, with subsequent model testing on a
‘new’ prospective target population (Steyerberg 2010). This would also allow an
evidence-based method of weighting risk factors rather than the process used for
most available Risk Assessment Instruments where there is no weighting or
arbitrary weighting. It is acknowledged that large datasets would be required to
develop a data driven Risk Assessment Instrument (Papanikolaou, Lyne and
Anthony 2007). This was a key consideration in the methodological approach of this
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PhD particularly in relation to the need for a Minimum Data Set and the content of
the Risk Assessment Framework.
2.7.3 Methodological Approach of PhD
Aspects of the methodology used in the development and validation of health status
and quality of life instruments and clinical prediction models noted above (section
2.7.2) were considered relevant to the aim of the PhD and provided the basis for
the development and validation of the pressure ulcer Risk Assessment Framework.
The approach incorporates six distinct phases, the first four of which comprise this
PhD and are concerned with developing the conceptual basis, content validity, and
acceptability and usability of the Risk Assessment Framework (Figure 2.1):
1) developing the evidence base by undertaking a systematic review of the
epidemiological literature relating to pressure ulcer risk factors to identify those
most predictive of pressure ulcer development.
2) consensus study, incorporating an expert group, consideration of the evidence
service user views to agree a list of patient characteristics and ensure content
validity for Minimum Data Set and Risk Assessment Framework.
3) conceptual framework development to underpin the PhD and the Risk
Assessment Framework.
4) design and pre-testing to confirm content validity with its intended end users
and ensure the Risk Assessment Framework is easy to understand and use.
This leads to two post PhD phases for clinical evaluation (Figure 2.1):
5) reliability, data completeness, clinical usability & validity (convergent,
discriminant & known groups).
6) responsiveness and the impact of using the Risk Assessment Framework on
the care process and patient outcomes in clinical practice
A detailed account of the aims, methods and results of each of the PhD work
phases will be undertaken in subsequent chapters of this Thesis and provides the
foundation for the ongoing validation of the new Risk Assessment Framework.
2.8 Summary
While there are limitations associated with the development and validation of
existing pressure ulcer Risk Assessment Instruments, they are routinely used in
clinical practice in order to identify those at risk of pressure ulcer development to
facilitate the instigations of preventative interventions. With more structured
approaches to risk assessment being favoured and increasing epidemiological
evidence being available, it is timely to consider the development and validation of
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a new evidenced-based decision tool, the Risk Assessment Framework for use in
adult populations in clinical practice. Its development will utilise a structure
approach drawing on methods used in the development and validation of other
types of health-related instruments. Each phase of development incorporating this
PhD will be discussed in detail in subsequent Thesis chapters.
.
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Chapter 3 Systematic Review of Pressure Ulcer Risk Factors
3.1 Introduction
This chapter discusses phase 1 of the development and validation of a Risk
Assessment Framework and underpinning Minimum Data Set, the systematic review.
This was undertaken to gain a clearer understanding of the risk factors most predictive
of pressure ulcer development, using the best quality evidence. The chapter provides a
detailed account of the methodological considerations, aims and methods of the review
with particular focus on the development of the quality appraisal and data synthesis
methods used. It goes on to present the results of the review and discusses the
implications of the findings as well as the limitations of the review methods and
literature.
3.2 Systematic reviews
Keeping up to date with relevant studies in a particular field is time consuming, requires
individuals to identify all relevant research and then be able to critically appraise this, in
order to decide whether it is credible and applicable to their area of practice. Individual
studies within a specific field may generate conflicting results, due to bias,
methodological flaws or by chance and this can make their interpretation difficult (CRD
2009). Systematic reviews facilitate an objective review of the literature and aim to
identify, evaluate and summarise all relevant individual studies to make evidence more
accessible to decision makers which could include health care workers, researchers
and policy makers (Egger, Smith and O'Rourke 2001; Cochrane 2009; CRD 2009).
Systematic reviews may also reveal inadequacies in the evidence base and the need
for further research in the field under consideration (Egger, Smith and O'Rourke 2001).
The key characteristics of a systematic review are (Cochrane 2009), Section 1.22):
 A clearly stated set of objectives with pre-defined eligibility criteria for studies
 An explicit, reproducible methodology.
 A systematic search that attempts to identify all studies that would meet the
eligibility criteria.
 An assessment of the validity of the findings of the included studies, for
example through the assessment of risk of bias.
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 A systematic presentation, and synthesis, of the characteristics and findings of
the included studies.
Guidance for undertaking each stage of a systematic review is available, though this is
weighted towards those related to interventions, rather than observational studies
(Cochrane 2009; CRD 2009). In addition there are also standards for the preferred
reporting items for systematic reviews and meta-analyses: the PRISMA statement
(Moher et al. 2009) which superseded the QUOROM (Quality Of Reporting Of Meta-
analyses) statement (Moher et al. 1999). These guidelines are not in themselves is for
assessing the quality of research.
3.3 The need for a systematic review in this PhD
Systematic reviews in the pressure ulcer field have been undertaken previously,
concerning Risk Assessment Instruments (Cullum et al. 1995; McGough 1999;
Pancorbo-Hidalgo et al. 2006; Moore and Cowman 2010; Moore and Cowman 2014;
NICE 2014). While of relevance to this PhD the systematic reviews of Risk Assessment
instruments focus on sensitivity and specificity and clinical effectiveness of the
instrument overall, rather than considering the predictive ability of their risk factor
components. The systematic review undertaken as part of this PhD is concerned with
identifying risk factors predictive of pressure ulcer development, which will involve
consideration of wider epidemiological literature, incorporating a comprehensive range
of risk factors. In the absence of an existing pressure ulcer risk factor systematic
review, this was considered a necessary step to ensure all important risk factors were
considered in order to develop a clear conceptual basis and facilitate content validity of
the Minimum Data Set and Risk Assessment Framework.
3.4 Aim
The aim of this study was to identify and consider risk factors independently predictive
of pressure ulcer development in adult patient populations.
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3.5 Methodological Considerations
To inform the development of the systematic review methodology a review of papers
identified in previous publications was undertaken (Nixon and McGough 2001; Nixon et
al. 2006b; NICE 2014). This identified some key methodological issues including:
 Poor general reporting of methods and results making it difficult to assess the
quality of some studies.
 A large number of poorly reported studies reporting univariate analyses.
 Different study designs considering pressure ulcer risk factors.
 Poor statistical design, e.g. insufficient number of events which is problematic
as it can produce overestimation and underestimation of the true effect
(Peduzzi et al. 1995).
 The unit of analysis not at the patient level, rather at ulcer or multiple time point
level without appropriate statistical adjustment. This presents a potential
problem as the number of events may be inflated and demonstrate spurious
statistical significance (Altman and Bland 1997).
 Inclusion of patients with and without pressure ulcers at cohort inception (and
different Grades/Stage), though it is recommended that systematic reviews of
prognostic studies should involve patients at the same starting point in the
disease (Altman 2001).
 Lack of comparable data fields for risk factors impacting on interpretation and
further use of the data in meta-analysis.
The review of papers identified in previous publications (Nixon and McGough 2001;
Nixon et al. 2006b) proved particularly useful for planning the eligibility criteria and
quality appraisal methods for the review.
3.5.1 Study Design Considerations
A key consideration of the eligibility criteria was identifying studies with appropriate
design. There are many types of studies which may inform our understanding of risk
factors. In many areas of medicine, the first step involves cross-sectional or prevalence
studies which allow the comparison of patient characteristics for those with and without
the disease. They provide the basis for hypothesis testing, but do not identify which
characteristics are predictive of the disease, nor can they differentiate cause and effect
from association (Mann 2003). Case control studies are useful for rare conditions,
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when there is an extended latent period between the exposure and the disease and
can help to determine hypotheses for future study (Mann 2003). This type of study is
prone to sampling and recall bias as well as confounding. Due to these limitations,
cross-sectional and case control designs were excluded from the review.
While RCTs are designed specifically to answer questions of treatment effectiveness
(CRD 2009), they can also provide risk factor evidence. However, patients enrolled in
RCTs often differ to those seen in everyday practice for a number of reasons including
the exclusion of minority groups such as women and the elderly (Gurwitz, Col and
Avorn 1992) and the setting in which they are undertaken is often different to general
treatment settings (Egger, Smith and Schneider 2001). In addition, patients have to
meet intervention related inclusion and exclusion criteria, which may make the sample
unrepresentative of the normal population, e.g. a limitation of studies considering
support surfaces for the prevention of pressure ulcers is that weight limits on some
mattresses, precludes the inclusion of patients with very low and very high weights.
However, a major advantage of RCTS is that all patients are recruited and followed up
prospectively and they can be a good source of high quality data (e.g. where attrition is
low and intention to treat analysis is undertaken (CRD 2009). So, despite the limitation
of RCTs, they were included in the review with quality related exclusion criteria.
Cohort studies are considered the most appropriate study design for determining the
incidence and natural history of a condition and are the predominant study design in
risk factor research (Mann 2003; Altman 2009; Moons et al. 2009; Jones 2010). Cohort
studies allow the measurement of potential causes (risk factors) before the outcome
occurs, enabling statistical analysis to calculate the effect of each variable on the
probability of the outcome (Mann 2003). As cohort studies are at risk of confounding, it
is important that all potentially relevant variables are considered to avoid any being
missed.
The advantages and disadvantages of prospective and retrospective cohort studies
were carefully considered. Prospective cohort studies allow the collection of risk factor
data that might not be available in medical records and allow the inclusion of potential
confounders. They also allow researchers to ensure the data is collected in an
standardised manner to reduce the risk of measurement bias (Moons et al. 2009;
Fletcher, Fletcher and Fletcher 2014). A potential area of bias for prospective studies is
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the need for patients to consent for inclusion in the research, which affects the
generalisability of study populations, e.g. the exclusion of patients who lack capacity to
consent or are very ill. This is not a problem for retrospective data sets, where patient
consent is not usually required. Prospective cohort studies can also be inefficient
where the incidence of the outcome of interest is low (Mann 2003). This can be a
problem in the pressure ulcer field, resulting in the need for large sample sizes, which
are often precluded by cost. As a consequence prospective studies in the field tend to
be small which limits the generalisability of the results.
Retrospective studies, often referred to as record reviews, are cheaper and easier to
conduct, as the data has already been collected, with the potential for making use of
existing computerised data bases (Mann 2003; Fletcher, Fletcher and Fletcher 2014).
Studies that use large institutional data sets also tend to have the added advantage of
longer follow-up periods (Altman 2009). Patient consent is often not required for this
type of study, facilitating a more representative sample. However, selection bias can be
a problem as the studies tend to be undertaken only where the data bases are
available and there is no opportunity to chase-up missing data. Other limitations
associated with this type of research include inadequacies of the data base fields used
(i.e. lack of comprehensive inclusion potential risk factors and confounding variables)
and that the information might not be collected in a standardised manner. However,
this is not always the case and the use of large comprehensive databases can be
particularly useful for studying potential risk factors (Fletcher, Fletcher and Fletcher
2005).
While there are advantages and disadvantages to prospective and retrospective
approaches, both were considered relevant to this review and were included in the
inclusion criteria (section 3.6.1.1). The overall quality of the study needs to be informed
by the thoroughness with which the study is conducted rather than solely on the basis
of the research design (CRD 2009; Mann 2003). Even the highest regarded study
designs can be poorly conducted and there is inconsistent use of study design ‘labels’
in the literature. It is therefore important that the specific aspects of the study design
that may introduce bias are considered when assessing the quality of any study in
order to make judgement about the credibility of the research (CRD 2009).
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3.5.2 Quality Appraisal Considerations
Various tools have been developed to assess the quality of primary research studies
which are often linked to the specific design of the study. The most developed area is
for RCTs where a review identified 25 scales and 9 checklists to assess the quality of
evidence about treatment effectiveness (Moher et al. 1995). The scales and checklists
include composite scales incorporating a range of quality components which are
combined in a single numerical score and have been criticized in relation to the varying
dimensions included, their size and complexity as well as the lack of transparency and
reliability (Juni, Altman and Egger 2001; Cochrane 2009). Presently a more transparent
approach to appraising study quality is advocated incorporating consideration of the
risk of bias in a number of domains e.g. for RCTs, selection bias, performance bias,
detection bias, attrition bias, reporting bias (GRADE Working Group 2004; Guyatt et al.
2008; Cochrane 2009).
For observational studies a systematic review for assessing study quality identified 53
checklists and 33 scales (Sanderson, Tatt and Higgins 2007). Of these one third were
designed for study specific reviews and one third for critical appraisal. In keeping with
tools for RCTs the review found that the inclusion of quality criteria and their weighting
was inconsistent and there was a lack of an obvious single tool for assessing the
quality of observational studies. The review authors concurred with those from other
fields about avoiding the use of summary scores and taking into account the particular
study design and topic area (Sanderson, Tatt and Higgins 2007). The review
highlighted the need for a rigorous development process for tool design and the need
to reach consensus on the quality domains that should be included.
When considering the quality appraisal method for this systematic review it was
recognised that specific design related aspects of quality would need to be addressed.
However as the aim of the study was to identify risk factors independently predictive of
pressure ulcer development, it was concluded that the detailed quality appraisal
needed to focus on the assessment of bias relating to risk factors. These type of
studies fall into the prognosis studies category and include ‘clinical studies of variables
predictive of future events as well as epidemiological studies of aetiological risk factors’
(Altman 2001). Though, there is no widely agreed quality criteria for the assessment of
prognostic studies (Altman 2001), following a review which evaluated the quality of
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prognosis studies in systematic reviews, a framework for the assessment of study
quality was proposed. This incorporates a total of 28 items organised into 6 key
domains including study participation, attrition, prognostic factor measurement,
outcome measurement, confounding measurement and account and analysis (Hayden,
Côté and Bombardier 2006). The framework incorporates principles of quality and bias
that were relevant for the risk factor studies of this review. These principles, in addition
to design related criteria and methodological considerations in the analysis, meta-
analysis and publication of observational studies provided the basis for the overall
approach to quality appraisal for this review (Harrell et al. 1985; Simon and Altman
1994; Peduzzi et al. 1995; Altman 2001; Egger, Smith and Schneider 2001; Mak and
Kum 2005; Maltoni et al. 2005; von Elm et al. 2007; Royston, Altman and Sauerbrei
2006; CRD 2009; Schulz et al. 2010; Steyerberg 2010; Altman 2009; Mallett et al.
2010). The application of these would be addressed in two ways; firstly through the
inclusion and exclusion criteria of the review, allowing studies with aspects of quality
and bias that was considered unacceptable to be screened out and; secondly, through
a detailed and consistent quality appraisal.
3.6 Methods
A systematic review of primary research was undertaken. The methodological
approach was based upon the systematic review methods recommended for questions
of effectiveness (Cochrane 2009; CRD 2009), and adapted to identify risk factor
studies with consideration of the methodological limitations including bias and
confounding associated with observational studies of prognosis (Harrell et al. 1985;
Simon and Altman 1994; Peduzzi et al. 1995; Altman 2001; Egger, Smith and
Schneider 2001; Mak and Kum 2005; Maltoni et al. 2005; von Elm et al. 2007; Hayden,
Côté and Bombardier 2006; Royston, Altman and Sauerbrei 2006; CRD 2009; Schulz
et al. 2010; Steyerberg 2010; Altman 2009; Mallett et al. 2010) and the PRISMA
statement (Appendix 5) (Moher et al. 2009).
3.6.1 Study Eligibility
Key aspects of methodological quality were considered in the eligibility criteria of the
systematic review:
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 The representativeness of the source and study population and that the level of
participation in the study by eligible patients was adequate (Altman 2001; Mak
and Kum 2005; Hayden, Côté and Bombardier 2006).
 Clearly defined outcome of interest to ensure this is the same for all patients
included in the study (Altman 2001; Mak and Kum 2005; Hayden, Côté and
Bombardier 2006).
 Sufficient length of follow-up to allow that the outcome of interest to manifest
(Altman 2001; Mak and Kum 2005; Hayden, Côté and Bombardier 2006).
 Study attrition for cohort studies including prospective and record reviews were
considered to ensure the proportion of the study sample completing the study
and providing outcome data adequately represented the sample (Altman 2001;
Mak and Kum 2005; Maltoni et al. 2005; von Elm et al. 2007; Hayden, Côté and
Bombardier 2006).
 Randomised allocation to treatment for RCT, to ensure that the intervention is
allocated by a play of chance and the groups are comparable with respect to
any known or unknown confounding factors analyses (CRD 2009; Schulz et al.
2010).
 Intention to treat analyses for RCTs, to ensure that all randomized patients
(whether they adhere to the study protocol or not) are included and analysed in
their original allocated group to avoid attrition bias (CRD 2009; Schulz et al.
2010).
 Multivariable analyses - to identify factors that are independently associated
with pressure ulcer development.
3.6.1.1 Inclusion criteria
i) primary research.
ii) adult study populations in any setting.
iii) outcome was the development of a new pressure ulcer(s).
vi) outcome clearly defined as ≥ grade/stage 1 (AHCPR 1992; EPUAP 1999) or 
equivalent.
iv) prospective cohort, retrospective record review or a controlled trial.
v) length of follow-up at least 3 days, with exception of operating room studies for
which no minimum was set.
vii) multivariable analyses were undertaken to identify factors affecting pressure ulcer
outcome.
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viii) the unit of analysis was the patient.
3.6.1.2 Exclusion criteria
i) paediatric study populations.
ii) cross-sectional, case-study.
iii) patient recall, patient self-report or analysis of General Practitioner records (due to
issues of reliability).
iii) duplicate publication of patient dataset.
iv) cohort studies (prospective and record reviews) were excluded from the review if
>20% of the study sample were excluded from analysis for reasons including
withdrawal, death, loss to follow-up and missing records (Altman 2001; Egger, Smith
and Schneider 2001; Maltoni et al. 2005; von Elm et al. 2007).
v) Controlled trials were excluded unless both the following minimum criteria applied:
randomised allocation to treatment and intention to treat analyses (CRD 2009; Schulz
et al. 2010).
No language restriction was applied.
3.6.2 Search and Data Sources
Fourteen electronic databases were searched, each from inception until March 2010
(Appendix 6): AMED, British Nursing Index, MEDLINE, EMbase, PsycINFO, CINAHL,
Cochrane Library, Proquest, Networked Digital Library of Theses and Dissertations,
International Theses in Progress, Theses Canada Portal, Australian Digital Theses
Program, and Russian Academy of Sciences Bibliographies and Index to Theses. The
search strategy sought to identify all published and unpublished research studies
investigating risk factors for the development of pressure ulcers. The search strategy
was designed with guidance from the collaborative team and includes pressure ulcer
search terms (Cullum et al. 2001), OVID maximum sensitivity filters for Prognosis and
Aetiology or Harm and OVID maximum sensitivity filter for RCTs (CRD 2009). In
addition we hand searched specialist journals and conference proceedings, contacted
13 experts, searched the UK National Research websites and performed a citation
search on all included studies and systematic reviews identified in the search
(Appendix 6).
3.6.3 Data extraction
Abstracts were screened for relevance by one reviewer (CG) and checked by a second
(JN). Abstracts assessed as potentially relevant were obtained in full and reviewed
70
against the eligibility criteria by one reviewer (CG or SC) and checked by a third (JN).
Where the statistical methods were unclear and eligibility could not be determined,
statistical review was undertaken (JB). Disagreements were dealt with through
consensus.
Where studies fulfilled the eligibility criteria data were extracted by a single reviewer
(CG or SC) and checked by a second reviewer (JN). Where data was missing from the
publication attempts were made to contact the authors. Where duplicate publications of
patient datasets were identified, the most detailed report was used for data extraction.
Experts in the field were asked to review/data extract abstracts and articles not
published in English.
3.6.4 Quality Assessment
The studies that met the inclusion criteria were subject to further detailed quality
appraisal based upon a framework for assessing the quality of prognostic studies
(Hayden, Côté and Bombardier 2006) and methodological guidance in the conduct of
multivariable analysis (Harrell et al. 1985; Simon and Altman 1994; Peduzzi et al. 1995;
Altman 2009; Steyerberg 2010; Mallett et al. 2010).
To prevent duplication, the aspects of quality that had already been considered during
study eligibility assessment (section 3.6.1), were not repeated in the detailed quality
appraisal. The detailed quality appraisal comprised 7 quality criteria and 4 key quality
domains. The 7 quality criteria are as follows:
1. The baseline study sample (i.e. individuals entering the study) is adequately
described for key characteristics.
2. A clear definition or description of the risk factor measured is provided (e.g.
including dose, level, duration of exposure and clear specification of the method
of measurement).
3. Continuous variables are reported or appropriate (i.e. not data-dependent) cut
points are used.
4. Adequate proportion of sample has complete data for risk factors
5. Range of potential risk factors are measured (i.e. Key variables in conceptual
model).
6. Range of potential risk factors are accounted for in the analysis (i.e. appropriate
the adjustment).
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7. There is no selective reporting of results.
The 4 key quality domains are detailed below:
A. There is sufficient number of events (rule of thumb >10 events per risk factor.)
B. There is sufficient presentation of data to assess the adequacy of method and
analysis.
C. The strategy for model building (i.e. inclusion of variables) is appropriate and is
based on a conceptual framework.
D. The selected model is adequate for the design of the study.
Domain A (sufficient number of events) was critical because the results from fitted
regression models may not be accurate or precise if the number of events per risk
factor variable in the multivariable analysis is too small, with the risk of producing an
overestimation and underestimation of the true effect (Harrell et al. 1985; Simon and
Altman 1994; Peduzzi et al. 1995; Altman 2009; Steyerberg 2010; Mallett et al. 2010).
Domains B-D were based on the analysis section of the framework for assessing
quality in prognostic studies (Hayden, Côté and Bombardier 2006). Domain B
(sufficient presentation of data) was considered central as poor presentation of data
makes it difficult to assess adequacy of the method of analysis. Domain C (strategy for
model building) was valuable in ensuring all potential risk factors are considered in the
model. Failure to do this could result in the exclusion of important potential risk factors
and an overestimation of the effect of other risk factor variables included in the model.
Domain D (selected model adequate for the design), was important in giving an
indication of the overall confidence in the validity of the results of the study.
The contribution of the quality criteria to the assessment of the key quality domains is
detailed in Table 3.1. It should be noted that the key quality domains are not
independent and their inter-dependent relationships are detailed in Table 3.2.
As an example, in order to assess whether there is sufficient number of events (A), the
strategy for model building including the number of risk factors entered into the
multivariable model (C) must be considered (Table 3.2).
The detailed quality appraisal was undertaken by two reviewers (JN, SC) and
compliance for each criteria and domain was assessed with four possible outcomes
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(i.e. yes, no, partial or uncertain). In addition, some limitations of the criteria and
domains were also noted (poor/partial reporting for baseline study sample
characteristics, use of inappropriate cut points, absence of p value and CIs,
inappropriate inclusion of time dependent co-variates and record review), in order to
provide a synopsis of key limitations.
3.6.5 Study Classification
Following quality appraisal studies were classified as high, moderate, low and very low
quality using 4 key domains and the following criteria:
 High quality studies: yes for all key domains A-D
 Moderate quality studies: yes for key domain A and 2 other key domains
 Low quality studies: no for key domain A and no or partial for 1 or 2 other key
domains
 Very low quality studies: no for key domain A and no or partial for all 3 other
key domains.
3.6.6 Data Synthesis
Meta-analysis of the data was not feasible for this review because of heterogeneity in
the study designs, patient populations, risk factor descriptors, interventions used and
outcomes reported. As the main aim was to identify risk factors, rather than quantify
the effect size of the relationship between those factors and pressure ulcer
development, a narrative synthesis was carried out (CRD 2009).
For each study all factors entered into multivariable modelling and those which
emerged as significant (p=≤0.05) were identified. For studies using stepwise regression 
we included non-significant factors (p = ≥0.05) if these were reported in the final model 
as being independently associated with pressure ulcer development. Risk factors were
categorised into domains and sub-domains which were developed following review of
the risk factors reported in the primary studies. Evidence tables were generated for
each risk factor sub-domain, with a summary narrative synthesis by sub-domain and
domain. For each sub-domain the total number of studies entering the variable and the
total number where the variable emerges in the multivariable analyses and the quality
of studies are summarised. In the evidence tables Grade and Stage are recorded as
reported in individual studies.
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Table 3.1 Relationship between the Quality Criteria and Domains
Criteria contributing to the assessment of key quality
domains
Key Quality Domains
A. There is
sufficient
Number of
events (rule
of thumb >10
events per
risk factor)
B. There is
sufficient
presentation of
data to assess
the adequacy of
method and
analysis
C. The strategy for
model building (i.e.
inclusion of
variables) is
appropriate and is
based on a
conceptual
framework
D. The
selected
model is
adequate for
the design of
the study
1. The baseline study sample (i.e. individuals entering the
study) is adequately described for key characteristics X
2. A clear definition or description of the risk factor measured is
provided X X
X
3. Continuous variables are reported or appropriate (i.e. not
data-dependent) cut points are used. X X
4. Adequate proportion of sample has complete data for risk
factors X X
X
5. Range of potential risk factors are measured (i.e. Key
variables in conceptual model) X
X
6. Range of potential risk factors are accounted for in the
analysis (i.e. appropriate the adjustment). X
X
7. There is no selective reporting of results X X X
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Table 3.2 Relationship between Key Quality Domains
Other Impacting Key
Quality Domain
Assessment
Key Quality Domains
A. There is sufficient
Number of events
(rule of thumb >10
events per risk factor)
B. There is sufficient
presentation of data to
assess the adequacy of
method and analysis
C. The strategy for model
building (i.e. inclusion of
variables) is appropriate and is
based on a conceptual
framework
D. The selected
model is adequate
for the design of
the study
A. There is sufficient
Number of events (rule of
thumb >10 events per risk
factor)
X X X
B. There is sufficient
presentation of data to
assess the adequacy of
method and analysis
X X X
C. The strategy for model
building (i.e. inclusion of
variables)
is appropriate and is
based on a conceptual
framework or model
X X X
D. The selected model is
adequate for design of the
study
X
Gray shading indicates same key quality domain
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3.7 Results
3.7.1 General Study Characteristics
Of 5462 abstracts retrieved, 365 were identified as potentially eligible. Of these 54
fulfilled the eligibility criteria including 34 prospective cohort, 9 retrospective record
reviews and 11 RCTs (Figure 3.1). A summary of included studies are detailed in Table
3.3.
Reprinted from the international Journal of Nursing Studies, Coleman S, Nelson E A, Closs SJ,
Defloor T, Halfens R, Farrin A, Brown J, Schoonhoven L, Nixon J. Patient risk factors for
pressure ulcer development: systematic review. 2013, 50; 794-1003.
Figure 3.1 PRISMA Flow Chart of Studies
Retrieved n=5462
Not satisfying eligibility
criteria- excluded n=5097
Assessed as potentially
relevant, obtained in full
for further scrutiny n=365
Included n=54
 Prospective cohort (n=34)
 Retrospective record review (n=9)
 RCTs (n=11)
Not satisfying eligibility criteria n=311
Cohort/Record review
>20% lost to follow-up (n=14)
No multivariable analysis used (n=228)
Non-independent data (n=3)
RCT
Not randomised allocation to treatment (n=5)
Not intention to treat (n=21)
No adjusted analysis undertaken (n=39)
Non-independent data (n=1)
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Table 3.3 Summary of included studies
Study,
Country and
reference
Study
population (n
recruited &
type)
Other inclusion
criteria
Design and
analysis
method
n final
model
(PU%), n PU
dev &
Stage/Grade
Results: n risk factors (n in
model), model risk factor names
P
value
OR CI Overall study quality
and limitation notes
Allman et al
(1995)
USA
286 pts
Setting: acute
care hospital;
Speciality:
multiple
Admitted to
hospital within
previous 3 days,
aged ≥55 yrs, 
expected LOS in
bed or chair ≥5 
days, had a hip
fracture, expected
LOS (hospital) ≥5 
days. Excluded
pts with Stage ≥2 
PU, Friday
admission, active
skin disease that
would interfere
with PU
assessment and
previous
enrolment to
study. Consent
required.
Cohort
Backward
stepwise
Cox
regression
286 (12.9%),
37 Stage ≥2 
PU
9 (5)
Nonblanchable erythema if intact
sacral skin
Immobility
Dry sacral skin
Decreased body weight
Lymphopenia
0.05
0.02
0.04
0.03
0.003
7.5
2.4
2.3
2.2
4.9
1.0-59.1
1.1-4.9
1.0-5.2
1.1-4.5
1.7-13.9
LQS
Insufficient number of
events.
Baldwin &
Ziegler (1998)
USA
36 pts
Setting: acute
care hospital;
Speciality:
trauma
Adults aged 15-60
yrs, hospitalised
due to severe
trauma, previously
healthy, did not
require burn fluid
resuscitation, and
expected LOS
(hospital) ≥1 wk 
Cohort
Forward
logistic
regression
36 (30.6%),
11 Stage ≥1 
PU
7 (2)
Braden mobility subscore
Braden moisture subscore
0.02
0.04
0.3
3.0
0.1-0.8
1.1-8.3
VLQS
Baseline characteristics
are not reported. The
sample size is too small
and insufficient number of
events.
Bates-Jensen
et al (2007)
USA
35 non-surgical
pts
Setting: NH;
Speciality:
Long-stay
residents in 2 NH
eligible for a larger
nutrition trial (not
referenced) and
provided informed
Cohort
Generalised
logistic
regression
35 (45.7%),
16 Stage ≥2 
PU
5 (2)
Subepidermal moisture (at 1 wk)
Total Braden score
≤0.05 
≤0.05 
1.0
6.8
1.004-1.012
0.6-72.3
LQS
Inadequate sample size
resulting in wide CI.
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Study,
Country and
reference
Study
population (n
recruited &
type)
Other inclusion
criteria
Design and
analysis
method
n final
model
(PU%), n PU
dev &
Stage/Grade
Results: n risk factors (n in
model), model risk factor names
P
value
OR CI Overall study quality
and limitation notes
elderly/geriatric written consent.
Baumgarten
et al (2004)
2285 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality: NR
Pts aged ≥65, 
newly admitted to
NH, black or white
skin colour,
consent or relative
assent. Excluded
if previously
resided in a NH or
chronic care
facility for ≥8 days 
in the yr before the
NH admission.
Cohort
Cox
proportional
hazards
model
1938
(23.2%), 450
Stage ≥ 2 PU 
12 (3)
Black race
n of ADL dependencies
PU on admission
0.032
0.001
0.001
1.3
1.4
1.8
1.0-1.7
1.3-1.5
1.4-2.3
MQS
All risk factors are
categorical data rather
than continuous. 20%
missing data from final
model.
Bergquist, &
Frantz (1999)
USA
1711 non-
surgical pts
Setting:
community
/homecare;
Speciality:
elderly/geriatric
Home healthcare
agency, aged ≥60, 
no PU on
admission, non-
hospice, non-IV
therapy. Consent
not required.
Record
review
Stepwise
Cox
proportional
hazards
1567 (3.2%),
55 Stage ≥2 
PU
45 (10)
Limited to wheelchair
ADL dressing
Incontinence bowel &/or bladder
Braden mobility
Anaemia
Adult child primary caregiver
Male
Recent fracture
Oxygen use
Skin drainage
0.0198
<0.001
0.0195
<0.001
0.0021
<0.001
0.0281
0.0019
<0.001
<0.001
2.8
2.7
2.8
5.2
4.0
5.8
1.9
3.5
3.9
6.6
1.2-6.5
1.5-4.8
1.2-6.8
2.4-11.1
1.6-9.5
2.1-15.9
1.1-3.2
1.6-7.6
2.1-7.6
2.3-19.2
LQS
Record review and
insufficient number of
events. Inadequate
measurement of risk
factors (record review).
Bergstrom, &
Braden (1992)
USA
200 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality:
elderly/geriatric
Consecutive pt
admissions to
teaching NH were
screened and
included if >65 yrs,
at risk of PU
development
(Braden score
<17), free of
existing PU,
estimated LOS
Cohort,
logistic
regression
(backward
elimination)
200 (73.5%),
147 Stage ≥1 
PU, (38.5%),
77 Stage ≥2 
PU
Model 1
Stage ≥1 
Model 2
Model 1 10 (5)
Braden score
Diastolic BP
Temperature
Age
Protein (%RDA)
Model 2 10 (4)
Braden score
<0.01
<0.01
ns
ns
<0.05
<0.001
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
MQS
No CI reported.
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Study,
Country and
reference
Study
population (n
recruited &
type)
Other inclusion
criteria
Design and
analysis
method
n final
model
(PU%), n PU
dev &
Stage/Grade
Results: n risk factors (n in
model), model risk factor names
P
value
OR CI Overall study quality
and limitation notes
>10 days. Consent
required from pts
or family.
Stage ≥2 
Model 3
Stage = 1
Age
Systolic BP
Protein (%RDA)
Model 3 10 (4)
Braden score
Diastolic BP
Temperature
Iron (%RDA)
<0.05
<0.01
ns
<0.01
<0.01
<0.05
<0.01
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
Bergstrom et
al (1996)
USA
843 pts
Setting:
multiple;
Speciality:
multiple
Pts from 2 NHs, 2
university
hospitals and 2
VAMCs, ≥19 yrs, 
no PU on
admission,
admitted for care
within 72 hours.
Cohort
Logistic
regression
843
(12.8%), 108
Stage ≥1 PU 
Model 1
age, gender,
race, Braden
Scale and
preventive
measures;
Model 2
mobility,
activity and
primary
diagnoses
(13);
Model 3
Braden total
score and
primary
diagnoses
(13)
Model 1 6 (3)
Braden scale score
Age
Race
Model 2 15 (3)
Braden mobility
Braden activity
Cardiovascular disease
Model 3 14 (1)
Braden total
<0.001
<0.001
0.012
<0.001
0.004
0.023
<0.001
1.3
1.0
2.7
1.7
1.5
2.5
1.4
1.2-1.4
0.95-0.98
1.3-6.0
1.3-2.3
1.1-1.9
1.1-5.5
1.3-1.5
HQS
Berlowitz, &
Wilking (1989)
USA
185 non-
surgical pts
Setting: chronic
All admissions to
chronic care
hospital (requiring
medical, skilled
nursing,
Cohort
Stepwise
logistic
185 (10.8%),
20 Stage ≥2 
PU
11 (3)
Cerebrovascular accident
Bed or chair bound
Impaired nutritional intake
<0.05
<0.05
<0.05
5.0
3.8
2.8
1.7-14.5
1.0-14.0
1.0-17.9
LQS
Insufficient number of
events. Data collection
relied on clinical staff and
only partial reporting of
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care hospital;
Speciality:
medicine
rehabilitative
services) with
chronic medical
conditions. Pt
excluded if died or
discharged within
1 wk of admission
or required
transfer to an
acute care
hospital within 24
hrs of admission
(i.e. had PU at
baseline). Consent
not required -
record review
regression baseline characteristics.
Bostrom et al
(1996)
USA
112 pts
Setting:
multiple;
Speciality:
multiple
Medical and
surgical pts
admitted to 3
hospitals (tertiary,
general,
community) aged
≥18 yrs, able to 
give consent and
expected LOS
(hospital) ≥48 hrs 
Cohort
Logistic
regression
112 (8.04%),
9 Stage ≥1 
PU
7 (1)
N of layers between pt & mattress 0.001 NR
VLQS
Insufficient number of
events. Analysis reporting
inadequate. No CI
intervals reported. Time
dependent variables
included in the analysis.
Bourdel-
Marchasson
et al (2000)
France
672 pts
Setting: acute
care hospital;
Speciality:
elderly/geriatric
Pts recruited from
University hospital
wards and
geriatrics units
(>40% of in-pts
aged >65 yrs),
including
neurology,
gastroenterology,
orthopaedic or
vascular surgery,
internal and
geriatric medicine.
RCT
Cox
proportional
hazards
model
672 (44.5%),
299 stage ≥1 
PUs
NR (5)
Hypoalbuminemia
Lower limb fracture
Norton score 5-10 vs. >14
Kuntzman score
Control vs. nutritional intervention
<0.001
<0.001
0.04
0.003
0.04
1.1
2.7
1.3
1.2
1.6
1.0-1.1
1.8-4.1
1.0-1.6
0.3-4.6
1.0-2.4
MQS
Full details of modelling
not provided. Adequate
number of events is
assumed as large number
of events (299).
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Pts aged >65 yrs,
in acute phase of
a critical illness,
unable to move or
eat independently,
no PU on
admission.
Consent
requirement not
reported.
Boyle &
Green (2001)
UK
534 pts
Setting: ICU
ICU pts not
consented. PUs
developing after
day 1 admission
included in
analysis; PU on
admission
excluded.
Cohort
Parametric
survival
regression
(Weibull)
534 (5.2%),
28 Grade ≥1 
PU
7 (2)
Coma/unresponsiveness/paralysed
& sedated
Cardiovascular instability
0.001
0.035
4.2
2.7
30-77
4-70
LQS
Baseline characteristics
not reported. Insufficient
number of events.
Brandeis et al
(1994)
USA
4232 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality:
elderly/geriatric
Residents >60 yrs,
admitted to NHC
NHs during 1988
and 1989, no PU
on admission and
at 3-mth FU
(baseline
assessment)
Eligible residents
remained in the
home for ≥3 mths 
after baseline
assessment up to
21 mths. Consent
not required
record review
Cohort
Pooled
logistic
regression
4232
(12.9%),
546 Stage ≥2 
Model 1
High
incidence
Homes
1322
(19.3%), 255
Stage ≥2 PU 
;
Model 2
Low
Incidence
Homes
1365 (6.5%)
89 Stage ≥2 
PU
Model 1 15 (4)
Ambulation difficulty
Faecal incontinence
Diabetes
Feeding ADL
Model 2 15 (3)
Ambulation difficulty
Feeding ADL
Male
<0.001
<0.001
<0.006
<0.001
<0.001
<0.001
<0.007
3.3
2.5
1.7
2.2
3.6
3.5
1.9
2.0-5.3
1.6-4.0
1.2-2.5
1.5-3.3
1.7-7.4
2.0-6.3
1.2-3.6
HQS
Record review.
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Chan et al
(2005)
Singapore
666 pts
Setting: acute
care hospital;
Speciality:
multiple
All hospital in-pts
on census date,
aged >18.
Excluded
infectious disease
wards, aggressive
psychiatric or
airborne infectious
pts, pts with
existing ulcers.
Cohort
Logistic
regression
666 (8.1%),
54 Stage ≥1 
PU
23 (1)
Braden score
(Braden score 12-15)
(Braden score 6-11)
0.001
0.001
0.001
7.0
12.5
3.5-17.1
4.5-34.6
LQS
Only partial reporting of
baseline characteristics.
Inadequate reporting of
analysis and modelling.
Inadequate number of
events.
Cobb et al
(1997)
USA )
123 pts
Setting: acute
care hospital;
Speciality: ICU
Aged >18 yrs,
weighed ≤290 
pounds, no pre-
existing PU,
expected LOS 1-2
wks, determined
at-risk based on
Braden scale.
Consent required.
All hospital wards
and ICU of large
military hospital
RCT
Wilcoxon
test
123 (16.3%),
20 Stage ≥1 
PU
4 (2)
Hypertension
Weight
0.03
0.05
NR NR
VLQS
Inadequate reporting of
analysis methods. No CI
reported. Insufficient
number of events.
Compton et al
(2008)
German
713 pts
Setting: Acute
care hospital,
non-surgical;
Specialty: ICU
Pts without PU on
admission to the
medical ICU
between Apr 2001
and Dec 2004. Pts
in ICU for <72 hrs
were excluded
from analysis.
Record
Review
698 (17%)
121 grade 2-
4
32 (6)
Male gender
Moist skin
Oedematous skin
Centralised circulation
Mottled skin
Reddened skin
0.014
0.001
0.002
0.001
0.016
0.001
1.8
2.4
2.2
2.4
2.0
2.3
LQS
Record review. Large
number of events but it
used 32 variables in
model. No CI reported.
Defloor &
Grypdonck
(2005)
Belgium )
1772 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality:
All in-pts in 11
long-term care
facilities during the
4-wk study period
RCT
Stepwise
logistic
regression
1458
Model 1
Grade ≥1, 
302/1458
(20.7%)
Model 2
Grade ≥2 
=171/
Model 1 19 (3)
Braden sensory perception
Skin condition
Existing PU
Model 2 19 (4)
Braden activity
0.02
<0.001
<0.001
0.03
0.8
1.5
2.3
0.7
0.6-1.0
1.2-1.9
1.4-3.5
0.5-1.0
HQS
Limitation partial reporting
of baseline.
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elderly/geriatric 1458
(11.7%)
Braden sensory perception
Skin condition
Existing PU
0.02
<0.001
0.01
0.7
1.6
1.9
0.6-1.0
1.3-2.1
1.1-3.0
De Laat et al
(2007)
Netherlands
399 pts
Setting: acute
care hospital;
Speciality: ICU
Pts admitted into
ICU, with
expected LOS >48
hours, without PU
on admission, and
screened within 48
hrs of admission.
Consent not
required.
Cohort
Cox
proportional
hazards
model
399 (35.1%),
140 Grade
≥2 PU 
11 (3)
Preventive transfers
Shock/resus
Friction/shear
<0.001
<0.001
0.02
0.2
1.5
1.3
NR
MQS
Ward staff recording data
and no CI reported. Time
dependent covariates
included in the analysis.
Donnelly
(2006)
UK
240 hip fracture
pts
Setting: acute
care hospital;
Speciality:
elderly/ geriatric
Aged ≥65 yrs on 
day of injury, new
fractured hip
(injury < 48 hrs
“old”), able to
undergo tests and
assessment
procedures.
Patient consent
required.
RCT
Cox
proportional
hazards
model
239 (16.3%),
39 Grade ≥1 
PU
20 (1)
Control group (standard mattress) 0.001 4.6 NR
LQS
Insufficient number of
events and no CI reported.
Ek (1987)
Sweden
515 non-
surgical pts
Setting: Chronic
care hospital;
Speciality:
medicine
Consecutive pts
admitted to a long-
term medical ward
who were
hospitalised for >3
days, with or
without PU at
baseline. Consent
requirement not
reported
Cohort
Logistic
regression
515 (7.6%),
39 ≥Stage 1 
equivalent
PU
Model 1
Baseline
measures;
Model 2
variables on
day of PU or
if PU free on
4th wk of care
Model 1 8 (1)
Norton mobility
Model 2 8 (2)
General physical condition
Norton activity
<0.05
<0.01
<0.01
NR
NR
NR
NR
NR
NR
VLQS
Partial reporting of
baseline. Inadequate
reporting of methods.
Insufficient number of
events and no CI reported.
Ek et al
(1991)
Sweden
501 non-
surgical pts
Newly admitted
long-term medical
ward admissions
RCT
Multiple
495 (10.1%),
51 stage ≥1 
equivalent
NR (4)
Albumin
Norton mobility
<0.001
<0.001
NR NR
VLQS
Partial reporting of
baseline. Inadequate
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Setting: Acute
care hospital;
Speciality:
Medicine
who remained in
hospital >3 wks.
Patient consent
required.
regression PU Norton activity
Food intake
<0.001
<0.05
reporting of methods and
analysis. No CI reported.
Adequacy of number of
events cannot be
assessed.
Feuchtinger et
al (2006)
Germany
175 surgical pts
Setting: acute
care hospital;
Speciality:
cardiac surgery
Aged ≥18 yrs, 
scheduled for
cardiac surgery
with ECC, not
included in
another study,
consent required.
RCT
Logistic
regression
175 (14.3%),
25 Grade ≥1 
PU
13 (1)
Renal insufficiency 0.05 NR NR
LQS
Inadequate reporting of
analysis and insufficient
number of events. No CI
reported.
Fife et al
(2001)
USA
186 pts
Setting: ICU
Pts admitted to
Neuro ICU (acute
SCI/head injuries/
gunshot wounds/
CVAs). No
consent required
(apart for
photographs).
Excluded if >2 PU
on initial
assessment,
discharge from
unit <24 hrs after
admission,
diagnosis of brain
death or life
support pending
organ donation, no
evaluation by
nursing staff within
12 hrs after
admission.
Cohort
Stepwise,
logistic
regression
149 (15.4%),
23 Stage ≥2 
PU
11 (2)
Braden score
Age
0.002
0.043
NR NR
LQS
Insufficient number of
events. OR and CI not
reported.
Goodridge et
al (1998)
Canada
330 non-
surgical pts
Setting: acute
Care-setting:
medical/elderly of
tertiary care and
long-term care
facilities, >65 yrs,
Cohort
Stepwise
logistic
330 (9.7%),
32 Stage≥1 
PU
5 (1)
N of prevention strategies used
prior to PU appearance
<0.001 1.4 NR
VLQS
Partial presentation of
baseline data. Nutritional
factors collected but not
analysed. Analysis
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care hospital;
Speciality:
elderly/geriatric
within 48-96 hours
of admission.
Excluded pre-
existing dermal
ulcers, terminal
stage cancer,
acute/ chronic
renal failure
regression reporting inadequate. No
CI or p values reported.
Insufficient number of
events. Time dependent
variable included in the
analysis.
Gunningberg
et al (2001)
Sweden
146 hip fracture
pts
Setting: acute
care hospital;
Speciality:
trauma
Pts with hip
fracture, ≥65 yrs, 
admitted without a
PU carried out in
the A&E or
orthopaedics
departments. Not
sure about
consent - assume
not
Record
review
Logistic
regression
146 (36.9%),
54 stage ≥1 
PU
3 (1)
Advanced age 0.03 1.1 NR
MQS
Partial reporting of
baseline characteristics
and analysis reporting
inadequate. No CI
reported.
Halfens et al
(2000)
Netherlands
320 pts
Setting: acute
care hospital;
Speciality:
multiple
No PU on
admittance,
Caucasian,
probable LOS
(hospital) ≥10 
days. Consent
required. 3
hospitals; pts from
surgical,
neurological,
orthopaedic and
internal medicine
Cohort
Stepwise
logistic
regression
320 (14.7%),
47 Grade ≥ 1 
PU
16 (4)
Braden sensory perception
Age
Braden friction/shear
Braden moisture
<0.01
<0.01
<0.01
<0.01
3.7
2.3
2.3
2.1
1.4-9.3
1.4-3.9
1.4-4.0
1.2-3.5
LQS
Partial reporting of
baseline characteristics
and insufficient number of
events.
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Hatanaka et
al (2008)
Japan
149 non-
surgical pts
Setting: Acute
Care Hospital;
Speciality:
Respiratory
Bedridden pts
hospitalised for a
respiratory
disorder, required
constant attentive
care or needed a
considerable
amount of
assisted care.
Cohort
Cox
proportional
hazards
model
149 (25.5 %)
38 Grade >2
NR(5)
Hb
CRP
Alb
Age
Gender
0.006
0.042
0.021
0.953
0.379
1.2
1.9
0.4
1.0
0.7
1.1-1.4
1.0-3.9
0.2-0.9
0.97-1.03
0.3-1.7
LQS
Clinical data collection
method not reported and
number of factors entered
into the stepwise
procedure not reported,
therefore adequacy of
number of events cannot
be assessed.
Inman et al
(1999)
Canada
149 pts
Setting: ICU
Aged ≥17 yrs, an 
APACHE II score
≥15, expected 
LOS (ICU) ≥3 
days. Pts
excluded if PUs at
baseline, not
expected to
survive, admitted
for compassionate
care or ICU
transfer.
Consecutive
admissions
randomised - not
concealed
allocation, consent
procedure not
detailed.
RCT
Stepwise
logistic
regression
144 (25.7%),
37 Stage ≥1 
PU
9 (2)
LOS in ICU
Increasing SURE score
NR NR NR
VLQS
Poor quality reporting and
insufficient number of
events. Limited number of
risk factors. Inadequate
stats reporting and the
independent variable is a
composite score which
includes the dependent
variable. P values, OR or
CI not reported. Data
reporting by ward staff.
Time dependent variable
included in the analysis
(LOS and increase SURE
score).
Kemp et al
(1993)
USA
84 non-surgical
pts
Setting:
multiple;
Speciality:
elderly/medical
Pts recruited from
hospital in-pt
(general medicine
and geriatric
medicine) and
long-term care
facilities. Included
if aged ≥65 yrs, 
Braden score ≤16 
and PU free.
RCT
Cox
regression
84 (39.3%),
33 Stage ≥1 
PU
11 (2)
Overlay type
Average Braden mobility
0.018
<0.001
NR NR
LQS
Inadequate number of
events; CI not reported.
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Consent
requirements not
detailed.
Lindgren et al
(2004)
Sweden
548 mixed pts
Setting: acute
care hospital;
Speciality:
multiple
Elective and acute
medical or surgical
pts admitted to 21
wards in
University
hospital, aged >17
yrs, expected LOS
(hospital) ≥5 days, 
for pts undergoing
surgery expected
time on operating
table of ≥1 hour 
and PU free.
Verbal consent
required (patient
or relative).
Consecutive pts
admitted in 3
defined days
included up to
max 9 per wk.
Cohort
Multiple
stepwise
logistic
regression
530 (11.7%)
62 Stage ≥1,  
Model 1
Total sample
530 (11.7%)
62
Model 2
Medical
patients
244 (8.6%)
21
Model 3
Surgical
patients
286 (14.3%)
41
Model 1 13 (5)
Mobility RAPS
Length of hospitalisation
Age
Weight
Surgical treatment
Model 2 13 (3)
Mobility RAPS
Length of hospitalisation
Diastolic BP
Model 3 13 (3)
Serum albumin RAPS
Length hospitalisation
Weight
0.011
0.002
0.014
0.006
<0.001
0.001
0.029
0.026
0.029
0.027
0.002
0.5
1.0
1.0
1.0
4.8
0.4
1.0
1.0
0.5
1.0
1.0
0.3-0.9
1.0-1.1
1.0-1.1
0.9-1.0
2.0-11.4
0.2-0.6
1.00-1.04
0.9-1.0
0.3-0.9
1.0-1.1
0.9-1.0
LQS
Insufficient number of
events. Time dependent
covariate was included in
the analysis.
Marchette et
al (1991)
USA
161 surgical pts
Setting: acute
care hospital;
Speciality: ICU
Pts aged >59 yrs
in ICU after a
surgery. Consent
not required.
Record
review
Discriminant
analysis
161 (39.1%),
63 Stage ≥2 
equivalent
PU
NR (5)
Skin redness
Days static air mattress for
prevention
Fecal incontinence
Diarrhea
Preoperative albumin
<0.001
<0.001
0.0013
0.0019
0.0028
NR NR
VLQS
Inadequate reporting of
methods and analysis. No
CI. Included time
dependent variables in the
analysis. Adequacy of
number of events cannot
be assessed.
Nijs et al
(2009)
Belgium
520 pts
Setting: acute
care hospital ,
surgical;
Speciality: ICU
Pts expected LOS
in surgical ICU of
an acute hospital
>24hrs. Excluded
<16 yrs old and
admitted for burn
Cohort
Multivariate
logistic
regression
463 (28.9%)
134 Grade 2-
4
19 (9)
Dopamine <5mcg/km/min
Medical history of vascular disease
IHD or CVVH
Adequate prevention
0.003
<0.001
0.045
0.002
6.1
4.5
3.8
6.0
1.9-19.5
2.0-10.2
1.0-13.9
1.9-18.6
MQS
Full details of modelling
not provided. Adequate
number of events is
assumed as large number
of events.
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injuries. Frequency of turning >6x/day or
alternating mattress
Turning
Use of sedatives
Body Temp >38.5C
Sitting in chair
<0.001
<0.001
0.006
0.029
<0.001
30.2
6.7
0.3
0.2
0.1
12.2-74.8
2.7-16.4
0.1-0.7
0.2-0.9
0.0-0.3
Nixon et al
(2006)
UK
1972 pts
Setting: acute
care hospital;
Speciality:
multiple
Aged ≥55 yrs, 
admitted to
orthopaedic,
vascular, medical
or care of elderly
wards, acute or
elective, expected
LOS ≥7 days, 
limited activity or
mobility, existing
Grade 2 PU.
Consent required
RCT,
Logistic
regression
1971
(10.5%), 207
Grade ≥2 PU 
13 (7)
Hospital
Acute admission
Baseline wound
Baseline skin trauma
Baseline grade 1
Age
Diabetes
0.02
<0.001
<0.001
0.05
0.001
0.03
0.047
3.7
3.0
1.7
2.0
1.0
1.6
2.3-5.9
1.7-5.1
1.0-2.8
1.3-2.9
1.002-1.04
1.0-2.6
HQS
Minor limitation - number
of pts in final model not
reported.
Nixon et al
(2007)
UK
109 surgical pts
Setting: acute
care hospital;
Speciality:
multiple
Aged >55 yrs,
expected LOS ≥5 
days, scheduled
for elective major
general or
vascular surgery
OR acute
orthopaedic (avg.
surgical time ≥90 
mins), with or
without PU at
baseline. Consent
required
Cohort
Forward
stepwise
logistic
regression
97 (15.5%),
15 Grade ≥2 
PU
8 (4)
Pre-op albumin
Grade 1 equivalent
Weight loss
Diastolic Bp min.
0.009
0.008
0.092
0.205
0.8
7.0
0.3
1.0
0.7-1.0
1.7-29.5
0.1-1.2
0.9-1.0
LQS
Inadequate number of
events. Included time
dependent variables in the
analysis.
Okuwa et al
(2006)
Japan
259 non-
surgical pts
Setting: long-
term nursing
care/NH;
Pts admitted to
long-term care
facility, aged ≥65 
yrs, bedfast,
without lower
extremity PU, LOS
(hospital) ≥14 
Cohort
Forward
stepwise
Cox
regression
259 (12.7%),
33 stage ≥2 
PU
9 (3)
Ankle brachial index
Length of bedfast period
Male gender
<0.001
0.003
0.001
0.1
3.0
1.0
0.0-0.2
1.5-6.0
1.004-1.015
LQS
Inadequate number of
events. Time dependent
variables reported.
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Speciality:
elderly/geriatric
days, at risk of
developing PU.
Consent required
(patient or family).
Olson et al
(1996)
USA
149 pts
Setting: acute
care hospital;
Speciality:
multiple
Medical and
surgical in-pts
aged ≥18 yrs, no 
PU on admission,
expected LOS
(hospital) ≥5 days, 
consent required.
Cohort
Stepwise
logistic
regression
143 (13.9%),
20 Stage ≥1 
PU
11 (3)
Haemoglobin
Hours in bed
Pulse pressure
0.0731
0.0551
0.3022
NR NR
LQS
Insufficient number of
events.
Ooi et al
(1999)
USA
5518 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality:
elderly/geriatric
NH residents free
from PUs at
baseline and 3
mth FU
assessment.
Excluded
residents in
homes <50.
Consent not
required record
review
Record
review
Logistic
regression
backward
elimination
5518
(11.4%), 629
Stage ≥2 PU 
6 (6)
Age
Diabetes
Faecal/urine incontinence
Transfers
Medicaid payments
Facility effects
(facility effects intermediate)
(facility effects high risk)
0.0081
0.0106
<0.001
<0.001
0.0623
<0.001
<0.001
1.0
1.4
1.6
1.5
1.2
1.6
1.9
1.00-1.03
1.1-1.7
1.2-2.0
1.2-1.8
1.0-1.4
1.3-2.0
1.5-2.4
MQS
Record review and limited
range of risk factors
considered (e.g. do not
have mobility in the
model).
Pancorbo-
Hidalgo &
Garcia-
Fernandez
(2001)
Spain
187 pts
Setting: acute
care hospital;
Speciality:
multiple
Pts at risk of PUs
(Gosnell score
≤12) and aged 
>70 yrs, admitted
to internal
medicine, ICU,
general surgery,
and orthopaedic
wards
Cohort
Logistic
regression
187 (16.6%),
31 Stage ≥1  
Model 1
Stage ≥1 
Model 2
Stage ≥2 
Model 1 16 (9)
LOS
Gosnell score
Incontinence
Skin alterations diminished
Highest systolic BP
Lowest diastolic BP
Low skin fold thickness
Diminished lymphocytes
Low haemoglobin
Model 2 (10)
Length of Stay
Gosnell score
Incontinence
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
1.1
1.2
2.2
1.4
1.0
1.1
1.3
1.2
2.2
1.2
1.1
1.2
1.1-1.2
1.1-1.2
1.7-2.9
1.0-1.9
0.9-1.0
1.06-1.13
1.0-1.6
1.0-1.5
1.3-3.9
1.1-1.2
1.1-1.2
1.1-1.2
LQS
Article was translated so
unable to undertake
detailed quality
assessment. Limitations
based on inadequate
number of events. Time
dependent variables
included in the analysis.
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NOVA activity diminished
Highest systolic BP
Lowest diastolic BP
Low skin fold thickness
Diminished lymphocytes
Low haemoglobin
Use of alternating overlay (at risk
pts)
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
<0.05
2.0
1.0
1.1
1.4
1.5
3.0
2.7
1.2-3.5
0.9-1.0
1.0-1.1
1.0-1.9
1.1-2.0
1.5-6.1
1.0-6.9
Perneger et al
(2002)
Switzerland
1190 pts
Setting: acute
care hospital;
Speciality:
multiple
All newly admitted
patients admitted
to mixed
specialties within a
teaching hospital
(with or without
PU at baseline).
Consent not
required
Cohort
Multivariate
proportional
hazards
model
1190
(10.8%), 129
stage ≥1 PU 
10 (3)
Braden/Norton mobility
Braden friction/shear
Age (16-59)
(age 60-69)
(age 70-79)
(age 80-89)
(age 90-96)
0.006
0.034
1.4
1.5
1.5
2.5
3.8
5.2
1.1-1.8
1.0-1.8
0.8-2.2
1.5-4.4
2.3-6.4
2.6-10.6
HQS
Limitation partial reporting
of baseline.
Rademakers
et al (2007)
Netherlands
722 hip fracture
pts
Setting: acute
care;
Speciality:
Trauma
Hip fracture pts
admitted to level-1
trauma centre.
Excluded aged
<60 yrs, (multiple)
high energy
trauma (fall from
higher than
ground level; road
traffic accident),
initial conservative
treatment, inter-
hospital transfer,
presence of PUs
on admission,
pathological
fractures and
recurrent fractures
Record
review,
Multivariate
logistic
regression
722 (29.6%),
214 Stage ≥2 
PU
10 (5)
Diabetes
post-op urinary tract infection
post-op hip dislocation
ASA class III/IV
time to surgery >12 hours
0.021
0.004
0.009
0.001
0.008
1.7
1.9
2.7
4.2
1.7
1.1-2.7
1.2-2.9
1.3-5.6
2.9-6.1
1.2-2.6
MQS
Large sample size but
limited number of risk
factors considered and not
based on a conceptual
framework (no nutrition or
skin moisture factors). In
adequate measurement of
risk factor. (Record
review).
Reed et al
(2003)
2771 non-
surgical pts
Record review
identifying:
Record
review
2771
(14.7%), 406
7 (6) HQS
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P
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USA
Setting: chronic
care hospital;
Speciality:
medicine
mobility impaired,
admitted to the
chosen hospital
wards between Jul
1st, 1994 to Oct
1st, 1997, LOS ≥1 
wk. Consent not
required - record
review, Grade 3
and 4 PUs
reported
Forward
stepwise
logistic
regression
Stage ≥2 PU Low albumin levels
Confusion
DNR
Urinary catheter on admission
Malnutrition
Stage 1 PU
0.014
0.001
<0.001
<0.001
<0.001
<0.001
1.4
1.5
1.5
1.6
1.7
3.1
1.1-1.8
1.2-1.8
1.2-1.9
1.4-1.8
1.3-2.2
2.4-4.1
Record review.
Rose et al
(2006)
Canada
111 pts
Setting: acute
care hospital;
Speciality: ICU
Consecutive
admissions to
university hospital
ICU. Consent not
reported
Cohort
Multiple
regression
111 (43.2%),
48 stage ≥1 
PU
NR (3)
Skin quality
Restricted movement
Temperature
NR NR NR
VLQS
Abstract only. Inadequate
information on
methodology and analysis.
No p values or CI
reported.
Salzberg et al
(1999)
USA
226 SCI pts
Setting: acute
care hospital;
Speciality:
trauma
SCI with a
neurological deficit
attributable to
damage of the
spinal cord;
excluding the
cortices and
brainstem, defined
by ICD-9CM,
acute SCI due to a
trauma, survival
≥14 days following 
acute SCI, and
level of SCI
between C4-S1.
Record
review
Model 1
forward
stepwise
linear
regression
Model 2
Cox
proportional
hazards
226 (38.5%),
87 Stage ≥1 
PU
Model 1 8 (3)
Extent of paralysis
Moisture
Serum creatinine
Model 2 8 (8)
Extent of paralysis
Moisture
Serum creatinine
Incontinence
Albumin
Mobility
Pulmonary disease
Level of activity
<0.001
<0.001
0.007
<0.001
0.003
0.006
<0.001
0.028
0.002
0.014
0.036
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
NR
MQS
Limited because of record
review and no CI reported.
Sayar et al
(2009)
Turkey
140 pts
Setting: acute
Surgical and
medical ICU pts.
Within 1-2 hrs
Cohort
Multiple
140 (14.3%)
20 Stage >1
PU
6 (2)
LOS
Activity level
<0.001
0.005
1.2
0.3
1.1-1.3
0.2-0.7
LQS
Insufficient number of
events.
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P
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care hospital;
Specialty: ICU
after admission to
ICU waterlow was
administered. Pts
scoring ‘at risk’
and ‘very high risk’
included
stepwise
logistic
regressions
Schnelle et al
(1997)
USA
105 non-
surgical pts
Setting: long-
term nursing
care/NH;
Speciality:
elderly/geriatric
Incontinent NH
residents, consent
required,
exclusion criteria
presence of stage
≥2 PU at baseline, 
catheters, <60 day
LOS
Cohort
Stepwise
multiple
regression
91 (20.9%),
19 Stage
≥1PU 
Model 1
Stage ≥1 
severity
index = NR;
Model 2
Stage ≥1 
only = NR
Model 1 NR (2)
Bed mobility
Blanchable erythema severity
Model 2 NR (1)
Blanchable erythema severity
NR NR NR
LQS
Insufficient number of
events and analysis
reporting inadequate. No p
values or CI reported.
Schoonhoven
et al 2002
Netherlands
223 surgical pts
Setting: acute
care hospital;
Speciality:
multiple
Pts scheduled for
surgery expected
to exceed 4 hrs
(post recruitment
exclusion if
surgery lasted <4
hrs)
Cohort
Multiple
logistic
regression
208 (10.1),
21 Grade ≥2 
PU
12 (1)
Length of surgery (in minutes) <0.05 1.0 1.0035-
1.0087
LQS
Baseline characteristics
not reported. Insufficient
number of events.
Schultz et al
(1999)
USA
413 surgical pts
Setting: acute
care hospital;
Speciality:
mixed
Pts scheduled for
inpatient care,
aged ≥18 yrs, with 
surgery scheduled
to last >2 hrs in
lithotomy or
supine position.
Excluded PUs at
baseline, severe
chronic skin
problems, or
receiving only
local anaesthesia.
RCT
Logistic
regression
413 (21.5%),
89 Stage ≥1 
PU
7 (5)
Age
Presence of diabetes
Less body mass
Use of the study mattress
Admission Braden score
0.005
0.013
0.015
0.044
0.013
1.1
2.5
0.9
1.9
0.8
1.0-1.1
1.2-5.3
0.9-1.0
1.0-3.7
0.7-1.0
HQS
Risk factors were
recorded by OR and ward
staff, although outcome
data was assessed by
research assistants.
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Serpa &
Santos (2007)
Brazil
170 pts
Setting: private
hospital;
Speciality: NR
Age ≥18 yrs, no 
PU at admission,
hospitalised for
≥24 hrs, total 
Braden score,
admitted to 2
private hospitals,
agreed to
participate.
Excluded chronic
renal failure,
dialysis treatment
for >1 mth,
presence of
hepatic
insufficiency
accompanied by
ascites.
Cohort
Multivariate
logistic
regression
170 NR 16 (5)
Sub Global Nut Assess
Albumin
Ureas
Age
Institution
<0.001
<0.001
<0.001
<0.001
<0.001
LQS
Unable to assess in detail,
abstract & author
communication available
only. Low quality study
based on assumed
inadequate no events.
Stage of PU definition
unknown.
Stordeur et al
(1998)
Belgium
174 surgical pts
Setting: acute
care hospital;
Speciality:
cardiac/vascular
Consecutive pts,
aged ≥16 yrs, who 
underwent cardiac
or vascular
surgery, min LOS
(hospital) >5 days.
Excluded pts who
died. Not sure
about consent -
assume not
Cohort
Stepwise
logistic
regression
163 (29.5%),
48 Stage ≥2 
PU
16 (3)
Postoperative Braden score
Haemoglobin concentration at
admission
Postoperative steroid therapy
<0.001
<0.001
0.020
NR NR
LQS
Insufficient number of
events and CI not
reported.
Suriadi et al
(2008)
Japan
253 pts:
Setting: acute
care hospital;
Specialty: ICU
Aged >18yrs, ICU
pts, admitted at
least 24hrs before
study enrolment,
bedfast, no
existing PU, able
to give informed
consent and
Indonesian origin.
Cohort
Logistic
regression
model
253 (28.4%)
72 Stage >1
Unknown (3)
Interface pressure
Body Temperature
Cigarette smoking
2.2
2.0
1.6
1.6-2.9
1.7-2.5
1.1-2.5
MQS
Inadequate reporting of
analysis and modelling.
Adequate number of
events is assumed as
large number of events.
Suriadi et al 105 pts Admitted to ICU
for ≥24 hrs and 
Cohort 105 (33.3%),
35 stage ≥1 
6 (4) LQS
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(2007)
Indonesia Setting: ICU
expected LOS
(ICU) ≥3 days, 
bedfast or unable
to walk, free from
PUs, informed
consent (by
patient or family).
Excluded pts
physically
incapable of
participating
(difficult to identify
skin condition
daily as pt could
not be
manipulated) or
did not wish to
participate.
Multivariate
logistic
regression
PU Interface pressure
Skin moisture
Smoking >10/day
Body temperature
<0.001
0.002
0.001
0.001
17.6
8.2
12.7
102.0
4.1-74.3
2.2-30.9
2.8-56.7
7.7-98.8
Insufficient number of
events.
Tourtual et al
(1997)
USA
291 non-
surgical pts
Setting: acute
care hospital;
Speciality:
medicine:
elderly/geriatric
All pts admitted to
4 nursing units
within an acute
hospital and gave
consent. Baseline
PU status not
recorded.
Cohort
Forward
stepwise
logistic
regression
291 (21.6%),
63 Stage  ≥1 
heel PU
17 (2)
Braden friction & sheer
Braden moisture
0.01
0.007
NR NR
LQS
Insufficient number of
events and CI not
reported.
Vanderwee et
al (2009)
235 pts
Setting: NH;
Specialty:
elderly non-
surgical
NH pts with no PU
(Grade 2-4,
EPUAP), if could
be repositioned,
expected LOS >3
days in NH and
with non-
blanchable
erythema at
pressure point on
the skin.
RCT
Multivariate
Cox
regression
analysis
235 (18.7%)
44 Grade >2
PU
16 (6)
Age >80-90
Age >90
CVA
Urinary inc
Dual inc
Contractures
Hypotension
0.16
0.015
0.042
0.004
0.086
0.04
0.002
0.6
0.4
1.9
0.2
0.5
2.0
3.4
0.3-1.2
0.2-0.8
1.1-3.7
0.1-0.6
0.2-1.1
1.0-4.0
1.6-7.5
LQS
Insufficient number of
events.
Watts et al 148 pts Victims of blunt or Cohort 148 (20. 20 (1) VLQS
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(1998)
USA Setting: acute
care;
Speciality:
trauma
penetrating injury,
aged ≥15 yrs, with 
traumatic injuries,
LOS ≥2 days and 
no pre-existing
PU.
Logistic
regression
3%), 30
Stage ≥1 PU 
Braden mobility NR 7.5 NR Baseline characteristics
not reported. Insufficient
number of events and
presentation of analysis.
Inadequate measurement
of risk factors. No CI or p
values reported.
Yepes et al
(2009)
150 pts
Setting: acute
care hospital;
Specialty: ICU
Pts without PU on
admission
hospitalised >48
hrs in ICU and
with any of the
following risk
factors for PUs:
intubated and on
mechanical
ventilation, with
vasopressor
support.
Cohort
Multivariate
logistic
regression
150 (26.7%)
40 stage >2
8 (3)
Infection
ICU LOS
APACHE II
0.023
0.005
0.044
2.9
1.1
1.1
1.2-7.2
1.1-1.2
1-1.1
LQS
Insufficient number of
events. Time dependent
variable included in the
analysis.
RCT Randomised Controlled Trial; PU Pressure Ulcer; ADL Activities of Daily Living; ICU Intensive Care Unit; SCI Spinal Cord Injury; LOS Length Of Stay; NR Not Reported; APACHE
Acute Physiology &Chronic Health Evaluation; ns not significant; NH nursing home; n number; pts patients; wks weeks; mth month; yrs years; FU follow-up; CI confidence interval; OR
odds ratio; BP blood pressure. Overall study quality: HQS (High Quality Study); MQS (Moderate Quality Study); LQS (Low Quality Study); VLQS (Very Low Quality Study). P values <0.001
reported as such. Odds Ratio and Confidence Intervals reported to one decimal place (where appropriate)
Reprinted from the International Journal of Nursing Studies, 50, Coleman S, Gorecki C, Nelson EA, Close SJ, Defloor T, Halfens R, Farrin A, Brown J, Schoonhoven L, Nixon J. Patient
risk factors for pressure ulcer development: systematic review. 2013; 974–1003
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The 54 studies (Table 3.3) include a total of 34,449 patients (median 237 per study).
Median pressure ulcer incidence was 16.6 (range 3.2% to 73.5%). Study patient
populations include intensive care, surgery, trauma, various mixed specialty acute care
environments, long-term rehabilitation and nursing home populations, community
populations and specific diagnostic groups (e.g. fractured hip and spinal cord injured).
Twenty eight studies defined pressure ulcer outcome as Grade ≥1 (Ek 1987; Ek et al.
1991; Kemp et al. 1993; Bergstrom et al. 1996; Bostrom et al. 1996; Olson et al. 1996;
Cobb, Yoder and Warren 1997; Schnelle et al. 1997; Tourtual et al. 1997; Baldwin and
Ziegler 1998; Goodridge et al. 1998; Watts et al. 1998; Inman et al. 1999; Salzberg et
al. 1999; Schultz et al. 1999; Bourdel-Marchasson et al. 2000; Halfens, Van Achterberg
and Bal 2000; Boyle and Green 2001; Gunningberg et al. 2001; Perneger et al. 2002;
Lindgren et al. 2004; Chan et al. 2005; Donnelly 2006; Feuchtinger et al. 2006; Rose,
Cohen and Amsel 2006; Suriadi et al. 2007; Suriadi et al. 2008; Sayar et al. 2009), 22
define pressure ulcer outcome as a Grade ≥2 (Marchette, Arnell and Redick 1991; 
Brandeis et al. 1994; Allman et al. 1995; Bergquist and Frantz 1999; Berlowitz and
Wilking 1989; Stordeur, Laurent and D'Hoore 1998; Ooi et al. 1999; Fife et al. 2001;
Schoonhoven et al. 2002; Reed et al. 2003; Baumgarten et al. 2004; Nixon et al.
2006b; Okuwa et al. 2006; Bates-Jensen et al. 2007; De Laat et al. 2007; Nixon,
Cranny and Bond 2007; Rademakers et al. 2007; Compton et al. 2008; Hatanaka et al.
2008; Nijs et al. 2009; Vanderwee et al. 2009; Yepes et al. 2009), 3 report both
(Bergstrom and Braden 1992; Pancorbo Hidalgo and Garcia Fernandez 2001; Defloor
and Grypdonck 2005) and 1 is unknown (Serpa and Santos 2007).
The majority of studies reported a dichotomous outcome, with fifteen reporting time to
the development of new pressure ulcers (Kemp et al. 1993; Allman et al. 1995; Cobb,
Yoder and Warren 1997; Bergquist and Frantz 1999; Salzberg et al. 1999; Bourdel-
Marchasson et al. 2000; Boyle and Green 2001; Perneger et al. 2002; Baumgarten et
al. 2004; Okuwa et al. 2006; Donnelly 2006; De Laat et al. 2007; Hatanaka et al. 2008;
Sayar et al. 2009; Vanderwee et al. 2009) in modelling .
Eleven studies reported more than one multivariable analysis (Ek 1987; Bergstrom and
Braden 1992; Brandeis et al. 1994; Bergstrom et al. 1996; Schnelle et al. 1997;
Salzberg et al. 1999; Pancorbo Hidalgo and Garcia Fernandez 2001; Lindgren et al.
2004; Defloor and Grypdonck 2005; Bates-Jensen et al. 2007; Nijs et al. 2009). Where
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more than one model was reported a primary model was identified based upon the
following hierarchy: primary endpoint of ≥ Grade 1, primary endpoint development of 
new pressure ulcer(s), model with the most comprehensive range of variables, total
sample or largest sub-groups of patients, largest number of pressure ulcers and
models with baseline values not time dependent variables.
3.7.2 Study Quality
The detailed quality appraisal for each included study is shown in Table 3.4. Seven
studies fulfilled all 4 quality criteria and were classified as high quality and a further 10
studies had sufficient numbers of event and were classified as moderate quality
studies. The remaining 37 studies (68.5%) had inadequate numbers of pressure ulcers
and other methodological limitations and comprised 27 low quality studies and 10 very
low quality studies (Table 3.4).
3.7.3 Risk Factor Domains and Sub-domains
Forty seven (87.0%) studies reported of the risk factors entered into multivariable
modelling and those which emerged as significant (independently predictive of
pressure ulcer outcome). Seven studies (Schnelle et al. 1997; Bourdel-Marchasson et
al. 2000; Ek et al. 1991; Rose, Cohen and Amsel 2006; Marchette, Arnell and Redick
1991; Serpa and Santos 2007; Hatanaka et al. 2008) only reported the risk factors
which emerged from multivariable modelling. The forty seven studies evaluated a
median of 11 (range 3-45) potential risk factors in multivariable analyses and identified
a median of 3 (range 1-10) factors as independently predictive of pressure ulcer
outcome.
A summary of risk factors entered into multivariable modelling (where known) and
those which emerged as significant are summarised by study (Table 3.3 ) and by risk
factor domain/sub-domain (Table 3.5). An example of the underpinning evidence tables
relating to skin condition are shown in Appendix 7 (full evidence tables are available at
http://ctru.leeds.ac.uk/PURE).
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Table 3.4 Quality Assessment of Included Studies
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Defloor &
Grypdonck
2005
P Y Y Y Y Y Y Y Y Y Y Limitation partial reporting of
baseline.
HQS
Schultz et al
1999
Y Y Y Y Y Y Y Y Y Y Y Risk factors were recorded by
OR and ward staff, although
outcome data was assessed
by research assistants.
HQS
Reed et al
2003
P Y Y U Y Y Y Y Y Y Y Record review. HQS
Perneger et
al 2002
P Y N U Y Y Y Y Y Y Y Limitation partial reporting of
baseline.
HQS
Brandeis et al
1994
Y Y Y Y Y Y Y Y Y Y Y Record review. HQS
Nixon et al
2006
Y Y Y U Y Y Y Y Y Y Y Minor limitation - number of
patient in final model not
reported.
HQS
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Bergstrom et
al 1996
Y Y Y U Y Y Y Y Y Y Y HQS
Rademakers
et al 2007
Y Y Y U N N Y Y Y N Y Large sample size but limited
number of risk factors
considered and not based on a
conceptual framework ( no
nutrition or skin moisture
factors). In adequate
measurement of risk factor.
(Record review).
MQS
Baumgarten
et al 2004
Y Y U N Y Y Y Y Y P Y all risk factors are categorical
data rather than continuous.
20% missing data from final
model.
MQS
Nijs et al
2009
P Y Y Y Y Y Y Y P P Y Full details of modelling not
provided. Adequate number of
events is assumed as large
number of events.
MQS
Suriadi et al
2008
P Y Y U Y Y Y Y N Y P Inadequate reporting of
analysis and modelling.
Adequate number of events is
assumed as large number of
events.
MQS
Gunningberg
et al 2001
P Y Y U Y U U Y P Y U Partial reporting of baseline
characteristics and analysis
reporting inadequate. No
confidence intervals reported.
MQS
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Limitations
Q
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n
Ooi et al
1999
Y Y Y U P P Y Y Y P Y Record review and limited
range of risk factors
considered (eg do not have
mobility in the model).
MQS
Bergstrom
and Braden
1992
Y Y Y U Y Y Y Y N Y Y No confidence intervals
reported.
MQS
Salzberg et al
1999
Y Y Y Y Y Y Y Y N Y Y Limited because of record
review and no confidence
intervals reported.
MQS
Bourdel-
Marchasson
et al 2001
P Y Y Y Y Y N Y N Y U Full details of modelling not
provided. Adequate number of
events is assumed as large
number of events (299).
MQS
De Laat et al
2007
Y Y Y U Y Y Y Y P Y Y Ward staff recording data and
no confidence intervals
reported. Time dependent
covariates included in the
analysis.
MQS
Bates-Jensen
et al 2007
Y Y Y U Y N U N Y Y N Inadequate sample size
resulting in wide confidence
intervals.
LQS
Chan et al
2005
P N U U U U U N N U N Only partial reporting of
baseline characteristics.
Inadequate reporting of
analysis and modelling.
Inadequate number of events.
LQS
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Limitations
Q
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n
Serpa and
Santos 2007
N N U U Y N U N P N N Unable to assess in detail,
abstract & author
communication available only.
Low quality study based on
assumed inadequate no
events. Stage of PU definition
unknown.
LQS
Yepes et al
2009
Y Y Y U Y Y Y N Y Y N Insufficient number of events.
Time dependent variable
included in the analysis.
LQS
Hantanaka et
al 2008
Y Y Y U Y Y Y U P Y U Clinical data collection method
not reported and number of
factors entered into the
stepwise procedure not
reported, therefore adequacy
of number of events cannot be
assessed.
LQS
Schoonhoven
et al 2002
N Y Y U P Y Y N Y Y N Baseline characteristics not
reported. Insufficient number of
events.
LQS
Boyle and
Green 2001
P Y N/A U Y Y Y N Y Y P Baseline characteristics not
reported. Insufficient number of
events.
LQS
Fife et al
2001
Y Y Y Y Y Y Y N Y Y N Insufficient number of events.
Odds ratios and confidence
levels not reported.
LQS
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Limitations
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n
Suriadi et al
2007
Y Y Y Y Y Y Y N Y Y P Insufficient number of events. LQS
Compton et
al 2008
Y Y Y U Y Y Y N Y Y P Record review. Large number
of events but it used 32
variables in model. No
confidence intervals reported.
LQS
Berguist and
Frantz 1999
Y Y Y Y Y Y Y N Y Y N Record review and insufficient
number of events. Inadequate
measurement of risk factors
(record review).
LQS
Sayar et al
2009
Y Y Y U Y Y Y N Y Y N Insufficient number of events. LQS
Vanderwee et
al 2009
Y Y Y Y Y Y Y N Y Y P Insufficient number of events. LQS
Tourtual et al
1997
Y Y Y U Y Y Y N Y Y P Insufficient number of events
and confidence intervals not
reported.
LQS
Schnelle et al
1997
Y Y Y Y Y U U N N Y N Insufficient number of events
and analysis reporting
inadequate. No P values or
confidence intervals reported.
LQS
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Limitations
Q
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n
Olson et al
1996
Y Y Y Y Y Y Y N Y U N Insufficient number of events. LQS
Allman et al
1995
Y Y Y U Y Y Y N Y Y P Insufficient number of events. LQS
Berlowitz &
Wilking 1989
P Y Y Y Y Y Y N Y Y N Insufficient number of events.
Data collection relied on
clinical staff and only partial
reporting of baseline
characteristics.
LQS
Stordeur et al
1998
Y Y Y U Y Y Y N Y Y N Insufficient number of events
and confidence intervals not
reported.
LQS
Pancorbo
Hidalgo &
Garcia
Fernandez
2001
U U U U Y Y U N Y U N Article was translated so
unable to undertake detailed
quality assessment. Limitations
based on inadequate number
of events. Time dependent
variables included in the
analysis.
LQS
Halfens et al
2000
P Y Y Y Y Y Y N Y Y N Partial reporting of baseline
characteristics and insufficient
number of events.
LQS
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Limitations
Q
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y
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n
Feuchtinger
et al 2006
Y Y Y U Y Y P N P Y N Inadequate reporting of
analysis and insufficient
number of events. No
confidence intervals reported.
LQS
Lindgren et al
2004
Y Y Y U Y Y Y N Y Y N Insufficient number of events.
Time dependent covariate was
included in the analysis.
LQS
Kemp et al
1993
Y Y Y Y Y Y Y N Y Y N Inadequate number of events,
Confidence intervals not
reported.
LQS
Nixon et al
2007
P Y Y Y Y Y Y N Y Y N Inadequate number of events.
Included time dependent
variables in the analysis.
LQS
Okuwas et al
2006
Y Y Y U Y Y Y N Y Y N Inadequate number of events.
Time dependent variables
reported.
LQS
Donnelly
2006
Y Y N/A U Y Y Y N P Y N Insufficient number of events
and no confidence intervals
reported.
LQS
Inman et al
1999
Y Y Y U N N U N N N P Poor quality reporting and
insufficient number of events.
Limited number of risk factors.
Inadequate stats reporting and
the independent variable is a
composite score which
includes the dependent
VLQS
104
A
ut
ho
ra
nd
Ye
ar
1.
Th
e
ba
se
lin
e
st
ud
y
sa
m
pl
e
(in
di
vi
du
al
s
en
te
rin
g
th
e
st
ud
y)
is
ad
eq
ua
te
ly
de
sc
rib
ed
fo
rk
ey
ch
ar
ac
te
ris
tic
s
2.
.A
cl
ea
rd
ef
in
iti
on
or
de
sc
rip
tio
n
of
th
e
ris
k
fa
ct
or
m
ea
su
re
d
is
pr
ov
id
ed
3.
C
on
tin
uo
us
va
ria
bl
es
ar
e
re
po
rt
ed
or
ap
pr
op
ria
te
(n
ot
da
ta
-d
ep
en
de
nt
)c
ut
po
in
ts
ar
e
us
ed
.
4.
A
de
qu
at
e
pr
op
or
tio
n
of
th
e
st
ud
y
sa
m
pl
e
ha
s
co
m
pl
et
e
da
ta
fo
rr
is
k
fa
ct
or
s
5.
R
an
ge
of
po
te
nt
ia
lr
is
k
fa
ct
or
s
ar
e
m
ea
su
re
d
(i.
e.
ke
y
va
ria
bl
es
in
co
nc
ep
tu
al
m
od
el
)
6.
R
an
ge
of
po
te
nt
ia
lr
is
k
fa
ct
or
s
ar
e
ac
co
un
te
d
fo
ri
n
an
al
ys
is
(i.
e.
ap
pr
op
ria
te
ad
ju
st
m
en
t)
7.
Th
er
e
is
no
se
le
ct
iv
e
re
po
rt
in
g
of
re
su
lts
8.
Su
ffi
ci
en
tn
um
be
ro
fe
ve
nt
s
(>
10
ev
en
tp
er
ris
k
fa
ct
or
)(
K
ey
do
m
ai
n
A
)
9.
Th
er
e
is
su
ffi
ci
en
t
pr
es
en
ta
tio
n
of
da
ta
to
as
se
ss
th
e
ad
eq
ua
cy
of
th
e
m
et
ho
d
an
d
an
al
ys
is
(K
ey
D
om
ai
n
B
)
10
.S
tr
at
eg
y
fo
rm
od
el
bu
ild
in
g
(i.
e.
in
cl
us
io
n
of
va
ria
bl
es
)i
s
ap
pr
op
ria
te
an
d
is
ba
se
d
on
a
co
nc
ep
tu
al
fr
am
ew
or
k
or
m
od
el
(K
ey
D
om
ai
n
C
)
11
.S
el
ec
te
d
m
od
el
is
ad
eq
ua
te
fo
rt
he
de
si
gn
of
th
e
st
ud
y(
K
ey
D
om
ai
n
D
)
Limitations
Q
ua
lit
y
le
ve
la
llo
ca
tio
n
variable. P values, Odds ratios
or confidence intervals not
reported. Data reporting by
ward staff. Time dependent
variable included in the
analysis (LOS and increase
SURE score).
Baldwin and
Ziegler 1998
N Y N/A U Y P Y N N P N Baseline characteristics are not
reported. The sample size is
too small and insufficient
number of events.
VLQS
Watts et al
1998
P Y U U Y Y Y N N P N Baseline characteristics not
reported. Insufficient number of
events. Insufficient
presentation of analysis.
Inadequate measurement of
risk factors. No confidence
intervals or p values reported.
VLQS
Goodridge et
al 1998
P Y N/A U Y P P N N N P Partial presentation of baseline
data. Nutritional factors
collected but not analysed.
Analysis reporting inadequate.
No confidence intervals or p
values reported. Insufficient
number of events. Time
dependent variable included in
the analysis.
VLQS
Bostrom et al1996 P Y N/A U P N y N N N N Insufficient number of events.Analysis reporting inadequate. No
confidence intervals reported.
Time dependent variables
VLQS
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included in the analysis.
Cobb et al1997 Y Y Y U Y U P N N U N Inadequate reporting of analysismethods. No confidence
intervals. Insufficient number of
events.
VLQS
Ek 1987 P Y N U Y Y Y N N N N Partial reporting of baseline.
Inadequate reporting of methods.
Insufficient number of events and
no confidence intervals reported.
VLQS
Ek et al 1991 P Y Y U Y Y N U N N N Partial reporting of baseline.
Inadequate reporting of methods
and analysis. No confidence
intervals. Adequacy of number of
events cannot be assessed.
VLQS
Marchette etal 1991 P N Y U Y U U U N N N Inadequate reporting of methodsand analysis. No confidence
intervals. Included time
dependent variables in the
analysis. Adequacy of number of
events cannot be assessed.
VLQS
Rose et al2006 N N U U U U U U N N N Abstract only. Inadequateinformation on methodology and
analysis. No p values or
confidence intervals.
VLQS
Study quality: HQS (High Quality Study), MQS (Moderate Quality Study), LQS (Low Quality Study), VLQS (Very Low Quality Study).
Y: Yes; N:No; P:Partial, U: uncertain; PU: pressure ulcer. Gray Shading indicates Key Quality Domains.
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Table 3.5 Summary of evidence for risk factor domains/sub-domains
Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Mobility/Activity Sub-Domains
RAS Mobility subscale
8 of 14 studies (57.1%)
1 HQS - Perneger et al 2002
3 LQS - Bergquist & Frantz 1999; Lindgren et
al 2004; Kemp et al 1993
4 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Ek 1987; Ek et al 1991
1 MQS - Salzberg et al 1999
4 LQS - Vanderwee et al 2009; Tourtual et al
1997; Pancorbo Hidalgo & Garcia Fernandez
2001; Halfens et al 2000
1 VLQS - Bostrom et al 1996
RAS Activity subscale
1 of 16 studies (6.2%)
1 VLQS - Ek et al 1991 3 HQS - Defloor & Grypdonck 2005; Perneger et
al 2002; Nixon et al 2006
1 MQS - Salzberg et al 1999
7 LQS - Bergquist & Frantz 1999; Vanderwee et al
2009; Tourtual et al 1997; Pancorbo Hidalgo &
Garcia Fernandez 2001; Halfens et al 2000;
Lindgren et al 2004; Kemp et al 1993
4 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Bostrom et al 1996; Ek 1987
Activity (Bed/ Chairfast/immobile)
descriptors
6 of 11 (54.5%)
1 MQS - Nijs et al 2009
5 LQS - Schnelle et al 1997; Olson et al 1996;
Allman et al 1995; Berlowitz & Wilking 1989;
Okuwa et al 2006
2 MQS - De Laat et al 2007; Baumgarten et al
2004
3 LQS - Fife et al 2001; Bergquist & Frantz 1999;
Donnelly 2006
107
Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Mobility/Activity ADL
4 of 7 (57.1%)
1 HQS - Brandeis et al 1994
1 MQS - Ooi et al 1999
1 LQS - Sayar et al 2009
1 VLQS - Rose et al 2006
1 MQS - Rademakers et al 2007
2 LQS - Bergquist & Frantz 1999; Donnelly 2006
General ADL
2 of 4 (50%)
1 MQS - Baumgarten et al 2004.
1 LQS - Bergquist & Frantz 1999
1 HQS - Brandeis et al 1994
1 LQS - Berlowitz & Wilking 1989
RAS Friction and shear
4 of 12 (33.3%)
1 HQS - Perneger et al 2002
1 MQS - De Laat et al 2007
2 LQS - Tourtual et al 1997; Halfens et al
2000
1 HQS - Defloor & Grypdonck 2005
4 LQS - Bergquist & Frantz 1999; Vanderwee et al
2009; Lindgren et al 2004; Kemp et al 1993
3 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Bostrom et al 1996
Factors affecting mobility
6 of 13 (46.1%)
3 MQS - Rademakers et al 2007; Salzberg et
al 1999; Bourdel-Marchasson et al 2000
3 LQS - Boyle & Green 2001; Bergquist &
Frantz 1999; Vanderwee et al 2009
1 HQS - Defloor & Grypdonck 2005
1 MQS - De Laat et al 2007
5 LQS - Fife et al 2001; Sayar et al 2009; Tourtual
et al 1997; Berlowitz & Wilking 1989; Feuchtinger
et al 2006
Interface pressures
2 of 2 (100%)
1 MQS - Suriadi et al 2008
1 LQS - Suriadi et al 2007
Skin/PU Status Sub-Domains
Stage/Grade 1
4 of 4 (100%)
2 HQS - Reed et al 2003; Nixon et al 2006
2 LQS - Allman et al 1995; Nixon et al 2007
Existing PU
2 of 5 (40%)
1 HQS - Defloor & Grypdonck 2005
1 MQS - Baumgarten et al 2004
1 HQS - Nixon et al 2006
2 LQS - Tourtual et al 1997; Stordeur et al 1998
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Previous PUs
0 of 2 (0%)
2 LQS - Allman et al 1995; Halfens et al 2000
General skin status
9 of 10 (90%)
2 HQS - Defloor & Grypdonck 2005
Nixon et al 2006
5 LQS - Compton et al 2008; Schnelle et al
1997; Allman et al 1995; Pancorbo Hidalgo &
Garcia Fernandez 2001; Bates-Jensen et al
2007
2 VLQS - Rose et al 2006; Marchette et al
1991
1 LQS - Boyle & Green 2001
Perfusion Sub-Domains
Diabetes
5 of 12 (41.6%)
3 HQS - Schultz et al 1999; Brandeis et al
1994; Nixon et al 2006
2 MQS - Rademakers et al 2007; Ooi et al
1999
7 LQS - Compton et al 2008; Vanderwee et al
2009; Berlowitz & Wilking 1989; Stordeur et al
1998; Halfens et al 2000; Feuchtinger et al 2006;
Donnelly 2006
Vascular disease
4 of 6 (66.6%)
1 MQS - Nijs et al 2009
3 LQS - Vanderwee et al 2009; Berlowitz &
Wilking 1989; Feuchtinger et al 2006
2 LQS - Tourtual et al 1997; Donnelly 2006
Circulation
3 of 6 (50%)
3 LQS - Compton et al 2008; Olson et al
1996; Okuwa et al 2006
1 HQS - Defloor & Grypdonck 2005
2 LQS - Tourtual et al 1997; Feuchtinger et al
2006
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Blood Pressure
6 of 11 (54.5%)
1 MQS - Bergstrom & Braden 1992
4 LQS - Boyle & Green 2001; Vanderwee et
al 2009; Pancorbo Hidalgo & Garcia
Fernandez 2001; Nixon et al 2007
1 VLQS - Cobb et al 1997
5 LQS - Fife et al 2001; Suriadi et al 2007; Olson
et al 1996; Lindgren et al 2004; Donnelly 2006
Smoking
2 of 4 (50%)
1 MQS - Suriadi et al 2008
1 LQS - Suriadi et al 2007
2 LQS - Feuchtinger et al 2006; Donnelly 2006
Oedema
1 of 4 (25%)
1 LQS - Compton et al 2008 1 MQS - Nijs et al 2009
2 LQS - Bergquist & Frantz 1999; Donnelly 2006
Haematological Measures Sub-Domains
U&Es
2 of 4 (50%)
1 MQS - Salzberg et al 1999
1 LQS - Serpa & Santos 2007
2 LQS - Berlowitz & Wilking 1989; Okuwa et al
2006
Protein
1 of 3 (33.3%)
1 LQS - Hatanaka et al 2008 1 LQS - Sayar et al 2009
1 VLQS - Marchette et al 1991
Albumin
7 of 11 (63.6%)
1 HQS - Reed et al 2003
1 MQS - Bourdel-Marchasson et al 2000
3 LQS - Serpa & Santos 2007; Hatanaka et al
2008; Nixon et al 2007
2 VLQS - Ek et al 1991; Marchette et al 1991
2 MQS - Bergstrom & Braden 1992; Salzberg et al
1999
2 LQS - Lindgren et al 2004; Kemp et al 1993
Lymphopenia
2 of 2 (100%)
2 LQS - Allman et al 1995; Pancorbo Hidalgo
& Garcia Fernandez 2001
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Haemoglobin (Hb)
6 of 11 (54.5%)
1 HQS - Nixon et al 2006
5 LQS - Hatanaka et al 2008; Bergquist &
Frantz 1999; Olson et al 1996; Stordeur et al
1998; Pancorbo-Hidalgo & Garcia Fernandez
2001
1 MQS - Gunningberg et al 2001
4 LQS - Serpa & Santos 2007; Feuchtinger et al
2006; Nixon et al 2007; Okuwa et al 2006
Moisture Sub-Domains
Moisture Subscales
4 of 12 (33.3%)
1 MQS - Salzberg et al 1999
2 LQS - Tourtual et al 1997; Halfens et al
2000
1 VLQS - Baldwin & Ziegler 1998
2 HQS - Defloor & Grypdonck 2005; Perneger et
al 2002
3 LQS - Bergquist & Frantz 1999; Vanderwee et al
2009; Kemp et al 1993
3 VLQS - Watts et al 1998; Bostrom et al 1996; Ek
1987
Urinary incontinence
1 of 7 (14.3%)
1 LQS - Vanderwee et al 2009 1 HQS - Brandeis et al 1994
2 MQS - Salzberg et al 1999; Baumgarten et al
2004.
3 LQS - Bergquist & Frantz 1999; Halfens et al
2000; Donnelly 2006
Faecal incontinence
2 of 11 (18.2%)
1 HQS - Brandeis et al 1994
1 VLQS - Marchette et al 1991
1 HQS - Reed et al 2003
1 MQS - Baumgarten et al 2004.
7 LQS - Boyle & Green 2001; Fife et al
2001;Suriadi et al 2007; Olson et al 1996; Allman
et al 1995; Halfens et al 2000; Donnelly 2006
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Dual incontinence
3 of 5 (60.0%)
1 MQS - Ooi et al 1999
2 LQS - Bergquist & Frantz 1999; Vanderwee
et al 2009
1 MQS - Baumgarten et al 2004.
1 LQS - Tourtual et al 1997
Incontinence other
1 of 1 (100%)
1 LQS - Pancorbo Hidalgo & Garcia
Fernandez 2001
Urinary Catheter
1 of 3 (33.3%)
1 HQS - Reed et al 2003 2 LQS - Compton et al 2008; Berlowitz & Wilking
1989
Skin moisture
3 of 5 (60.0%)
3 LQS - Suriadi et al 2007; Compton et al
2008; Bergquist & Frantz 1999
1 MQS - De Laat et al 2007
1 LQS - Halfens et al 2000
Body Temperature Domain
Body Temperature
5 of 8 (62.5%)
3 MQS - Nijs et al 2009; Suriadi et al 2008;
Bergstrom & Braden 1992
1 LQS - Suriadi et al 2007
1 VLQS - Rose et al 2006
2 LQS - Vanderwee et al 2009; Feuchtinger et al
2006
1 VLQS - Ek 1987
Nutrition Sub-Domains
Nutritional Scales
1 of 14 (7.1%)
1 LQS - Serpa & Santos 2007 3 HQS - Defloor & Grypdonck 2005; Perneger et
al 2002; Nixon et al 2006
6 LQS - Vanderwee et al 2009; Tourtual et al
1997; Pancorbo Hidalgo & Garcia Fernandez
2001; Halfens et al 2000; Lindgren et al 2004;
Kemp et al 1993
4 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Bostrom et al 1996; Ek 1987
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Food intake
4 of 7 (57.1%)
1 HQS - Brandeis et al 1994
1 MQS - Bergstrom & Braden 1992
1 LQS - Berlowitz & Wilking 1989
1 VLQS - Ek et al 1991
1 HQS - Defloor & Grypdonck 2005
1 MQS - De Laat et al 2007
1 LQS - Bergquist & Frantz 1999
Malnourishment
1 of 3 (33.3%)
1 HQS - Reed et al 2003 2 LQS - Schoonhoven et al 2002; Donnelly 2006
Weight
4 of 12 (33.3%)
3 LQS - Allman et al 1995; Lindgren et al
2004; Nixon et al 2007
1 VLQS – Cobb et al 1997
1 MQS - Bergstrom & Braden 1992
5 LQS - Yepes et al 2009; Boyle & Green 2001;
Compton et al 2008; Olson et al 1996; Kemp et al
1993
2 VLQS - Inman et al 1999; Watts et al 1998
BMI
2 of 9 (22.2%)
1 HQS - Schultz et al 1999
1 LQS - Fife et al 2001
2 HQS - Defloor & Grypdonck 2005; Brandeis et al
1994
5 LQS - Serpa & Santos 2007; Compton et al
2008; Vanderwee et al 2009; Feuchtinger et al
2006; Lindgren et al 2004
Arm measurements
1 of 3 (33.3%)
1 LQS - Pancorbo Hidalgo & Garcia
Fernandez 2001
2 LQS - Serpa & Santos 2007; Allman et al 1995
Other measures
0 of 4 (0%)
2 LQS - Yepes et al 2009; Compton et al 2008
2 VLQS - Inman et al 1999; Watts et al 1998
Age Domain
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Increasing Age
12 of 32 (37.5%)
4 HQS - Schultz et al 1999; Perneger et al
2002; Bergstrom et al 1996; Nixon et al 2006
3 MQS - Ooi et al 1999; Bergstrom & Braden
1992; Gunningberg et al 2001
5 LQS - Serpa & Santos 2007; Hatanaka et al
2008; Vanderwee et al 2009; Halfens et al
2000; Lindgren et al 2004
2 HQS - Defloor & Grypdonck 2005; Brandeis et al
1994
2 MQS - De Laat et al 2007; Baumgarten et al
2004.
12 LQS - Chan et al 2005; Yepes et al 2009; Fife
et al 2001; Compton et al 2008; Bergquist &
Frantz 1999; Tourtual et al 1997; Olson et al 1996;
Allman et al 1995; Berlowitz & Wilking 1989;
Feuchtinger et al 2006; Kemp et al 1993; Nixon et
al 2007
4 VLQS - Inman et al 1999; Watts et al 1998;
Goodridge et al 1998; Cobb et al 1997
Sensory Perception Domain
Sensory perception Braden
subscale
2 of 9 (22.2%)
1 HQS - Defloor & Grypdonck 2005
1 LQS - Halfens et al 2000
1 HQS - Perneger et al 2002
3 LQS - Vanderwee et al 2009; Tourtual et al
1997; Kemp et al 1993
3 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Bostrom et al 1996
Mental Status Sub-Domains
Mental Status
Subscales
1 of 5 (20%)
1 HQS - Perneger et al 2002 1 HQS - Defloor & Grypdonck 2005
2 LQS - Pancorbo Hidalgo & Garcia Fernandez
2001; Donnelly 2006
1 VLQS - Ek 1987
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Mental status study specific
measures
1 of 8 (12.5%)
1 HQS - Reed et al 2003 1 HQS - Brandeis et al 1994
1 MQS - Baumgarten et al 2004.
5 LQS - Bergquist & Frantz 1999; Sayar et al
2009; Pancorbo Hidalgo & Garcia Fernandez
2001; Halfens et al 2000; Donnelly 2006
Race Domain
Race
2 of 5 (40%)
1 HQS - Bergstrom et al 1996
1 MQS - Baumgarten et al 2004
1 HQS - Brandeis et al 1994
2 LQS - Bates-Jensen et al 2007; Chan et al 2005
Gender Domain
Gender
4 of 15 (26.6%)
4 LQS - Compton et al 2008; Bergquist &
Frantz 1999; Okuwa et al 2006; Hatanaka et al
2008
2 HQS - Brandeis et al 1994; Bergstrom et al 1996
1 MQS - Baumgarten et al 2004.
6 LQS - Chan et al 2005; Serpa & Santos 2007;
Boyle & Green 2001; Fife et al 2001; Lindgren et
al 2004; Donnelly 2006
2 VLQS - Inman et al 1999; Goodridge et al 1998
General Health Status Sub-Domains
ASA
1 of 2 (50%)
1 MQS - Rademakers et al 2007 1 LQS - Donnelly 2006
APACHE 2
1 of 4 (25%)
1 LQS - Yepes et al 2009 1 MQS - Nijs et al 2009
1 LQS - Compton et al 2008
1 VLQS - Inman et al 1999
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Norton score measures
0 of 3 (0%)
2 HQS - Defloor & Grypdonck 2005; Perneger et
al 2002
1 VLQS - Ek 1987
Chronic wounds
1 of 2 (50%)
1 HQS - Nixon et al 2006 1 LQS - Nixon et al 2007
Other factors
8 of 26 (30.8%)
3 HQS - Schultz et al 1999; Reed et al 2003;
Nixon et al 2006
2 MQS - Rademakers et al 2007; Nijs et al 2009
2 LQS - Yepes et al 2009; Lindgren et al 2004
1 VLQS - Marchette et al 1991
2 HQS - Defloor & Grypdonck 2005; Brandeis et al
1994
2 MQS –Salzberg et al 1999; De Laat et al 2007
12 LQS - Bates-Jensen et al 2007; Chan et al
2005; Serpa & Santos 2007; Schoonhoven et al
2002; Fife et al 2001; Compton et al 2008;
Bergquist & Frantz 1999; Halfens et al 2000;
Feuchtinger et al 2006; Nixon et al 2007; Okuwa
et al 2006; Donnelly 2006
2 VLQS - Inman et al 1999; Watts et al 1998
Medication Domain
Medication
3 of 10 (30%)
1 MQS - Nijs et al 2009
2 LQS - Bergquist & Frantz 1999
Stordeur et al 1998
1 HQS - Brandeis et al 1994
6 LQS - Yepes et al 2009; Schoonhoven et al
2002; Compton et al 2008; Vanderwee et al 2009;
Olson et al 1996; Donnelly 2006
Risk Factor Sub-Domains
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Domain summary: Variable
significant/total number
studies entered variable (%)
Number and quality of studies variable
significant in multivariable model
Number and quality of studies variable non-
significant in multivariable model
Braden Scale total score
7 of 16 (43.75%)
2 HQS - Schultz et al 1999; Bergstrom et al 1996
1 MQS - Bergstrom & Braden 1992
4 LQS - Bates-Jensen et al 2007; Chan et al
2005; Fife et al 2001; Stordeur et al 1998
6 LQS - Yepes et al 2009; Serpa & Santos 2007;
Bergquist & Frantz 1999; Tourtual et al 1997;
Kemp et al 1993; Donnelly 2006
3 VLQS - Baldwin & Ziegler 1998; Watts et al
1998; Goodridge et al 1998
Other scales
3 of 7 (42.8%)
1 MQS - Bourdel-Marchasson et al 2000
1 LQS - Pancorbo Hidalgo & Garcia Fernandez
2001
1 VLQS - Inman et al 1999
4 LQS - Compton et al 2008; Sayar et al 2009;
Stordeur et al 1998; Lindgren et al 2004
Study quality: HQS (High Quality Study), MQS (Moderate Quality Study), LQS (Low Quality Study), VLQS (Very Low Quality Study).
ASA: American Soceity of Anathesiologists; APACHE: Acute Physiology &Chronic Health Evaluation; PU: pressure ulcer; RAS: Risk Assessment Scale; BMI: Body
Mass Index. Reprinted from the International Journal of Nursing Studies, 50, Coleman S, Gorecki C, Nelson EA, Close SJ, Defloor T, Halfens R, Farrin A, Brown J,
Schoonhoven L, Nixon J. Patient risk factors for pressure ulcer development: systematic review. 2013; 974–1003.
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3.7.3.1 Mobility/Activity
Mobility/activity variables were classified into 8 sub-domains including activity risk
assessment scale subscales, mobility risk assessment scale subscales, activity
descriptors (bedfast/chair fast/immobility), mobility/activity ADL (Activities of Daily
Living), general ADL, friction and shear, factors affecting mobility and interface
pressures. Activity subscales categorize patients as bedfast, chair fast, walking with
limitations, walking with no limitations, whilst mobility subscales tend to categorize
frequency or magnitude of movement.
Overall 36 studies entered one or more mobility/activity related variables into their
statistical models (Table 3.5). In 29 (80.5%) of these studies a mobility /activity
related variable emerged as statistically significant (this included 2 large, high
quality studies). The variables that emerged most consistently were mobility sub-
scales (8 of 14 studies), mobility/activity ADL (4 of 7 studies) and activity
(bedfast/chairfast/immobile descriptors (6 of 11 studies). In all studies the direction
of the relationship was that poorer mobility/activity increased the risk of pressure
ulcer development.
Study specific activity descriptors were used in 11 studies and the use of non-
standardised measures also impacts upon interpretation and clinical application of
findings. A distinction is found in the literature between measures of activity which
are at the macro level (that is, bedfast, chairfast, ambulation) and mobility which
capture frequency and magnitude of movement. An important observation is that 14
studies used standardised measures (risk assessment scale subscales) and
included both activity and mobility subscales in multivariable modelling. Both
subscales emerged in 1 very poor quality study (Ek et al. 1991), in 7 the mobility
subscale rather than the activity subscale emerged (Ek 1987; Kemp et al. 1993;
Baldwin and Ziegler 1998; Bergquist and Frantz 1999; Watts et al. 1998; Perneger
et al. 2002; Lindgren et al. 2004) illustrating that mobility measures are more able to
distinguish between patients who will or will not develop pressure ulcers.
3.7.3.2 Skin/Pressure Ulcer Status
Skin/ pressure ulcer status were categorised into 5 areas comprising general skin
status (relating to factors which may make the skin more vulnerable to pressure
ulcer development, e.g. redness, blanching erythema, dryness), stage/grade 1
equivalent, existing pressure ulcers, and previous pressure ulcers. Overall sixteen
studies entered one or more skin/ pressure ulcer status related variables into their
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statistical models (Table 3.5). In 12 (75.0%) of these studies skin/pressure ulcer
status related variables emerged in multivariable modelling as independently
predictive of pressure ulcer development, and this included 3 high quality studies.
There is strong association between Stage/Grade 1 pressure ulcers (Allman et al.
1995; Reed et al. 2003; Nixon et al. 2006b; Nixon, Cranny and Bond 2007) and
subsequent >Stage/Grade 2 pressure ulcers. All of the studies reported odds ratios
and confidence intervals and the 2 large high quality studies (Reed et al. 2003;
Nixon et al. 2006b) suggest that the presence of a Stage/Grade 1 pressure ulcer
increases the odds of subsequent Stage/Grade 2 by 2-3 fold.
General skin status also appears to be important and emerged in 9 of the 10
studies which considered it (Marchette, Arnell and Redick 1991; Allman et al. 1995;
Schnelle et al. 1997; Pancorbo Hidalgo and Garcia Fernandez 2001; Defloor and
Grypdonck 2005; Nixon et al. 2006b; Rose, Cohen and Amsel 2006; Bates-Jensen
et al. 2007; Compton et al. 2008) including 2 high quality studies (Defloor and
Grypdonck 2005; Nixon et al. 2006b). However, the large number of descriptors
and more recent technologies to quantify underlying inflammation (e.g. Sub-
Epidermal Moisture Bates-Jensen et al 2007), make interpretation difficult. The
presence of existing pressure ulcers emerged only in long-term elderly patient
populations (Baumgarten et al. 2004; Defloor and Grypdonck 2005), whilst the
presence of existing pressure ulcer and previous pressure ulcer did not emerge in
acute hospital patient studies.
3.7.3.3 Perfusion
Perfusion related variables were categorised into diabetes, vascular disease,
circulation, blood pressure, smoking and oedema. Overall twenty seven studies
considered 1 or more perfusion related variables within their analysis (Table 3.5).
Of these, in 19 studies (70.4%) a perfusion related variable emerged.
There is strong evidence that diabetes increases the probability of pressure ulcer
development. Twelve studies (Berlowitz and Wilking 1989; Brandeis et al. 1994;
Stordeur, Laurent and D'Hoore 1998; Ooi et al. 1999; Schultz et al. 1999; Halfens,
Van Achterberg and Bal 2000; Feuchtinger et al. 2006; Nixon et al. 2006b; Donnelly
2006; Rademakers et al. 2007; Compton et al. 2008; Vanderwee et al. 2009)
included the diagnosis of diabetes in multivariable modelling. Of these 5 studies
comprising of 3 high quality studies (Brandeis et al. 1994; Schultz et al. 1999; Nixon
et al. 2006b) and 2 moderate quality studies (Ooi et al. 1999; Rademakers et al.
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2007) including both acute and long-term care patient populations found diabetes to
be associated with pressure ulcer development. The 7 studies where diabetes did
not emerge were all of low quality having serious limitations, including insufficient
number of events. Where diabetes emerged, the odds ratios associated with
diabetes ranged from 1.35 to 2.52.
Evidence from the wide range of other ‘perfusion-related’ variables suggest that
factors which impair circulation increase the probability of pressure ulcer
development, but the evidence is limited by study quality – only 4 of 20 studies are
high/moderate quality studies and interpretation is limited by the large range of
variable descriptors. Further confirmatory research in this area is required.
3.7.3.4 Haematological Measures
Haematological measures were categorised into U&Es, Protein, Albumin,
Lymphopenia and Haemoglobin (Hb). Overall, twenty two studies considered 1 or
more haematological measures within their analysis (Table 3.5).
Eleven studies (Ek et al. 1991; Marchette, Arnell and Redick 1991; Bergstrom and
Braden 1992; Kemp et al. 1993; Salzberg et al. 1999; Bourdel-Marchasson et al.
2000; Reed et al. 2003; Lindgren et al. 2004; Nixon, Cranny and Bond 2007; Serpa
and Santos 2007; Hatanaka et al. 2008) included albumin as a variable in
multivariable modelling. In 7 studies (63.6%) (Ek et al. 1991; Marchette, Arnell and
Redick 1991; Bourdel-Marchasson et al. 2000; Reed et al. 2003; Nixon, Cranny and
Bond 2007; Serpa and Santos 2007; Hatanaka et al. 2008) inlcuding 1 high quality
(Reed et al. 2003) and 1 moderate quality study (Bourdel-Marchasson et al. 2000)
albumin emerged as significant, the direction of the relationship suggesting that
lower albumin levels are associated with pressure ulcer development. Analyses are
limited by the use of categorical data.
Eleven studies (Olson et al. 1996; Stordeur, Laurent and D'Hoore 1998; Bergquist
and Frantz 1999; Gunningberg et al. 2001; Pancorbo Hidalgo and Garcia
Fernandez 2001; Feuchtinger et al. 2006; Nixon et al. 2006b; Nixon, Cranny and
Bond 2007; Okuwa et al. 2006; Serpa and Santos 2007; Hatanaka et al. 2008)
involving acute hospital, community and nursing home patient populations included
haemoglobin or anaemia as a variable in multivariable analyses and in 6 studies
(54.5%) (Olson et al. 1996; Stordeur, Laurent and D'Hoore 1998; Bergquist and
Frantz 1999; Pancorbo Hidalgo and Garcia Fernandez 2001; Nixon et al. 2006b;
Hatanaka et al. 2008) haemoglobin/anaemia emerged as a significant factor. The
120
direction of the relationship reported in 6 studies, which comprised of 1 high quality
study (Nixon et al. 2006b) and 5 low quality studies (Olson et al. 1996; Stordeur,
Laurent and D'Hoore 1998; Bergquist and Frantz 1999; Pancorbo Hidalgo and
Garcia Fernandez 2001) was that reduced haemoglobin/ anaemia is associated
with pressure ulcer development. However, in one study (Hatanaka et al. 2008) the
relationship was reversed but the study population comprised of respiratory patients
where an increased haemoglobin level is indicative of severity of respiratory
disease.
Four studies (Berlowitz and Wilking 1989; Salzberg et al. 1999; Okuwa et al. 2006;
Serpa and Santos 2007) included a variety of serum blood measures (creatinine,
urea, chloride, and sodium) as variables in multivariable analysis and in 1 moderate
quality study (Salzberg et al. 1999) and 1 low quality study (Serpa and Santos
2007) the variable emerged as significant (creatinine and urea). C-reactive protein
was modelled in 2 low quality studies (Hatanaka et al. 2008; Sayar et al. 2009) and
emerged in 1 (Hatanaka et al. 2008). Another very low quality study (Marchette,
Arnell and Redick 1991) considered pre op protein but this did not emerge in the
multivariable analyses. Two low quality studies (Allman et al. 1995; Pancorbo
Hidalgo and Garcia Fernandez 2001) included the variables lymphopenia and
diminished lymphocytes within their multivariable analysis and both emerged as
significant. Both studies were in acute hospital patient populations.
3.7.3.5 Moisture
Moisture related variables were categorised as moisture subscales of risk
assessment scales, urinary incontinence, faecal incontinence, dual incontinence,
incontinence other, urinary catheters and measures of skin moisture. Overall twenty
seven studies entered one or more moisture related variables into their statistical
models. In 13 (48 %) of these studies including 2 high quality studies (Brandeis et
al. 1994; Reed et al. 2003) and 2 moderate quality studies (Salzberg et al. 1999;
Ooi et al. 1999) a moisture related variable emerged as statistically significant
(Table 3.5). Overall, there is some evidence that moisture is a factor in pressure
ulcer development with the measures relating to dual incontinence and skin
moisture emerging more consistently compared to moisture risk assessment sub-
scales, urinary and faecal incontinence.
3.7.3.6 Body Temperature
Eight studies included temperature within their multivariable analysis (Table 3.5). In
5 studies, including 3 moderate quality studies (Suriadi et al. 2008; Bergstrom and
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Braden 1992; Nijs et al. 2009), 1 low quality study (Suriadi et al. 2007) and 1 very
low quality study (Rose, Cohen and Amsel 2006) temperature emerged in
multivariable modelling as independently predictive of pressure ulcer development.
In 3 of these studies (Bergstrom and Braden 1992; Suriadi et al. 2007; Suriadi et al.
2008) the direction of the relationship linked increased body temperature with
pressure ulcer development; in 1 study increased temperature reduced the risk
(Nijs et al. 2009), and in 1 study (Rose, Cohen and Amsel 2006) the direction of the
relationship was not reported. It is noteworthy that temperature emerged in all 4
ICU patient studies (Rose, Cohen and Amsel 2006; Suriadi et al. 2007; Suriadi et
al. 2008; Nijs et al. 2009). There are methodological limitations with the studies
which limit interpretation. The majority of studies defined the temperature variable
categorically. Only 3 of the 4 studies reporting statistical significance included odds
ratios and confidence intervals (Suriadi et al. 2007; Suriadi et al. 2008; Nijs et al.
2009). Overall, there is some evidence that increased body temperature may be an
important predictor of pressure ulcer development, but further confirmatory
research is required.
3.7.3.7 Nutrition
Nutrition related variables were categorised into nutritional scales, food intake,
malnourishment, weight, BMI, arm measurement and other measurement. Overall
34 studies included 1 or more nutrition related variable in their analyses and in 13
(38.2%) a nutrition related variable emerged as an important predictor of pressure
ulcer development (Table 3.5).
The variables that emerged most consistently were related to food intake and
weight . Of 7 studies considering food intake 4 studies emerged in multivariable
modelling comprising 1 high quality study (Brandeis et al. 1994), 1 moderate quality
study (Bergstrom and Braden 1992), 1 low quality study (Berlowitz and Wilking
1989) and 1 very low quality study (Ek et al. 1991). Of 12 studies considering
weight 4 studies comprising 3 low quality studies and 1 very low quality study
emerged in multivariable modelling. Fourteen studies (Ek 1987; Kemp et al. 1993;
Bostrom et al. 1996; Tourtual et al. 1997; Baldwin and Ziegler 1998; Watts et al.
1998; Halfens, Van Achterberg and Bal 2000; Pancorbo Hidalgo and Garcia
Fernandez 2001; Perneger et al. 2002; Lindgren et al. 2004; Nixon et al. 2006b;
Defloor and Grypdonck 2005; Serpa and Santos 2007; Vanderwee et al. 2009)
involving (in the main) acute care hospital patient populations, included nutritional
scales which comprised of the Braden Nutrition subscale (10 studies), other
nutrition subscales (3 studies) and one study that considered both the Subjective
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Global Nutrition Assessment (SGNA) and the Braden subscale. In only one low
quality study (Serpa and Santos 2007) did the nutrition scale (SGNA) emerge as
independently associated with pressure ulcer development. The studies where
nutritional scales did not emerge in multivariable modelling included 3 large high
quality studies.
Of note is that 13 studies entered other subscales of the risk assessment
instruments in the multivariable analysis and the nutrition subscale was not found to
be important in the presence of other key risk factors. In three studies none of the
risk assessment subscales emerged in the model (Bostrom et al. 1996; Pancorbo
Hidalgo and Garcia Fernandez 2001; Vanderwee et al. 2009), and in 10 studies
one or more other subscales including mobility (Ek 1987; Kemp et al. 1993; Baldwin
and Ziegler 1998; Watts et al. 1998; Perneger et al. 2002; Lindgren et al. 2004),
moisture (Tourtual et al. 1997; Baldwin and Ziegler 1998; Halfens, Van Achterberg
and Bal 2000), friction and shear (Tourtual et al. 1997; Halfens, Van Achterberg and
Bal 2000) and sensory perception (Halfens, Van Achterberg and Bal 2000; Defloor
and Grypdonck 2005) did emerge as important predictors of pressure ulcer
development.
3.7.3.8 Increasing Age
Thirty two studies evaluated age as a variable in their analysis (Table 3.5). Of these
increased age emerged in 12 (37.5%) studies (Bergstrom and Braden 1992;
Bergstrom et al. 1996; Ooi et al. 1999; Schultz et al. 1999; Halfens, Van Achterberg
and Bal 2000; Gunningberg et al. 2001; Perneger et al. 2002; Lindgren et al. 2004;
Nixon et al. 2006b; Serpa and Santos 2007; Hatanaka et al. 2008; Vanderwee et al.
2009). It was anticipated that age would not emerge in homogenous study
populations, however, reporting of mean age and age range of study populations is
not comprehensive. The trend of increasing age and risk is noted in the high and
moderate quality studies. Seven high and moderate quality studies included
heterogeneous study populations and in six (Bergstrom and Braden 1992;
Bergstrom et al. 1996; Ooi et al. 1999; Schultz et al. 1999; Perneger et al. 2002;
Nixon et al. 2006b) age emerged in multivariable modelling as an important
predictor of pressure ulcer development, whilst in two high quality studies of very
aged homogenous patient populations (Brandeis et al. 1994; Defloor and
Grypdonck 2005), age did not emerge as an important factor in the presence of
other risk factors in multivariable modelling.
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3.7.3.9 Sensory Perception
Nine studies involving acute care hospital, long-term and ICU patient populations
included the sensory perception subscale of the Braden scale within their
multivariable analysis (Table 3.5). In two studies comprising 1 high quality study
(Defloor and Grypdonck 2005) and 1 low quality study (Halfens, Van Achterberg
and Bal 2000) this factor emerged as statistically significant. However, it did not
emerge in the remaining 7 studies.
3.7.3.10 Mental Status
Overall eleven studies considered mental status, using a range of measures and
descriptors in multivariable analysis and 2 (18.2%) high quality studies (Perneger et
al. 2002; Reed et al. 2003) found mental health variables to be of significance
(Table 3.5). Mental status did not emerge as a key risk factor in pressure ulcer
development.
3.7.3.11 Race
Five studies considered race as a variable in modelling (Table 3.5). In two studies
comprising 1 high quality study (Bergstrom et al. 1996) and 1 moderate quality
study (Baumgarten et al. 2004) race emerged as an independent predictor of
pressure ulcer development , however findings were contradictory, since in one
study white race was associated with increased risk (Bergstrom et al. 1996) and in
the other black race was associated with increased risk (Baumgarten et al. 2004).
In the remaining three studies race did not emerge as being significant. Overall
there is limited evidence relating to the relationship between race and pressure
ulcer development.
3.7.3.12 Gender
Fifteen studies included gender in multivariable modelling (Table 3.5). Only 4 low
quality studies (Bergquist and Frantz 1999; Okuwa et al. 2006; Hatanaka et al.
2008; Compton et al. 2008) demonstrated a relationship between gender and
pressure ulcer development, with 3 (Bergquist and Frantz 1999; Okuwa et al. 2006;
Compton et al. 2008) identifying males at increased risk and 1 (Hatanaka et al.
2008) suggesting that males were at reduced risk. Eleven studies, including 2 high
quality and 1 moderate quality did not find gender to be a significant factor in
pressure ulcer development. Overall there is minimal evidence to suggest that
gender is a risk factor associated with pressure ulcer development.
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3.7.3.13 General Health Status
We categorised General Health Status into ASA (American Society of
Anaesthesiologists) classification, APACHE 2 (Acute Physiology and Chronic
Health Evaluation), Norton measures, chronic wounds and other factors. Overall
twenty eight studies considered 1 or more general health status measures within
their analysis (Table 3.5). In 8 studies (28.6%) a general health status measure
emerged as important in modelling. The presence of chronic wound also emerged
in 1 of the 2 studies that included it in the statistical model. The variety of measures
used has made it difficult to consider the overall importance of the findings.
3.7.3.14 Medication
Ten studies included various medication therapies in multivariable modelling (Table
3.5). In three studies (Stordeur, Laurent and D'Hoore 1998; Bergquist and Frantz
1999; Nijs et al. 2009) medication emerged as a significant variable and these
included, use of sedatives, dopamine 5mcg/kg/min, oxygen use and post-operative
steroid therapy. In one study (Nijs et al. 2009) of an ICU population use of sedative
emerged as significant, however, the direction of the relationship was that it acted
as a protective factor.
Overall there is limited evidence that any particular medication predisposes patient
to develop pressure ulcers, rather they are likely to be a surrogate indicator of
underlying disease pathology which may contribute to risk.
3.7.3.15 Risk Assessment Instruments
Overall, 22 studies included a risk assessment scales total score within their
analysis and in 10 (45.4%) the risk assessment instrument total score emerged as
statistically significant (Table 3.5). The risk assessment total score emerged in all
the high quality (Bergstrom et al. 1996; Schultz et al. 1999) and moderate quality
(Bergstrom and Braden 1992; Bourdel-Marchasson et al. 2000) studies which
included this variable. However, it is also noteworthy that in general, where studies
included both total score and subscales of the Risk Assessment Instrument (Kemp
et al. 1993; Tourtual et al. 1997; Baldwin and Ziegler 1998; Watts et al. 1998;
Bergquist and Frantz 1999; Pancorbo Hidalgo and Garcia Fernandez 2001;
Lindgren et al. 2004) a subscale emerged as independently predictive of pressure
ulcer development (Kemp et al. 1993; Tourtual et al. 1997; Baldwin and Ziegler
1998; Watts et al. 1998; Bergquist and Frantz 1999; Lindgren et al. 2004) rather
than the total score.
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3.8 Discussion
This is the first systematic review of risk factors related to pressure ulcer
development. A strength of the review was that each of the included studies were
subject to detailed quality assessment allowing limitations to be identified and taken
into consideration in interpretation. This was informed by consideration of the
assessment of limitations and bias of risk factor and prognostic factor studies and
methodological considerations in the analysis, meta-analysis and publication of
observational studies prognosis (Harrell et al. 1985; Simon and Altman 1994;
Altman 2001; Peduzzi et al. 1995; Egger, Smith and Schneider 2001; Mak and Kum
2005; Maltoni et al. 2005; Hayden, Côté and Bombardier 2006; Royston, Altman
and Sauerbrei 2006; von Elm et al. 2007; Altman 2009; CRD 2009; Mallett et al.
2010; Schulz et al. 2010; Steyerberg 2010) enabling the development of a two
staged approach to quality assessment. The first stage was integrated into the
eligibility criteria and the second stage involved detailed quality appraisal of
included studies. This provided an efficient method for quality appraisal, as the
eligibility criteria allowed studies with bias that was considered unacceptable to be
screened out, ensuring a minimum standard of quality for included studies. The
integration of critical design specific aspects of quality (e.g. exclusion of controlled
trials without randomised allocation to treatment and intention to treat analyses) in
the eligibility criteria also meant that the detailed quality appraisal could focus on
risk factor measurement rather than study design. This allowed a consistent
approach to the overall assessment of study quality to be achieved.
The detailed quality appraisal provided information on each criteria and key domain
for each study in keeping with other other quality appraisal systems (GRADE
Working Group 2004; Guyatt et al. 2008; Cochrane 2009). In addition, each study
was classified to provide an overall summary of study quality to facilitate the
development of the evidence tables, interpretation of the results and to give an
indication of the strength of evidence for each risk factor. However, there were
some potential limitations that should be acknowledged. In the absence of
published guidance for the classification of study quality for risk factor research, an
approach was developed for this review. This was not specified prior to the quality
assessment, rather it was developed following appraisal of all criteria. While this
approach could be criticised, it was required to assist in identifying the differences
between high and low quality studies in the context of the pressure ulcer field and in
developing the classification system.
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The key domains that were identified focussed on the analysis methods of the
included studies and this could be viewed as not being balanced with regard to
other important aspects of quality i.e. study participation, attrition, risk factor
measurement and outcome measurement (Hayden, Côté and Bombardier 2006).
The focus on analysis was considered necessary to emphasise the fundamental
importance for ensuring the validity of the results. While the other quality criteria
(items 1-7 Table 3.1) were viewed as very important (and contributed to the
assessment of the key quality domains), all of these could be achieved, but poor
methods of analysis would still result in a poor quality study, in which there was a
high degree of uncertainty about the validity of the results (Kemp et al. 1993; Olson
et al. 1996; Bergquist and Frantz 1999; Fife et al. 2001; Suriadi et al. 2007;
Vanderwee et al. 2009). In addition, the studies which were classified as high or
moderate quality tended to meet most of the quality criteria (items 1-7 Table 3.1).
Others could view the analysis appraisal as superficial as there are specific
statistical considerations that could have been considered, for example, the
appropriateness of the multivariate analysis used, or whether the number of
patients in the final model was reported.
The study classification system was also limited as it did not cover all potential
combinations of compliance with the four key domains (i.e. whether they met - yes,
no, partial, uncertain). This meant that 8 studies (Ek et al. 1991; Marchette, Arnell
and Redick 1991; Cobb, Yoder and Warren 1997; Bourdel-Marchasson et al. 2000;
Gunningberg et al. 2001; Rose, Cohen and Amsel 2006; Suriadi et al. 2008; Nijs et
al. 2009) did not actually fall into the strict classification definitions, e.g. four
moderate quality studies (Gunningberg et al. 2001; Bourdel-Marchasson et al.
2000; Suriadi et al. 2008; Nijs et al. 2009) met domain A but only fully met 1 other
quality domain rather than 2 (the third being partially met). On these occasions the
decision to allocate the study to the moderate quality category was influenced by
the importance of key domain A, or the adequacy of the number of pressure ulcers
developed in relation to the number of risk factors considered and emerging in the
model. Difficulties in the derivation of studies also led to one study being
misclassified as a low quality study (Serpa and Santos 2007) when it should have
been allocated as very low quality. Fortunately this did not affect the interpretation
of the results. It is acknowledged that if this system is to be used in future work,
further development is required to accommodate all potential outcomes in the
classification of study quality.
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It is also important to note that some of the included key quality domains are not
independent of one another and require informed judgements to be made by those
undertaking the appraisal and classification of study quality. Judgements were also
made where the reporting of methods were lacking, in determination of Domain A
(whether there was sufficient number of events (rule of thumb >10 events per risk
factor)). There were 9 studies (Ek et al. 1991; Marchette, Arnell and Redick 1991;
Bourdel-Marchasson et al. 2000; Serpa and Santos 2007; Rose, Cohen and Amsel
2006; Hatanaka et al. 2008; Suriadi et al. 2008; Nijs et al. 2009) where the number
of risk factors entered into the model was not clearly specified and judgements
were made based on 3 sources of information incorporating the number of events
reported, the number of risk factors described in the methods and the number of
risk factors in the final model. Judgements were then made as ‘probably yes’ (i.e.
very large number of events and maximum number of possible risk factors does not
exceed >10 events per risk factor), ‘definitely no’ (i.e. the model itself has <10
events per risk factor) and ‘uncertain’. Further judgement was then required in three
studies (Ek et al. 1991; Marchette, Arnell and Redick 1991; Rose, Cohen and
Amsel 2006) where there was uncertainty for key domain A. As none of the other
key criteria were met the studies were allocated to the very low quality study
category.
Despite these noted limitations the quality appraisal method provides a pragmatic
approach that was integrated into the evidence tables of the review and helped to
clarify the overall strength of evidence for each risk factor which facilitated
interpretation of the results. While the approach may be of relevance to researchers
in other fields, it is acknowledged that further work should be undertaken with
methodological experts to reach consensus on the most important criteria required
to assess the quality of exploratory risk factor studies to develop and validate a tool
to specifically for this.
The results of the review are consistent with pressure ulcer aetiology conceptual
frameworks confirming major domains of mobility/activity, and perfusion (Defloor
1999), whilst identifying for the first time the importance of skin/pressure ulcer
status and diabetes. However, the review also highlights important limitations with
the current evidence and methodological challenges associated with the conduct
and interpretation of risk factor reviews in the absence of clear guidelines. A key
limitation is the large number of descriptor variables used to describe risk factors
which impacts upon interpretation and further use of the data in meta-analysis,
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highlighting the need for an internationally agreed minimum data set. Study quality
is also generally poor (sample size considerations, analysis methods and standards
of reporting). In general, sample size considerations for multivariable analyses have
not been used to inform study design and only seventeen studies fulfilled the ‘rule
of thumb’ sample size estimate of 10 events (or pressure ulcers) per variable in the
multivariable model (Harrell et al. 1985; Simon and Altman 1994; Peduzzi et al.
1995; Altman 2009; Mallett et al. 2010; Steyerberg 2010). The impact of this is
demonstrated in studies which report Confidence Intervals (CIs). For example, four
studies report non-blanchable erythema as an independent predictor of Grade ≥2 
pressure ulcer development (Allman et al. 1995; Reed et al. 2003; Nixon et al.
2006b; Nixon, Cranny and Bond 2007).Two studies had inadequate numbers of
pressure ulcers and reported large odds ratios with wide CIs (Allman et al. 1995;
Nixon, Cranny and Bond 2007), whereas the two larger studies (Reed et al. 2003;
Nixon et al. 2006b) with adequate numbers of pressure ulcers reported lower odds
ratios and narrow CIs. Future research should ensure adequate numbers of
pressure ulcers to maximise the validity of study results.
Continuous data has been analysed as continuous data (Olson et al. 1996;
Stordeur, Laurent and D'Hoore 1998; Nixon et al. 2006b; Nixon, Cranny and Bond
2007; Hatanaka et al. 2008), but also as categorical data (Bergquist and Frantz
1999; Bourdel-Marchasson et al. 2000; Pancorbo Hidalgo and Garcia Fernandez
2001; Reed et al. 2003; Serpa and Santos 2007; Nijs et al. 2009), with no
standardisation of category values. Continuous data allows comparability of results
from various studies. Categorisation of continuous data should be avoided in
regression models since it leads to a loss of power and residual confounding. In
addition, the use of data-derived cut points can lead to serious bias (Altman et al.
1994; Royston, Altman and Sauerbrei 2006).
A further consideration is the recommendation that systematic reviews of prognostic
factors studies are limited to those with patients at the same ‘starting point’ in the
disease trajectory (Altman 2001). However, as this was the first systematic review
of pressure ulcer risk factors, the emphasis was to explore the breadth of available
evidence and studies of patients with and without pressure ulcers at baseline, from
acute, rehabilitation, long-term care and community populations, including
heterogeneous and homogeneous patient populations were included. Interpretation
was complicated by poor reporting of patient baseline characteristics and hence
difficulty in assessing heterogeneity. It is important to note that the heterogeneity of
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study populations will impact upon multivariable analysis and also other factors
entered into models for example, some studies included only bed/chairfast/ mobility
restricted patients (Kemp et al. 1993; Allman et al. 1995; Inman et al. 1999;
Salzberg et al. 1999; Bourdel-Marchasson et al. 2000; Boyle and Green 2001; Fife
et al. 2001; Gunningberg et al. 2001; Reed et al. 2003; Defloor and Grypdonck
2005; Donnelly 2006; Nixon et al. 2006b; Okuwa et al. 2006; Suriadi et al. 2007;
Rademakers et al. 2007; De Laat et al. 2007; Compton et al. 2008; Hatanaka et al.
2008; Suriadi et al. 2008; Nijs et al. 2009; Yepes et al. 2009; Sayar et al. 2009;
Vanderwee et al. 2009) therefore it is unlikely that a relationship between
mobility/activity and pressure ulcer development would be observed, as all patients
were similarly immobile. Future work should be undertaken to identify a sub-set of
studies deemed similar enough and of good quality, and the potential for meta-
analysis explored with or without individual patient data.
In general researchers did not consider a comprehensive range of key risk factors
in multivariable analyses and this limits interpretation and overall conclusions. For
example, the study by Serpa and Santos includes 10 descriptors relating to
nutrition, but no variables relating to activity/mobility or perfusion (Serpa and Santos
2007). Similarly a large number of studies do not include a mobility/activity factor in
their analysis even where the study population is heterogeneous for activity/mobility
(Cobb, Yoder and Warren 1997; Goodridge et al. 1998; Ooi et al. 1999; Chan et al.
2005). Furthermore, the primary studies of the review do not test for statistical
interaction between risk factors within their regression models. The review is
therefore limited to the confines of the original study analysis. Future primary
research should consider which risk factor interactions are most predictive of
pressure ulcer development.
A number of studies use only the Risk Assessment Instrument total score in the
multivariable analysis (Bergstrom and Braden 1992; Stordeur, Laurent and D'Hoore
1998; Inman et al. 1999; Schultz et al. 1999; Fife et al. 2001; Bourdel-Marchasson
et al. 2000; Chan et al. 2005; Bates-Jensen et al. 2007; Compton et al. 2008;
Yepes et al. 2009). This does not enable the dominant risk factors to be identified.
Future research should ensure that key risk factors are included in multivariable
analyses, so that validation of the core set of risk factors can be achieved and
prognostic variables can be utilised widely.
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In addition general standards for the reporting of risk factor studies do not meet
basic criteria recommended by international guidelines on the reporting of
observational studies (von Elm et al. 2007). A large number of studies were
excluded due to two key criteria – loss to follow-up rates and use of multivariable
analysis. Of the 45 cohort studies and RCTs included in the review only eighteen
fulfilled basic reporting requirements (Hayden, Côté and Bombardier 2006; von Elm
et al. 2007), including reporting of baseline study population characteristics, levels
of significance and CIs (Brandeis et al. 1994; Bergquist and Frantz 1999; Allman et
al. 1995; Ooi et al. 1999; Fife et al. 2001; Baumgarten et al. 2004; Lindgren et al.
2004; Nixon et al. 2006b; De Laat et al. 2007; Okuwa et al. 2006; Sayar et al. 2009;
Schultz et al. 1999; Bates-Jensen et al. 2007; Rademakers et al. 2007; Suriadi et
al. 2007; Hatanaka et al. 2008; Vanderwee et al. 2009; Yepes et al. 2009). These
are essential components for the interpretation of results. Future researchers
should ensure adequate reporting of risk factor studies to improve the validity and
generalisability of study results. This may be assisted by published standards of
reporting for primary research of different designs including CONSORT Statement,
guidelines for reporting parallel group randomized trials (Begg et al. 1996; Moher et
al. 2001; Schulz et al. 2010) and STROBE Statement: guidelines for reporting
observational studies (von Elm et al. 2007).
The methodological limitations are further complicated by the use of different
outcome measures, that is both Grade ≥1 and Grade ≥2 outcomes are utilised. 
Some might suggest that risk factors associated with Grade 1 pressure ulcers are
different to risk factors associated with Grade 2 pressure ulcers but this was outside
the scope of this review and requires formal review and further analysis to inform
future research and clinical practice. The majority of pressure ulcer development in
the studies of the review are superficial pressure ulcers since cohort studies fail to
recruit patients who develop severe pressure ulcers; therefore the review is limited
to risk factors associated with superficial pressure ulcer development.
The strong association between Stage/Grade 1 pressure ulcers and subsequent
>Stage/Grade 2 pressure ulcers resonates with what is experienced in clinical
practice and nurses often see the presence of non-blanching erythema as a
warning of potential further deterioration. Additionally the presence of an existing
>Stage/Grade 2 pressure ulcer would alert the nurse of the possibility of additional
pressure ulcer development and the need for secondary prevention.
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Another potential area of uncertainty is whether the superficial pressure ulcers
reported in the studies of the systematic review are incontinence associated
dermatitis (IAD) rather than pressure ulcers. Historically trunk wounds have been
labelled as pressure ulcers but there is confusion between IAD and superficial
pressure ulcers (Beeckman et al. 2011; Doughty 2012). Only 1 study specifically
reported that the training of staff undertaking skin assessment incorporated the
differentiation of IAD and pressure ulcers (Vanderwee et al. 2009). Moreover, there
is a possibility that the importance of pressure ulcer risk factors may vary in relation
to specific skin sites and this is still to be elucidated.
Finally, the methodological limitations within the pressure ulcer literature are similar
to those reported in other areas of medicine (Altman 2001; Egger, Smith and
Schneider 2001; Maltoni et al. 2005; Riley, Sauerbrei and Altman 2009). While it is
recognized that as multiple similar studies accumulate it is important to identify and
evaluate all of the relevant studies to develop a more reliable overall assessment
(Altman 2001), the methodological limitations of the studies identified precluded
combining study results using meta-analysis.
3.9 Conclusions
Overall there is no single factor which can explain pressure ulcer risk, rather a
complex interplay of factors which increase the probability of pressure ulcer
development. The review highlights the limitations of over-interpretation of results
from individual studies and the benefits of reviewing results from a number of
studies to develop a more reliable overall assessment of factors which are
important in affecting patient susceptibility. This was assisted by the development of
an efficient quality appraisal system to identify study quality. Study quality was
integrated into evidence tables for each risk factor sub-domain, providing
transparency and facilitating the interpretation of the results.
The risk factors which emerge most frequently as independent predictors of
pressure ulcer development in studies using multivariable analyses are consistent
with pressure ulcer aetiology conceptual frameworks, confirming major domains of
mobility/activity and perfusion (including diabetes). In addition skin/ pressure ulcer
status particularly relating to stage/grade 1, emerged as a major risk variable and
this is an important finding of this systematic review.
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Other factors including skin moisture, age, haematological measures, nutrition and
general health status are also important, but do not emerge as frequently as the
three main domains. Other factors which may be important but were included in
only a small number of studies include body temperature and immunity and these
require further confirmatory research. Our review shows that there is minimal or
limited evidence that either race or gender is important.
The review provides a foundation for the further development of a conceptual
framework of pressure ulcer development to bridge the gap between the
epidemiological, physiological and biomechanical evidence and enhance our
understanding of the role of individual risk factors in pressure ulcer development.
This will facilitate the development and content validity of a pressure ulcer minimum
standard dataset and Risk Assessment Framework and inform future risk factor
research.
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Chapter 4 Using Consensus Methods to Develop a Pressure
Ulcer Risk Factor Minimum Data Set and Risk
Assessment Framework
4.1 Introduction
This chapter provides a general overview of consensus methods incorporating the
Delphi method, nominal group technique, RAND/UCLA appropriateness method
and consensus conference and critically examines the similarities and differences
between these methods. It considers key methodological issues relating to validity,
reliability, expert groups, patient involvement, consensus definitions and analysis
and goes on to detail the rationale for undertaking a consensus study to agree a
draft pressure ulcer risk factor minimum data set and Risk Assessment Framework.
Following this the consensus study will be discussed, giving the rationale for the
methods used, the results of the study and discussion.
4.2 Consensus Methods
Structured consensus methods are used to define levels of agreement on
controversial subjects (Fink et al. 1984). Consensus methods incorporating the best
available evidence and the views of experts are increasingly being used in the
development of clinical guidelines and healthcare priorities, (Rycroft-Malone 2001;
Washington et al. 2003; Hutchings and Raine 2006; Hutchings et al. 2006; Kadam
et al. 2006; Jackson et al. 2009). They have advantages (Jones and Hunter 1995;
Murphy et al. 1998; Raine et al. 2004) over informal approaches (e.g. committees)
as they:
 Are carefully structured to reduce the influence of dominating personalities.
 Allow participants to change their opinion (or not) over the course of the
process in light of group opinion/feedback.
 Provide privacy for individual participant judgements.
 Provide transparency with regard to the synthesis of judgements and group.
decisions based on pre-set methods of analysis.
The most frequently encountered consensus methods include the Delphi method,
the nominal group technique and the Research and Development/ University of
California at Los Angeles (RAND/ UCLA) appropriateness method, though there are
134
many variations in the application of these methods in the literature which are
sometimes referred to as ‘modified’ consensus methods (Nair, Aggarwal and
Khanna 2011). For completeness the consensus development conference is also
mentioned, though this methodology has largely been discarded (Black 2006) in
favour of the methodologies detailed above. The key characteristics of these
methods and informal consensus methods are summarised in Table 4.1 and
discussed in more detail in sections 4.3 to 4.6.
Table 4.1 Summary of characteristics of informal and formal consensus
methods
Consensus
method
characteristic
Classi
c
Delphi
Classi
c
NGT
RAND/UCLA
Appropriatene
ss
Consensus
developme
nt
conference
Informal
consensu
s
Explicit
consideration of
literature/systema
tic review
evidence
X* X* √ √ X 
Face-to-face
contact
X √ √ √ √ 
Structured
interaction
√ √ √ X X 
Rating/voting √ √ √ X X 
Mailed
Questionnaires
√ X √ X X 
Private decisions
elicited
√ √ √ X X 
Formal feedback
of group
decisions
√ √ √ X X 
Opportunity to
change opinion
(re-rate)
√ √ √ X X 
Method of
synthesis of
judgement and
group decisions
explicit
√ √ √ X X 
* adapted versions of the method incorporate evidence
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4.3 Delphi Method
The Delphi method was originally developed in the 1950’s by the Research and
Development (RAND) Corporation for forecasting in defence research in the US
(Dalkey and Helmer 1963) and has since been used in healthcare settings to reach
consensus on a variety of matters relating to healthcare, though not usually for
clinical guideline development (Murphy et al. 1998). The Delphi method’s objective
is ‘to obtain the most reliable consensus of opinion of a group of experts’ (Dalkey
and Helmer 1963). The method typically involves a series of intensive
questionnaires which classically includes 4 rounds, but this can be adjusted to meet
the investigators needs (Fink et al. 1984). The method includes controlled
feedback but no face-to-face interaction between group members (Table 4.1). An
overview of the process is detailed below (Jones and Hunter 1995):
 Round 1: development of the initial questionnaire by the researcher or in
collaboration with experts.
 Round 2: participants rank their agreement with the questionnaire
statement/cues using a Likert scale.
 Round 2 and subsequent rounds: results of the preceding round are
summarised and participants are then able to re-rank their agreement with
statements/cues in light of this feedback. Statements/cues where consensus
is reached at round two may not be included in subsequent rounds.
Advantages of the Delphi method include that it facilitates information exchange in
an iterative process and can incorporate the views of numerous and geographically
dispersed participants cheaply (Jones and Hunter 1995; Murphy et al. 1998). It also
encourages opinion that is free from peer pressure, though participants can alter
their judgements in light of group feedback (Williams and Webb 1994). Additionally
the controlled feedback avoids participants being side-tracked (McKenna 1994).
Although the advantages have been highlighted, some believe that the lack of face
to face interaction may prevent the identification of reasons for disagreement and
diminish the opportunity for finding common ground (Murphy et al. 1998; Raine,
Sanderson and Black 2005). Others have also suggested that it could lead to a lack
of accountability for expressed views (Sackman 1974).
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4.4 Nominal Group Technique
The nominal group technique was originally developed to facilitate effective
committee decision making (Van de Ven and Delbecq 1971) but was also
considered appropriate for use in the healthcare context (Van de Ven and Delbecq
1972). The nominal group technique is a structured face-to-face meeting that
attempts to provide an orderly procedure for obtaining qualitative information from
target groups who are most closely associated with a problem area (Van de Ven
and Delbecq 1972). The key characteristics of the nominal group technique are
summarised in Table 4.1. While in recent years there has been variations in the
approach, classically the nominal group technique involves a group of 5 to 8
participants (who have direct experience or expertise of the problem area being
explored) involved in the following process (Van de Ven and Delbecq 1972):
 Introduction.
 Silent generation of ideas by individual group participants with regard to
barriers to achieving the task.
 Structured round robin listing of ideas with each participant suggesting an
idea in turn until all ideas have been exhausted.
 Discussion of ideas to allow clarification or develop new ideas that may
emerge through discussion.
 Private ranking of the top 10 priorities by participants which are tallied.
 Voting on the top 10 items.
 Discussion of vote.
 Private re- ranking and rating priorities.
 Conclusion.
The advantages of the nominal group approach are that the structured interaction of
the group facilitates contributions by all participants and makes it more difficult for
those with more dominant personalities to take control of the meeting (Murphy et al.
1998). As the generation of ideas elements are undertaken in a round robin format
and are separated from the discussion element, it allows more ideas to be
expressed, prevents pursuit of a single train of thought and avoids quick decision
making (Van de Ven and Delbecq 1971; Gallagher et al. 1993). The structured
discussion element of the process allows the ideas to be evaluated and where
necessary to be clarified (Van de Ven and Delbecq 1971; Fink et al. 1984).
Criticisms of the approach include the lack of explicit evidence integration (Vakil),
though variations of classical nominal group technique methodology have been
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used in healthcare to incorporate up to date evidence (see 4.5) RAND/UCLA
appropriateness method (Fitch et al. 2001)). Other concerns relate to reliability, as
the views of a small group may be unrepresentative of the wider community and
practical issues relating to the time and financial resources required to undertake
face-to-face meetings (Raine, Sanderson and Black 2005).
4.5 RAND/UCLA Appropriateness Method
The RAND/UCLA appropriateness method incorporates elements of both the
nominal group technique and the Delphi method and was originally developed to
measure overuse and underuse of surgical procedures (Fitch et al. 2001). It was
developed in response to the lack of robust ‘gold standard’ or sufficiently detailed
evidence often encountered to support clinical decision making regarding patient
care in practice. It aimed to combine the best available scientific evidence with the
collective judgements of experts relating to the appropriateness of performing
surgical procedures for patient specific groups (in light of symptoms, medical history
and test results) (Fitch et al. 2001). It has since been used more generally to rate
appropriateness and develop criteria for wider healthcare treatment interventions,
clinical guidelines and quality indicators (Buetow and Coster 2000; Rycroft-Malone
2001; Halbert et al. 2006; Kroger et al. 2007; To et al. 2010). The key
characteristics of the RAND/UCLA appropriateness method are summarised in
Table 4.1. An overview of the process is detailed below (Fitch et al. 2001):
 Literature review and synthesis of evidence.
 List of indications and definitions.
 The above are sent to expert panel members who are asked to rate the
indications on a 9 point Likert scale prior to a face to face meeting.
 Face-to-face facilitated 1-2 day meeting of expert group members in which
the results of the above are discussed with a focus on areas of
disagreement and adjustments to the indications/definitions may be made, if
required.
 Following the discussion the indications are privately re-rated by expert
group members.
 Finally each indication is classified as ‘appropriate’, ‘uncertain’ or
‘inappropriate’ which is based on predetermined methods of analysis.
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The outcomes are then used prospectively to aid clinical decision making to
increase appropriateness and retrospectively to compare clinical records with the
criteria outcomes (Fitch et al. 2001). The method combines some of the positive
aspects of the classic nominal group technique and Delphi method i.e. private rating
of questionnaires and the face-to-face meeting of participants at the second round
where areas of disagreement can be discussed and clarified giving greater potential
for eventual agreement. In addition, an important element which is more prominent
than for the classic nominal group technique and Delphi method (though apparent
in some adaptations of the methods) is the explicit consideration and synthesis of
relevant research evidence.
4.6 Consensus Development Conference
The key characteristics of the consensus development conference are summarised
in Table 4.1. It was originally developed by the US National Institute of Health and
has developed over time. Typically the process involved a decision making group of
about ten people who convened in a chaired meeting to reach consensus about the
issue under consideration (Murphy et al. 1998). In the open meeting evidence from
experts or various interest groups was presented. The decision making group then
retired to consider the evidence and attempt to reach consensus.
4.7 Methodological Issues Concerning Consensus Methods
4.7.1 Validity
It has been recognised that it is difficult to determine the validity of consensus
judgements (i.e. whether ‘good judgements’ are made) at the time the judgements
are made (Murphy et al. 1998). Several possibilities for the assessment of validity
have been considered including comparisons with gold standards, predictive
validity, concurrent validity and internal logic (Murphy et al. 1998).
Consensus studies are undertaken when there is uncertainty and this usually
means there is no conclusive evidence (i.e. no gold standard) of the best way to
proceed for a given situation. Therefore the judgements made cannot be compared
with a ‘correct’ answer as it does not exist at the time of undertaking the consensus
study. Likewise in consensus studies that relate to forecasting (e.g. in the
development of clinical Risk Assessment Instruments), predictive validity could be
assessed as new evidence emerges, but not at the time of the consensus study.
Concurrent validity can also be assessed by considering whether the group
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judgements deviate from research evidence without good reason which could be
considered invalid (Murphy et al. 1998).
Due to the difficulties associated with measuring the validity of consensus studies it
is important that the consensus process is as rigorous as possible (Raine,
Sanderson and Black 2005). This should be demonstrated by the application of
good practice in the planning and delivery of each stage of the consensus process.
4.7.2 Reliability
Another criticism of consensus methods is the lack of reliability, that is the ability of
the method (including the same information and questions) to produce the same
results with different groups (Sackman 1974; Williams and Webb 1994; Keeney,
Hasson and McKenna 2001; Hasson, Keeney and McKenna 2000; Raine,
Sanderson and Black 2005). Indeed, a new approach has been suggested that
checks the representativeness of the expert group views with the wider community
(Raine, Sanderson and Black 2005).
4.7.3 Expert Groups
There is debate in the literature regarding expert groups, the most appropriate
composition of participants in consensus studies and the effect this has on group
decisions. Experts have been described as a panel of informed individuals
(McKenna 1994) while others suggest that they incorporate characteristics relating
to experience, credibility, continuing education and demonstrating an active
contribution to educational needs (Williams and Webb 1994). Fink et al suggests
that consensus participants should comprise of participants who are representative
of their professions, have power to implement findings, or because they are not
likely to be challenged as experts in the field (Fink et al. 1984). Vakil suggests that
the panel should incorporate enthusiasts and sceptics (Vakil 2011).
There is also concern of how to identify suitable experts (Hasson, Keeney and
McKenna 2000) and the potential for selection bias (Jones and Hunter 1995;
Keeney, Hasson and McKenna 2001). It is therefore important that this is carefully
considered when developing the methodology and that the selection process is
transparent. The nature of the consensus study will influence the required
characteristics of participants e.g. studies of clinical matters should include
clinicians practising in the field, but there may also be value in gaining the insight of
a non-specialist to provide an alternative view (Jones and Hunter 1995). Indeed, a
systematic review of consensus studies which considered the effects of specialty
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mix on consensus judgements found that practitioners who perform the procedure
under consideration are more likely to make judgements of appropriateness,
compared with those who did not and that mixed groups rather than single specialty
groups have a moderating effect on differences (Hutchings and Raine 2006). This
suggests that mixed specialty groups rather than single speciality groups should be
favoured, as they facilitate consideration of a wider range of opinions leading to
some knowledge transfer between participants of different specialties (Hutchings
and Raine 2006).
Another consideration relates to international differences and the effect multi-
nationality panels, compared to single nationality panels have on levels of
consensus. A systematic review incorporating six primary studies considered the
differences in levels of consensus between groups from different countries (3 Swis
v US, 1 UK v US, 1 Dutch v US, 1 UK v Israel) when comparing appropriateness
ratings for various interventions. The results revealed varying differences in
appropriateness ratings which are suggested to be related to the diversity of each
country with regard to the organisation of health care and available resources
(Hutchings and Raine 2006).
The review also identified two studies comparing differences in levels of consensus
between national and multi-national groups. They concluded that the extent of bias
(one group rating more favourably) was lower for multi-national studies than
national studies (Hutchings and Raine 2006). One of the included studies compared
the consensus ratings for the appropriateness of treatments for benign prostatic
hyperplasia of a Dutch panel (of single specialty urologists) with a European panel
(with urologist from Spain, the Netherlands, Germany, Sweden and England)
(McDonnell et al. 2001). This study found that 84% of appropriateness indications
(of 1152 ) were identical and only one indication was rated as inappropriate by the
European panel compared to the appropriate rating of the Dutch panel which could
be attributed to chance. They found statistically significant, but clinically minor
differences relating to rating of uncertainty with the Dutch panel having fewer
uncertain ratings and concluded that international panels ‘can deliver essentially the
same appropriateness ratings as national panels’ which could save money and
reduce undesirable practice variation (McDonnell et al. 2001). The other
comparison study comparing a Dutch panel and multi-national panel regarding the
appropriateness of coronary revascularisation came to similar conclusions with no
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significant differences in appropriateness ratings between the two groups
(Bernstein et al. 2002).
The number of group members involved in the consensus process is influenced by
the type of consensus methodology employed. For groups that meet face-to-face
consideration should be given to the co-ordination and facilitation of the group
(Murphy et al. 1998). In practice group sizes tend to be between 9-12 (Scott and
Black 1991; Rycroft-Malone 2001; Kadam et al. 2006; Carpenter et al. 2007) though
larger groups (incorporating 15-23 members) have also been used (McDonnell et
al. 2001; Shiffman et al. 2003). This appears to be based on practical experience
and limited research of a peer review of medical care study, which showed that as
the group size increased, over a range of 1 -10 members so did reliability (levelling
off after 10) (Richardson 1972). This study also showed that on average 16, 21 and
28 participants were needed to generate judgements with a reliability of 0.95
suggesting that increased group membership may be favourable. However, when
deciding group numbers a careful balance needs to be struck between maximising
reliability, preventing co-ordination problems and diminishing returns (Murphy et al.
1998).
4.7.4 Use of Evidence
The information presented to participants in consensus studies is an important
element of their decision making (Murphy et al. 1998). A lack of relevant
synthesised evidence is more likely to result in participants relying solely on their
own reading and experience which maybe limited (Fink et al. 1984). A study
exploring the determinants of group judgements considered the effectiveness of
mental-health interventions on three chronic conditions (Raine et al. 2004). The
study involved 16 nominal groups, half of whom were provided with a relevant
literature review and half who were not. The study demonstrated that where a
literature review was provided the decisions made were more likely to be consistent
(60% of 192 group median ratings) with the research evidence than if no review
(42% of 192 group median ratings) was provided. If the evidence supported group
member’s clinical practice they were more likely to accept it. Divergence from the
evidence related to weak or irrelevant evidence, clinical experience, patient
preference, treatment availability, and reluctance to do nothing (Raine et al. 2004).
This provision of evidence has obvious implications for the validity of the decisions
made in consensus studies. In practice, particularly in the area of clinical
criteria/guideline development, consideration of systematic review evidence is
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commonly incorporated into the process (Buetow and Coster 2000; Rycroft-Malone
2001; Halbert et al. 2006; Jackson et al. 2009).
4.7.5 Patient Involvement
While the involvement of patients and carers as key stakeholders are advocated in
the consensus process (Fink et al. 1984; Black 2006), there is little evidence of this
in the literature relating to clinical guideline development. Difficulties in involving
patients and carers in the development of technical and clinical guidelines have
been raised previously (Rolls and Elliott 2008). Of the few reported studies which
incorporate patients/carers, the nature of their involvement mainly involves
membership of the expert group (Rycroft-Malone 2001; Jackson et al. 2009). A
limitation of this approach is the minimal number of patient/carer participants on the
expert groups, which could be in part due to the small size of the groups. In
addition, the complex nature of the research evidence considered in clinical
guidelines could be a barrier for effective patient/carer involvement. These
limitations could lead to under-representation of patients/carer views in guideline
development. Of note in the Rycroft-Malone study is the additional patient/carer
involvement at the end of the process where patient/care representatives (along
with other stakeholders) were asked to comment on the draft guideline before it was
finalised (Rycroft-Malone 2001). Using this approach may facilitate patient/carer
endorsement of the guideline, but it could be argued that more rigorous involvement
of patients and carers earlier in the consensus process could provide useful
information to help shape the guideline and improve its acceptability to patients.
Looking at the wider literature there is some evidence of patient/carer involvement
in health related priority setting which incorporate some, though less structured
elements of consensus methodology. An example of such an initiative relates to
establishing urinary incontinence research priorities and was undertaken by the
James Lind Alliance (Buckley et al. 2010). This involved representation of
patient/carer organisations as well as clinical organisations in identifying and
ranking research priorities via questionnaires in adapted nominal group workshops.
Limitations associated with this work from a consensus methods perspective was
the unstructured nature in which the initial information and ranking information was
obtained by the represented organisations i.e. there was no pre-specified
methodology for obtaining this information, and represented organisations
developed their own means of undertaking this, being asked only to describe the
process and the people involved (Buckley et al. 2010). This increases the potential
for introducing selection bias in the process and could impact on the validity and
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reliability of the results. Nethertheless, the work provides an example of how
patients/carers can be involved in a priority setting exercise. Another example of
priority setting work relates to a study which considered patient-centred
professionalism in community nursing. This used an adapted nominal group
technique with five separate groups including two community nursing groups, one
newly qualified group, one stakeholder group and one patients/carers (Hutchings et
al. 2012). Each group meeting involved exemplar generation and ranking. This was
followed up by a mixed group meeting where the outputs from the initial group
meetings were discussed and privately ranked giving the final ranked list of the
positive and challenging exemplars of patient-centred professionalism.
Of note in both the priority setting examples above is that patients/carers were not
required to consider detailed complex research evidence, rather their input was
sought to capture their personal experiences. It would seem that the role of
patient/carer involvement in structured consensus studies which develop clinical
guidelines needs to be clearer. This would help to determine how to most effectively
incorporate their views into the process.
4.7.6 Defining Consensus
There are two main issues relating to the achievement of consensus, one relating to
when consensus should be determined and the other relating to how it should be
defined. When consensus is determined varies between methods, so in the Delphi
methods there could be 4 rounds of consensus questionnaires (though often there
are less) while for nominal group and the RAND/UCLA method there are only 2
rounds. Too many round potentiates participant fatigue (Hasson, Keeney and
McKenna 2000). A crucial consideration about when consensus is determined is
that participants should have the opportunity to change their views in light of
discussion/feedback so a minimum of two rounds is necessary.
There is diversity regarding how consensus is defined in consensus studies (Fink et
al. 1984; Murphy et al. 1998). When defining consensus consideration should be
given to levels of agreement: this relates to agreement with the
statement/cue/indication under consideration and the extent that participants agree
with one another (Jones and Hunter 1995). So for example when individual group
judgements are aggregated it could result in a lack of agreement with a
statement/cue/indication, but agreement amongst participants (often referred to as
within group agreement) regarding this decision. Clearly when considering the
analysis methods the strictness of definitions used will influence the amount of
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consensus reached and these should be determined prior to data collection and
analysis (Black 2006).
When analysing the levels of agreement with the questionnaire
statements/cues/indications a measure of central tendency is required. As group
views are rarely normally distributed the group median rather than the mean is
preferred (Black 2006). Generally if a 9 point Likert scale is used (this is the most
frequently used as smaller scales give less information about levels of consensus)
the group median responses for each statement are categorised into 3 tertiles so
that group medians falling in the 1-3 tertile would indicate disagreement with the
statement/cue/indication, group medians falling in the 4-6 tertile would indicate
uncertainty and group medians falling in the 7-9 tertile would indicate agreement
with the statement/cue/indication.
Many studies also require there to be within group agreement about the decisions
made and this can analysed using a measure of dispersion. Measures used in the
literature include the interquartile range (Murphy et al. 1998; Black 2006), the mean
absolute deviation from the median (Hutchings et al. 2005) and the RAND
Disagreement index (Fitch et al. 2001). The mean absolute deviation from the
median (MADM), rather than the standard deviation is preferred because it does not
give extra weight to extreme observations (though they are included in the
calculation) and it measures variations about the median, which is the most
commonly used measure of central tendency for consensus studies (Hutchings et
al. 2005). The disagreement index is a measure of dispersion which incorporates
rules based on the classic definition of disagreement of the RAND/UCLA
appropriateness method: in a 9-panel members group there is disagreement when
at least three panellists rated the indication in the 1-3 tertile, and at least three
panellists rate it in the 7-9 tertile (Fitch et al. 2001). The disagreement index was
developed by investigators of the Carlos III Health Institute in Madrid due to
problems in applying the classic definition to panels where membership was more
or less than 9 and can be used for panels of any size.
4.8 Comparisons of Consensus Methods
Few studies have been undertaken to compare different consensus approaches on
study outcomes. Of these some indicate there is little difference to study outcomes
between in-person and mail only methods (Washington et al. 2003; Kadam et al.
2006) while others indicate important differences. Hutchings et al undertook
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research to compare the nominal group technique and the Delphi method in relation
to clinical guideline development of four mental health treatments (Hutchings et al.
2006). The study incorporated four Delphi groups (comprising 2 GP only groups
and 2 GPs and mental health practitioner groups) and 6 nominal groups (matched
from a larger sample of nominal groups detailed in Raine et al 2004) comprising of
3 GP only groups and 3 GP and mental health practitioner groups). Findings
indicated that nominal groups have closer within group agreement, whilst the Delphi
groups have improved reliability (k coefficients 0.88 and 0.89 compared with 0.41
and 0.65.) and concluded that a hybrid approach should be used (Hutchings et al.
2006). Such an approach was also suggested earlier by Raine, Sanderson and
Black (2005). A hybrid approach would enable the nominal group and Delphi
technique to work in a complementary manner, facilitating close consensus whilst
maximising reliability.
4.9 The rationale for the Pressure Ulcer Risk Factor
Minimum Data Set and Risk Assessment Framework
Consensus Study
The systematic review (Chapter 3) allowed the risk factors independently
associated with pressure ulcer development to be identified providing a clearer
notion of the critical pressure ulcer risk factors. However, there are remaining gaps
in the literature for some potentially important risk factors which require further
research. In addition, pressure ulcer risk factors were inconsistently represented in
the modelling of the primary studies of the systematic review, and this limits both
the interpretation and overall conclusions.
These shortfalls explain the lack of agreement of the key risk factors and data items
to summarise patient risk and highlight the need to agree a pressure ulcer risk
factor minimum data set. This is important from a research perspective as it will
facilitate the standardised and consistent collection of data relating to pressure
ulcer risk factors, facilitating future multivariable modelling and meta-analysis which
was not possible in our systematic review (Chapter 3). From a clinical perspective
the Minimum Data Set can be incorporated into a Risk Assessment Framework to
provide the fundamental components for pressure ulcer risk assessment in practice
and provide a standardised data set for case-mix adjustment. This may also have
an economic impact in terms of resource allocation.
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In the absence of absolute evidence relating to pressure ulcer risk factors, the need
to consult with experts in the pressure field using a transparent and robust method
was highlighted. This would require the experts to consider the systematic review
evidence and other pertinent scientific (physiological and biomechanical) evidence
and its relevance to clinical practice and risk assessment. This was undertaken
using structured consensus methods.
4.10 Consensus study
4.11 Aim
To develop a draft pressure ulcer risk factor Minimum Data Set and Risk
Assessment Framework for pre-testing and clinical evaluation. The new decision
tool is intended to be used for the prevention and management of generic mobility
related pressure ulcers. The objectives were:
1. To agree a list of patient characteristics to form a Minimum Data Set suitable for
routine collection of key risk factors.
2. To develop a Risk Assessment Framework incorporating the Minimum Data Set
and support for decision making with:
a) a simple screening stage to quickly identify not at risk patients.
b) a detailed full assessment stage for patients who are at potential/actual risk
or have an existing pressure ulcer.
c) Decision pathways i.e. not currently at risk, primary prevention (at risk) or
secondary prevention and treatment pathway (with pressure ulcer).
4.12 Design
To maximise content validity a consensus study using a modified nominal group
technique based on the RAND/UCLA (Research and Development / University of
California at Los Angeles) appropriateness method (Fitch et al. 2001) was used.
This was favoured over other methods as it incorporates key characteristics of the
Delphi method and the nominal Group Technique detailed in Table 4.1
(rating/voting, private decisions elicited, formal feedback of group decisions,
opportunity to change opinion (re-rate), method of synthesis of judgement and
group decisions explicit) and critically for this study it:
 incorporates the explicit integration of evidence which was an important
element of the study.
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 allows structured face-to-face interaction of the group (missing from the
Delphi method) which was necessary given the complexity of the evidence
and subject area.
 incorporates questionnaire completion using a 9 point Likert scale to give
more information about levels of agreement (as opposed to simple voting in
classic nominal group technique).
The approach in our study was also modified further to incorporate facilitated face-
to-face interaction of a Patient and Public Involvement (PPI) service user group
(Pressure Ulcer Research Service User Network: PURSUN). As pressure ulcer risk
assessment practice is part of routine care, the aim of the PPI component was to
explore the acceptability of proposed risk assessment elements with patients and
carers. In light of the limitations of patient/carer involvement in structured
consensus methods highlighted above (section 4.7.5) and the aim of their
involvement in this study, there seemed to be more value in holding separate
PURSUN meetings. This would allow more time to be devoted to patient/carer
insights and the consideration of a larger number of service user views, than if we
had a patient representative on the expert group. There was a need to ensure that
PURSUN members’ perspectives were integrated into the consensus process and
this would be achieved by feedback at the expert group meetings or inclusion of
PURSUN comments into questionnaires, so that the group could consider the
patient/carer perspective alongside other evidence.
4.13 Sample/Participants
The expert group comprised internationally recognized clinical/academic leaders
identified via their publication record in pressure ulcer or relevant research. The
group was purposively sampled to include the perspectives of nurses (academic
and clinical nurse specialists), doctors (diabetologist, vascular surgeon, elderly care
medicine and public health), bioengineers, epidemiologist, and individuals with
organisational development and decision science expertise. These characteristics
were considered relevant to the aim of the study and a multi-specialty group was
favoured in order to incorporate a wider range of opinions (Hutchings and Raine
2006). In addition the involvement of international participants within the group may
facilitate wider use of the minimum data set in pressure ulcer research in the future.
Seventeen members were recruited to allow for attrition, as twelve was considered
the optimum number for the face-to-face meetings, in relation to preventing co-
ordination problems whilst maximising reliability (Murphy et al. 1998). However co-
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ordinating seventeen participants was considered manageable (with effective
facilitation) should all be able to attend the face-to-face meetings.
The service user group, involved members of PURSUN UK, (web address:
http://www.pursun.org.uk/) which was set up to improve the quality of PPI in
pressure ulcer research. Seven members were involved in the study and included
people with experience of having a pressure ulcer, people with experience of living
with pressure ulcer risk and carers.
4.14 Data Collection
Data collection was undertaken between Dec 2010 and Dec 2011. The consensus
process incorporated an initial expert group meeting and an initial PURSUN
meeting, followed by 2 consensus cycles. It was envisaged that the first consensus
cycle would consider the Minimum Data Set and the second cycle would consider
the Risk Assessment Framework. However at the initial expert group meeting it was
apparent that there were difficulties in considering the Minimum Data Set and Risk
Assessment Framework separately as the two are interlinked. Discussion at the
meeting highlighted the need to identify the key pressure ulcer risk factors and
assessment items (i.e. the way in which the risk factors are measured) that would
be included in the Minimum Data Set and incorporated in the Risk Assessment
Framework. Therefore the first consensus cycle focussed on agreeing the risk
factors to be included in the Minimum Data Set and Risk Assessment Framework,
while the second consensus cycle focussed on agreeing the assessment items.
Each cycle comprised an expert group face-to-face meeting and pre and post
meeting consensus questionnaire completion (Figure 4.1). A PURSUN meeting was
also undertaken at the end of cycle 1 (Figure 4.1).
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Figure 4.1 Overview Consensus Cycle
Reprinted from Journal of Advanced Nursing, Coleman, S., Nelson, E., A., Keen, J., Wilson, L., McGinnis, E.,
Dealey, C., Stubbs, N., Muir, D., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D., Jude, E.,
Vowden, P., Bader, D.L., Gefen, A., Oomens, C.W.J., Schoonhoven, L. & Nixon, J. Developing a Pressure Ulcer
Risk Factor Minimum Data Set and Risk Assessment Framework. 2014 Online, DOI: 10.1111/jan.12444
Reviewing the pressure ulcer risk factor evidence was an important element of the
study and was integrated throughout all cycles of the consensus process. The
systematic review (Chapter 3) provided evidence regarding the current state of
knowledge surrounding pressure ulcer risk factors but the group also considered
wider scientific evidence that was drawn from the expertise of the group. The
relevance of the evidence to clinical practice as well as the practicalities of pressure
ulcer risk assessment was also considered by the group.
Questionnaires were completed by all expert group members privately before and
after the cycle 1 and 2 meeting (Figure 4.1). In each questionnaire participants were
asked to rate their level of support for statements (relating to the inclusion of risk
factors/ assessment items to the Minimum Data Set and Risk Assessment
Framework) on a 9 point Likert scale where 1 indicated strong disagreement and 9
indicated strong agreement (Figure 4.2). Each statement was preceded by the
relevant summary of the pressure ulcer systematic review evidence as well as
expert group discussions, summary of PURSUN group discussions (as applicable)
and follow-up/ explanatory notes (as applicable). Electronic links to the full
systematic review evidence tables and the full summary of the preceding expert
group discussions were also available within the questionnaires. The completion of
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the questionnaire after the meeting allowed individuals to change their ratings in
light of discussions and/or where necessary for questionnaire items to be amended.
Figure 4.2 Example questionnaire items from the cycle 1 questionnaire
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Questionnaires were administered and completed via a commercial online survey
platform (Survey Monkey). Participants were asked to complete the questionnaire
within two weeks of initial posting. One or two reminders were sent (and on one
occasion, due to a holiday period a third reminder was sent) to participants who had
not completed the questionnaire within the allotted two week period. The surveys
were closed to response at 10-weeks following initial posting.
In keeping with the RAND/UCLA Appropriateness method each expert group
meeting was conducted over the course of the day (Fitch et al. 2001). The meetings
were conducted in a pleasant room at the University of Leeds and regular
refreshment breaks were provided throughout. The meetings were audio-recorded
and led by trained facilitators to ensure a structured approach and that all
participants were given the opportunity for discussion (Murphy et al. 1998). The
researcher (SC) was the main facilitator with the support of two others (JN and
EAN). There was also additional support to ensure the smooth running of the
meetings (i.e. for scribing on flip charts and administration purposes).
Unlike a traditional RAND/UCLA method where the first face-to-face meeting occurs
following questionnaire completion an initial face-to-face meeting was undertaken to
review the pressure ulcer evidence and consider the views of the group to inform
the development of the cycle 1 risk factor questionnaire (Raine, Sanderson and
Black 2005). At cycle 1 and 2 expert group meetings (Figure 4.1) the pre-meeting
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collective questionnaire responses were anonymously fed-back to the group.
Members were also provided with a reminder report of their individual questionnaire
responses and a copy of the summary of the discussions of the previous expert
group meeting. The questionnaire results highlighted areas of agreement and areas
of uncertainty and disagreement which provided a focus for the group discussions
to ascertain whether there was genuine uncertainty or disagreement, or if there was
ambiguity in the wording of the questionnaire.
At the initial PURSUN meeting (Figure 4.1) participants were introduced to the aims
of the study, the purpose of the meetings and discussed potential assessment
components of the Minimum Data Set and Risk Assessment Framework. Views
were fed back to the expert group by the Patient and Public Involvement Officer
(cycle 1). At the second PURSUN meeting (cycle 1, Figure 4.1) members were
asked to consider the risk factors that the expert group had agreed should be
included in the Minimum Data Set and Risk Assessment Framework, potential
assessment items and the acceptability of collecting this information on a routine
basis. Views were fed back to the expert group via the cycle 2 pre-meeting
questionnaire (which included a summary PURSUN discussions) prompting
discussion at the expert group meeting.
4.15 Ethical Considerations
The study was reviewed and approved by the University of Leeds School of
Healthcare Research Ethics Committee (Appendix 8). Informed consent was gained
from expert group members (Appendix 9 and 10) prior to participation and they
remained free to withdraw from the study without giving reasons.
4.16 Data Analysis
The researcher (SC) listened to the audio-tapes and read the associated transcripts
in total to ensure completeness. The data was then coded, with categories based
on the pressure ulcer risk factor systematic review, in keeping with a directed
content analysis approach (Hsieh and Shannon 2005). As new themes emerged
from the expert group discussions further codes were added. A summary report of
each meeting was generated by the researcher. The report was reviewed by the
facilitators and members of a working group (sub-group of expert group) to ensure it
reflected group discussions.
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Careful notes were taken throughout the PURSUN meetings and a summary of
discussions was written by the researcher (SC). The summary was circulated to the
facilitator and group participants to ensure it reflected the discussions of the
meeting.
Questionnaire statements were summarised using the median group response as a
measure of central tendency. In keeping with the RAND/UCLA Appropriateness
methods and other studies (Scott and Black 1991; Shiffman et al. 2003; Kroger et
al. 2007; Fitch et al. 2001) Likert scale group median responses for each statement
were categorised into 3 tertiles. For this study the categories were 1-3 disagree, 4-6
uncertain, 7-9 agree. Within-group agreement was measured using the RAND
Disagreement index (Fitch et al. 2001), which considers the dispersion of individual
scores to identify areas of disagreement (where panellists rate at both ends of the
Likert Scale). This involves calculating the interpercentile range (IPR: 0.3-0.7) and
the IPR adjusted for symmetry (IPRAS) to detect disagreement (if the IPR is larger
than the IPRAS there is disagreement) (Fitch et al. 2001): by calculating the ratio of
these an index of >1 indicates disagreement. This method of analysis was favoured
over the MADM and the interquartile range as it pre-specifies the requirement for
the classification of disagreement, in line with good statistical principles (ICH Expert
Working Group 1998).
Consensus definitions were determined prior to data collection and analysis and
were based on the RAND/UCLA Appropriate method criteria: using the group
median response and the disagreement index for each statement (regarding risk
factors/assessment items) the following principles were applied following post
meeting questionnaire completion (Figure 4.1):
 Group medians of 1-3 without disagreement would be excluded
 Group medians of 7-9 without disagreement would be included
 Where the disagreement index was >1 or where the median was 4-6 they
would be excluded but noted as potential areas for further research.
4.17 Validity and Reliability
As it is difficult to determine the validity of consensus judgements at the time the
judgements are made (see section 4.7.1) it is important that the consensus process
is as rigorous as possible (Raine, Sanderson and Black 2005). This study applied
principles of good practice in the planning and delivery of the consensus process
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incorporating the involvement of a mixed-speciality expert group (Hutchings and
Raine 2006) and the views of service users (PURSUN). Other key principles
included careful preparation and consideration of relevant evidence throughout the
consensus process, questionnaire content informed by expert group discussions
(and reviewed by a working group to ensure content validity), private completion of
questionnaires by expert group members, facilitated face-to-face meetings and the
inclusion of a measure of dispersion as well as central tendency in the reporting
(Murphy et al. 1998). While the reliability of expert group judgements were not
assessed in this study, future work is being planned to check the
representativeness of the expert group views with the wider community (Raine,
Sanderson and Black 2005).
4.18 Results
The expert group comprised of 17 international experts in the pressure ulcer field,
comprising 9 female and 8 male participants. There was 100% completion of all
questionnaires, 77.9% (n=53/68) were completed within the 2-week allotted time
period; 13.2% (n=9/68) were completed up to 1-week late; 2.9% (n=2/68) up to 4-
weeks late; 1.5% (n=1/68) up to 6-weeks late; 1.5% (n=1/68) up to 7-weeks late;
and 2.9% (n=2/68) up to 8-weeks late) and 86.3% attendance at the face to face
meetings (n=17/17 attended the first meeting, n=13/17 attended the second
meeting, and n=14/17 attended the third meeting).The results concerning the risk
factors (cycle 1) and assessment items (cycle 2) of the Minimum Data Set and Risk
Assessment Framework are detailed below.
4.19 Cycle 1 Risk Factors
The expert group agreed that three risk factors should be incorporated into the
screening stage of the Minimum Data Set and Risk Assessment Framework for the
assessment of all patients and comprised immobility, existing and previous
pressure ulcer. Table 4.2 indicates the questionnaire responses before and after
the expert group meetings. In the pre-meeting questionnaire responses there was
support for inclusion of 3 risk factors and exclusion of 13 risk factors, with
uncertainty for 10 risk factors (3 with disagreement). Following the consensus
meeting and discussion of the areas of uncertainty and disagreement the post
meeting questionnaire responses indicated agreement for inclusion of 3 risk factors
and exclusion of 21 risk factors (Table 4.2)
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Table 4.2 Risk Factors for Screening Stage of Minimum Data Set and
Risk Assessment Framework
Pre-meeting
Questionnaire
Responses
Post-meeting
Questionnaire
Responses
Group
Median
Disagreement
Index
Group
Median
Disagreement
Index
Immobility status 9.00 0.00 9.00 0.00
Existing pressure
status
9.00 0.13 9.00 0.00
Previous pressure
ulcer status
7.00 0.29 8.00 0.29
General skin
status
5.00 1.87* 3.00 0.74
Sensory
perception
4.00 0.68 3.00 0.72
Acute illness 5.00 0.59 3.00 0.54
Infection 5.00 0.98 2.00 0.33
Body temperature 5.00 0.97 2.00 0.29
Nutrition 5.00 0.55 2.00 0.75
Friction and shear 2.00 0.16 2.00 0.29
Chronic wounds 3.00 0.65 2.00 0.29
Diabetes 4.00 0.55 2.00 0.37
Summary
measure of
general health
status.
2.00 0.20 2.00 0.13
Perfusion - - 2.00 0.75
Albumin 3.00 0.48 2.00 0.29
Skin moisture 4.00 1.61* 2.00 0.29
Dual incontinence 5.00 1.70* 2.00 0.33
Medication 3.00 0.33 1.00 0.02
Mental status 2.00 0.65 1.00 0.13
Age 4.00 0.67 1.00 0.16
Race 2.00 0.49 1.00 0.02
Gender 1.00 0.29 1.00 0.02
Haemoglobin 2.00 0.37 1.00 0.16
Pitting oedema 3.00 0.67 1.00 0.13
BP 3.00 0.67 - -
Smoking 2.00 0.37 - -
Cardiovascular
disease
3.00 0.67 - -
Dark grey: group median 1-3 (inclusion not supported), Mid grey: group median 4-6
(uncertain), Light grey: group median 7-9 (inclusion supported)*disagreement
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The expert group agreed that eleven risk factors namely immobility, existing and
previous pressure ulcer, general skin status, perfusion, skin moisture, dual
incontinence, diabetes, sensory perception, nutrition and albumin should be
incorporated into the full assessment stage of the Minimum Data Set and Risk
Assessment Framework for patients who were considered to be at potential/actual
risk or have an existing pressure ulcer from the screening stage.
Table 4.3 indicates the questionnaire responses before and after the expert group
meetings. In the pre-meeting questionnaire responses there was support for
inclusion of 12 risk factors and exclusion of 2 risk factors, with uncertainty for 12
risk factors (2 with disagreement). Following the consensus meeting and discussion
of the areas of uncertainty and disagreement the post meeting questionnaire
responses indicated agreement for inclusion of 11 risk factors, exclusion of 4 risk
factors and uncertainty for 9 risk factors (1 with disagreement). A summary of the
key discussion points relating to the uncertain risk factors is detailed in Table 4.4.
After reviewing the evidence the post meeting questionnaire was revised and Blood
Pressure (BP), smoking and cardiovascular disease were combined into a general
category of ‘perfusion’.
Using the decision rules highlighted in section 4.16 the Minimum Data Set and Risk
Assessment Framework comprised only those risk factors where there was
agreement (group median 7-9 without disagreement). The progression of risk
factors through the consensus study are detailed in Figure 4.3. This shows that of
the original 15 risk factor domains and 46 sub-domains identified through the
systematic review (Chapter 3), 26 risk factors were considered to potentially
warrant inclusion in the Minimum Data Set and Risk Assessment Framework and
progressed to consensus cycle 1.
The risk factors for inclusion were mainly agreed in the cycle 1 post meeting
questionnaire but there were some refinements of the risk factors in the cycle 2 pre-
meeting questionnaire. The expert group recognised that albumin emerged strongly
in the systematic review and that it was important in relation to potential changes in
oncotic pressure and the development of oedema. Some also thought it was linked
to nutritional status. The expert group agreed that albumin should be included at the
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Table 4.3 Risk Factors for the Full Assessment Stage of Minimum Data
Set and Risk Assessment Framework
Pre-meeting
Questionnaire
Responses
Post-meeting
Questionnaire
Responses
Group
Median
Disagreement
Index
Group
Median
Disagreement
Index
Immobility status 9.00 0.16 9.00 0.00
Existing pressure
ulcer status
9.00 0.13 9.00 0.16
Previous
pressure ulcer
status
7.00 0.40 8.00 0.16
General skin
status
8.00 0.23 8.00 0.29
Skin moisture 8.00 0.29 8.00 0.33
Diabetes 8.00 0.29 8.00 0.33
Nutrition 7.00 0.67 8.00 0.16
Perfusion - - 8.00 0.40
Albumin 7.00 0.20 7.00 0.45
Sensory
perception
8.00 0.29 7.00 0.29
Dual incontinence 8.00 0.19 7.00 0.33
Friction and
shear
5.00 1.10* 6.00 0.52
Chronic wounds 6.00 0.42 6.00 0.37
Medication 5.00 0.41 5.00 0.08
Acute illness 7.00 0.07 5.00 0.59
Infection 5.00 1.10* 5.00 0.41
Body temperature 7.00 0.52 5.00 0.88
Pitting oedema 6.00 0.30 5.00 1.04*
Age 5.00 0.49 5.00 0.50
Summary
measure of
general health
status
4.00 0.62 4.00 0.65
Haemoglobin 5.00 0.32 3.00 0.72
Mental status 5.00 0.72 2.00 0.75
Race 2.00 0.49 1.00 0.13
Gender 2.00 0.29 1.00 0.02
BP 5.00 0.52 -
Smoking 5.00 0.59 - -
Cardiovascular
disease
6.00 0.42 - -
Dark grey: group median 1-3 (inclusion not supported), Mid grey: group median 4-6
(uncertain),Light grey: group median 7-9 (inclusion supported) *disagreement
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Table 4.4 Uncertain risk factors
Uncertain Risk
Factors
Key Discussion Points
Friction and shear  Important concept in relation to biomechanics and
tissue loading
 Debate about whether a patient characteristic
 Difficult to measure in practice
 Different definition of terms (e.g. nurses and
bioengineers)
 Interlinked with immobility
 Should to be minimised in care
Acute illness
Infection
Body temperature
(elements of
general health
status)
 Felt to be important clinically
 Links between the 3 elements recognised
 Impact on mobility, perfusion and moisture
acknowledged
Chronic Wound  Did not emerge as a strong risk factor in the
systematic review
 Link to other factors including nutritional depletion,
moisture (exudate), oedema, diabetes and general
skin condition recognised
 Would be captured by other key risk factors e.g.
general ‘skin status’, nutrition, moisture and diabetes
Pitting oedema  Relatively unexplored area in the literature
 Leads to changes in the mechanical properties of the
tissues
 May result in reduced mobility due to heavy
oedematous legs
 Some felt that oedema should be considered under
the skin status umbrella
Medication  Acknowledged that the systematic review evidence
associated with medication was weak.
 Links between specific medications and risk factors
were made e.g. the effects of sedation, epidurals and
analgesia on sensation and movement which, steroids
on skin condition (tissue paper skin)
 Use of vasoconstrictors in specialist areas important
 Complicated by dose-dependent effects
 Difficult to measure
Age  Some felt that age formed an important element of
assessment
 Others felt it was a proxy for other measures e.g. skin
condition and immobility
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Figure 4.3 Risk Factor Progression
15 Risk factor domains
and 46 sub-domains of the
systematic review reduced
to 26 risk factors following intial
expert group meeting
1. Immobility
2. Existing PU
3. Previous PU
4. General skin status
5. Chronic wound
6. Friction and shear
7. Sensory Perception
8. Diabetes
9. Pitting oedema
10. Lowering BP
11. Smoking
12. Cardiovascular disease
13. Albumin
14. Haemoglobin
15. Skin moisture
16. Dual incontinence
17. Medication
18. Acute illness
19. Infection
20. Body Temp
21. General health status
22. Nutrition
23. Mental status
24. Race
25. Gender
26. Age
Cycle 1: Risk factor pre-
meeting questionnaire
1. Immobility
2. Existing PU
3. Previous PU
4. General skin status
5. Diabetes
6. Nutrition
7. Sensory Perception
8. Dual incontinence
9. Skin Moisture
10. Acute Illness
11. BodyTemp
12. Albumin
Cycle 1: Risk factor post-
meeting questionnaire
1. Immobility
2. Existing PU
3. Previous PU
4. General skin status
5. Perfusion
6. Diabetes
7. Nutrition
8. Sensory Perception
9. Skin Moisture
10. Dual incontinence
11. Albumin
Cycle 2: Minor Refinement
of Risk Factors
(incorporated in pre-
meeting questionnaire)
1. Immobility
2. Existing PU
3. Previous PU
4. General skin status
5. Perfusion
6. Diabetes
7. Nutrition
8. Sensory Perception
9. Moisture
Risk Factors for
Screening and Full
Assessment Stage
of MDS and RAF
Screening Stage
Immobility
PU Status (existing and
previous)
Full Assessment Stage
Immobility
PU Status (existing and
previous)
General skin status
Perfusion
Diabetes
Sensory perception
Moisture
Nutrition
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second stage of the assessment (Table 4.3). However at a subsequent PURSUN
meeting concern was raised about the need to undertake an additional blood test
for assessment of albumin. This concern was fed-back to the expert group in the
cycle 2 pre-meeting questionnaire and members were asked whether there was a
clinical indication for undertaking an additional blood test to measure albumin for
patients to establish level of pressure ulcer risk. It was concluded that this was
unnecessary and would not be included in the Minimum Data Set and Risk
Assessment Framework. The expert group also concluded that skin moisture and
dual incontinence could be combined into one measure.
4.20 Cycle 2: Assessment Items for Risk Factors
There was support (group median 7-9 without disagreement) for all statements in
the cycle 2 questionnaire concerning the assessment items of Minimum Data Set
and Risk Assessment Framework. However, following group discussion at the cycle
2 meeting it was felt that some changes were necessary to specific items. As the
group were content with the majority of the pressure ulcer risk factor Minimum Data
Set items highlighted in the cycle 2 pre-meeting questionnaire, the post-meeting
questionnaire focussed on items that required adjustment. The agreed assessment
items for the screening and full assessment stage are detailed in Table 4.5. In
addition the expert group agreed that the Risk Assessment Framework would
facilitate the identification of a risk profile for each patient, rather than condense the
risk from different aspects into a single score. This would support care planning with
interventions selected in response to specific risk factors.
4.21 Draft Risk Assessment Framework
Using the results from cycle 1 and 2 of the study an initial draft of the Risk
Assessment Framework (Figure 4.4) was made incorporating the screening and full
assessment stage and decision pathways of the assessment process i.e. not
currently at risk, primary prevention (at risk) or secondary prevention and treatment
pathway (existing pressure ulcer or scarring from a previous pressure ulcer). This
will undergo further graphic design in preparation for pre-testing.
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Table 4.5 Minimum Data Set (to be incorporated in Risk Assessment
Framework)
Screening Stage
Mobility:
a. Does the patient walk without help?
b. Does the patient change position?
PU status:
a. Current PU (>1 category)
b. Reported history of PU
Full Assessment stage
Immobility items to incorporate the frequency of independent movement e.g.:
a. Doesn’t move
b. Moves occasionally
c. Moves frequently
Immobility items to incorporate the magnitude of independent movement e.g.
a. Doesn’t move
b. Slight position changes
c. Major position changes
Immobility items to incorporate general, clinically relevant descriptions of
movement e.g.:
a. Bedfast
b. Chairfast
c. Walks with assistance
Sensory perception:
a. Does the patient feel and respond appropriately to discomfort from pressure
PU (existing and previous PU):
a. Category of PU (where possible for previous PU)
b. Site of PU
c. Presence of scar tissue (for previous PU)
General skin status:
a. Confirmation of vulnerable skin, e.g. dryness, paper thin and redness
b. Pressure area skin site
Perfusion:
a. Conditions affecting central circulation, e.g. shock, heart failure and hypotension
b. Conditions affecting peripheral circulation, e.g. peripheral vascular/arterial
disease.
Diabetes:
a. Presence of diabetes
Moisture:
a. Presence of moisture due to perspiration, urine, faeces or exudate.
Frequency:
b. Frequent (1 or 2 times a day)
c. Constant
Nutrition:
a. Unplanned weight loss
b. Poor nutritional intake
c. Low BMI
d. High BMI
PU: pressure ulcer
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Figure 4.4 Draft Risk Assessment Framework with Underpinning Minimum Data Set
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Reassess if condition changes and at locally
specified times
Currently not at risk. Advise
patients of PU risk factors
Presence of other PU
Risk Factors (tick all applicable)
Yes No
Diabetic
Nutrition: Unplanned weight
loss
Poor nutritional intake
Low BMI
High BMI
Perfusion: Conditions affecting
central circulation e.g. shock,
heart failure, hypotension
Conditions affecting peripheral
circulation e.g. peripheral
vascular/arterial disease
Tick applicable
No Frequent
(1 or 2 times
a day)
Constant
Moisture:
due to
perspiration,
urine, faeces
or exudate
Mobility Status (tick applicable) Yes No PU Status (tick applicable) Yes No
Does the patient walk without help? Current PU (category>1)?
Does the patient change position? Reported history of PU?
Ticks in all un-shaded boxes Ticks in any shaded boxes proceed to full assessment
Immobility
General Immobility Descriptors (tick applicable to patient)
Bedfast
Chairfast
Walks with assistance
Frequency and Magnitude of Movement
Frequency
of
position
changes
(circle
applicable
category)
Where the
2 meet indicates
level of risk
related to
immobility
Magnitude of independent
movement (relief of pressure
areas). Circle applicable category
Doesn’t
move
Slight
position
changes
Major
position
changes
Doesn’t move At risk N/A N/A
Moves
occasionally N/A At risk At risk
Moves frequently N/A At risk Potentiallyat risk
Sensory Perception Yes No
Does the patient feel and respond
appropriately to discomfort from
pressure
Skin Site Vulnerable Skin
e.g. redness, dryness,
paper thin.(tick all
applicable)
NPUAP/
EPUAP
PU Category
Sacrum
L Buttock
R Buttock
L Ischial
R Ischial
L Hip
R Hip
L Heel
R Heel
L Ankle
R Ankle
L Elbow
R Elbow
Other
History of PU NPUAP/
EPUAP Cat.
Scar
(tick if app)
Site:
Site:
Pathway allocation
Primary prevention pathway (at risk)Not at risk pathway
Secondary prevention and treatment pathway
(pressure ulcer category 1 or above or
scarring from previous pressure ulcer)
D
etailed
FullAssessm
ent
forsom
e
patients
Screening
forall
patients
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4.22Discussion
The consensus study allowed the evidence of the systematic review to be carefully
reviewed by an expert group, taking into account the wider scientific evidence, its
relevance to clinical practice, and the views of PURSUN UK. It allowed the risk
factors and assessment items for a draft Minimum Data Set and Risk Assessment
Framework to be agreed establishing the content validity of the tool. The consensus
methods were particularly useful in allowing identification of risk factors for inclusion
in the Risk Assessment Framework and Minimum Data Set. While they were also
useful in identifying the key principles of the assessment items, the method was
inappropriate for considering the specific wording of items. Of note was the
agreement that the risk factors and assessment items should be the same for the
Minimum Data Set and the Risk Assessment Framework i.e. no additional risk
factor information to supplement the Minimum Data Set was considered necessary
for a Risk Assessment Framework for assessment in clinical practice. The draft
Risk Assessment Framework differs from other Risk Assessment Instruments in
two main ways: the incorporation of a screening stage within the Risk Assessment
Framework will allow those who are obviously ‘not at risk’ to be quickly identified
preventing the need for a more detailed full assessment which will save time in
clinical practice. The integration of existing pressure ulcer (and/or scarring from a
previous pressure ulcer) and the secondary prevention and treatment pathway
within the Risk Assessment Framework has the potential to facilitate escalation of
interventions to prevent deterioration and promote healing. Further research is
required to confirm this.
Being well organised and prepared for the expert group face-to-face meetings
helped the meetings to run smoothly. Effective facilitation ensured all participants
were involved in the process even when all members of the expert group were in
attendance. Of note to others when preparing such a meeting is the benefit of
having additional facilitators involved, who can step in to ensure optimum facilitation
at all times throughout the course of the meeting. There was strong commitment
from the expert group to be involved throughout the study, though there were a few
occasions where participants were unable to attend the face-to-face meetings
(13/17 attended the second meeting and14/17 attended the third meeting). On
these occasions special arrangements were made to ensure they were properly
updated and could continue to participate in the process. One to one telephone
meetings were organised between the researcher and these individuals after the
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expert group meeting. The participant was sent the same information considered at
the expert group meeting and the researcher presented the same power point
presentations and summarised the discussions of the expert group meeting. The
participant then completed the online questionnaire (all completed the pre-meeting
questionnaires at the same time as the rest of the group). Every effort was made to
ensure that these participants remained engaged in the consensus process but
there remains the possibility that these participants might have made different
questionnaire responses had they been subject to the actual expert group
discussions.
The use of the systematic review evidence (Chapter 3) provided the foundation for
the evidence base of the consensus study, but the expert group also considered
wider scientific evidence, clinical and practical implications as well as the views of
PURSUN when deciding which risk factors should be included at the screening
stage and the full assessment stage of the Minimum Data Stand Risk Assessment
Framework. The expert group meetings allowed facilitated exploration of the risk
factors and assessment items considered important for summarising patient risk.
The post meeting questionnaire completion element of the consensus process
allowed expert group members to privately rate their level of support for including
risk factors and assessment items in the Risk Assessment Framework in light of the
expert group discussions. The private rating of the questionnaires and subsequent
anonymised results allowed expert group members to make their ratings, free from
peer pressure. In addition, the pre-defined consensus definitions based on the
RAND/UCLA Appropriateness method gave clarity on the levels of support required
for risk factor and assessment item inclusion i.e. only those with group medians of
7-9 without disagreement in the post-meeting questionnaire would be included in
the Risk Assessment Framework (Fitch et al. 2001). The approach worked well and
enabled the expert group to agree the key risk factors and assessment items to be
included in the Risk Assessment Framework.
However it was recognised that other risk factors that did not reach the required
levels of support and were excluded may still have a role in the pressure ulcer
causal pathway via their relationship with the primary risk factors and may be
important at an individual patient level e.g. the use of inotropes impacts on
perfusion. Pressure ulcer causal pathways were considered more closely in a
follow-up piece of work which developed a conceptual framework (Chapter 5).
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As with all consensus studies the measurement of validity at the time of conducting
the study is problematic. The methodology and conduct of the study was
undertaken in as rigorous a manner as possible and took into account the evidence
and service user opinion. From a concurrent validity perspective the risk factors
included in the Minimum Data Set and Risk Assessment Framework included those
with strong epidemiological evidence (immobility, existing pressure ulcer, general
skin status, perfusion (including diabetes), as well as those with less consistent
epidemiological evidence which were felt to be important in clinical practice
(moisture, nutrition, sensory perception). Examples of expert group discussions
influencing support for the inclusion of specific risk factors are detailed below.
The epidemiological evidence relating to diabetes suggesting a two fold increase in
pressure ulcer development in patients with the condition, prompted much
discussion and debate within the expert group. It was recognised that the impact
diabetes may have on pressure ulcer risk could be influenced by the duration of the
condition and how well it was controlled. However, the primary studies of the
systematic review did not include this level of reporting and it was restricted to the
presence of the condition only. Clinical members of the expert group felt that it was
the complications of diabetes, rather than diabetes per se that were of importance:
they felt that diabetes may impact the risk of pressure ulcer development due to the
increased likelihood of reduced sensory perception (neuropathy), poor perfusion
and abnormal anatomy and tissue property changes. These suggestion were based
on expert group members’ clinical or scientific knowledge of diabetes, as the
primary studies of the systematic review did not discern this level of detail. It is
recognised that further research is required to fully establish and understand the
relationship between diabetes, reduced sensory perception, poor perfusion,
abnormal anatomy and tissue property changes and pressure ulcer development.
Previous pressure ulcer was included on the basis of clinical and service user
opinion and theoretical bioengineering evidence rather than by the epidemiological
evidence. Conversely albumin which has strong epidemiological evidence was
initially agreed for inclusion in the Minimum Data Set and Risk Assessment
Framework by the expert group, but was subsequently excluded due to concerns
raised by PURSUN. In these examples, where the group diverged from the
epidemiological evidence the reasons were in keeping with some of those
previously reported including clinical experience and patient preference (Raine et
al. 2004). Ultimately whether the judgements of the study are correct, i.e. predictive
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of pressure ulcer development, needs to be assessed in future modelling work and
in the on-going development of the Risk Assessment Framework.
The outcomes detailed above also demonstrate the impact of integrating the
PURSUN perspective throughout the study and to the author’s knowledge is the
first study to use such an approach. While others using consensus methods have
incorporated patient/carer representation to their expert groups (Rycroft-Malone
2001; Jackson et al. 2009), this study used an alternative approach. The new
approach allowed whole meetings to be dedicated to patient/carer insights with
structured feedback to the expert group to ensure their views were integrated into
the process. This new approach to PPI involvement in a structured consensus
method may also be appropriate for other subject areas and could be used as an
example of how to effectively incorporate patient/carer views into the process. As
noted previously (section 4.7.5) this would also depend on the nature of the study
being undertaken and the specific aim of patient/carer involvement.
While the study involved an expert group with considerable experience a weakness
of the methodology relates to reliability and whether the results of this study are
representative of the views of other experts in the field. This could prove especially
important for uncertain areas such as friction and shear (excluded) where the
expert group identified a close relationship with immobility and difficulties in
measuring this risk factor in clinical practice. Raine, Sanderson and Black proposed
a new approach in developing clinical guidelines which includes checking the
representativeness of the groups ratings with a large similarly composed group
(Raine, Sanderson and Black 2005). As the intention is to continually update the
Risk Assessment Framework, further work is currently being planned to consider
the risk factors that should be considered in the Minimum Data set and Risk
Assessment Framework with a larger group. This will also allow new evidence to be
brought forward and integrated into the work.
In addition, while the consensus study has provided us with a draft Minimum Data
set and Risk Assessment Framework further development work is necessary
incorporating further liaison with the expert group and PURSUN, graphic design to
improve usability and pre-testing with clinical nurses to assess the acceptability,
usability and clarity of the Risk Assessment Framework. This maybe particularly
important for risk factors such as general skin status and its related assessment
items as the expert group acknowledged difficulties associated with measuring this
in clinical practice at the present time. Further work with clinical nurses is necessary
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to identify the best way of assessing skin status and they may also have alternative
views of when this assessment should occur.
4.23 Conclusion
Using a modified nominal group technique based on the RAND/UCLA
appropriateness method, incorporating an expert group, review of the pressure
ulcer evidence and the views of a PPI service user group (PURSUN) we have
agreed risk factors, assessment items and have drafted a Minimum Data Set and
Risk Assessment Framework. The Risk Assessment Framework comprises of two
stages of assessment, the screening stage for all patients and the full assessment
stage for patients at potential/actual risk or with an existing pressure ulcer. The Risk
Assessment Framework allows patient to be allocated to a not currently at risk,
primary prevention (at risk) or secondary prevention and treatment pathway
(existing pressure ulcer or scarring from a previous pressure ulcer). The continuing
development of the Risk Assessment Framework is discussed in the chapters that
follow.
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Chapter 5 Development of a New Pressure Ulcer Conceptual
Framework
5.1 Introduction
This chapter explores the work undertaken to develop a new conceptual framework
for pressure ulcer development. It builds on the consensus study (Chapter 4) which
brought together the relevant fields of enquiry to clarify key risk factors for pressure
ulcer development. The consensus study emphasised the need to revise the
pressure ulcer conceptual framework (NPUAP/EPUAP 2009) to provide clearer
linkage between the physiological, biomechanical and epidemiological evidence.
This translates the physiological and biomechanical elements to characteristics
which nurses can observe in their patients.
5.2 Aim
To consider the critical determinants of pressure ulcer development in order to
propose a new conceptual framework. The objectives were to:
1. Review and update the biomechanical/physiological elements of the original
NPUAP/ EPUAP (2009) conceptual framework.
2. Propose a theoretical causal pathway for pressure ulcer development.
3. Map risk factors identified in the consensus study to the updated conceptual
framework.
5.3 Design
The expert group of the consensus study (Chapter 4) reconvened to address the
aims and objectives detailed above. The facilitated meeting was audio-recorded
and transcribed, allowing key themes to be identified.
5.4 Data Collection
The meeting was held in December 2011 and was planned so that members had
access to the outcomes of the consensus study (Chapter 4), the systematic review
(Chapter 3) and causal factor terminology prior to the face-to-face meeting.
Familiarity with the causal factor terminology allowed us to explore the role of the
risk factors in the pressure ulcer causal pathway. This was facilitated by
consideration of definitions suggested by (Brotman et al. 2005).
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 Risk factor – a variable with a significant statistical association with a clinical
outcome.
 Independent risk factor - a risk factor that retains its statistical association
with the outcome when other established risk factors for the outcome are
included in a statistical model.
 Non-independent risk factor - a risk factor that loses its statistical
association with the outcome when other established risk factors for the
outcome are included in a statistical model.
Brotman et al suggests that a causal factor is a risk factor that has a causal
relationship with a clinical outcome and is defined experimentally (known to affect
outcome) rather than statistically. They make a distinction between direct and
indirect causal factors (Brotman et al. 2005):
 Direct causal factor - directly impacts the outcome (or the likelihood of the
outcome).
 Indirect causal factor - impacts the outcome (or affects its likelihood of
occurrence) by changing a direct causal factor. If the direct causal factor is
prevented from changing, then changes in the outcome will not be
produced.
Indirect causal factors were further categorised into key indirect causal factors
(where the epidemiological/wider scientific evidence and/or clinical resonance was
stronger) and other indirect causal factors. Discussions frequently incorporated
consideration of pressure ulcer aetiology incorporating physiological and
bioengineering research (Chapter 1, Section 1.9).
5.5 Data Analysis
The findings of the consensus study (Chapter 4) which identified the pressure ulcer
risk factors considered important for summarising patient risk provided the initial
structure to address the study aims. In addition, the researcher (SC) listened to the
audio-tapes of the conceptual framework expert group meeting discussions and
read the associated transcripts in total to ensure completeness. The analysis
provided the basis for the new proposed pressure ulcer conceptual framework and
theoretical causal pathway.
5.6 Validity and Reliability
Validity and reliability issues relating to this study are linked to the preceding
consensus study (Chapter 4, Section 4.7.1). Following analysis of the conceptual
169
framework meeting discussion the researcher (SC) drafted the new proposed
pressure ulcer conceptual framework and theoretical causal pathway and circulated
this to the expert group via email to gain feed-back regarding content validity. This
led to minor revisions of the work.
5.7 Results
The in-depth discussions of the expert group led to amendments to the original
NPUAP/EPUAP conceptual framework (2009). The original and amended version
of the conceptual framework are detailed in Figure 5.1 and Figure 5.2. Most
notably, it was recognised that while mechanical properties of the tissues and
geometry (morphology) of the tissues and underlying bones impact on the internal
strains and stresses (as an example subjects who are either very emaciated or very
obese will have enhanced strains and stresses within the soft tissues) its impact
was considered to be more relevant to the susceptibility of the individual, i.e.
impacting on the damage threshold and so was moved as detailed in Figure 5.2.
Furthermore transport (perfusion and lymphatic drainage) also impacts on the
damage threshold of the individual and this would also be affected by temperature
in terms of vasodilation/vasoconstriction thereby affecting tissue perfusion. The
underlying physiology of an individual will also have an impact on their repair
capacity and this was an important consideration that was captured in the amended
conceptual framework (Figure 5.1). The amended conceptual framework and its key
components provided the foundation on which to link to the epidemiological
evidence.
Table 5.1 shows the mapping of the direct causal factors and key indirect causal
factors against the key components of the enhanced NPUAP/ EPUAP (2009)
conceptual framework. Though it was recognised that the presence and weighting
of specific risk factors may vary in relation to the anatomical site of the pressure
ulcer it was not possible to delineate the evidence to skin site level risk factors. The
process of mapping risk factors facilitated the proposal of a causal pathway for
pressure ulcer development detailing the direct, key indirect and other potential
indirect causal factors as discussed below and illustrated in the theoretical schema
(Figure 5.3).
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Figure 5.1 NPUAP/EPUAP (2009) Original Conceptual Framework - Factors that Influence Susceptibility
Used with permission from the National Pressure Ulcer Advisory Panel, 8th May 2014
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Figure 5.2 Amendment of NPUAP/EPUAP (2009) Conceptual Framework -Factors that Influence Susceptibility for Pressure
Ulcer Development
Reprinted from Journal of Advanced Nursing, Coleman, S., Nixon, J., Keen, J., Wilson, L., McGinnis, E., Dealey, C., Stubbs, N., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D.,
Jude, E., Vowden, P., Schoonhoven, L., Bader, D.L., Gefen, A., C.W.J., O. & Nelson, E.A. A New Pressure Ulcer Conceptual Framework 2014 online, DOI:10.1111/jan.12405
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Table 5.1 Mapping of Direct Causal and Key Indirect Causal Factors to
the Conceptual Framework
Risk
Factor
Mechanical
Boundary
Conditions:
Type of loading
(shear, pressure,
friction) and
magnitude &
duration of
mechanical load
Individual
Geometry
(Morphology)
of the tissue
& bones
Individual
Mechanical
Property of
the
Tissues
Individual
Transport
& Thermal
Properties
Individual
Physiology
& Repair
Immobility X
Skin/PU
Status
X X X X
Poor
Perfusion
X X
Poor
Nutrition
(x) in
extreme
cases
(x) in
extreme
cases
X X
Moisture X X
Poor
Sensory
Perception
&
Response
(x) through
immobility
Diabetes (x) through
sensory
perception
(x) through
perfusion
Low
Albumin
(x) through
perfusion
Reprinted from Journal of Advanced Nursing, Coleman, S., Nixon, J., Keen, J., Wilson, L., McGinnis, E., Dealey,
C., Stubbs, N., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D., Jude, E., Vowden, P.,
Schoonhoven, L., Bader, D.L., Gefen, A., C.W.J., O. & Nelson, E.A. A New Pressure Ulcer Conceptual Framework
2014 online, DOI:10.1111/
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Outcome
Pressure Ulcer
Immobility
Poor perfusion
Key Indirect Causal Factors Direct Causal FactorsOther Potential Indirect CausalFactors
Moisture
Diabetes
Skin/PU Status
Low Albumin
Older age
Medication
Figure 5.3 Theoretical Schema of Proposed Causal Pathway for Pressure Ulcer Development
The solid arrows show the causal relationship between the key indirect causal factors and direct causal factors and the outcome. Interrupted arrows show the
causal relationship between other potential indirect causal factors and key indirect causal factors and between direct causal factors. Interrupted arrows also
demonstrate interrelationships between direct causal factors and indirect causal factors
Reprinted from Journal of Advanced Nursing, Coleman, S., Nixon, J., Keen, J., Wilson, L., McGinnis, E., Dealey, C., Stubbs, N., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D.,
Jude, E., Vowden, P., Schoonhoven, L., Bader, D.L., Gefen, A., C.W.J., O. & Nelson, E.A. A New Pressure Ulcer Conceptual Framework 2014 online, DOI:10.1111
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5.7.1 Direct Causal Factors
Three characteristics were classified as direct causal factors: immobility,
skin/Pressure Ulcer status and perfusion. Immobility is a necessary condition for
pressure ulcer development as through its impact on mechanical boundary
conditions (Table 5.1) it directly impacts the outcome (or the likelihood of the
outcome). It is therefore considered a direct causal factor (Figure 5.3). Of note is
that friction and shear are not specified as a patient characteristic, rather a
characteristic of the mechanical boundary condition (Table 5.1).
Identifying whether skin/pressure ulcer status (incorporating existing and previous
pressure ulcer and general skin status) and poor perfusion represent direct or
indirect risk factors was less straight-forward. It could be assumed that they are
indirect factors as without some degree of immobility a pressure ulcer would not
develop. However, this is not in keeping with the definitions of causal factors
detailed above and oversimplifies the complex interplay of factors required to lead
to tissue damage. There is strong epidemiological/wider scientific evidence (as
detailed in chapter 1 and chapter 3) that poor perfusion and skin/ pressure ulcer
status reduce the patients’ tolerance to pressure and increases the likelihood of
pressure ulcer development. This suggests they are direct causal factors and may
explain why some immobile patients develop pressure ulcers while others do not.
Further insight was gained by mapping skin/pressure ulcer status and poor
perfusion to the conceptual framework and it was apparent that they were clearly
implicated in the susceptibility and tolerance aspect of the framework (Table 5.1).
Skin/pressure ulcer status mapped to the individual geometry (morphology) of the
tissue and bones, the mechanical property of the tissues, the transport and thermal
properties and the physiology and repair aspects of the framework. Perfusion
mapped to the individual transport and thermal properties and the physiology and
repair element of the framework and is related to factors which impair circulation.
Within the expert group it was recognised that the oxygen carrying capacity was
important in maintaining healthy tissues. Other factors such as the delivery of
nutrients and waste removal were also considered important, though at present it is
difficult to ascertain the most crucial factors relating to perfusion. Further
confirmatory research is needed to more clearly ascertain the aetiological
mechanisms of importance.
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5.7.2 Key Indirect Causal Factors
Moisture, sensory perception, diabetes, low albumin and poor nutrition were
considered key indirect causal factors, as they impact the outcome (or affect its
likelihood of occurrence) by changing a direct causal factor (Figure 5.3).
5.7.3 Other Potential Causal Factors
The theoretical conceptual schema (Figure 5.3) was further developed to include
other indirect causal factors to illustrate the potential relationships and impact of
diverse factors which may be involved in the causal pathway. However, it is
recognised that the interrelationships among potential and key indirect causal
factors are complex and require further elucidation. Other indirect causal factors
include those with weak or limited epidemiological/wider scientific evidence, but are
thought to impact on key indirect and direct causal factors. They include age,
medication, pitting oedema as well as other factors relating to general health status
including infection, acute illness, raised body temperature and chronic wound.
5.7.4 New Conceptual Framework
Following consideration of the causal pathway for pressure ulcer development
(Figure 5.3) and mapping of direct and key indirect causal factors for pressure ulcer
development against the components of the enhanced conceptual framework
(Figure 5.2), a new conceptual framework (Figure 5.4) is proposed. This enables
the epidemiological evidence to be linked to the physiological and biomechanical
elements of the conceptual framework. The new framework proposes the
relationship between the mechanical boundary conditions and the susceptibility and
tolerance of the individual. The risk factors that impact the mechanical boundary
conditions and the susceptibility and tolerance of the individual are detailed in the
framework and are based on the direct causal factors including immobility,
skin/Pressure Ulcer status and poor perfusion, as well as the key indirect causal
factors of poor sensory perception and response, diabetes, poor nutrition, moisture
and low albumin. For simplicity the risk factors are represented under the elements
they are thought to predominantly affect (either mechanical boundary conditions or
susceptibility and tolerance of the individual). However, the interrupted line running
under the risk factors indicates that some risk factors may have an effect on both
sides of the framework which is more clearly articulated in the theoretical schema
(Figure 5.3) and risk factor mapping (Table 5.1). The absence of risk factors on
either the individual susceptibility and tolerance or the mechanical boundary
conditions side of the framework would affect the likelihood of pressure ulcer
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development i.e. a patient with good perfusion may be able to tolerate higher levels
of immobility (without developing a pressure ulcer) than someone with poor
perfusion.
5.8 Discussion
Building on the work of the consensus study (Chapter 4) and the views of the expert
group a new theoretical causal pathway for pressure ulcer development and a
conceptual framework was developed. These bring together the epidemiological
(Chapter 3), physiological and biomechanical evidence (Chapter 1), enhancing our
understanding of the role of individual risk factors in pressure ulcer development.
This was enabled by consideration and enhancement of the NPUAP/ EPUAP
(2009) conceptual framework, mapping of risk factors to the conceptual framework
and the proposal of a theoretical causal pathway for pressure ulcer development.
Agreeing the proposed elements of the new conceptual framework proved
challenging as while the physiological and bioengineering research, the systematic
review and the outcomes of the consensus study provide a good starting point,
there are still many gaps in the evidence base. The proposal of the causal pathway
for any condition/disease is a complicated process. For simplicity the pathway
detailed in this paper only considers a one directional relationship between risk
factors but, in reality, bi-directional relationships exist and causal factors may have
multiple roles within a pathway (e.g. moisture impacts the vulnerability of the skin
and may also effect the impact of immobility by increasing friction and shear).
It should be noted that the new conceptual framework does not consider varying
parameters of risk factors (e.g. patients have varying levels of mobility, nutrition,
moisture etc.) within the causal pathway and how these impact on pressure ulcer
outcome. Furthermore, it does not explain how varying combinations of risk factors
increase the likelihood of pressure ulcer development. The importance of individual
risk factors may also vary in relation to body site, for example a patient with
peripheral vascular disease may have reduced tolerance to pressure to their heels
but not to their trunk areas. Patients may also have conditions such as contractures
which may increase their risk of pressure ulcers at less commonly encountered
body sites. In addition the new conceptual framework does not clearly articulate the
aetiological mechanisms of importance for risk factors. For example there is still
uncertainty about the specific mechanisms of importance relating to perfusion.
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Figure 5.4 New Pressure Ulcer Conceptual Framework
Reprinted from Journal of Advanced Nursing, Coleman, S., Nixon, J., Keen, J., Wilson, L., McGinnis, E., Dealey, C., Stubbs, N., Farrin, A., Dowding, D., Schols, J.M.G.A., Cuddigan, J., Berlowitz, D.,
Jude, E., Vowden, P., Schoonhoven, L., Bader, D.L., Gefen, A., C.W.J., O. & Nelson, E.A. A New Pressure Ulcer Conceptual Framework 2014 online, DOI:10.1111
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The development of the conceptual framework through the combination of
bioengineering and epidemiological expertise and evidence also highlights that
current methods available to assess the direct and indirect causal factors involved
in pressure ulcer development including the mechanical boundary conditions and
factors affecting tissue tolerance (geometry, mechanical properties of tissue,
transport and thermal properties and physiology and repair) are very crude clinical
assessments.
Limitations of the approach relate to the uncertainties associated with the primary
research considered in the development of the new conceptual framework. The
bioengineering research is limited due to its development in animal or tissue
engineered muscle models as opposed to human subjects (Chapter 1). The
evidence of the systematic review is limited by poor reporting, heterogeneity of
patient populations, inconsistent inclusion of pressure ulcer domains, inconsistent
measurement of risk factor variables, the use of different outcomes and lack of
differentiation between pressure ulcer sites (Chapter 3). Furthermore, the primary
studies of the systematic review mainly observed superficial pressure ulcers, while
much of physiological and bioengineering research relates to muscle tissue and it
could be argued that the associated aetiological mechanisms differ. However, there
is no evidence that the key direct causal factors for superficial or deep pressure
ulcers are different, rather it is the nature of surface loading that influences the type
of pressure ulcer that develops (i.e. initially developing superficially or within muscle
tissue) (Bouten et al. 2003).
Notwithstanding these limitations, the present approach facilitated consideration of
a wide range of literature and the consensus study resulting in the proposal of a
new pressure ulcer conceptual framework with agreement from a wide range of
experts in the pressure ulcer field. The conceptual framework proposes clearer
linkage between the physiological and biomechanical determinants of pressure
ulcer development and patient risk factors identified through epidemiological
research. This facilitates translation of the physiological and biomechanical
elements to characteristics which nurses can observe in their patients. It could lead
to increased understanding and has the potential to influence risk assessment
guidance and practice, for example the new conceptual framework underpins the
development of the pressure ulcer Risk Assessment Framework, which will
influence risk assessment practice following implementation.
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The proposed conceptual framework also has implications for nursing research
relating to pressure ulcers. It provides an up to date account of how existing
evidence has been used to develop theory and helps to identify gaps in our
knowledge base. This could be used to underpin and guide future research,
building on the evidence and enabling us to more clearly define the role of
individual pressure ulcer risk factors conceptually and operationally.
5.9 Conclusion
The proposal of the new pressure ulcer conceptual framework incorporated
consideration of physiological, biomechanical and epidemiological evidence as well
as the outcomes of the consensus study and the views of an expert panel. This was
enabled by consideration and enhancement of the NPUAP/ EPUAP (2009)
conceptual framework, the development of a theoretical causal pathway for
pressure ulcer development and mapping of risk factors to the conceptual
framework. It could lead to increased understanding and improvements in risk
assessment practice and underpins the pressure Ulcer Risk Assessment
Framework developed as part of this PhD Thesis. The conceptual framework could
also be used to underpin and guide future pressure ulcer research, to further
explore the relationship between risk factors and increase our understanding of
pressure ulcer development.
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Chapter 6 Design and Pre-testing of the Risk Assessment
Framework (incorporating risk factor Minimum Data Set)
6.1 Introduction
This chapter critically examines the next phase in the development of the Risk
Assessment Framework (incorporating risk factor Minimum Data Set). It will detail
the design of the Framework which involved using the key components agreed in
the consensus study (Chapter 4) and incorporated in the proposed pressure ulcer
conceptual framework (Chapter 5), consideration of the weighting and colour coding
of risk factor items and collaboration with a graphic designer. It will also report how
the draft Risk Assessment Framework was assessed by clinical nurses to improve
its usability in a pre-test study. The pre-test study aims, methods and results will be
described as well as a discussion of the findings.
6.2 Design of Risk Assessment Framework
The initial draft of the Risk Assessment Framework (Chapter 4, Figure 4.4) which
incorporated the agreed risk factors, assessment items and the intended structure
(screening and full assessment stage and decision pathways) underpinned the
graphic design of the decision tool. The consensus study also agreed the need for
the Risk Assessment Framework to facilitate the development of a patient specific
risk profile. This was favoured over the traditional approach to Risk Assessment
Instruments, where a condensed single score from different risk factors was used to
determine different levels of risk and guide decision making about care
interventions. It was envisaged that a patient specific risk profile would encourage
the development of an individualised plan of care to address the actual risk factors
present.
It was anticipated that the risk profile approach would provide enhanced support for
decision making relating to the depth of the assessment required (i.e. screening
and/or full more detailed assessment) and the relative importance of specific risk
factors when considering the patients risk status. To reduce the temptation of
condensing risk factor items into a single score and in keeping with other
assessment systems within the NHS, the use of colour was considered a viable
alternative to a numerical scale. The colour coding system adopted was as follows:
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 Blue: ‘no problem’ with risk factor assessment item
 Yellow: risk factor present which may impact upon pressure ulcer risk
 Amber: risk factor present which puts the patient at risk and requires primary
prevention
 Pink: patient has a pressure ulcer or scar from previous pressure ulcer and
requires secondary prevention/treatment
The use of colour required informed judgements to be made regarding the
importance of the risk factor items within the Risk Assessment Framework and their
influence and weighting on the patients risk status. It was not possible to delineate
this from the systematic review evidence (Chapter 3) alone. Rather, this was
achieved by consideration of the overall strength of evidence which was influenced
by each of the development phases of this work. For each of the risk factors agreed
to be important in summarising patient risk (Chapter 4) the strength of
epidemiological evidence (Chapter 3) and/or wider scientific evidence (physiological
and biomechanical), its clinical resonance and its role in the pressure ulcer causal
pathway i.e. whether it was considered a direct or indirect causal factor (Chapter 5)
were considered. Under the leadership of the researcher (SC), these strands of
evidence were discussed by the working group (sub-group of expert group) where
agreement was reached regarding the weighting and colour coding of risk factors
(Table 6.1).
Risk factors which had strong or good evidence and were considered direct causal
factors were allocated to amber or pink (existing pressure ulcer or scarring from a
previous pressure ulcer), with the exception of previous pressure ulcer. For this risk
factor the epidemiological evidence was weak, though it was considered particularly
important to patients and carers (PURSUN) and has clinical resonance.
Additionally, from a bioengineering perspective the presence of scarring results in
ongoing vulnerability to pressure at the skin site. To reflect these concerns previous
pressure ulcer was allocated to yellow but the presence of scarring would escalate
this to pink.
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Table 6.1 Colour coding of risk factors
Risk factor agreed for
inclusion in the Risk
Assessment Framework
Overall
strength of
evidence
Type of
causal
factor
Risk assessment
Framework Colour
coding
Immobility Strong Direct
causal
factor
Amber (yellow for
one category)
Skin/PU Status:
Existing Pressure Ulcer
Previous Pressure Ulcer
General skin status
Strong
Good
Strong
Direct
causal
factors
Pink
Yellow (pink if
scarring present)
Amber
Perfusion Strong Direct
causal
factor
Amber
Sensory Perception Good Indirect
causal
factor
Amber
Moisture:
Skin moisture
Dual incontinence
Good
Good
Indirect
causal
factors
yellow
Diabetes Good Indirect
causal
factor
Yellow
Nutrition Good Indirect
causal
factor
Yellow
Sensory Perception Good Indirect
causal
factor
Amber
Strong evidence: strong epidemiological/wider scientific evidence and clinical resonance;
Good evidence: good epidemiological/wider scientific evidence but showing some
inconsistency in their statistical association with pressure ulcer development and/or good
clinical resonance;
Risk factors with good evidence that were considered indirect causal factors were
generally allocated to yellow, with the exception of sensory perception due to its
links with diabetes. Throughout the consensus study clinical members of the expert
group questioned the epidemiological evidence relating to diabetes (suggesting a
two fold increase in pressure ulcer development). They did not feel it reflected what
they observed in clinical practice i.e. they did not see a disproportionate number of
diabetic patients with pressure ulcers when compared with the general population.
They proposed that it was the complications of diabetes that were of importance
and their impact on three areas including sensory perception (neuropathy),
perfusion and abnormal anatomy and tissue property changes. After careful
consideration of the evidence and to be consistent with the other risk factors that
were affected by diabetes (i.e. perfusion and skin/Pressure Ulcer status) the
working group concluded that sensory perception should be allocated to amber.
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Instructions regarding the colour coding were integrated throughout the Risk
Assessment Framework to support decision making. The design of the Risk
Assessment Framework was led by the researcher (SC) and involved frequent
liaison with the graphic designer to ensure all the agreed elements were addressed.
The drafted Risk Assessment Framework was then pre-tested with clinical nurses.
6.3 Pre-test Study Aims
The aim was to assess and improve the acceptability, usability, format, design,
clarity, comprehension, language and data completeness of the draft Risk
Assessment Framework (incorporating risk factor Minimum Data Set) with clinical
nurses. While content validity was a key consideration of the consensus study
(Chapter 4), the pre-test would confirm this with intended end users.
6.4 Methods
Cognitive pre-testing methods were used to evaluate how clinical nurses interpreted
questions, response categories and instructions while using the draft Risk
Assessment Framework (Collins 2003). This methodology is well established in the
development of health status and patient reported outcome measures and is
considered important for improving precision, confirming content validity and
ensuring the instrument is understood and relevant to the target population (SAC
2002; FDA DHHS 2009; Rothman et al. 2009; Gorecki et al. 2012). The benefits of
the approach were considered relevant to the development and eventual
implementation of the Risk Assessment Framework.
The pre-test was conducted over three sessions and incorporated three focus
groups and 12 ‘think out loud’ interviews, which were estimated as the number
required for data saturation. The study was conducted to allow analysis and
adjustment to the Risk Assessment Framework to be undertaken between pre-test
sessions so that three different versions of the decision tool could be pre-tested and
improvements made in an interative process.
6.4.1 Focus Groups
A focus group is a group interview which incorporates group interaction as part of
the method and is useful in exploring peoples, knowledge, attitudes and experience
(Kitzinger 1995). The method allows the facilitator to explore ‘structured’ and ‘free’
inquiries (Krueger 1994). It was anticipated that for this PhD study, focus groups
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with clinical nurses would facilitate greater understanding of the usability of the Risk
Assessment Framework, and would benefit from the proposed advantages of the
method, allowing group members to “spark ideas off one another” which may lead
to greater disclosure (McColl 2005).
6.4.2 Think Out Loud interviews
In addition to the focus groups, one-to-one think out loud interviews (Willis 2005)
were undertaken to allow the researcher (SC) to identify specific problems with the
Risk Assessment Framework that were amenable to resolution by modification.
This method encourages participants to vocalise their thoughts or ‘think out loud’
while they are concurrently undertaking a task (Ericcson and Simon 1980). The
interviewer may also probe the participant concurrently or retrospectively following
completions of the task (Ericcson and Simon 1980). Willis ascertains that flexibility
in the approach of cognitive interviewing is a beneficial feature and pracitioners
often mix these techniques into the same interview (Willis 2005). For this study,
while participants were instructed to ‘think out loud’, verbal probing was also
undertaken with less naturally vocal participants. Potential scripted probes were
prepared in advance, but interviewers were also at liberty to use sponstaneous
probes as relevant to the particular interview.
6.4.3 Participants
Nurses were recruited from a large acute Teaching Hopsital Trust, a District
General Hospital and two Primary Care Trusts. Purposive sampling was undertaken
to ensure that Tissue Viability Nurses, Staff Nurses and Sisters from hospital and
community settings were recruited from each of the four participating sites.
Participants included those who had an interest in tissue viability (e.g. a link nurse
or member of a local pressure ulcer or wound care working group).
6.5 Ethics
This study recruited Registered Nurses and the related ethical issues were minimal,
mainly relating to the time taken to attend the Risk Assessment Framework pre-test
session (incorprating training and audio-taped focus groups or one-to-one think out
loud interviews). There were no other forseen risks to participants. The study was
approved (Appendix 11) by the University of Leeds, School of Healthcare Research
Ethics Committee (SHREC). Potential participants were given an information sheet
(Appendix 12) and encouraged to ask questions about the study. Informed consent
was obtained prior to participation in the study (Appendix 13). The right of potential
participants to refuse without giving reasons was respected. Participants were also
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free to withdraw at any time from the study without giving reasons, though this did
not happen.
6.6 Data collection
The three facilitated pre-test sessions were led by the researcher (SC) with the
support of several working group members (LW, EMc and DM). Each pre-test
session involved 8-12 nurses from the four participating sites, who were grouped
according to their job role (staff nurse, sister/charge nurse and tissue viability nurse
specialist/research nurse) to facilitate openness, as heterogeneous groups can lead
to inhibition in raising issues that do not seem to be shared by others (Morgan and
Krueger 1993; McColl 2005). This was thought to be particularly important for this
group as a hierarchy might have stifled disclosure (e.g. a staff nurse might not want
to disagree with the views of his/her ward sister). Having nurses from different
centres minimised familiarity which can lead to participants relying on ‘taken for
granted’ assumptions (McColl 2005). The sessions were held away from the clinical
area in a comfortable university setting, lasted 2.5 hours in total with refreshments
available throughout and a break in the middle of the session (Kitzinger 1995). At
the pre-test session, the nurses were trained in how to use the Risk Assessment
Framework and then were randomly allocated to either a focus group or a one-to-
one think out loud interview (Agenda, Appendix 14).
Training involved the researcher (SC) giving a short presentation and
demonstration of how to use the draft Risk Assessment Framework with a
simulated patient. Each nurse then completed the draft Risk Assessment
Framework using a simulation of a real patient situation via written vignette case
studies (Appendix 15). These were accompanied by photographs of pressure ulcers
and were appropriate to the nurses’ area of practice (i.e. community nurses used
vignettes of community patients). The vignettes were co-developed by the project
lead, the working group (clinical and academic leaders in the pressure ulcer field)
and members of PURSUN UK to ensure they were realistic and clinically relevant.
Nurses were encouraged to ask questions throughout the training session.
The sessions were planned to ensure four to eight nurses (Kitzinger 1995) per pre-
test were assigned to the focus group and asked to complete the Risk Assessment
Framework again, using three vignette case studies relevant to their area of
practice prior to the focus group meeting. Nurse participants were encouraged to
highlight any areas they found confusing on the Risk Assessment Framework form.
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A co-facilitator assessed data completeness and listed areas where data items
were not completed or not completed as required, as well as areas noted by the
nurses as confusing. The focus group meeting then convened to discuss the use of
the Risk Assessment Framework. The meeting was facilitated by (SC) and co-
facilitated by (LW), and was audio recorded. The facilitator promoted group
interaction and guided discussions around a topic guide (Appendix 16 ), which
considered the usability and areas of confusion regarding the use of the Risk
Assessment Framework, as well as any anticipated problems with using it in clinical
practice. This was informed by the data completeness assessment.
Up to four nurses from each session were assigned to the one-to-one think out loud
interview. The researcher (EMc or DM) conducted the interviews around a topic
guide (Appendix 17). Firstly the nurse participants were guided through the think
out loud technique. Once the nurses were content with the approach, they were
asked to complete the Risk Assessment Framework again using three vignette
case studies appropriate to their area of practice in the presence of the researcher.
The researcher encouraged the nurses to vocalise their thoughts as they completed
the Risk Assessment Framework. This allowed specific issues relating to difficulty in
interpreting items or confusion about aspects of the Framework to be identified. The
interviews were audio-recorded.
6.7 Analysis
The acceptability, data completeness and usability of the Risk Assessment
Framework forms were assessed using both quantitative and qualitative methods.
The quantitative methods are summarised in Table 6.2.
Table 6.2 Summary of Quantitative Analysis
Test property Definition/test Criteria
Acceptability/
Data
completenes
s
- The extent to which the RAF
items are completed and used to
allocate a risk category; quality of
data is assessed by data
completeness for each element of
the RAF and a risk category.
-% item level data missing
-% of risk categories allocated
-% of items missing where a
risk category has been
allocated
Usability Compliance with decision rules of
the RAF
-% compliance Step 1
-% compliance progression to
Step 2
- % compliance risk allocation
Content analysis of think out
loud interviews and focus
groups
RAF: Risk Assessment Framework
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From a qualitative perspective the focus group meetings and the think out loud
interviews were audio-taped and transcribed. The researcher (SC) listened to the
audio-tapes and read the transcripts to ensure accuracy and that they had a good
overview of the focus group and one-to-one think out loud discussions. The data
was then coded, which was directed by the risk factor items of Risk Assessment
Framework, using a directed content-analysis approach (Hsieh and Shannon 2005).
The emphasis was on identifying themes across the focus groups and think out
loud interviews which impacted on the application of the Risk Assessment
Framework in clinical practice. A summary report of each meeting was reviewed by
the facilitators to ensure it reflected discussions. The report was considered by a
working group (who comprised of clinical and academic leaders in the pressure
ulcer field) and adjustments were made to the draft Risk Assessment Framework,
which was pre-tested at the subsequent session in an iterative process. Following
pre-testing, the Risk Assessment Framework was also reviewed by PURSUN UK
and the consensus study expert group.
6.8 Results
The pre-test sessions were well attended by 34 nurses from acute (n=16) and
community settings (n=18). Over the three pre-test sessions, 101 Risk Assessment
Framework assessments were undertaken using vignette case studies by 11 tissue
viability nurse/research nurses (n=32 Risk Assessment Framework assessments),
12 staff nurses (n=36 Risk Assessment Framework assessments) and 11 Sisters
(n=33 Risk Assessment Framework assessments). At each pre-test session, four
nurses undertook the think out loud interviews and seven or eight nurses attended
the focus groups. Tables 6.3-6.6 detail the level of data completion for each pre-test
session, which can be seen to improve as the Risk Assessment Framework was
amended over the three pre-test sessions.
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Table 6.3 Item level completion for assessments that concluded at step 1 (screening)
Pre-test 1: N
items requiring
completion p/a
Pre-test 1:
(TVN/RNs)
Items completed
Pre-test 2: N
items requiring
completion p/a
Pre-test 2: (Staff
Nurse)
Items
completed
Pre-test 2: N items
requiring
completion p/a
Pre-test 3:
(Sisters)
Items
completed
Mobility 4 100% (24/24) At least 1 of 4 100% (10/10) At least 1 of 4 100% (8/8)
Skin/ Pressure Ulcer
status
2 66.7% (8/12) At least 1 of 4 90% (9/10) At least 1 of 4 100% (8/8)
Decision pathway
allocated
1 0% (0/6) 1 100% (10/10) 1 87.5% (7/8)
Total Item completion - 76.2% (32/42) - 96.7% (29/30) - 95.8% (23/24)
Total Item completion
where decision pathway
allocated
- 0% - 96.7% (29/30) - 100% (21/21)
N number; p/a per assessment; TVN tissue viability nurse; RN research nurse; PU pressure ulcer
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Table 6.4 Item level completion for assessments that included step 1(screening) and 2(full assessment)
Pre-test 1: N
items requiring
completion p/a
Pre-test 1:
(TVN/RNs)
Items
completed
Pre-test 2: N
items requiring
completion p/a
Pre-test 2:
(Staff Nurse)
Items
completed
Pre-test 2: N
items requiring
completion p/a
Pre-test 3:
(Sisters)
Items
completed
Mobility (1st stage) 4 93.3% (97/104) At least 1 of 4 96.2% (25/26) At least 1 of 4 100% (25/25)
Skin/ Pressure Ulcer status
(1st stage)
2 98.1% (51/52) AA 100% (3/3) AA 100% (1/1)
Movement Matrix 1 100% (26/26) 1 100% (26/26) 1 96% (24/25)
Sensory Perception 1 96.2% (25/26) 1 of 2 100% (26/26) 1 of 2 100% (25/25)
Current DSA - listed sites 15 71.5%
(279/390)
13 75.4%
(255/338)
13 97.2%
(316/325)
Current DSA – other sites AA 0% (0/0) AA 50.0% (1/2) AA 0% (0/0)
Current PU AA 84.2% (16/19) AA 83.3% (20/24) AA 80.0% (20/25)
Previous PU history AA 75% (9/12) AA 77.8% (7/9) 1 of 2 (if yes 3,
AA)
85.3% (29/34)
Scarring 2 55.8% (29/52) AA 100% (1/1) AA 100% (1/1)
Perfusion 2 92.3% (48/52) At least 1 of 3 73.1% (19/26) At least 1 of 3 100% (25/25)
Nutrition 4 76.9% (80/104) At least 1 of 5 100% (26/26) At least 1 of 5 100% (25/25)
Moisture 1 (if yes 2 as
applicable)
74.1% (40/54) 1 of 3 84.6% (22/26) 1 of 3 100% (25/25)
Diabetes 1 100% (26/26) As applicable 100% (5/5) 1 of 2 100% (25/25)
Decision pathway allocated 1 of 3 53.8% (14/26) 1 of 3 96.2% (25/26) 1 of 3 100% (25/25)
Total Item completion - 78.5%
(740/943)
- 81.7%
(461/564)
- 96.6%
(566/586)
Total Item completion
where decision pathway
allocated
- 83.7%
(417/498)
- 83.7%
(452/540)
- 96.6%
(566/586)
N number; p/a per assessment; AA as applicable; DSA detailed skin assessment; TVN tissue viability nurse; RN research nurse; PU pressure ulcer
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Table 6.5 Overall total Item completion for assessments
Pre-test 1: (TVN/RNs)
Items completed
Pre-test 2: (Staff Nurse)
Items completed
Pre-test 3: (Sisters)
Items completed
Total item completion for assessments concluding at
step1
76.2% (32/42) 96.7% (29/30) 95.8% (23/24)
Total item completion for assessments including step 1
and 2
78.5% (740/943) 81.7% (461/564) 96.6% (566/586)
Overall total item completion 78.4% (772/985) 82.5% (490/594) 96.6% (589/610)
TVN tissue viability nurse; RN research nurse
Table 6.6 Overall total Item completion for assessments with decision pathway allocated
Pre-test 1: (TVN/RNs)
Items completed
Pre-test 2: (Staff Nurse)
Items completed
Pre-test 3: (Sisters)
Items completed
Total item completion for assessments concluding at
step1 where decision pathway allocated
0% 96.7% (29/30) 100% (21/21)
Total item completion for assessments including step 1
and 2 where decision pathway allocated
83.7% (417/498) 83.7% (452/540) 96.6%
(566/586)
Overall total Item completion where decision pathway
allocated
83.7% (417/498) 84.4% (481/570) 96.7% (587/607)
TVN tissue viability nurse; RN research nurse
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Figure 6.1 illustrates how the levels of missing data decreased over the 3 pre-test
sessions overall and where a decision pathway was allocated.
Figure 6.1 Percentage of missing data at each pre-test session
Figure 6.2 illustrates how the number of decision pathways allocated increased
notably from the first to the second pre-test.
Figure 6.2 Percentage decision pathway allocated at each pre-test
session
Table 6.7 presents the appropriateness of the decision pathways allocated
according to the decision rules of the Risk Assessment Framework and the item
responses for each assessment. An inappropriate decision pathway was allocated
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in the first pre-test when an assessment detailed the presence of an ulcer indicating
that it should have been allocated to the ‘pressure ulcer Category 1 or above or
scarring’ pathway but was allocated to the ‘at risk’ pathway (see Table 6.7).
Uncertainty about the appropriateness of the allocated pathway related to missing
data, for example a patient was allocated to the ‘not currently at risk’ pathway but
the skin assessment items were not fully completed, hence there was the possibility
that a higher pathway was appropriate.
Table 6.7 Appropriate decision pathway allocation
Pre-Test Session
1
(TVN/RNs)
Pre-Test Session
2
(Staff Nurse)
Pre-Test
Session 3
(Sisters)
Appropriate pathway
allocation
78.6 % (11/14) 91.4% (32/35) 90.6% (29/32)
Inappropriate pathway
allocation
7.1% (1/14)
Pathway allocated but
some uncertainty of
appropriateness due to
missing data items
14.3% (2/14) 8.6% (3/35) 9.4% (3/32)
.
TVN Tissue Viability Nurse; RN research nurse
Changes made to the Risk Assessment Framework between pre-test sessions in
response to the analysis of data completeness, think out loud interviews, and focus
groups are summarised (Figure 6.3) and relate to three main areas, including flow
and format, decision support, and wording of specific items. The changes to these
main areas can be seen in the successive versions of the Risk Assessment
Framework used at the pre-test sessions (Figure 6.4-6.6) for example at step 1 of
the assessment. It should be acknowledged that following the step 1 changes,
some nurses still completed the skin/ulcer items despite not needing to. This could
be related to the use of vignette case studies in the pre-test sessions where
information regarding skin/ulcer status was readily available, while in clinical
practice this information may be less obvious.
Other notable changes made over the course of the pre-test sessions (Figure 6.4-
6.6) related to the move from landscape to portrait orientation to improve the flow of
the Framework and the development of specific items (e.g. the terminology relating
to ‘bedfast’ and ‘chairfast’ of the step 1 mobility items were found to be confusing
and there was a need to incorporate an element of frequency to the items which
were subsequently amended and tested at the next session). The think out loud
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participants from the first pre-test also highlighted that items, where a positive
response indicated the patient did not have a problem, were confusing. This related
to step 1 mobility items and the step 2 sensory perception item, and changes were
made to the Risk Assessment Framework used at subsequent sessions.
Participants of the first pre-test focus group felt that there should be some provision
within step 1 of the Risk Assessment Framework to enable nurses to use their
clinical judgement of other significant risk factors (which may be exceptions to the
rule) that they should take into account when considering if the patient should
progress to the more detailed step 2 assessment. This could relate to the severity
of a risk factor (e.g. terminally ill patients, severe diabetes, perfusion problems and
severe nutritional problems). Having ‘other items’ at step 1 was considered by the
working group but there was concern that the screening stage could become too
large. Taking into account the causal pathway for pressure ulcer development, it
was decided that a ‘vulnerable skin’ item would be included instead to focus the
assessment on the potential impact other medical conditions might have on the
skin, rather than the presence or absence of many different conditions.
The data completeness assessment (Table 6.3-6.6 and Figure 6.1) showed poor
decision pathway allocation in the first pre-test. The corresponding focus group
discussions highlighted confusion about where to indicate pathway allocation.
Some nurses had attempted to indicate a pathway on the form though they were
clearly unsure of where to do this. This brought to light a significant omission and
lack of clarity within the Risk Assessment Framework, and the need to include a
response box within the ‘not currently at risk’ pathway at the first stage of the
assessment, and to make the pathway allocation tick boxes at stage 2 of the
assessment more obvious. In addition, the think out loud interviews in the first pre-
test session highlighted an issue relating to the ordering of the decision pathway
boxes in the first draft Risk Assessment Framework. This related to the first
pathway (left) being the blue ‘not currently at risk pathway’ the second (middle)
being the amber primary prevention pathway and the third (right) being the red
secondary prevention/treatment pathway, and the resultant possibility of ticking the
primary prevention pathway before getting to the secondary prevention/treatment
pathway. It was suggested that as ‘red trumps amber’, the boxes should be re-
ordered so that the red one was first and this was undertaken for the second pre-
test (Figure 6.5 and Figure 6.6).
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Flow and Format
 To improve data completion and to make the tool less busy and more inviting to complete the format
of the Risk Assessment Framework was changed from many compulsory yes/no items to a ‘no
problem’ option for each risk factor domain/sub-domain section (with the exception of diabetes and
previous PU history) and then tick as applicable options.
 The flow of the stage 1 assessment was changed to make it clearer when it is necessary to complete
the stage 1 skin items and to allow a patient with mobility problems to move directly to the second
stage of the assessment (preventing unnecessary duplication of skin items).
 A skin vulnerability item was added to the stage 1 assessment to capture the potential effects of
other medical conditions on skin condition e.g. peripheral vascular disease. A normal skin option was
also added as it was felt that a confirmation of normal skin was needed to allow a patient to be
allocated not currently at risk at stage 1 of the assessment.
Decision Support
 The arrows of the stage 1 assessment were adjusted to clarify that both the mobility and skin/PU
status items should be completed before a patient was deemed not currently at risk.
 The decision support box relating to pathway allocation was clarified.
 Provision to indicate the patient was not currently at risk at the 1st stage of the assessment was
made. Tick boxes relating to pathway allocation at the second stage were made more obvious.
 The order of the pathways was changed to assist with decision making (i.e. red/pink indicates
secondary prevention pathway).
Wording of Specific Items
 Items where a positive response indicated there wasn’t a problem (including mobility stage 1 items
and the sensory perception item) were adjusted in line with the other items so that a positive
response indicated the patient had a problem with the risk factor item.
 The stage 1 mobility items underwent major changes to incorporate an element of frequency of
movement, to remove terminology of ‘bedfast’ and ‘chairfast’ and to clarify what was meant by ‘help’
in relation the walking item.
 A normal skin option was also added to the stage 2 current detailed skin assessment (to replace the
vulnerability yes/no items). The instructions were clarified to highlight that these items related to
current rather than history. Further instructions were added to the vulnerable skin item (‘precursor to
PU’). Vulnerability examples and were amended slightly and moist was added. Other skin sites were
made into if applicable items
 The wording within the analysis of movement item was changed to make – ‘magnitude’ was replaced
with ‘extent’ and ‘relief of pressure areas’ was replaced with ‘relief of all pressure areas’. The
instructions for completing the item were slightly amended.
 It was clarified that the previous PU history item was an ‘if applicable item’. The category box within
the item was coloured yellow. The scar item was to be completed as applicable.
 The parameters of the moisture item were changed from ‘1-2 times a day’ to ‘2-4 times a day’.
Flow and Format
 The layout of the tool was changed from landscape to portrait to allow the tool to flow more easily
and to fit in with assessment documents used in clinical practice.
 The stages of the assessment were changed to ‘steps' and descriptions added (step 1: screening,
step 2: full assessment’ with instructions to ‘complete all sections’. A step 3 ‘assessment decision’
section was added to encourage pathway allocation.
Decision Support
 The format of the step 1 of the assessment was changed to make it more obvious when the step 1
skin/PU item should be completed and when a patient should progress to step 2 or be allocated to
the not currently at risk pathway.
 Instructions in 2 decision boxes were clarified (step 1 skin/PU yellow and step 3 amber).
 A summary of the EPUAP/NPUAP PU classification system was added
Wording of Specific Items
 A ‘not diabetic’ option was added to the diabetic item.
 The previous PU history item was changed from a tick if applicable item to ‘no known PU history’ or
‘PU history’. If a history was indicated the approx. date, site and PU cat should be detailed.
 Parameters were added to the BMI items.
Flow and Format
 The blue not currently at risk boxes were changed to green like other RAG assessment systems
Wording of Specific Items
 The moisture ‘no problem’ item was changed to ‘no problem/occasional’.
 The analysis of movement title was changed to analysis of ‘independent’ movement.
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Figure 6.3 Changes to Risk Assessment Framework following each pre-test sessions
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Figure 6.4 Pre-Test 1 Risk Assessment Framework (Draft)
Copyright © Clinical Trials Research Unit, University of Leeds and Leeds Teaching Hospitals Trust, 2013 (do not use without permission) Colour Key: Blue: - ‘no problem’;Yellow- risk factor
present which may impact upon pressure ulcer risk; Amber- risk factor present which puts the ptient at risk; Pink- patient has a pressure ulcer or scar from previous pressure ulcer
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Figure 6.5 Pre-Test 2 Risk Assessment Framework (Draft)
Copyright © Clinical Trials Research Unit, University of Leeds and Leeds Teaching Hospitals Trust, 2013 (do not use without permission) Colour Key: Blue: - ‘no problem’;Yellow- risk factor
present which may impact upon pressure ulcer risk; Amber- risk factor present which puts the patient at risk; Pink- patient has a pressure ulcer or scar from previous pressure ulcer
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Figure 6.6 Pre-Test 3 Risk Assessment Framework (Draft)
Copyright © Clinical Trials Research Unit, University of Leeds and Leeds Teaching Hospitals Trust, 2013
(do not use without permission). Colour Key: Blue: - ‘no problem’;Yellow- risk factor present which may
impact upon pressure ulcer risk; Amber- risk factor present which puts the patient at risk; Pink- patient has
a pressure ulcer or scar from previous pressure ulcer
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6.9 Review by PURSUN and Expert Group
The review of the Risk Assessment Framework by PURSUN UK and the expert
group (following pre-testing), led to a final change to the Risk Assessment
Framework. While PURSUN felt that the Risk Assessment Framework was clear
and understandable, they raised concern about the wording of the sensory
perception item relating to the ‘ability to feel and respond’ aspect of the item. The
group agreed that the patient might only be able to fulfil one of these requirements
which should be considered a problem, but the wording suggested that it would only
be a problem if the patient could not do both. They felt that the terminology should
be ‘feel and/or respond’. This led to the wording of the sensory perception item
being re-considered at the subsequent expert group meeting and amendments
being made.Preliminary Risk Assessment Framework
6.10 Preliminary Risk Assessment Framework
The pre-test facilitated the development of the preliminary Risk Assessment
Framework (Figure 6.7) which incorporates 9 risk factors (mobility, existing
pressure ulcer, previous pressure ulcer, vulnerable skin, sensory perception,
perfusion, diabetes, nutrition and moisture) and related assessment items. It also
informed the development of a user guide (Appendix 18) which provides information
on how to use the Risk Assessment Framework and how to interpret the included
assessment items. At Step 1 of the Risk Assessment Framework there are four
mobility options with ‘tick all applicable’ instructions. If only the blue coded criteria
‘walks independently with or without walking aids’ is ticked the instructions are to
progress to Step 1 Skin status. If any other mobility criteria (which are all coded
yellow) are ticked, the instructions are to progress to Step 2 (Figure 6.7).
The Step 1 Skin status also has 4 options with ‘tick all applicable’ instructions. If
only the blue coded ‘normal skin’ is ticked the instructions are to allocate the patient
to the Green assessment decision - ‘No pressure ulcer not currently at risk’
pathway. If any other skin status criteria are ticked (coded yellow and pink), the
instructions are to progress to Step 2 full assessment (Figure 6.7).
Step 2 includes assessment of the following:
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 Analysis of independent movement: five options, including four coded amber
(with varying limitations to frequency and extent of independent movement)
and one coded yellow (making major position changes frequently).
 Detailed skin assessment for 13 skin sites (with the option for ‘other’ skin
sites): with three options for each including: ‘normal skin’ coded blue;
‘vulnerable skin’ coded amber and; pressure ulcer category (1) coded pink.
 Previous pressure ulcer history: two options including: ‘no known pressure
ulcer history’ coded blue and; ‘pressure ulcer history’ coded yellow, with
presence of scar (if applicable only) coded pink
 Sensory perception: two options, including: ‘no problem’ coded blue and;
‘patient is unable to feel and/or respond to discomfort from pressure’ coded
amber.
 Perfusion: three options including ‘no problem’ coded blue and two options
coded amber including: ‘conditions affecting central circulation e.g. shock,
heart failure, hypotension’ and; ‘conditions affecting peripheral circulation
e.g. peripheral vascular/arterial disease’.
 Nutrition: five options including: ‘no problem’ coded blue and four options
coded yellow including: ‘unplanned weight loss’; ‘poor nutritional intake’; ‘low
BMI’ and; ‘high BMI’
 Moisture: three options including: ‘no problem/occasional’ coded blue and;
two options coded yellow - frequent’ and ‘constant’.
 Diabetes: two options including: ‘not diabetic’ coded blue and; ‘diabetic’
coded yellow.
Step 3 involves allocation of an assessment decision and incorporates support for
decision making as outlined in Table 6.8.
Table 6.8 Step 3 Assessment decision instructions
Colour code Assessment Assessment decision
Any Pink Pressure ulcer of
Category 1 or above or
scarring from previous
pressure ulcer
RED:
Secondary prevention and
treatment pathway
Any Amber (but no pink) No pressure ulcer but at
risk
AMBER
Primary prevention
pathway
Only Yellow and blue Nurse to consider risk
factors present and decide
AMBER
Primary prevention
pathway OR
GREEN
Not currently at risk
pathway
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Figure 6.7 Preliminary Risk Assessment Framework for Clinical
Evaluation
Copyright © Clinical trials Research Unit, University of Leeds and Leeds Teaching Hospitals Trust, 2013
(do not use without permission). Colour Key: Blue: - ‘no problem’;Yellow- risk factor present which may
impact upon pressure ulcer risk; Amber- risk factor present which puts the patient at risk; Pink- patient
has a pressure ulcer or scar from previous pressure ulcer
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6.11Discussion
Designing the Risk Assessment Framework was facilitated by the results of the
consensus study and conducted in liaison with a graphic designer. Further
consideration of the colour coding and weighting of risk factors was also necessary
when designing the Framework. Decisions about risk factor weighting were
facilitated by consideration of each of the developmental phases of this work. This
was particularly important for risk factors with less robust evidence. Further
statistical modelling work will be needed to assess whether the allocated weighting
for each risk factor is appropriate and this may lead to amendments of the Risk
Assessment Framework. The design process led to the first graphic designed draft
of the Risk Assessment Framework and was subject to the pre-test study.
This is the first study to incorporate pre-testing as a key methodological component
in the development of a pressure ulcer Risk Assessment Instrument, drawing on
methodologies used in the development of other health measurement Instruments
and patient reported outcome measures (SAC 2002; Streiner and Norman 2008;
FDA DHHS 2009; Rothman et al. 2009; Gorecki et al. 2012). The approach worked
well and was relevant to the development of the Risk Assessment Framework as it
allowed areas of confusion to be identified and improvements to be made to
enhance the usability and acceptability of the Risk Assessment Framework. It also
allowed confirmation of content validity with clinical nurses, the intended end users
of the Framework.
It could be argued that undertaking a pre-test using vignette case studies, is no
substitute for assessing the Risk Assessment Framework in clinical practice. A
limitation of the approach relates to it being an artificial situation and it is
acknowledged that participants may have responded differently in a real life
situation (Lanza 1990). However, the need to assess and improve the acceptability
of the Risk Assessment Framework with clinical nurses was considered a robust
and logical step to ensure content validity and usability, prior to evaluation in clinical
practice with real patients. In addition, the vignettes were co-developed by the
project lead, clinical and academic leaders in the pressure ulcer field and patients
and carers (members of PURSUN UK) to ensure they were realistic, clinically
relevant and to give an indication of external validity (Flaskerud 1979). The use of
vignettes has been used previously by social scientists in various fields (Flaskerud
1979) and in dental, medical and nursing education (Littlefield et al. 2003; Dillon et
al. 2004; Goodstone et al. 2013) and to establish the validity of pressure ulcer Risk
Assessment Instruments (Gould et al. 2002; Gould et al. 2004). In keeping with
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those who have used vignettes previously, the present PhD study, benefitted from
the approach as it allowed exploration of participants knowledge, attitudes and how
they might respond to a simulated event (Lanza 1990; Gould 1996).
The use of homogenous groups of nurses in similar roles, prevented hierarchical
issues impeding group member involvement in the sessions and was felt to
facilitate greater disclosure (Morgan and Krueger 1993; McColl 2005). The order of
the pre-test sessions (in terms of the job role of the nurses involved) was carefully
considered during the planning stages. This was to ensure usability issues were
identified as quickly as possible, so that changes could be made to the draft Risk
Assessment Framework and pre-tested in the subsequent session. The Tissue
Viability Nurses pre-test session was conducted first as it was anticipated that as
specialist nurses in the pressure ulcer field, they were best placed to identify any
subject specific and key usability issues which could be addressed in subsequent
versions. Additionally, the third and last pre-test session deliberately involved
Sister/charge Nurses so that Risk Assessment Framework (incorporating changes
that were made in response to pre-test 1 and 2) could be considered by senior
nurses responsible for patient care. The chosen order (of the nurses job role)
worked well as demonstrated by the decreasing number of changes made to the
Risk Assessment Framework (Figure 6.3) which is also indicative that saturation
had been reached. However, there remains ambiguity as to whether this related to
the order of the nurses undertaking the pre-test or the general process i.e. similar
results may have been obtained if a different order had been used.
The focus groups and think out loud interviews were undertaken in accordance with
principles of good practice, held in a pleasant environment and were carefully
planned to encourage disclosure amongst participants which would not have been
possible in a busy clinical area. In addition, topic guides were used by trained
facilitators, group numbers were congruent to facilitation and participants were fully
briefed and had opportunities to ask questions prior to the actual interview/focus
group. The use of both focus groups and think out loud interviews is unusual for
evaluation purposes, but this is mainly due to differences in backgrounds and
cultures of researchers which use the techniques (Willis 2005). The use of both
techniques in the context of developing the Risk Assessment Framework was
advantageous as while there was some overlap between the groups in terms of the
nature of the issues raised (i.e. both groups identified issues relating to specific
usability and wider application), they also worked in a complimentary manner. The
think out loud interviews most consistently highlighted specific usability issues (e.g.
relating to specific items) while the focus groups most consistently identified issues
relating to the wider application/implementation of the Framework in clinical practice
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(Willis 2005). This ensured that all aspects of usability were considered and led to
key changes to the Framework related to three main areas including the flow and
format, decision support, and the wording of specific items. This led to the
development of the preliminary Risk Assessment Framework which requires further
clinical evaluation to assess its reliability and validity.
6.12Conclusion
The design of the Risk Assessment Framework was underpinned by the consensus
study, consideration of the weighting of risk factor items and with the support of a
graphic designer. This was then subject to pre-testing with clinical nurses to assess
and improve its usability. The pre-test incorporated clinical nurses being trained in
the use of the Risk Assessment Framework and participating in focus groups or
think out loud interviews. The analysis facilitated changes to the Risk Assessment
Framework relating to three main areas including the flow and format, decision
support, and the wording of specific items. This is the first study to incorporate pre-
testing with clinical nurses in the development of a Risk Assessment Instrument
and allowed important usability issues to be identified and addressed and content
validity to be confirmed leading to the development of a preliminary Risk
Assessment Framework in readiness for clinical evaluation.
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Chapter 7 General Discussion
7.1 Introduction
Due to the noted limitations of existing pressure ulcer Risk Assessment
Instruments, the need for a transparent and consistent approach to assessment in
clinical practice and increasing evidence relating to pressure ulcer risk factors, this
PhD thesis aimed to describe the development of a new decision tool, the Risk
Assessment Framework (with underpinning Pressure Ulcer Minimum Data Set) for
use with adult populations. The overall methodological approach drew on research
from other fields and comprised four distinct phases including a systematic review
of pressure ulcer risk factors (Chapter 3), consensus study (Chapter 4), conceptual
framework development (Chapter 5) and design and pre-testing (Chapter 6).
A detailed account of each phase of the PhD including research aims,
methodological development, results and discussions are detailed in the previous
chapters. Therefore this final chapter will summarise the key findings of this PhD
and discuss the overall methodological approach, its limitations and highlight areas
of methodological development and limitations. It will go on to discuss the
implications of this PhD for clinical practice and research and plans for the ongoing
validation of the Risk Assessment Framework.
7.2 Summary of Findings
7.2.1 Phase 1, Pressure Ulcer Risk Factor Systematic Review
The first study, the systematic review of pressure ulcer risk factors provided the
foundation of this PhD. The review comprised 54 eligible studies and identified a
large number of potential risk factors (15 domains, 46 sub-domains including over
250 named variables) and lack of comparable data fields for measurement of the
same constructs and key risk factors not being routinely recorded in all studies
(chapter 3). Due to these limitations meta-analysis was not possible and a narrative
synthesis was undertaken. The review highlights the advantages of considering
numerous studies (rather than single studies) to provide a more reliable approach
to identifying risk factors which increases pressure ulcer probability.
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The narrative synthesis of the review found that the most consistently emerging risk
factor domains in multivariable analysis were immobility (mobility/activity) and
perfusion (including diabetes). In addition skin/ pressure ulcer status particularly
relating to stage/grade 1, emerged as a major risk variable. Other important but less
consistently emerging risk factor domains included nutrition, moisture, age,
haematological measures, general health status, sensory perception and mental
status. A small number of studies suggest a relationship between body temperature
and immunity and pressure ulcer development and these factors require further
research. The evidence regarding race and gender was equivocal. While immobility
assessment is included in existing pressure ulcer Risk Assessment Instruments, the
inclusion of skin/Pressure Ulcer status and perfusion (including diabetes) is not
universal.
The systematic review highlighted the need to re-consider which risk factors should
be considered in pressure ulcer risk assessment, how these should be assessed
and the overall assessment process. In addition, a key recommendation of the
review was the development of a risk factor Minimum Data Set, to encourage the
use of consistent risk factors across pressure ulcer studies, facilitating large scale
multivariable analysis, meta-analysis and case mix adjustment (Berlowitz et al.
2001). It was also proposed that to enable routine recording in practice, the
Minimum Data Set would be incorporated into the Risk Assessment Framework.
The review provided the basis for the proposal of a new conceptual framework of
pressure ulcer development to bridge the gap between the epidemiological,
physiological and biomechanical evidence and enhance our understanding of the
role of individual risk factors in pressure ulcer development.
7.2.2 Phase 2, Consensus Study
The consensus study used a modified nominal group technique based on the
RAND/UCLA appropriateness method. This incorporated an international expert
group, review of the pressure ulcer evidence including the systematic review
(chapter 3) and wider scientific evidence and its relevance to clinical practice. The
consensus study incorporated facilitated face-to face interaction of the expert group
and the use of questionnaires before and after the meetings to quantify the level of
support for the inclusion of risk factors and assessment items in the Minimum Data
Set and Risk Assessment Framework. In additions the views of a PPI service user
group (PURSUN) were sought, particularly relating to the acceptability of collecting
risk factor and assessment items information on a routine basis. Their views were
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incorporated into each cycle of the consensus process ensuring that service user
views were considered when deciding the risk factors and assessment items to be
included in the Risk Assessment Framework (incorporating the Minimum Data Set).
The consensus study facilitated the structured and transparent consideration of the
initial 15 risk factor domains and 46 sub-domains of the systematic review (chapter
3). This led to the agreement that nine risk factors (immobility, existing pressure
ulcer, previous pressure ulcer, general skin status, perfusion, sensory perception,
nutrition, moisture and diabetes) and their assessment items should be included in
the Risk Assessment Framework (incorporating the Minimum Data Set). This
allowed an initial draft of the framework to be made.
7.2.3 Phase 3, Conceptual Framework
Building on the phase 2 consensus study further consideration was given to the
proposal of the new pressure ulcer conceptual framework and theoretical causal
pathway (Chapter 5). This incorporated consideration of physiological,
biomechanical (Chapter 1, Section 1.9) and epidemiological evidence (Chapter 3)
as well as the outcomes of the consensus study and the views of an expert panel.
The theoretical causal pathway was developed with consideration of causal factor
terminology (Brotman et al. 2005) and it was agreed that immobility, skin/pressure
ulcer status and perfusion were direct causal factors (directly impacts the outcome,
or the likelihood of the outcome); poor sensory perception and response, diabetes,
moisture, poor nutrition and low albumin were key indirect factors (impacts the
outcome, or affects its likelihood of occurrence by changing a direct causal factor);
and older age, medication, pitting oedema, chronic wound, infection, increased
temperature and acute illness were other potential indirect factors.
The development of the new conceptual framework was also enabled by
consideration and enhancement of the NPUAP/ EPUAP (2009) conceptual
framework, the theoretical causal pathway for pressure ulcer development and
mapping of risk factors to the conceptual framework. The new proposed pressure
ulcer conceptual framework incorporates key physiological and biomechanical
components and their impact on internal strains, stresses and damage. The direct
and key indirect factors suggested in a theoretical causal pathway are mapped to
the physiological and biomechanical components of the framework. The new
proposed conceptual framework provides the basis for understanding the critical
determinants of pressure ulcer development.
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7.2.4 Phase 4, Design and Pre-testing of the Risk Assessment
Framework
The design of the Risk Assessment Framework was underpinned by the consensus
study, consideration of the weighting of risk factor items and the support of a
graphic designer. To increase support for decision making and encourage nurses to
plan the patients care in response to their individual risk profile (rather than a
numerical score), the use of colour was adopted. To do this the importance of
included risk factor items and their impact on the patients risk status was
considered. This was achieved by consideration of the overall strength of evidence,
which was influenced by each of the development phases of this work leading to a
colour system to indicate risk factor weighting. Instructions regarding the colour
coding were integrated in the Risk Assessment Framework to support decision
making and the physical development of the Framework involved frequent liaison
with the graphic designer.
The graphically designed draft Risk Assessment Framework was then subject to
pre-testing with clinical nurses to assess and improve its usability. The pre-test was
undertaken over 3 sessions incorporating, training, focus groups and think out loud
interviews. Changes to Risk Assessment Framework were made after each
session, allowing enhancement and further pre-testing at the subsequent session.
The key changes made over the course of the pre-test related to the format and
flow, decision support and the wording of specific items. This led to the
development of a preliminary Risk Assessment Framework in readiness for clinical
evaluation.
7.3 The Preliminary Risk Assessment Framework
The preliminary Risk Assessment Framework incorporates 3 steps to the
assessment, 9 risk factors and related assessment items, the use of colour to
weight the importance of risk factors and integrates support for decision making
throughout (Chapter 6, section 6.2). It has been developed for use with adult
populations in clinical practice. Step 1 of the Risk Assessment Framework,
comprises screening which is intended for all adult patients and incorporates
mobility status and skin status assessment items and allows those who are clearly
not at risk to be identified, preventing the need for a full assessment. Step 2, the full
assessment is intended for patients at potential/actual risk (identified by step1) and
incorporates assessment items relating to immobility, sensory perception, current
skin status, previous pressure ulcer, perfusion, nutrition, moisture and diabetes.
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Step 3, the assessment decision involves the nurse considering the individual risk
profile of the patient and with support for decision making integrated into the Risk
Assessment Framework, allocating the patient to the secondary prevention and
treatment pathway (for those with an existing pressure ulcer or with scarring from a
previous pressure ulcer), the primary prevention pathway (for those at risk of a
pressure ulcer) or the not currently at risk pathway.
The development of the Risk Assessment Framework incorporated rigorous
development methods to ensure the fundamental properties of content validity and
acceptability and usability were met. Content validity is important in ensuring the
decision tool adequately represents the domain it is supposed to measure and in
this context is underpinned by empirical evidence of a systematic review,
conceptual framework development and a consensus study incorporating the views
of experts in the pressure ulcer field as well as service users. This methodological
approach identified the importance of skin/ pressure ulcer status and poor perfusion
as primary risk factors, which are not universally incorporated in existing
instruments. Their inclusion in the new decision tool facilitates the nurse to consider
them in her assessment and subsequent care planning. Content validity of the new
decision tool was confirmed in a pre-test with its intended end users, clinical nurses.
The pre-test also allowed areas of confusion to be identified and improvements to
be made to the decision tool to enhance the usability and acceptability of the Risk
Assessment Framework.
Of note is that the Risk Assessment Framework requires nurses’ to assess the
presence of most risk factors in a subjective manner, as at present there are no
objective measures routinely available in clinical practice to achieve this. A user
guide (Appendix 18) was developed following the pre-test to provide information on
how to use the Risk Assessment Framework and how to interpret the included
assessment items. This will help to standardise the assessment, though it is
recognised that clinical judgement has a key role in the assessment process. Some
risk factors require more clinical judgement than others for example, diabetes is not
reliant on clinical judgement, rather the presence of the condition and this
information could be obtained from the patient or clinical record.
Other risk factors rely more heavily on clinical judgement for example, the analysis
of independent movement item. This incorporates consideration of the extent and
frequency of independent movement. While the user guide (Appendix 18) provides
some clarity on how the item should be interpreted (i.e. a slight position change
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would involve the patient shifting their position a little when in bed or chair which
may result in some, but not complete pressure relief while a major position change
would result in complete pressure relief), the nurse would need to use her clinical
judgment, informed by observation of the patient, history taking and clinical records
to decide whether the patient’s extent of movement was slight or major and the
frequency of movement which would influence the category the patient falls into.
Essentially the nurse is judging the extent to which the patient is able to
independently relieve their pressure areas. This item is based on pressure ulcer
aetiology and the importance of intensity and duration of pressure in ulcer
development (Linder-Ganz et al. 2006; Stekelenburg et al. 2007). While these
factors are key to pressure ulcer development, it is still difficult to determine the
relative contribution of these two parameters and they are influenced by the
patient’s susceptibility and tolerance to pressure, which in turn are affected by the
presence of risk factors. While the analysis of independent movement gives an
indication of the intensity and duration of pressure, the ongoing skin assessment,
allows the impact of this to be established.
The nurse’s clinical judgement is also important when considering the pathway the
patient should be allocated to and this is particlaurly relevant where the patient has
a mixture of blue ‘no problem’ and yellow ‘risk factor present which may impact
upon pressure ulcer risk’ items. In this situation the nurse must consider the risk
profile of the patient and use their clinical judgement to determine whether the
patient is ‘at risk’ or ‘not currently at risk’. This would be influenced by the number of
yellow boxes ticked i.e. increased numbers of yellow boxes ticked may lead the
nurse to consider the patient to be ‘at risk’. It would also be influenced by
knowledge of the patient’s individual circumstance. For example, a patient may only
have the presence of unplanned weight loss, but may be terminally ill and nearing
the end of life where the general trajectory of dependence will increase and the
nurse may therefore consider the patient to be ‘at risk’. Alternatively a diabetic
patient who has undergone acute surgery but is recovering well and the general
trajectory is increasing independence, may be considered ‘not currently at risk’.
These examples demonstrate that clinical judgement has a key role in the use of
the Risk Assessment Framework, as it allows wider knowledge of the patient to be
considered when deciding appropriate pathway allocation and provides a safety net
for identifying ‘at risk’ and ‘not currently at risk’ patients.
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7.3.1 Main Differences Between the Preliminary Risk Assessment
Framework and Other Widely Used Pressure Ulcer Risk
Assessment Instruments
The Risk Assessment Framework marks a new approach to the assessment of
pressure ulcer risk. It moves away from the traditional approach used in Risk
Assessment Instruments where the total scores from numerical scales are used to
underpin care provision, to a decision tool which encourages a more thoughtful
approach to the assessment process.
This empirically derived decision tool differs to existing Risk Assessment
Instruments in a number of ways. Firstly, the Risk Assessment Framework
incorporates a two stage assessment process with support for decision making
regarding the depth of assessment required. This facilitates more appropriate use
of nursing time as it allows patients’ who are clearly not at risk to be screened out
with only those who are potentially ‘at risk’ (as identified at screening stage)
undergoing full detailed risk assessment. The new Risk Assessment Framework
assists nurses to identify the presence of risk factors and identify the patient’s
individual risk profile. This provides more meaningful information than that obtained
from the total scores of existing instruments, as it facilitates individualised care
planning to address the patient’s specific needs.
The use of colour makes a distinction between primary risk factors and those with
weaker evidence i.e. yellow risk factors. This supports clinical decision making to
facilitate appropriate pathway allocation and the discrimination of those with existing
pressure ulcers who should be allocated to the secondary prevention/treatment
pathway, those ‘at risk’ of developing pressure ulcers who should be allocated to
the primary prevention pathway and those not at risk who should be allocated to the
‘not currently at risk’ pathway. Unlike existing Risk Assessment Instruments, this
ensures the presence of an existing pressure ulcer is taken into account within the
assessment and decision making process and aims to facilitate the escalation of
care interventions to prevent deterioration of an existing pressure ulcer, promote
healing and prevent additional pressure ulcer development. The Risk Assessment
Framework also incorporates a risk factor Minimum Data Set which can be used at
an organisational level for case-mix adjustment and to facilitate large multivariable
modelling, which will enhance our understanding of pressure ulcer risk factors in the
future.
Finally there is a subtle but important shift in focus in the new decision tool when
compared with existing Risk Assessment Instruments. The literature relating to
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existing Risk Assessment Instruments has concentrated on predictive validity and
this has led to a lack of clarity of the aims of existing instruments and how they
should be evaluated. The intention of the new decision tool is not to predict
pressure ulcer development, but to identify pressure ulcer risk or presence so that
appropriate primary prevention or secondary prevention/treatment interventions can
be put in place. Being very clear about this at the outset sends a clear message to
nurses of the need to take action in response to the patient’s risk profile and
assessment outcome. It also has the potential to divert future researchers away
from undertaking inappropriate predictive validity evaluations to focussing on the
impact the decision tool has on care processes and patient and pressure ulcer
outcomes.
In summary the main differences between preliminary Risk Assessment Framework
and other widely used Risk Assessment Instruments are as follows:
 Content based on empirical evidence including systematic review,
consensus study, conceptual framework and pre-test study
 Aims to identify pressure ulcer risk or presence rather than predict pressure
ulcer development
 Integration of skin / pressure ulcer status and poor perfusion
 Incorporation of a screening stage for all patients and a full assessment
stage for those at potential/actual risk or with an existing pressure ulcer
allowing those who are obviously ‘not at risk’ to be quickly identified.
 Enhanced support for decision making with regard to the depth of the
assessment required (i.e. screening and/or full more detailed assessment)
and the relative importance of specific risk factors when considering the
patients risk status.
 Consideration of the patients individual risk profile (i.e. risk factors present),
rather than a condensed score to provide a ‘framework’ for care
(i.e.underpin appropriate care planning and the instigation of
preventative/management interventions).
 The use of colour to weight the importance of risk factors and aid decision
making.
 Clear distinction between primary and secondary prevention.
 Incorporation of a risk factor Minimum Data Set within the actual
assessment items to facilitate multivariable modelling.
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7.4 Methodological development
The overall approach used in the development of the Risk Assessment Framework
incorporating a systematic review, consensus methods and pre-testing has, to the
author’s knowledge, never been undertaken previously for pressure ulcer Risk
Assessment Instrument development. Most other instruments were developed on
the basis of clinical/expert opinion (Andersen et al. 1982; Norton, McClaren and
Exton-Smith 1962), literature review and/or pressure ulcer surveys (Abruzzese
1985; Waterlow 1985; Bergstrom et al. 1987), existing instruments (Gosnell 1973;
Pritchard 1986; Cubbin and Jackson 1991; Song and Choi 1991; Lindgren et al.
2002), with only a few recent studies with serious methodological limitations
considering multivariable analyses (Perneger et al. 2002; Suriadi et al. 2006; Page,
Barker and Kamar 2011). Consequently the content of these Instruments is variable
(chapter 2, section 2.4.1.1) raising questions about their overall validity.
The methodology described in this thesis provides a much more robust approach to
identifying the content of the Risk Assessment Framework, as it considers the
evidence of the systematic review (incorporating 54 primary studies including
multivariable analyses and 34,449 patients) and the views of an international expert
group, patients and carers and clinical nurses. The approach drew on
methodologies from other fields including patient health status and quality of life
instruments and patient reported outcome measures (SAC 2002; FDA DHHS 2009)
and was influenced by the development and validation of clinical prediction models
(Steyerberg 2010). The similarities and differences of developing and validating a
pressure ulcer Risk Assessment Framework, when compared with instruments for
these other fields of enquiry were carefully considered in the development of
methodological approach of this PhD.
Systematic reviews of Risk Assessment Instruments have been undertaken
previously, (Cullum et al. 1995; McGough 1999; Pancorbo-Hidalgo et al. 2006;
Moore and Cowman 2010; Moore and Cowman 2014; NICE 2014). However, while
of relevance to this PhD they focus on sensitivity, specificity and clinical
effectiveness of the instrument overall, rather than considering the predictive ability
of their risk factor components. The systematic review undertaken as part of this
PhD is the first to consider risk factors predictive of pressure ulcer development and
allowed objective deliberation of a much wider range of risk factor variables. The
review was considered a necessary step to ensure all important risk factors were
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considered in order to develop a clear conceptual basis and facilitate content
validity for the Minimum Data Set and Risk Assessment Framework.
The methodology for the quality appraisal and classification of the primary studies
of the systematic review were developed in the absence of published guidance for
risk factor research. It incorporated a two stage assessment process, the first of
which was nestled into study eligibility criteria to ensure a minimum standard for the
quality of included studies (including design specific aspects of quality). This
provided an efficient means of screening out studies with bias that was considered
unacceptable and meant that the second stage, detailed quality appraisal could
focus on risk factor measurement allowing a consistent approach to the overall
assessment of study quality to be achieved. As with other quality appraisal systems
(GRADE Working Group 2004; Guyatt et al. 2008; Cochrane 2009) the detailed
quality appraisal of this study provided information on the criteria and key domain
for each study (Table 3.4). In addition, each study was classified to provide an
overall summary of study quality to facilitate the development of the evidence
tables. The evidence tables worked well and provided a transparent approach to
identifying the strength of evidence for each risk factor and facilitated the
interpretation of the results.
The results of the review identified several important pressure ulcer risk factors
which emerged strongly in multivariable modelling, but which are not included in
most existing Risk Assessment Instruments (poor perfusion and skin/ pressure
ulcer status). This suggests there was merit in considering a wide range of risk
factors which could have important implications for the predictive ability of the Risk
Assessment Framework. The systematic review makes an important and unique
contribution to the evidence base of the pressure ulcer field and can be used to
underpin future studies and clinical guideline development.
The consensus study was also considered an important phase in the development
of the Minimum Data Set and Risk Assessment Framework, as unfortunately, a
direct risk factor item pool could not be identified from the systematic review
(Steyerberg 2010). An alternative option might have been for the author alone to
decide the risk factors and assessment items of the Minimum Data Set and Risk
Assessment Framework. However, the benefit of using a group rather than being
reliant on one person is that it is supported by a wider range of knowledge and
experience. This should promote consideration of a wider range of options (Murphy
et al. 1998) which may lead to greater validity and reliability of the judgements
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made (Raine, Sanderson and Black 2005). Another approach might have been to
incorporate group decision making in a less structured way. However, the
structured approach used in this PhD thesis provided a transparent means of
synthesising individual views, allowed greater insight to the reasons for divergent
opinion and encouraged the involvement of all participants, rather than the
dominance of a few (Raine, Sanderson and Black 2005). The approach worked well
and allowed a large number of potential risk factors and assessment items to be
considered and focussed down to a clinically manageable number of items
considered important for summarising patient risk.
The decision to use an international expert group in the consensus study was
considered important for two reasons. Firstly the pressure ulcer field is a relatively
small one and specialised expertise relating to certain aspects, particularly
biomechanics and epidemiology is only available internationally. Secondly, the
benefits of engaging key opinion leaders and recognised experts in the field could
increase credibility for end users of the Minimum data Set and Risk Assessment
Framework (Fink et al. 1984; Vakil 2011).
The involvement of PURSUN has been instrumental throughout the development of
the Risk Assessment Framework, incorporating the consensus study, the
development of vignette case studies for the pre-test and final review of the
preliminary decision tool. It is the first pressure ulcer Risk Assessment Instrument to
incorporate the patient/carer perspective throughout its development and it is
anticipated that this will ensure the acceptability of the assessment items to patients
in practice. It was doubtful that the representation of 1 or 2 patient/carers on the
expert group as used in previous consensus studies (Rycroft-Malone 2001;
Jackson et al. 2009) would have generated the depth of discussion encountered in
the separate PURSUN meetings used in the PhD. Here we were able to draw on
their personal experience to explore the acceptability of pressure ulcer assessment
items, rather than in the consideration of complicated literature and this approach is
in keeping with other PPI priority exercises (Buckley et al. 2010; Hutchings et al.
2012). An important aspect of the methodology used in the consensus study of the
PhD was ensuring that PURSUN insights were considered by the expert group
when they made individual judgements about item inclusion. This was facilitated by
verbal feedback at the expert group meetings and integration of the PURSUN
perspective in questionnaires. Indeed, it was apparent from some of the outcomes
of the study that the PURSUN perspective influenced the decision making of the
expert group (particularly relating to the exclusion of albumin and inclusion of
previous pressure ulcer in the Minimum Data Set and Risk Assessment
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Framework). This is a new approach to PPI in consensus studies and may be
appropriate for future studies in other areas.
The pre-test provided a structured approach to assess and improve the usability
and confirm content of the Risk Assessment Framework with the intended key
users, clinical nurses. This was particularly important given the increased support
for decision making and instructions that were integrated in the Risk Assessment
Framework. Their insight led to the identification of areas of confusion and
subsequent changes to the Framework. Ultimately this allowed improved usability in
preparation for its onward validation in clinical practice. This is was an important
stage of the Risk Assessment Frameworks development and is the first study to
use such an approach in the development of a pressure ulcer Risk Assessment
Instrument. The involvement of clinical nurses has only been reported briefly in the
development literature of other instruments (Abruzzese 1985; Waterlow 1985;
Pritchard 1986; Cubbin and Jackson 1991). The pre-test also provides an example
of how the use of both focus groups and think out loud interviews can work in a
complementary manner as suggested previously (Willis 2005). In addition, while the
use of vignette case studies has been used previously for the validation of existing
instruments (Gould et al. 2002; Gould et al. 2004), it has not been used as part of
the development process for pressure ulcer Risk Assessment Instruments. The
involvement of patients/carers (via PURSUN) in the development of the vignette
case studies made them more realistic and this approach could be used in other
areas of research.
Overall the methodological approach of this PhD, which comprised 4 distinct work
packages and drew on guidance from the development and validation of health
measurement instruments in other fields (SAC 2002; FDA DHHS 2009; Steyerberg
2010) provided a logical and rigorous means of developing the Risk Assessment
Framework. However, there were some limitations and these are discussed below.
7.5 Methodological Limitations
A fundamental component of this PhD was to identify the content for the Risk
Assesment Framework. Ideally this would have incorporated a methodological
approach used in the development and validation of clinical prediction models
where multivariable modelling is used to identify the content items for a risk
instrument, with subsequent model testing on a ‘new’ prospective target population
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(Steyerberg 2010). This would have also allowed a robust method for weighting risk
factors. However, this was not possible due to specific limitations in the literature
including inadequate sample sizes and inconsistent inclusion of risk factors in
multivariable modelling, compounded by the large number of associated descriptor
variables in risk factor studies. To address these limitations and make large scale
multivariable modelling a possibility in the future, an alternative approach was
undertaken, whereby the content of a risk factor Minimum Data Set was identified
and integrated into the new Risk Assessment. In the future, the Minimum Data Set
can serve as the core risk factor variables to be considered in future studies
allowing meta-analysis. The approach taken made use of the best available
epidemiological and scientific evidence as well as the views of experts in the field
and patients and carers to identify the risk factors that should be included in the
Risk Assessment Framework and their relative weighting. Despite this further large-
scale multivariable modelling is necessary for refinement of the Framework which
could lead to changes to the weighting of specific risk factors. It could also lead to
the exclusion of some risk factors currently incorporated in the Risk Assessment
Framework.
There are also methodological limitations associated the component studies of this
PhD which have potential implications to the validity of the Minimum Data Set and
Risk Assessment Framework. The systematic review highlighted methodological
challenges associated with the conduct and interpretation of risk factor systematic
reviews. The challenges included the absence of clear guidance or
recommendations for the quality appraisal and classification of risk factor studies
and the poor quality of primary research undertaken in the field (Chapter 3). These
challenges necessitated the development of a study specific quality appraisal
process of the primary studies of the review to ensure any weaknesses were
considered in the analysis and interpretation of the results. It is recognised that
further work should be undertaken with methodological experts to reach consensus
on the most important criteria required to assess the quality of exploratory risk
factor studies to develop and validate a tool specifically for this.
The approach for quality appraisal that was developed for this study allowed studies
to be classified into high, moderate, low or very low quality studies. However the
classification of studies was not specified prior to the quality assessment, rather it
was developed following appraisal of all criteria. Though this could been viewed as
a limitation, the approach was necessitated by the lack of published guidance and
the need to fully consider the strengths and weaknesses of research in the pressure
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ulcer field. It is also recognised that the classification system was limited as it did
not cover all potential combinations of compliance with the four key domains (i.e.
whether they met - yes, no, partial, uncertain). Where there was uncertainty
regarding compliance with each domain a logical approach to study derivation was
adopted (see section 3.8), though it is recognised that this should be developed
further in future work, to accommodate all potential outcomes in the classification of
study quality.
While the consensus methods used in this PhD were developed and conducted in
as rigorous manner as possible it is important to acknowledge inherent limitations in
the approach. Consensus methods provide a structured process with consideration
of relevant information to facilitate valid decision making. However there is always
the risk that the method will capture ‘collective ignorance’ rather than wisdom
(Murphy et al. 1998). Indeed, establishing the validity of the decisions made at the
time of conducting the study is problematic in consensus methods. Ultimately this
will need to be established in the on-going validation of the Risk Assessment
Framework. The reliability of the judgements made and whether they are
representative of other experts in the field is also another elements that will be
considered in the ongoing validation of the decision tool (Raine, Sanderson and
Black 2005). In addition, while the consensus method was useful for identifying the
risk factors important for summarising patient risk and for identifying the key
principles of the assessment items, the method was inappropriate for considering
the specific wording of items. This is due to the large volume of work required (i.e.
re-rating of questionnaires) to reach consensus on small changes to wording.
Another consideration for others who might use the method is the time consuming
nature involved in the preparation and planning of the study, including the
development of evidence based materials, questionnaires and the planning and co-
ordination of expert group/service user meetings. While these are fundamental to
ensuring as rigorous approach as possible, they also involve a large amount of
work which needs to be achieved in a timely manner. This has the potential to
create undue burden on the researcher and it is therefore important that a team
approach is adopted to lessen the load on individuals. The support of the working
group and the small team of facilitators was funded and certainly valued by the
researcher in the undertaking this study. Adequate funding should certainly be
considered by others who might use the method. Cost has been raised previously
(Raine, Sanderson and Black 2005; Vakil 2011) as a potential barrier for face-to-
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face group processes and this could be particularly evident when involving
international group member in the process. Fortunately, for the consensus study of
this PhD, additional funding was secured to meet the travel and subsistence costs
of the international expert group and the benefits of involving international leading
experts was considered to outweigh the cost.
While the pre-test provided a structured approach to assess and improve the
usability of the Risk Assessment Framework it could be argued that a pre-test is an
artificial situation and that participants may respond differently in a real life situation
(Lanza 1990; Gould 1996). However, while acknowledging these suggestions the
pre-test was considered a logical step to ensure content validity and usability, prior
to evaluation in clinical practice with real patients. It worked well to prepare the Risk
Assessment Framework for ongoing validation in clinical practice.
7.6 Future Validation of the Risk Assessment Framework
The next stage of the development process for the Risk Assessment Framework
involves evaluation of the reliability and validity of the decision tool. Evaluation of
reliability (inter-rater and test re-test) will establish the consistency and stability of
the instrument (Streiner and Norman 2008). This property is important for the
clinical decision tool, as poor reliability could lead to a lack of confidence in the
assessment outcomes and inconsistent care planning which may not address the
patient’s needs. This would raise questions about the usefulness of the instrument
to support appropriate decision making in clinical practice and therefore hamper its
implementation. The acceptability and usability of the Risk Assessment Framework
also needs to be considered in clinical practice to ensure it is interpreted as
intended and to facilitate the long-term implementation of the decision tool.
Another psychometric property which is relevant to the decision tool is construct
validity incorporating convergent, discriminant and known groups validity. These are
important in facilitating greater understanding of the instrument by demonstrating
evidence of logical relationships among items, domains and concepts that should
exist with measures of related concepts or scores (FDA DHHS 2009). This is
particularly relevant for the risk factor items within the decision tool which can be
compared with items from existing Risk Assessment Instruments to establish logical
relationships. Another relevant property that has not been considered in existing
Risk Assessment Instruments and is relevant to the Risk Assessment Framework is
its responsiveness to detect clinically significant changes. This is important as
changes in the patient’s condition may require an escalation or reduction in care
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interventions and has implications for patient care and the appropriate use of
scarce resources.
A property which has been extensively used in the evaluation of existing Risk
Assessment Instrument is predictive validity. The appropriateness of this has been
challenged (Deeks 1996; Defloor and Grypdonck 2004) and the limitations
discussed (see sections 2.4.7, 2.4.9, 2.7.1 and 7.31). Reflecting on this, predictive
validity is not an appropriate property to evaluate the Risk Assessment Framework,
rather the impact of using the decision tool on processes of care and their
effectiveness in reducing pressure ulcer incidence would provide more appropriate
evaluation.
It is envisaged that future electronic records in the NHS will facilitate large-scale
multivariable modelling allowing further refinement of the Framework. Another area
of development for the Risk Assessment Framework is the adaptation of a lay
person version. This was suggested to be an important consideration by PURSUN
to enable patients and carers to undertake self-assessment. The Risk Assessment
Framework may also be adapted and validated for paediatric populations. Further
adaptations for specialist environments such as the operating theatre and
ambulance services may also be considered.
7.7 Implications of the PhD for Clinical Practice
The Risk Assessment Framework is a decision tool that provides a new approach
to pressure ulcer risk assessment for adult populations in clinical practice. It is
underpinned by enhanced support for clinical decision making and an up to date
evidence base and the views of experts, clinicians and patients and carers and has
enhanced content validity when compared with other Risk Assessment Instruments.
The Risk Assessment Framework encourages a more holistic approach for care
planning as risk assessment encourages consideration of the individual patient’s
risk profile, rather than a numerical score as used in traditional Risk Assessment
Instruments. Furthermore the increased weighting of key risk factors, i.e. those
most predictive of pressure ulcer development is taken into account in the decision
making guidance of the Risk Assessment Framework. These factors could lead to
the instigation of more appropriate preventative interventions, individualised care
planning with the potential for improved care and pressure ulcer outcomes.
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The use of the Risk Assessment Framework could be integrated into existing
pressure ulcer prevention policies and initiatives (section 1.11.5) such as the SKIN
Bundle (Whitlock 2011), though these would need to be further developed to ensure
that important risk factors identified by this PhD and not currently considered (i.e.
perfusion, sensory perception) are integrated into the approach. Alternatively the
Risk Assessment Framework could provide the basis for the development of new
pressure ulcer prevention initiatives where intervention guidance and care plans
could be developed to assist in identifying potential interventions for primary and
secondary/treatment pathways.
The Risk Assessment Framework was developed in recognition of the complexity of
modern healthcare provision and the need for a quick and easy to use framework
for care. The incorporation of the screening stage and support for decision making
allows those who are obviously ‘not at risk’ to be quickly identified and prevents the
need for a more time consuming full risk assessment. This allows nursing time to be
used more efficiently and prevents their attention being unnecessarily diverted
away from other priorities.
The incorporation of skin/pressure ulcer status actually within the Risk Assessment
Framework ensures this important risk factor is integral to the assessment process.
It also allows a distinction to be made between primary prevention for those at risk
(without an existing pressure ulcer) and secondary prevention and treatment for
those with an existing pressure ulcer (or scarring from a previous pressure ulcer).
This is important in clinical practice since both groups of patients need a framework
for care. Furthermore, the distinction between the groups limits the possibility of
nurses disregarding the presence of an existing ulcer in their decision making and
failing to escalate care intervention to prevent the progression to a more severe
pressure ulcer (Pinkney et al. 2014). The inclusion of perfusion within the Risk
Assessment Framework will raise awareness of this important risk factor and
ensure it is considered in the assessment of pressure ulcer risk. This has the
potential to lead to the instigation of more appropriate care provision and improved
pressure ulcer and patient outcomes. It is noteworthy that few existing Risk
Assessment Instruments incorporate this important risk factor despite their being
strong evidence of it’s importance.
The new conceptual framework and theoretical causal pathway together propose
clearer linkage between the physiological and biomechanical determinants of
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pressure ulcer development and patient risk factors. They provide a framework for
understanding the critical determinants of pressure ulcer development and facilitate
the translation of physiological and biomechanical elements to characteristics which
nurses can observe in their patients. The new conceptual framework could be used
as an educational aid for student and qualified nurses to help raise awareness of
this important health care issue. The new conceptual framework has been included
(with permission) in the updated NPUAP/EPUAP international guidelines which will
be published later in 2014.
Another important component of relevance to clinical practice is the integration of
the Minimum Data Set within the Risk Assessment Framework. At a local level this
could facilitate case mix adjustment and allow care organisations to plan their
resources effectively particularly relating to equipment (bedframes, mattresses,
seating and cushions etc.) and treatment (equipment and wound care) provision, as
well as staffing ratios, specialist services and staff training in response to their
patient populations needs. It also has the potential to be used in the review of care
standards. In a wider sense Minimum Data Set information from health care
organisations could be used centrally to undertake large scale multivariable
analysis which could lead to refinement of the Risk Assessment Framework making
a more useful decision tool for clinical practice.
7.8 Implications of the PhD for Research
The new conceptual framework and theoretical causal pathway also have
implications for research. They provide an up to date account of how existing
evidence can be used to develop theory and help to identify gaps in our knowledge
base. Particularly, the causal pathway provides a hierarchy of risk factors which
could be used in setting research priorities. These could be used to underpin and
guide future research, building on the evidence and enable us to more clearly
define the role of individual pressure ulcer risk factors conceptually and
operationally.
An overall limitation of pressure ulcer prevention is the remaining limited means of
patient assessment in clinical practice, which is based primarily on observation of
risk factors (e.g. visual skin assessment) or the presence of predisposing conditions
(e.g. factors which affect perfusion). The new conceptual framework facilitates the
translation of epidemiological evidence to its biomechanical components and it is
hoped that this linkage will increase the wider scientific community and industry’s
understanding of how clinicians currently identify pressure ulcer risk in practice.
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This could influence the development of more objective and improved assessment
techniques with greater precision, allowing the key biomechanical mechanism of
importance to be measured and interpreted in routine practice.
At the present time an objective measure to identify overall pressure ulcer risk
which could replace clinical risk assessment is unrealistic. This type of development
work is in its infancy and is confined to considering the assessment of
biomechanical elements which link to pressure ulcer risk factors. In the future
biomechanical measurements could be considered and integrated into the Risk
Assessment Framework to improve its validity and usefulness in supporting clinical
decision making for nurses in practice. An example of where this would be most
useful relates to finding a more objective means of measuring skin vulnerability
which is difficult to assess in clinical practice, particularly relating to patients with
darker skin tones. Recent guidance still advocates the use of finger palpation,
visual skin assessment and consideration of patient reported pain or discomfort
(NICE 2014) and relies on the nurse’s skill and experience of undertaking the
assessment. Preliminary work has been undertaken to measure sub-epidermal
moisture by use of a hand-held dermal phase meter as a means of predicting future
pressure ulcer development (Bates-Jensen, McCreath and Pongquan 2009). While
this work requires further development and testing, it is a device such as this that
has the potential to provide a more objective measure of skin vulnerability and
inform this element of the Risk Assessment Framework to support clinical decision
making. Another example relates to the need to more fully understanding the
physiological mechanisms of importance relating to poor perfusion and develop
more objective measures of these that can inform the relevant sections of the Risk
Assessment Framework.
In terms of the implications of this thesis to epidemiological studies, the use of the
Minimum Data Set will ensure the core risk factor variables considered to be most
predictive of pressure ulcer risk are included, facilitating future meta-analysis
allowing more fruitful analysis and interpretation of results. The core Minimum Data
Set and the theoretical causal pathway should provide the foundation for the
exploration of other potential important risk factors or in clarifying the specific
aspects of importance in established risk factors. It is also hoped that the new
approach of the Risk Assessment Framework as a decision tool will steer future
researchers away from evaluating its predictive validity, to more appropriately
considering the effect of using the decision tool on care processes and patient and
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pressure ulcer outcomes, as this has more scope to impact and improve clinical
practice.
7.9 Conclusion
The aim of this PhD was to develop a pressure ulcer Risk Assessment Framework
underpinned by a Minimum Data Set, and incorporated a 4 phase approach. The
systematic review identified 3 primary risk factor domains, mobility/activity,
skin/pressure ulcer status and perfusion (including diabetes) and other risk factors
which emerged less consistently. The review highlighted the lack of comparable
data fields which limited interpretation, prevented meta-analysis and highlighted the
need for a risk factor Minimum Data Set. This was addressed in the consensus
study which facilitated the agreement of risk factors and assessment items of the
Minimum Data Set establishing content validity and allowing the development of a
draft Risk Assessment Framework. It also facilitated the development of the new
pressure ulcer conceptual framework and theoretical causal pathway. The design
and pre-testing of the Risk Assessment Framework confirmed content validity and
led to improved usability.
The work of this PhD makes an important contribution to the pressure ulcer field,
drawing on wider instrument development methodologies. The incorporation of the
systematic review of pressure ulcer risk factors to underpin Risk Assessment
Framework development is the first to be undertaken in the field. This allowed
further consideration of the conceptual framework and clearer linkage of
epidemiological and biomechanical/physiological evidence, leading to the
development of the first pressure ulcer theoretical causal pathway. The structured
inclusion of service users (PURSUN) and clinical nurses in the development of the
Risk Assessment Framework provides another example of the innovative approach
adopted throughout this research. Methodological development is also evident
throughout each phase of the PhD, which is important for the pressure ulcer field
but may also have wider application to other health related instrument development.
The resulting decision tool, the Risk Assessment Framework incorporates the
Minimum Data Set and a 2 stage assessment process including a screening stage
which considers mobility and pressure ulcer and skin status and a full assessment
stage which considers immobility, pressure ulcer and skin status, perfusion,
diabetes, skin moisture, sensory perception and nutrition. The Risk Assessment
Framework also includes primary prevention and secondary prevention/treatment
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pathways and support for decision making and pathway allocation. It provides a
fresh approach to pressure ulcer risk assessment in clinical practice which
encourages individualised care planning in response patient need and offers
enhanced support for clinical decision making throughout the assessment process.
The Risk Assessment Framework now requires further clinical evaluation and
validation to assess the reliability, convergent, discriminant and known group
validity and clinical usability of the decision tool. In the longer-term evaluation of
impact of using the decision tool on processes of care and its effectiveness in
reducing pressure ulcer incidence should be established.
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Appendix 4 Pressure Ulcer Risk Assessment Scale Validity
Search
Four electronic databases were searched through OVID web gateway including
AMED, MEDLINE, EMbase and CINAHL from their inception, using the search
template detailed below. The search plan included pressure ulcer search terms 24
1. decubitus.sh.
2. skin ulcer.sh,tw.
3. exp decubitus ulcer/
4. decubitus ulcer$.tw.
5. pressure ulcer$.tw.
6. pressure damage$.tw.
7. pressure sore$.tw.
8. bed sore$.tw.
9. or/1-8
10 risk assessment
11. scale
12 tool
13 score
14. instrument
15. or/11-14
16. content validity
17. construct validity
18. convergent validity
19. known group$
20. discriminant validity
21. responsiveness
22. or/16-22
23. 9 and 15 and 22
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Appendix 5 PRISMA Checklist
Section/topic # Checklist item For Section 5.3 Systematic Review of PU Risk Factors
Reported
on page
#
TITLE
Title 1 Identify the report as a systematic review, meta-analysis, or both. √ 
ABSTRACT
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions
and implications of key findings; systematic review registration number.
n/a
INTRODUCTION
Rationale 3 Describe the rationale for the review in the context of what is already known. √ 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, interventions,
comparisons, outcomes, and study design (PICOS).
√ 
METHODS
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available,
provide registration information including registration number.
x
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years
considered, language, publication status) used as criteria for eligibility, giving rationale.
√ 
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify
additional studies) in the search and date last searched.
√ 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such that it could be
repeated.
√ 
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Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if
applicable, included in the meta-analysis).
√ 
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any
processes for obtaining and confirming data from investigators.
√ 
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions
and simplifications made.
n/a
Risk of bias in individual
studies
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this
was done at the study or outcome level), and how this information is to be used in any data synthesis.
√ 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). √ 
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including measures of
consistency (e.g., I2) for each meta-analysis.
n/a
Risk of bias across studies 15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective
reporting within studies).
√ 
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done,
indicating which were pre-specified.
n/a
RESULTS
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for
exclusions at each stage, ideally with a flow diagram.
√ 
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up
period) and provide the citations.
√ 
Risk of bias within studies 19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12). √ 
Results of individual
studies
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.
√ 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of consistency. n/a
Risk of bias across studies 22 Present results of any assessment of risk of bias across studies (see Item 15). √ 
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Additional analysis 23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item
16]).
n/a
DISCUSSION
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; consider their
relevance to key groups (e.g., healthcare providers, users, and policy makers).
√ 
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval
of identified research, reporting bias).
√ 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications for future
research.
√ 
FUNDING
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders
for the systematic review.
n/a
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(6):
e1000097. doi:10.1371/journal.pmed1000097
For more information, visit: www.prisma-statement.org.
Page 2 of 2
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Appendix 6 Systematic Review Search Strategy
Four electronic databases were searched through OVID web gateway including
AMED, MEDLINE, EMbase and CINAHL from their inception, using the search
template detailed below. The search plan included pressure ulcer search terms 24
and OVID maximum sensitivity filters for Prognosis and Aetiology or Harm 25.
1. decubitus.sh.
2. skin ulcer.sh,tw.
3. exp decubitus ulcer/
4. decubitus ulcer$.tw.
5. pressure ulcer$.tw.
6. pressure damage$.tw.
7. pressure sore$.tw.
8. bed sore$.tw.
9. or/1-8
10. exp cohort-studies/
11. exp risk/
12. (odds and ratio$).mp. [mp=title, original title, abstract, name of substance word,
subject heading word]
13. (relative and risk$).mp. [mp=title, original title, abstract, name of substance
word, subject heading word]
14. (case and control$).mp. [mp=title, original title, abstract, name of substance
word, subject heading word]
15. or/10-14
16. incidence.tw.
17. exp mortality/
18. Follow-Up Studies/
19. prognos$.tw.
20. predict$.tw.
21. course.tw.
22. Survival Analysis/
23. or/16-22
24. 9 and 15
25. 9 and 23
26. 24 or 25
27. case report.sh.
28. historical article.pt.
29. review of reported cases.pt.
30. review, multicase.pt.
31. letter.pt.
32. comment.pt.
33. editorial.pt.
34. or/27-33
35. 26 not 34
36. limit 35 to humans
The first 200 retrieved abstracts were screened and key words from non-relevant
papers identified and used to further refine the search (i.e. increase specificity).
37. leg ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
38. varicose ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
39. pilonidal.tw.
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40. surgical flaps.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
41. skin transplantation$.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
42. burn$.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
43. gunshot.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
44. corneal ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
45. exp dentistry/
46. peptic ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
47. duodenal ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
48. stomach ulcer.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
49. fistula$.mp. [mp=ab, hw, ti, it, sh, tn, ot, dm, mf, nm]
50. bite.tw.
51. or/37-50
52. 36 not 51
Hand Search
 Proceedings of the 1st European Conference on Advances in Wound
Management, September 1991, Cardiff, UK
 Proceedings of the 2nd European Conference on Advances in Wound
Management, October 1992, Harrogate, UK
 Proceedings of the 3rd European Conference on Advances in Wound
Management, October 1993, Harrogate, UK
 Proceedings of the 4th European Conference on Advances in Wound
Management, September 1994, Copenhagen, Denmark
 Proceedings of the 5th European Conference on Advances in Wound
Management, November 1995, Harrogate, UK
 Proceedings of the 6th European Conference on Advances in Wound
Management, October 1996, Amsterdam, The Netherlands
 Proceedings of the 7th European Conference on Advances in Wound
Management, November 1997, Harrogate, UK
 Proceedings of the 8th European Conference on Advances in Wound
Management, April 1998, Madrid, Spain
 Proceedings of the 9th European Conference on Advances in Wound
Management, November 1999, Harrogate, UK
 Proceedings of the 10th European Conference on Advances in Wound
Management, May 2000, Stockholm, Sweden
 Proceedings of the 11th Conference of the European Wound Management
Association, May 2001, Dublin, Ireland
 Proceedings of the 12th Conference of the European Wound Management
Association, May 2002, Granada, Spain
 Proceedings of the 13th Conference of the European Wound Management
Association, May 2003, Pisa, Italy
 Proceedings of the 15th Conference of the European Wound Management
Association, September 2005, Stuttgart, Germany
 Proceedings of the 16th Conference of the European Wound Management
Association, May 2006, Prague, Czech Republic
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 Proceedings of the European Wound Management Association and Journal of
Wound Care Autumn Conference, November 1998, Harrogate, UK
 Proceedings of the European Wound Management Association and Journal of
Wound Care Conference, April 1997, Milan, Italy
 2nd World Union of Wound Healing Societies’ Meeting, July 2004, Paris,
France.
 Journal of Wound Healing 2nd Conference, September 2005, Stuttgart,
Germany
 Wounds UK Conference, November 2004, Harrogate, UK
 The 1st European Pressure Ulcer Advisory Panel Open Meeting, September
1997, Oxford, UK
 The 2nd European Pressure Ulcer Advisory Panel Open Meeting, September
1998, Oxford, UK
 The 3rd European Pressure Ulcer Advisory Panel Open Meeting, September
1999, Amsterdam, The Netherlands
 The 4th European Pressure Ulcer Advisory Panel Open Meeting, September
2000, Pisa, Italy
 The 5th European Pressure Ulcer Advisory Panel Open Meeting, September
2001, Le Mans, France
 The 6th European Pressure Ulcer Advisory Panel Open Meeting, September
2002, Budapest, Hungary
 The 7th European Pressure Ulcer Advisory Panel Open Meeting, September
2003, Tampere, Finland
 The 8th European Pressure Ulcer Advisory Panel Open Meeting, May 2005,
Aberdeen, Scotland
Hand searched the EPUAP Reviews from Volume 1, issue 2, 1999 until volume 7,
issue 2, 2006
 European Tissue Repair Society, Focus Meeting, November 2000, St Anne’s
College, Oxford
 European Tissue Repair Society, Annual Conference, September 2001,
Cardiff, UK
 European Tissue Repair Society, Focus Meeting, September 2002, Nice,
France
 13th Annual European Tissue Repair Society Meeting, September 2003,
Amsterdam, The Netherlands
 European Tissue Repair Society, Focus Meeting, March 2005, Southampton,
UK
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Appendix 7 Skin Conditions Evidence Tables
Find below the detailed evidence tables relating to skin condition. NB: the studies with an asterisk * or green background are studies where the
specific variable emerged as a risk factor in multivariable analyses, while the ones without an asterisk or background didn’t. A # sign indicates
studies with variables that have emerged in the model as well as related variables that have not.
Stage/Grade 1
Author
and Year
Study
Limitations Study Limitation Notes
Study
Design
PU Events/
Sample Specific Variable
Odds
Ratio
Confidence
Interval Study Population
*Reed et
al 2003
High Quality
Study Record review.
Record
Review 406/2771 Stage 1 PU 3.13 2.41-4.06
Chronic care hospital,
medicine, non-
surgical
*Nixon et
al 2006
High Quality
Study
Minor limitation - number of
patient in final model not
reported. RCT 207/1971 Baseline grade 1 1.95 1.31-2.91
Acute care hospital,
multiple specialities,
mixed
*Allman et
al 1995
Low Quality
Study Insufficient number of events. Cohort 37/286
Non blanchable
erythema of sacral
skin
RRa
7.52 1.00 - 59.12
Acute care hospital,
multiple specialties,
mixed
*Nixon et
al 2007
Low Quality
Study
Inadequate number of events.
Included time dependent
variables in the analysis. Cohort 15/97
Grade 1
equivalent 7.02 1.67-29.49
Acute care hospital,
multiple specialities,
surgical
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Existing PU
Author and
Year
Study
Limitations Study Limitation Notes
Study
Design
PU Events/
Sample
Specific
Variable
Odds
Ratio
Confidence
Interval Study Population
*Defloor &
Grypdonck
2005
High Quality
Study
Limitation partial reporting of
baseline. RCT 302/1458 Existing PU 2.25 1.43-3.54
Long-term nursing
care/nursing home,
elderly/geriatric, non-
surgical
*Baumgarten et
al 2004
Moderate
Quality Study
All risk factors are categorical
data rather than continuous.
20% missing data from final
model. Cohort 450/1938
PU on
admission
HR
1.8 1.40-2.32
Long-term nursing
care/nursing home, non-
surgical
Nixon et al 2006
High Quality
Study
Minor limitation - number of
patient in final model not
reported. RCT 207/1971 Existing PU 0.97 0.52-1.79
Acute care hospital, multiple
specialities, mixed
Tourtual et al
1997
Low Quality
Study
Insufficient number of events
and confidence intervals not
reported. Cohort 63/291
Admitted
with PU nr nr
Acute care hospital,
medicine, non-surgical
Stordeur et al
1998
Low Quality
Study
Insufficient number of events
and confidence intervals not
reported. Cohort 48/163
PU at
baseline nr nr
Acute care hospital,
cardiac/vascular, surgical
Previous PU
Author
and Year
Study
Limitations Study Limitation Notes
Study
Design
PU Events/
sample
Specific
mobility
Variable
Odds
Ratio
Confidence
Interval Study Population
Allman et
al 1995
Low Quality
Study Insufficient number of events. Cohort 37/286 Previous PU nr nr
Acute care hospital,
multiple specialties,
mixed
Halfens et
al 2000
Low Quality
Study
Partial reporting of baseline
characteristics and insufficient
number of events. Cohort 47/320 PU in the past nr nr
Acute care hospital,
multiple specialities,
mixed
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General Skin Status
Author and
Year
Study
Limitations Study Limitation Notes
Study
Design
PU
Events/
Sample
Specific
Variable
Odds
Ratio
Confidence
Interval Study Population
*Defloor &
Grypdonck
2005
High Quality
Study
Limitation partial reporting of
baseline. RCT 302/1458 Skin condition 1.49 1.21-1.85
Long-term nursing
care/nursing home,
elderly/geriatric, non-
surgical
*Nixon et al
2006
High Quality
Study
Minor limitation - number of patient
in final model not reported. RCT 207/1971
Baseline skin
trauma 1.67 0.999-2.80
Acute care hospital,
multiple specialities,
mixed
*Compton et al
2008
Low Quality
Study
Record review. Large number of
events but it used 32 variables in
model. No confidence intervals
reported.
Record
Review 121/698 Mottled skin 2.021 nr
Acute care hospital ,
ICU, non-surgical
Reddened
skin 2.305 nr
*Schnelle et al
1997
Low Quality
Study
Insufficient number of events and
analysis reporting inadequate. No
p values or confidence intervals
reported. Cohort 19/91
Blanchable
erythema
severity nr nr
Long-term nursing
care/nursing home,
elderly/geriatric, non-
surgical
*Allman et al
1995
Low Quality
Study Insufficient number of events. Cohort 37/286
Dry sacral
skin
RR
2.31 1.02 - 5.21
Acute care hospital,
multiple specialties,
mixed
*Bates-Jensen
et al 2007
Low Quality
Study
Inadequate sample size resulting
in wide confidence intervals. Cohort 16/35
Sub epidermal
moisture at 1
week 1.008 1.004-1.012
Nursing home,
elderly/geriatric, non-
surgical
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*Pancorbo
Hidalgo &
Garcia
Fernandez
2001
Low Quality
Study
Article was translated so unable to
undertake detailed quality
assessment. Limitations based on
inadequate number of events.
Time dependent variables included
in the analysis. Cohort 31/187
Skin
alterations
diminished 1.39 1.03-1.86
Acute care hospital,
multiple specialities,
mixed
*Rose et al
2006
Very Low
Quality Study
Abstract only. Inadequate
information on methodology and
analysis. No p values or
confidence intervals. Cohort 48/111 Skin quality nr nr
Acute care hospital,
ICU,
*Marchette et
al 1991
Very Low
Quality Study
Inadequate reporting of methods
and analysis. No confidence
intervals. Included time dependent
variables in the analysis.
Adequacy of number of events
cannot be assessed.
Record
Review 63/161 Skin redness nr nr
Acute care hospital,
ICU, surgical
Boyle & Green
2001
Low Quality
Study
Baseline characteristics not
reported. Insufficient number of
events. Cohort 28/534
Unhealthy
skin nr nr
Acute care hospital,
ICU, mixed
#Bates-Jensen
et al 2007
Low Quality
Study
Inadequate sample size resulting
in wide confidence intervals. Cohort 16/35
Sub epidermal
moisture at
baseline 1.002 0.996-1.008
Nursing home,
elderly/geriatric, non-
surgical
#Compton et
al 2008
Low Quality
Study
Record review. Large number of
events but it used 32 variables in
model. No confidence intervals
reported.
Record
Review 121/698
Skin
condition,
hyperaemic
skin nr nr
Acute care hospital ,
ICU, non-surgical
Skin condition
livid skin nr nr
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Appendix 9 Nominal Group Information Sheet for Consensus
Study
Pressure UlceR Programme Of ReSEarch
The Development of a Pressure Ulcer Minimum Dataset (PU-MDS) and
Pressure Ulcer Risk Assessment Framework (PURAF) Study
PU-MDS NOMINAL GROUP PARTICIPANT INFORMATION SHEET
You have been invited to take part in the study detailed above. Before you decide
whether to accept, we would like to explain why the research is being done and
what it will involve. Please read this information carefully, and ask us if anything is
unclear, or if you would like more information.
What is the purpose of the study?
The purpose of this study is to agree a Pressure Ulcer Minimum Data Set (PU-
MDS) and develop an evidence based Pressure Ulcer Risk Assessment Framework
(PURAF) for use in clinical practice. This information sheet relates to the PU-MDS
element of the study.
Why have I been chosen?
You have been invited to be a member of the Nominal Group because of your
subject expertise, which is relevant to the assessment or measurement of pressure
ulcer risk factors.
Do I have to take part?
Taking part in this study is entirely voluntary and you are under no obligation to take
part – it is up to you to decide after reading this information sheet and asking any
questions you may have. If you wish to participate you will be asked to provide
consent by returning a Word Document with your electronic signature. You will be
able to retain a copy of this for your records and one will be held by the researcher.
You will be free to withdraw from the study at any time including before, during or
after nominal group meetings and before, during or after questionnaire completion,
without giving a reason. Data collected from you prior to withdrawal will be used in
the final study analysis. However if you do not want your existing data from nominal
group meetings or completed questionnaires to be used you can inform the
researcher and this data will be destroyed and excluded from the study.
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What does Nominal Group Membership involve?
If you agree to take part in the study, you will be required attend two meetings over
a 12- 18 month period. Standard rate travel expenses will be reimbursed. The
meetings will involve 12-14 academic or healthcare experts from a number of
countries and will include in-depth discussions and debate about the factors for
inclusion in a PU-MDS. Each meeting will last approximately 3.5 hours and will
include refreshments and comfort breaks. The meetings will be led by trained
facilitators and will be audio-taped and transcribed to allow thematic analysis of the
meeting to occur. You will also be required to read a pressure ulcer systematic
review summary report, comment on the content of consensus questionnaires and
to complete two web-based consensus questionnaires. Within the questionnaire
you will also be asked to provide anonymous demographic data including: age,
gender, nationality, area of expertise, role and sector i.e. university, community or
acute hospital to allow the nominal group characteristics to be described. The
summary report will take approximately 30 minutes to read and each questionnaire
will take approximately 15 minutes to complete. Further email and telephone
correspondence may also be required.
What are the possible disadvantages and risks of taking part?
We do not foresee any disadvantages or risks to you in taking part in this study.
However, you are being asked to give some of your time and this may involve you
travelling for meetings.
What are the possible benefits of taking part?
You will be contributing to the development of a PU-MDS which will facilitate the
interpretation and further use of pressure ulcer research data and meta-analysis.
This will contribute to the development of an evidence based PURAF which could
lead to improvements in patient care. Nominal group members will be listed as
contributors for the main study publication, subject to your agreement. The
researcher will write to you prior to publication to ask you about this. If you agree to
this you will be asked to complete a short form indicating that you agree to be listed
as a contributor.
Will my taking part be kept confidential?
As part of the nominal group your identity would be apparent to other group
members due to the face to face meetings but your questionnaire responses would
be anonymised before being presented to the nominal group or being detailed in
any reports. Your individual responses would not be revealed by the Clinical Trials
Research Unit (CTRU). However, whilst under no obligation to do so, you would be
free to share this with the group should you wish to.
All information collected will be handled, processed, stored, and destroyed in
accordance with the Data Protection Act 1998. Where personal data is provided this
will be stored separately to questionnaire data and held on the CTRU secure IT
system which has restricted password protected access to only the CTRU research
team working directly on the study. Anonymous questionnaire responses will be
held on the secure web-based survey platform and will only be accessible by the
web-based survey provider and the CTRU research team on a password protected
restricted access database. At the end of the study, data will be securely archived
at the CTRU for a minimum of 10 years and arrangements for confidential
destruction will then be made.
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Who has organised and sponsored the research?
The study is being organised and coordinated by the CTRU at the University of
Leeds, who is sponsoring the study. This study is a part of a larger pressure ulcer
research programme funded by the National Institute of Health Research that aims
to reduce the impact of pressure ulcers on patients.
Who has reviewed the study?
The study has been peer reviewed by the National Institute of Health Research
before approval for the funding was given. In addition, this study has been reviewed
by the University
of Leeds, School of Healthcare Research Ethics Committee (SHREC).
What will happen to the results of the research study?
When the study is complete the results will be included in a final report and
disseminated by publishing in scientific/ health related journals and through
conference presentations.
Further information and contact details
If you have any questions please contact:
Susanne Coleman
PU-MDS and PURAF Project Lead
Clinical Trials Research Unit
University of Leeds
Leeds
LS2 9JT
Tel: 0113 343 4854
Fax: 0113 343 1471
Email: medscole@leeds.ac.uk
Website: www.ctruleeds.co.uk
What do I do now?
If you wish to participate please provide consent by returning the Word Document
(attached in the introductory email) with your electronic signature.
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Appendix 10 Nominal Group Participant Consent Form for
Consensus Study
Participant Study Number: Office use
only
Participant initials:
PU-MDS NOMINAL GROUP PARTICIPANT CONSENT FORM
Pressure UlceR Programme Of ReSEarch
The Development of a Pressure Ulcer Minimum Dataset (PUMDS) and Pressure
Ulcer Risk Assessment Framework (PURAF) Study
The participant should complete the whole of this sheet himself/herself
Please confirm the
statements by
putting your initials
in the box below
I confirm that I have read and understand the information
sheet (dated 14th September 2010, version 2), for the
above study. I have had the opportunity to ask questions
and have had these answered satisfactorily.
I agree to allow any information or results arising from the
study to be used for training and developing new research.
I understand that my questionnaire data may be looked at
by responsible individuals from the study office where it is
relevant to my taking part in the study. I give permission
for these individuals to have access to my information and
questionnaire data.
I consent to the storage including electronic, of personal
information (name, contact details and place of work)
which will be used by the researcher for ongoing contact
with me for the purposes of this study only. I understand
that my completed questionnaire data will remain
anonymous.
I consent to being audio-taped in nominal group meetings.
I agree to take part in this study
Participant Name: Participant Electronic Signature:
Date:
Thank you for agreeing to take part in this study.
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Appendix 12 Participant Information Sheet for Pre-test Study
Pressure UlceR Programme Of ReSEarch
The Pressure Ulcer Risk Assessment Framework (PURAF) Pre-Test Study
NURSE PARTICIPANT INFORMATION SHEET
You have been invited to take part in the study detailed above. Before you decide
whether to accept, we would like to explain why the research is being done and
what it will involve. Please read this information carefully, and ask us if anything is
unclear, or if you would like more information.
What is the purpose of the study?
The clinical guidelines and policies in place in the NHS focus on risk assessment as
being the key to prevention of PUs but risk assessment tools have not been
updated for decades. While existing tools offer some structure to PU risk
assessment they were developed in the 1970-80s through expert opinion and
outdated literature reviewing methods when the evidence was limited. The
preliminary PURAF (Pressure Ulcer Risk Assessment Framework) was developed
following a systematic review of pressure ulcer risk factors and a consensus study
involving international experts in the pressure ulcer field to establish what elements
need to be included in pressure ulcer risk assessment. The purpose of this study is
to assess the acceptability of the preliminary PURAF amongst nurses in relation its
clarity and ease of use.
Why have I been chosen?
You have been invited to participate in this study as you are a practising Registered
Nurse who is involved with the planning and delivery of pressure area care.
Do I have to take part?
Taking part in this study is entirely voluntary and you are under no obligation to take
part – it is up to you to decide after reading this information sheet and asking any
questions you may have. If you wish to participate you will be asked to provide
informed written consent. You will be able to retain a copy of this for your records
and one will be held by the researcher. You will be free to withdraw from the study
at any time including before, during or after the PURAF training, focus group or
one-to-one interview, without giving a reason. Data collected from you prior to
withdrawal will be used in the final study analysis.
What does the study involve?
If you agree to take part in the study, you will be required to attend a 4 hour PURAF
session. The session will incorporate training in the use of the PURAF which will be
followed by your participation in either a focus group meeting or one-to-one
interview. It will involve you travelling to the venue in Leeds and standard rate
travel expenses will be reimbursed.
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The training will involve 8-12 other nurses in similar roles to yourself and will involve
the researcher explaining how to use the PURAF and demonstrating this with a
simulated patient (an actor taking on the role of a patient). You will then be asked to
practice using the PURAF with a training case study relevant to your area of
practice and photographs of pressure ulcers/areas, noting any areas of confusion
on the PURAF form.
Following training you will then participate in either the focus group with
approximately 4-8 other nurses or a one-to-one interview with the researcher.
Allocation to the focus group and one-to-one interview will be done using
randomisation in advance of the session.
If you are assigned to the focus group you will be asked to complete the PURAF
again using another case study before the focus group meeting; you will be
encouraged to highlight any areas which you find confusing on the PURAF
documentation form which will inform the discussions of the focus group meeting.
This is not a test and there are no ‘right or wrong’ answers. At the focus group
meeting you will be invited to discuss your thoughts about using the PURAF in a
group setting. It is anticipated that working in a group may spark further discussion
and highlight any issues you found difficult or unclear when using the PURAF. The
focus group will be led by a trained facilitator and will be audio-taped.
If you are assigned to the one-to-one interview you will be asked to complete the
PURAF again using another case study. The researcher will ask you to ‘think out
loud’ as you complete the PURAF. This is not a test and there are no ‘right or
wrong’ answers; it will allow the researcher to get a better understanding of areas of
the PURAF which nurses find confusing to complete. The interview will be audio-
recorded.
The audio-tapes from the interview and the focus group will be transcribed to allow
thematic analysis of the issues relating to PURAF. At the session you will also be
asked to provide anonymous demographic data including: age, gender, nationality,
role and sector i.e. community or acute hospital to allow the group characteristics to
be described.
What are the possible disadvantages and risks of taking part?
We do not foresee any disadvantages or risks to you in taking part in this study.
However, you are being asked to give some of your time and this will involve you
travelling to the session.
What are the possible benefits of taking part?
You will be contributing to the development of a PURAF which could lead to more
useful nurse assessment and improvements in patient care. You would also be
involved in research which would help you to develop your professional portfolio in
relation to being involved in research to enhance patient care. As this is dedicated
research activity outside of clinical hours, the payment of £105 (subject to
deductions for national insurance and tax) will be made to participants to attend the
session.
Will my taking part be kept confidential?
As part of the PURAF session your identity would be apparent to other group
members due to the face to face nature of the session. Focus group and individual
interview responses would not be revealed by the Clinical Trials Research Unit
(CTRU).
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All information collected will be handled, processed, stored, and destroyed in
accordance with the Data Protection Act 1998. Where personal data is provided this
will be stored separately to focus group and interview data and held on the CTRU
secure IT system which has restricted password protected access to only the CTRU
research team working directly on the study. At the end of the study, data will be
securely archived at the CTRU for a minimum of 10 years and arrangements for
confidential destruction will then be made.
Who has organised and sponsored the research?
The study is being organised and coordinated by the CTRU at the University of
Leeds, who is sponsoring the study. This study is a part of a larger pressure ulcer
research programme funded by the National Institute of Health Research that aims
to reduce the impact of pressure ulcers on patients.
Who has reviewed the study?
The study has been peer reviewed by the National Institute of Health Research
before approval for the funding was given. In addition, this study has been reviewed
by the University of Leeds, School of Healthcare Research Ethics Committee
(SHREC).
What will happen to the results of the research study?
When the study is complete the results will be included in a final report and
disseminated by publishing in scientific/ health related journals and through
conference presentations.
Further information and contact details
If you have any questions please contact:
Susanne Coleman
PURAF Project Lead
Clinical Trials Research Unit
University of Leeds
Leeds
LS2 9JT
Tel: 0113 343 4854
Fax: 0113 343 1471
Email: medscole@leeds.ac.uk
Website: www.ctruleeds.co.uk
What do I do now?
If you wish to participate please provide written consent.
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Appendix 13 Consent Form for Pre-test Study
Participant Study Number: Office use
only
Participant initials:
PURAF PRE-TEST NURSE PARTICIPANT CONSENT FORM
Pressure UlceR Programme Of ReSEarch
The Pressure Ulcer Risk Assessment Framework (PURAF) Pre-Test Study
The participant should complete the whole of this sheet himself/herself
Please confirm the
statements by
putting your initials
in the box below
I confirm that I have read and understand the information
sheet dated 31/01/2012 (version 1.1) for the above study.
I have had the opportunity to ask questions and have had
these answered satisfactorily.
I agree to allow any information or results arising from the
study to be used for training and developing new research.
I understand that my focus group and interview data may
be looked at by responsible individuals from the study
office where it is relevant to my taking part in the study and
I give permission for these individuals to have access to
my information and data.
I consent to the storage including electronic, of personal
information (name, contact details and place of work)
which will be used by the researcher for ongoing contact
with me for the purposes of this study only.
I understand that my completed interview and focus group
data will remain anonymous.
I consent to being audio-taped in the focus group meeting
or one-to-one meeting.
I agree to take part in this study
Participant Name: Participant Signature: Date:
Thank you for agreeing to take part in this study.
I have given written information and a verbal explanation to the person named
above who has freely given their consent to participate.
__________________________ _________ _________________________
Name of Person Taking Consent Date Signature
1 copy for nurse, 1 copy for Investigator Site File, 1 copy CTRU.
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Appendix 14 Agenda for Pre-test session
Pre-Test Agenda
Date: Tuesday 19th June 2012
Time: 12.45-16.45
Venue: CTRU, University of Leeds
Time Agenda
12.45 Coffee
13.00 Introductions SC
13.15 Introduction to PURAF studies
Aims of Pre-Test
Scope of PURAF
PURAF
SC
13. 45 Demonstration of PURAF with simulated patient LW/DM
14.05 PURAF Practice training session using Case
Studies
All
14.45 Coffee
15.00 Focus Group
Use of PURAF with
Case study
Focus Group Meeting
Think out Loud
Introduction and
Interviews
All
16.30 Summary of Day SC
16.45 Close of day
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Appendix 15 Vignette Case Studies for Pre-test Study
Acute Sector Case Studies
Case Study 1
Trudie is a 75 year old lady who lives with her husband. She is admitted to hospital
for investigations into her intermittent abdominal pain. She is active and mobile and
other than intermittent abdominal pain reports being fit and well. Trudie walked on
to the ward unaided. She reports no skin problems.
Case Study 2
Susan is a 21 year old student who is admitted with a severe headache. She is a
keen hockey player and reports being usually fit and well. Susan refuses analgesia
as it makes her feel ‘strange’. She is fully mobile: due to her pain she can’t get
comfortable and moves from bed to chair frequently and walks to the toilet. She
reports no skin problems.
Case Study 3
John is a 29 year old gentleman who is admitted with acute appendicitis. John is a
keen rugby player and is normally fit and well, though he is an insulin dependent
diabetic which is well controlled and he does not have peripheral neuropathy. On
admission John has a lot of pain, feels generally unwell and remains in bed. He has
pain relief but is fully alert. John moves around in bed independently and frequently
walks to the toilet unaided. John generally has a good diet and has a muscular
stocky build, but is put nil by mouth on admission and is to have an IVI put up. He
has no moisture or circulation problems. The staff nurse assesses John’s pressure
ulcer risk as part of her admission procedures.
Skin Assessment
Normal
Case Study 4
Hilda is an 80 year old lady who is admitted to the elderly care ward following a
chest infection. Hilda lives in a warden controlled flat with her 85 year old husband.
Hilda has a history of COPD and previous chest infections. Hilda is usually quite
active and mobile within in her home but is restricted to the distance she can walk
due to breathlessness.
On admission to the ward Hilda is weak and not as mobile as usual: she is able to
transfer herself but needs the aid of one nurse to accompany her when walking to
the toilet as she feels unsteady. She is able to change her position independently
and does when she feels uncomfortable, but is lethargic and spends most of her
time in the chair. Hilda has lost her appetite and says she has lost weight in the last
2-3 weeks and appears to be very thin and bony. She has been taking steroids and
her skin appears thin and dry. She doesn’t have any moisture problems and is not
diabetic. The staff nurse assesses Hilda’s pressure ulcer risk as part of her
admission procedures.
Skin Assessment
(Insert photo of blanchable redness)
Sacrum as above
Other skin normal
Case Study 5
Jenny is an 80 year old married lady who is admitted to surgical ward with
abdominal pain following an elective laparoscopic cholecystectomy 14 days ago.
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On admission she has a temperature of 39 – 40 degrees C and is very sweaty. She
is being treated in a side room due to a possible infection and diarrhoea. She is ‘nil
by mouth’ and commences IV fluids and antibiotics, though normally eats well and
is a healthy weight. Jenny is given morphine as pain relief which makes her very
sleepy. She is very lethargic and rests in her bed. She is able to transfer to the
commode with the assistance of one nurse. She is able to change her position
independently in bed but due to her lethargy doesn’t very often. Prior to her recent
health problems Jenny was in good health, is not diabetic and doesn’t have any
circulatory problems. The staff nurse assesses Jenny’s pressure ulcer risk as part
of her admission procedures.
Skin Assessment
Normal
Case Study 6
Joan Smith, a 72 year old lady who lives alone, has just been admitted to an acute
medical ward following a stroke. Joan works part-time as a florist. She was found
unconscious on the floor by her friend. It is unclear how long she had been on the
floor but no one had seen her for 18 hours. Prior to having the stroke Joan’s son
reported she was in reasonable health and was fully mobile, though she does have
hypertension which is controlled with medication. He reported that she had a good
appetite, was not diabetic and didn’t have any problems with her circulation.
On admission Joan is conscious but dazed and had been incontinent of urine. She
has a right sided hemiplegia and is unable to walk or weight bear. Joan is presently
being nursed in bed and a physio assessment is being undertaken later today. She
is unable to change her position in bed. Joan is to be ‘nil by mouth’ until she has a
swallow test, was dehydrated on admission and so has an IVI is in place. She is
overweight.
Skin Assessment
(Insert photos of category 2’s to both)
Right heel as above Right hip as above
Other skin normal
Case Study 7
Joe is a 65 year old retired tool maker who has been in hospital for the last 4 days
for investigations of vascular disease. He lives with his partner and until the last
6months was quite active enjoying gardening in his allotment. Joe reports that he
used to be a heavy smoker but managed to stop smoking 18months ago. He has
severe pain in his left calf when walking which has led to a reduction in mobility: he
is able to walk short distances unaided. He has obvious poor peripheral circulation.
He is if of normal build, eats a good diet and is not diabetic
On the second day of his hospital stay Joe developed a chest infection and a high
temperature and felt generally unwell. He has spent the last few days mainly in bed
though has walked to the toilet occasionally and is continent. While in bed he was
able to change his position when uncomfortable but remained mostly in the
recumbent position. The staff nurse reassesses Joe’s pressure ulcer risk in
response to his changing condition and in response to him reporting a sore left
heel.
Skin Assessment
(Insert photo of unstageable)
Left heel, as above
Other skin normal
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Community Sector Case Studies
Case Study 1
Sally is a 19 year old student and newly diagnosed diabetic. She is visited by the
Diabetic Specialist Nurse for training and support in relation to giving her own
insulin. Sally leads a very active outdoor life and other than her diabetes is fit and
well. She reports no skin problems.
Case Study 2
Hilda is a 70 year old lady with rheumatoid arthritis who lives with her husband. She
has recently had a short hospital stay after stumbling and fracturing her humerus.
Hilda normally gets about her home well often using the furniture and a walking
frame when necessary (particularly outside the home). The hospital nurses were
concerned that her mobility had reduced and that she needed help to walk as she
couldn’t use the frame due to her fractured humerus: they requested a District
Nurse visit to assess her pressure ulcer risk at home.
The District Nurse visited Hilda at home on the day after her discharge from
hospital. Hilda reported that other than her long-term problem of rheumatoid arthritis
she was quite well and independent. She eats a balanced diet, is a normal weight
and is not diabetic. She doesn’t have any circulatory problems and is continent. She
acknowledged that while she had found walking in the hospital difficult this has not
been a problem since she had returned home: she explained that while she was
unable to use the walking frame she was able to use the furniture in her home to
get around and she had lots of aids and adaptations to help her– obviously this had
not been possible on the hospital ward. She reported that she had been glad to get
home where she had regained her independence and was enjoying ‘pottering’ at
home and changed her position frequently. She was also glad to be enjoying home
cooked food rather than the ‘hospital slop’.
Skin Assessment
Normal
Case Study 3
John is an 82 year old, retired teacher who lives in his detached bungalow on his
own following the death of his wife 2 years ago. His son lives away and his
daughter lives in the next town 10 miles away. John has peripheral vascular
disease, is diabetic and has peripheral neuropathy. John had a recent hospital stay
following a chest infection and difficulties managing his diabetes with oral
medication: he is now insulin dependent. Whilst in hospital John developed a
category 2 pressure ulcer on his right heel but this is now reported to be healed.
The District Nurse visits John on his return home to assess his needs and pressure
ulcer risk and to administer his daily insulin. He has meals on wheels and homecare
to help with food preparation, cleaning and helping him to bed. He has a good
appetite and is slightly overweight. Johns neighbour brings him a paper each
morning and checks he is ok. John spends most of the day in his chair, only moving
when he needs the toilet and is continent. He is able to walk in his home with a
walking frame but sometimes needs prompting.
Skin Assessment
(Insert photo of dry heels – vulnerable but not PU category)
Both heels as above
Other skin normal
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Case Study 4
Eileen is a 75 year old retired secretary and is in the end stages of terminal uterine
cancer. She is being cared for at home by her husband and their daughter with
support from the District Nursing Team. As Eileen’s condition deteriorates the
District Nurse reassesses her pressure ulcer risk. Eileen is very weak and spends
most of her time in bed though does get up for short periods. She has just started
having a morphine syringe driver and is quite lethargic. She can independently turn
over in bed but doesn’t do this very often. She needs the help of another person to
transfer. Eileen developed a raised temperature and was found to have a UTI for
which she is having antibiotics: due to this has been incontinent of urine. Eileen
has a poor appetite and is just eating small amounts, though appears to be of
normal weight. She is not diabetic and does not have any circulatory problems.
Skin Assessment
Normal
Case Study 5
Jack is an 86 year old retired builder who lives in a residential home due to
dementia. The District Nurse has been called to assess his pressure ulcer risk as
his condition has recently deteriorated. He has developed a chest infection which is
related to swallowing difficulties. Jack needs to be fed by the carers and has
recently been refusing to eat and has lost weight, though appears to be of normal
weight. He is not diabetic and doesn’t have any circulatory problems. He is regularly
incontinent of urine and faeces. Jack spends most of his time in the chair or bed
and needs 2 nurses to assist him to transfer. He can only make small independent
movements when in his bed or chair. He gets very agitated at times.
Skin Assessment:
(Insert photo of blanchable redness)
Sacrum as above
Other skin normal
Case Study 6
Beatrice is 50 years old and has primary progressive MS. Beatrice had to give up
her job as a dinner lady 7 years ago when her mobility deteriorated to the point that
she could no longer work. Since that time her mobility has steadily declined and got
significantly worse over the last 6 months. She is now unable to walk or talk making
communication very difficult. She is cared for at home (in a ground floor flat) by
her husband and 2 daughters who managed quite well up until the last 6 months
when she has become very dependent. Care workers come in rarely. Her husband
works full time, plus extra hours to support the family as he has a poorly paid job.
The family have had little advice about how to care for Beatrice as her condition has
declined. After her husband visits the GP in distress saying they are struggling to
cope and Beatrice is becoming sore, a District Nurse is requested to visit to assess
Beatrice’s care needs and her pressure ulcer risk.
Beatrice is doubly incontinent with her urinary incontinence being a constant
problem. They use pads in bed, but this has been difficult as they don’t have an
adequate supply. She spends all her time in her single divan bed. She is unable to
move independently and is not turned regularly as her daughters have not been told
what to do to help her. No one inspects her skin condition regularly at home. She
cannot eat properly and is losing weight, though is of normal build and is not
diabetic. She doesn’t have any circulatory problems. She is unable to tell anyone if
she is in pain and is unable to move herself to get comfortable.
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Skin Assessment
(Insert photos of category 2 and 3)
Sacrum and buttocks as above left heel as above
Other skin normal
Case Study 7
Stephen is a 35 year old gentleman who was left paralysed from the waist down
following a motorbike accident 10 years ago: he is a full-time wheelchair user. He
lives with his partner and their son. He runs his own IT Company. Stephen eats a
good diet and is a healthy weight. He does not have any circulatory problems or
diabetes. He is uses intermittent catheterisation. He transfers from his chair
independently. Stephen has been under a lot of pressure at work and has not been
undertaking skin inspections or position changes as he was taught and has been
spending long periods of time in the same position working at his desk. He has also
had a recent urine infection but continued to work without taking a break.
The GP was called after Stephen’s wife noticed blood on the bed sheets and a
District Nurse visit was requested to undertake a pressure ulcer risk assessment.
Skin Assessment
(Insert photo of category 3)
Sacrum as above
Other skin normal
277
Appendix 16 Pre-Test Focus Group Topic Guide
1. Introduction of moderators and group members by name
2. The overall aims of the study and how the focus group contributes to this will be
explained by the moderator.
3. Aims of the session: to consider the acceptability of using PURAF incorporating:
 What was liked about the PURAF
 What was disliked about the PURAF
 Usability of the PURAF and nurses found using the PURAF overall (were
there any confusing areas)
 If nurses anticipate any problems in using the PURAF in clinical practice
4. Ground rules: Everyone will have chance to speak and be heard. There are not
right or wrong answers. The moderator will remind the group that the meeting will
be audio-taped, answer any questions and confirm that everyone is happy to
proceed with the meeting.
5. Ice breaker: discussion in pairs of what was liked about the PURAF and list on a
flip chart and group feedback.
6. Group discussion of what was disliked like about the PURAF. Note on flip chart.
7. Group discussion of the usability of the PURAF and the nurses found using the
PURAF overall (were there any confusing areas). The moderator will use the data
completeness forms taken from the training element to inform discussions. Note on
flip chart.
8. Group discussion of any anticipated problems in using the PURAF in clinical
practice. Note on flip chart.
9. Potential areas for discussion (dependent on what is raised):
 Magnitude of movement
 Skin Vulnerablity
 Moisture constant/frequent
 Usability of the PURAF and nurses found using the PURAF overall (were
there any confusing areas)
 Movement from stage 1 to 2 – is it clear
 Was it clear that you needed to complete all of stage 2
 Did you understand how to decide which intervention pathway the patient is
on
 Is there anything missing in the interventions section
 Would you want to document the applicable interventions at this point
 Anticipatory risk
 Jasper case study
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Appendix 17 Pre-Test Think out loud Topic Guide
1. Introduction of researcher to nurse.
2. Reminder of background to PURAF – systematic review and consensus study.
Emphasise that PURAF still in the development stage and it’s not the final version.
3. To develop the PURAF further so it can be used in clinical practice we want to
know how the specific items in the current PURAF are interpreted and if they are
consistently interpreted in the same way. We want to identify any specific items
which cause confusion when using the PURAF as well as the PURAF as whole.
Stress that there are no right or wrong answers.
4. Tell the nurse about the ‘think out loud’ technique – you will be asked to complete
the PURAF using a case study. As you complete it I want you to tell me everything
you are thinking as you do it, however insignificant it may seem to you. I am
interested in everything that you have considered during the process of formulating
your answer/response
5. Ask them to have a go thinking out loud: visualise the place where they live, and
think about how many windows there are. As you count the windows tell me what
you are seeing and thinking about.
Demonstrate what you mean using the PURAF: ‘so I am looking at the PURAF after
reading the case study. I’m looking at the question relating to ‘reported history of
PU’. I wonder if this is reported by the patient or their carer. Sometimes they don’t
know if they’ve had one so we could look in their medical/nursing records. From
the case study I think we can say that they don’t have a reported history of PU
because this particular patient is fully alert and would know’.
6. Remind the nurse that interview will be audio-taped, answer any questions and
confirm that she is happy to proceed with the interview.
7. Throughout the interview you may need to prompt the nurse to ‘think out loud’ as
she completes the PURAF (some will find this more difficult than others). If she/he
just ticks the boxes without explaining what she is thinking ask her to explain. You
can ask for clarification on things as they think out loud, as they go along or if this is
disrupting the nurse’s flow and thoughts, you can go back to the areas at the end of
the interview. You can also ask the nurse to mark any areas they want to discuss at
the end of the interview and go back to them.
8. If the nurse asks questions to clarify the meaning of the PURAF and its items,
explain that we are interested in what they think they mean and reassure them that
there is no wrong or right answer, we are still in the development stage
9. The anticipatory prompts below have been put together, but obviously the
prompts you use will depend on how clear and articulate the nurse is. We cannot
foresee all the prompts you may require for specific items. Keep in mind that we are
interested in how things are interpreted and if there are any areas of confusion, we
do not want to lead the nurse.
a. Do you think the PURAF (specific) item is easy to understand?
b. How do you interpret the (specific) item (what do you think it means/is
asking)?
c. Is there anything about the (specific) item that you find confusing?
d. Does the 1st stage of the PURAF make sense to you?
e. After completing the 1st stage of the PURAF do you feel clear about when
someone is presently not at risk?
f. After completing the 1st stage of the PURAF do you feel clear about when
you should proceed to the 2nd stage?
g. After completing the 2nd stage of the PURAF are you able to identify if the
patient is at risk?
h. Is there anything about the 2nd stage that you find confusing
i. After completing the 2nd stage of the PURAF are you able to identify which
pathway the patient should be on?
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j. How do you interpret the interventions?
k. Is there anything you find unclear about the interventions?
l. Overall how did you find the PURAF to complete?
m. Are there any areas of the PURAF that you think need to be further
developed?
n. What could we change/add to make the PURAF easier to complete?
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Appendix 18 Risk Assessment Framework User Guide
Pressure Ulcer Risk Assessment Framework- PURPOSE T User Guide
Summary of PURPOSE T
PURPOSE T (Pressure Ulcer Risk Primary or Secondary Evaluation Tool) is a
pressure ulcer risk assessment framework (PURAF) intended to identify adults at
risk of pressure ulcer development and makes a distinction between primary
prevention (applicable to those at risk of pressure ulcer development) and
secondary prevention (applicable to those who already have a pressure ulcer). It
has been developed for use in adult populations in hospital and community settings
by qualified nursing staff.
NB: PURPOSE T is not intended to assess the risk of pressure from external
devices such as naso-gastric tubes and catheters etc.
The development of PURPOSE T incorporated a systematic review of pressure
ulcer risk factors and a consensus study involving international experts in the
pressure ulcer field (including review of pressure ulcer evidence): this allowed the
numerous risk factors associated with pressure ulcer development to be carefully
considered and only the most important risk factors to be included in PURPOSE T.
Furthermore the use of colour within the tool allows us to identify the presence of
key and less influential pressure ulcer risk factors. PURPOSE T was also pre-tested
with practicing nurses allowing ambiguous or confusing elements to be identified
and clarified in Field test version of PURPOSE T.
PURPOSE T does not utilise a score as other tools do - it encourages nurses to
consider the profile of a patients’ risk (PU risk factors present) to identify whether
they are ‘not currently at risk’, ‘at risk’, or have an existing pressure ulcer and
allocate them to the appropriate care pathway.
PURPOSE T has 3 steps including:
 Step 1 – Screening: complete for all patients
 Step 2 - Full Assessment: complete for those potentially at risk as
determined by step 1
 Step 3 – Assessment Decision: to be undertaken for all patients who have
undergone step 2
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1. Step 1 – Screening: Complete for all patients
Step 1 comprises of two possible sections to complete:
 Mobility Status
 Skin status
Step 1 Assessment
1.1 Mobility Status
This section examines mobility status items that have been developed to assess
varying levels of mobility. Mobility is a key pressure ulcer risk factor, which is why it
is included in the first step of the assessment.
It is important that you consider and tick all the item boxes that apply to your
patient: a patient may walk independently but remain in the same position for long
periods and /or spend the majority of time in bed or chair.
Mobility Status Items
‘Walks independently’ means they don’t need assistance from another person, and
‘walking aid’ could be a walking stick, walking frame or even furniture. The second
item ‘help of another person’ could involve physical assistance or verbal prompting.
The latter 2 items require an element of judgement by the nurse in terms of whether
the patient’s length of time in one position is considered normal.
1.2 Mobility Decision Boxes
The decision boxes and colour coding will help you decide if you need to go to step
2 of the assessment straight away or if you need to complete the Step 1 skin status
items: if you have ticked any yellow boxes you should progress to Step 2 without
completing the Step 1 skin status items. If you have only ticked the blue box you
should complete the Step1 skin status items.
1.3 Skin Status
This section examines skin status items which have been developed in recognition
of the importance of skin status in the assessment of pressure ulcer risk. The items
give a range of possibilities of pressure area skin status as commonly encountered
in clinical practice.
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Skin Status Items
It is important that you tick all of the boxes that apply to your patient as they may
have more than one, for example a patient may have a reported history of previous
pressure ulcer and skin vulnerability.
The item ‘normal skin’, requires judgement since there is no clear definition of what
constitutes normal skin. It would certainly include the absence of skin vulnerability
or pressure ulcers: nurses should use their clinical judgement to determine if a
patient’s skin is normal. The ‘vulnerability’ skin item gives examples of redness,
dryness, paper thin and moist: these describe the visual appearance of vulnerable
skin but this is not exhaustive list and you may also consider other factors.
The nurse will need to make a judgement about the approach required to complete
this section (i.e. history taking/ clinical records/ full skin inspection), while
recognising that the most accurate way to assess skin status is to visually examine
the skin: this may be influenced by the context of care and level of patient
dependency. Any patients with a skin status problem (vulnerable, current or
previous PU) will progress to Step 2 of the assessment (incorporating full visual
skin inspection).
1.4 The Skin Status Decision Boxes
The decision boxes and colour coding will help you decide if you need to go to Step
2 of the assessment, or if the patient is not currently at risk.
If you have ticked any yellow or pink boxes you should progress to Step 2 of the
assessment. If you have only ticked the blue box then the patient is not currently at
risk and you should indicate this by ticking the ‘not currently at risk’ box and end the
assessment without progressing to Step 2.
2. Step 2 - Full Assessment: Complete for those potentially at risk as
determined by step 1
Step 2 consists of 8 sections which must be fully completed. The sections
comprise:
 Analysis of independent movement
 Sensory perception and response
 Current detailed skin assessment
 Previous pressure ulcer history
 Perfusion
 Nutrition
 Moisture
 Diabetes
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Step 2 – Full Assessment
Each section will give a range of possibilities as you would encounter in clinical
practice. It is important that if the patient does not have a problem with a particular
risk factor that this is indicated by ticking the ‘no problem’ item showing the
assessment has been undertaken. If you follow the flow of the sections from top to
bottom and left to right you are less likely to miss any sections out, though some
nurses have found it more practical to complete the visual skin inspection at the end
of the assessment.
2.1 Analysis of Independent Movement
This section was developed to capture information about the patients’ independent
movement. ‘Independent movement’ relates to movement that is undertaken by the
patient without the assistance of another person, i.e. it does not relate to the
movement encountered when nurses changes the patients’ position or turns the
patient.
.
Analysis of Independent Movement Item
A matrix is used to bring the frequency (i.e. how often) and extent (i.e. amount) of
movement together and each component has a range of options for you to consider
in light of patients movement pattern. When completing the frequency element the
nurse must consider what would be considered normal frequency of movement and
use her clinical judgement to inform which category the patient falls into.
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The 3 options relating to the extent of movement include ‘the patient doesn’t move’,
‘minor position changes’ and ‘major position changes’. Major position changes
could include the patient turning over in bed or standing up resulting in complete
pressure relief. Minor position changes could include the patient shifting their
position a little when in the bed or chair which may result in some but not complete
pressure relief. The patient doesn’t move item relates to no pressure relief of
pressure areas.
To complete the section the nurse must consider both frequency and extent of
independent movement in the matrix and tick the box where the two elements meet.
2.2 Sensory Perception and Response
This section relates to sensory perception and response and comprises just 2
items. It is a tick as applicable section and only one item applies, i.e. does the
patient have a problem with sensory perception and response or not.
Sensory Perception and Response Items
In your assessment you need to consider if the patient is unable to feel and/or
respond appropriately to discomfort from pressure. This item recognises that
patients will vary in terms of whether they can do both i.e. some patients will not be
able feel discomfort from pressure and so will not respond, while others may be
able to feel but not respond appropriately. Either of these scenarios indicates there
is a problem with sensory perception and could lead to reduced movement and
pressure relief. Factors that may (though not always) influence the patients’ ability
to feel and respond appropriately to discomfort from pressure, comprise underlying
medical conditions or treatments such as MS, CVA, head injury, spinal injury,
neuropathy, dementia, depression, epidural, anaesthetics and opiates. When
undertaking the assessment the nurse must consider whether the presence of such
factors affects the patients’ sensory perception.
2.3 Current Detailed Skin Assessment
Requires a visual skin inspection and assessment of skin sites listed in the table:
these include the most common pressure area skin sites though patients
sometimes develop pressure ulcers in other areas and there is space for ‘other’ skin
sites if required. This should be completed for all skin sites shown in the table.
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Current Detailed Skin Assessment Items
Each skin site should be inspected to assess if the skin is normal, vulnerable (red,
dry, moist, paper thin) or if there is an existing pressure ulcer (also see section 1.3).
The nurse should only choose one of these options for each skin site by ticking the
appropriate box. The category of any existing pressure ulcer is recorded in the pink
column. The abbreviated NPUAP/EPUAP Pressure Ulcer Classification System
(2009) is listed to help you and the full version of this will be available in the study
documentation.
2.4 Previous Pressure Ulcer History
The first 2 items relate to whether the patient has a reported history of a pressure
ulcer and is a tick as applicable section and only one item applies, i.e. the patient
either has a reported history of pressure ulcer or they don’t. Some patients may not
know and the patients’ clinical record could provide a good source of information.
Previous Pressure Ulcer History Items
If the patient has a reported history of pressure ulcer development the approximate
date, site and PU category should be recorded. The nurse should also indicate if a
scar is present which could be ascertained when undertaking the current detailed
skin assessment. This is important as scarring results in ongoing skin vulnerability
to pressure.
2.5 Perfusion
The perfusion section includes ‘no perfusion problems’ and 2 items relating to
conditions that affect the central circulation (shock, heart failure or hypotension) and
conditions that affect peripheral circulation (peripheral vascular/arterial disease).
These give some examples of conditions affecting perfusion, but this is not
exhaustive list and you may also consider other factors such as poor capillary refill.
If the patient doesn’t have any perfusion problems then the nurse should tick ‘no
problem’. If the patient does have perfusion problems the nurse should tick the all
applicable items as some patients’ may have both central and peripheral circulatory
problems.
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Perfusion Items
2.6 Nutrition
The nutrition items have been developed to capture patients with the varying
nutrition problems as you would encounter in clinical practice. It is important that
you consider all the items and tick all the item boxes that apply to your patient as
there may be more than one applicable item. However, if your patient has no
problems with nutrition you will only tick the applicable box.
Nutrition Items
The 4 items indicating there is a problem with nutrition comprise ‘unplanned weight
loss’, ‘poor nutritional intake’, ‘low BMI’ and high ‘BMI’. ‘Unplanned weight loss’
relates to weight loss that isn’t sought by the patient, i.e. they haven’t been trying to
lose weight and may have lost it due to illness. ‘Poor nutritional intake’ may be
relevant to patients with poor appetite who are not eating well. It may also be
applicable for those are nil by mouth and obtaining no other form of nutritional
support. Low BMI is less than 18.5 and high BMI is 30 or more.
2.7 Moisture
The moisture section comprises of 3 items and relates to moisture due to
perspiration, urine, faeces or exudates. This is a tick as applicable section and only
one item applies. The first item relates to patients’ without a moisture problem or
with occasional moisture which does not impact on the patients’ risk of pressure
ulcer development. The other items relate to the frequency of moisture with some
guidance of these parameters i.e. ‘frequent (2-4 times a day)’ and ‘constant’
meaning all of the time.
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2.8 Diabetes
This item relates to the presence of diabetes and gives 2 options. This is a tick as
applicable section and only one item applies.
Diabetes Items
3. Step 3 – Assessment Decision
Step 3, the assessment decision should be undertaken following step 2.
Each item in Step 2 is highlighted by a blue, yellow, orange or pink box. These
colours represent the importance of the risk factors as indicated by the level of
scientific or epidemiological evidence and/or the results of the consensus study:
 Pink box items indicate the patient has an existing pressure ulcer or scarring
from a previous pressure ulcer
 Orange box items indicate the presence of a key pressure ulcer risk factor
 Yellow box items indicate the presence of less influential pressure ulcer risk
factors (but still important in considering the overall risk profile of a patient
and in the delivery of appropriate preventative care)
 Blue box items indicate the absence of a risk factor.
When completing step 3 the nurse must carefully review the step 2 assessment to
decide whether the patient should be allocated to the secondary prevention and
treatment pathway, primary prevention pathway or the not currently at risk pathway.
This is facilitated by decision boxes in the PURPOSE T which indicate:
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 If any pink boxes are ticked it indicates that the patient has an existing
pressure ulcer or scarring from a previous pressure ulcer. The patient
should be allocated to the secondary prevention and treatment pathway
indicated by ticking the red box in the pathway.
 If any orange boxes (but no pink boxes) are ticked the patient does not have
a pressure ulcer but is at risk of pressure ulcer development and should be
allocated to the primary prevention pathway indicated by ticking the orange
box in the pathway.
 If only yellow or blue boxes are ticked the nurse must consider the risk
profile of the patient and use clinical judgement to determine whether the
patient is ‘at risk’ or ‘not currently at risk’. The nurse should consider the
number of yellow boxes ticked and the patients’ individual circumstance, for
example a patient may only have the presence of unplanned weight loss but
may be terminally ill and nearing the end of life where the general trajectory
of dependence will increase and the nurse may therefore consider the
patient to be ‘at risk’ or a young diabetic patient may have undergone acute
surgery but be recovering well where the general trajectory is increasing
independence so the nurse may consider the patient to be ‘not currently at
risk’, but would want to review this if the patients’ condition changed.
Patients with a number of yellow boxes ticked are more likely to be
considered ‘at risk’.
